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SUMMARY 
Single ventricle heart defects are a rare but serious form of congenital heart disease, 
which affect approximately 2000 children born in the United States each year. Staged 
surgical palliation, culminating with the “Fontan Procedure,” is typically required to 
achieve adequate supply of blood to both the pulmonary and systemic circulations while 
avoiding chronic ventricular volume overload. Thus, the surgery reroutes the systemic 
veins to the pulmonary arteries, forming a total cavopulmonary connection (TCPC), to 
completely bypass the right side of the heart and restore a series configuration to the 
cardiovascular circuits. Despite improved survival through this operative course in first 
weeks and years of life, Fontan patients are subjected gradual attrition and decreased 
life expectancy through a multitude of chronic complications. It is suspected that the 
adverse hemodynamics of this surgically altered physiology, including those specific to 
the surgical TCPC, play a role in determining patient outcome. However, the small and 
heterogeneous patient population has hindered decisive progress and there is still not a 
good understanding of the optimal care strategies on a patient-by-patient basis. 
In recent decades, advances in medical imaging and image-based computational fluid 
dynamics (CFD) have redefined the realm of possibility for studying complex biomedical 
phenomena. Combined, these methods provide the means to create and evaluate 
patient-specific models of a wide range of cardiovascular structures, including the TCPC, 
with potentially high fidelity. Results from these models can then be used for a wide 
array of different analyses, such as identifying regions of flow separation or stagnation, 
calculating hemodynamic power loss, or quantifying local flow distribution patterns.  
Through significant effort from numerous past investigators, a robust set of validated 
computational and image processing tools has been assembled, along with the largest 
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library of cardiac magnetic resonance (CMR) data of TCPC anatomy and flow. These 
tools are leveraged in this thesis to characterize the functional implications of TCPC 
power loss at an unprecedented scale: we report the largest CFD analysis of patient-
specific TCPC hemodynamics to date with particular focus on identifying functional 
correlates. Combining these data with imaging-based analysis of ventricle function, we 
directly compare the CFD-derived hemodynamics to the performance of the single 
ventricle for the first time. Motivated by the physiologic significance of these findings, the 
same patient-specific CFD framework is used for the translational application of 
prospective surgery planning for hemodynamic optimization, including the first 
implementation of a novel TCPC connection design hypothesized to uniquely streamline 
the energetic performance. We conclude with a first look at the longitudinal evolution of 
patient functional status to begin understanding how factors such as TCPC 
hemodynamics contribute to poor long-term performance in these patients.
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Chapter 1. INTRODUCTION 
 
Single ventricle heart defects are a rare but complex form of congenital heart disease in 
which there is only a single pumping chamber to move blood throughout the body. 
Surgery is often required to balance the distribution of blood between the pulmonary and 
systemic circuits, and it is typically done in stages to balance the need for ventricular 
unloading against the high vascular resistances in infants. In the first stage, a systemic-
to-pulmonary shunt is introduced in the form of either a modified Blalock-Taussig shunt 
(right sub-clavian artery to pulmonary artery (PA)), or a right ventricle to PA shunt 
(Sano). Here, the systemic and pulmonary circuits are in parallel with the single ventricle 
supplying blood flow to both. The second procedure removes the shunt and replaces it 
with a superior vena cava (SVC) to PA connection; hence, the pulmonary circuit is 
placed in series with the superior half of the systemic circuit, while the inferior vena cava 
(IVC) remains connected to the heart. Finally, the Fontan procedure completes the right 
heart bypass by routing the IVC blood flow to the pulmonary arteries, which places the 
systemic and pulmonary circuits completely in series. In the modern era, a modified 
version of Fontan’s procedure is typically performed, called the total cavopulmonary 
connection (TCPC). 
The Fontan procedure has generally low operative mortality; yet, it is still considered 
palliative treatment given the fact that life expectancy is greatly reduced for single 
ventricle patients, and there are numerous long-term complications that reduce quality of 
life as well. These complications are the result of a complex combination of both 
ventricular and vascular dysfunctions, and frequently include arrhythmias, systemic 
hypertension, liver disease, poor exercise capacity, and protein-losing enteropathy. In 
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some of these cases, there is evidence to suggest that the surgical design of the TCPC 
and its associated hemodynamics may play a role in the cause or exacerbation of the 
disease. Hence, the TCPC has been the focus of a large body of research over the past 
two decades with the general goal of minimizing energy losses and balancing the 
distribution of hepatic blood flow in the IVC to the PAs. 
Through multi-center collaborations with leading pediatric surgeons and cardiologists 
over the past 15+ years, the Cardiovascular Fluid Mechanics Laboratory at Georgia 
Tech has established an extensive set of validated engineering tools (e.g., medical 
image processing, computational fluid dynamics solvers) and a large library of cardiac 
magnetic resonance (CMR) data for single ventricle patients. Combined, these assets 
provide an unparalleled ability to study the patient-specific hemodynamics of the TCPC 
and identify generalizable trends. 
In this thesis, this study of TCPC hemodynamics is expanded to an unprecedented 
scale. Rather than focusing on small sample sizes and test cases as many prior studies 
have done, we consider a large patient cohort with the complementary goals of 
establishing population averages for parameters of interest; relating the local 
hemodynamics to broader functional end points, such as ventricular function; and begin 
to observe how this complex physiology changes through time. In short, we seek to 
make functional connections to TCPC hemodynamics to being to understand its broader 
role and contributions to Fontan failure. At the same time, several promising strategies 
for systematically improving these hemodynamics (i.e., patient-specific surgical planning 
and bifurcated Fontan connection designs) will be investigated to demonstrate the 
translational engineering possibilities for improving patient outcomes. 
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Chapter 2. SPECIFIC AIMS 
 
Every year, approximately 2000 children are born in the US with a series of congenital 
heart defects that result in the functional use of only one ventricle1. In this pathology, the 
single ventricle (SV) is both volume loaded (supplying both pulmonary and systemic 
circuits in parallel) and inefficient with respect to oxygen transport; severe cyanosis and 
death likely ensue if left untreated. A series of staged, palliative surgical procedures are 
the most common clinical course, resulting in the total cavopulmonary connection 
(TCPC), which connects the venae cavae to the pulmonary arteries. Thus, the right side 
of the heart is bypassed, and the sole driving pressure behind pulmonary flow is the 
systemic venous return. The development of these surgical techniques has greatly 
extended the life expectancy of SV patients and decreased early mortality; however, 
gradual attrition with chronic complications, including ventricular dysfunction and 
diminished exercise capacity are common. The incidence of these complications can vary 
widely, suggesting a patient-to-patient dependence on the severity of ventricular 
dysfunction, altered vascular hemodynamics (including TCPC-mediated inefficiency), or 
both. Many previous studies have considered the single ventricle and TCPC components 
in isolation; few have sought to understand their connection. The cardiac magnetic 
resonance (CMR) database of SV patients at Georgia Tech (GT), which includes anatomy 
and flow information for both the TCPC and SV, provides a unique opportunity to address 
this shortcoming. We propose a two-pronged approach: a) elucidate the relationship 
between TCPC hemodynamics and ventricular function; and b) explore the clinical 
potential of promising means to improve these hemodynamics. The hypothesis for this 
study is that high TCPC power losses adversely affect vascular hemodynamics  and 
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ventricular function in SV patients, with both deteriorating with time; surgical 
planning and novel surgical approaches may improve these hemodynamics.  
Aim 1- Characterize Fontan hemodynamics from a large patient series. Computational 
fluid dynamics (CFD) have become a popular standard means of evaluating local blood 
flow dynamics through patient-specific models of the TCPC. These studies, while valuable 
for exploring the connection between TCPC geometry and flows, are often hindered by 
small sample sizes making it difficult to identify population trends for important parameters 
of interest. In this aim, CFD from 100 patient-specific simulations will be analyzed to 
establish population baselines and relationships between variables, as well as make 
comparisons across anatomical templates. Metrics of interest include TCPC power loss 
(normalized as resistance and indexed energy dissipation), maximal pressure drop, 
hepatic flow distribution, cardiac index, and systemic venous flow rate. 
Aim 2- Relate single ventricle function to TCPC hemodynamics. Short axis cine CMR 
data of the SV will be used to assess global ventricular function (VF) for a 40 patient 
subset of the patients from SA1. Parameters of interest include cardiac index, end 
diastolic and systolic volumes, stroke volume, ejection fraction, peak filling and ejection 
rates, and time to peak filling rate. Three comparisons will be drawn. First, the mean 
values for the 40 patients will be compared to literature values to assess their functional 
status. Second, the sample will be sub-divided based on ventricular morphology and VF 
measures compared to identify potential biases within the single ventricle population. 
Finally, the VF for each patient will be related to their corresponding hemodynamic 
efficiency metrics. Thus, we will be able to explicitly identify the impact that the TCPC, 
and specifically the hydrodynamic power it dissipates, has on global measures of VF. 
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Aim 3- Investigate the utility and reliability of prospective Fontan surgical planning for a 
wide array of single ventricle patients Pre-operative modeling of the Fontan procedure is 
a novel means of improving TCPC hemodynamics by identifying the optimal surgical 
approach before the operation. Preliminary investigations in a limited patient population 
have been promising, but comparison to post-operative hemodynamic outcomes have 
been lacking. We present our continuing experience of prospective surgical planning in 
10 patients including expanded clinical indications and anatomical templates. Particular 
focus will be placed on the comparison to post-operative patient data to compare 
realized surgical outcomes to model predictions.  
Aim 4- Evaluate the clinical feasibility of the Fontan Y-Graft for improving TCPC 
hemodynamics 
An alternative proposal for systematically improving TCPC hemodynamics is the use of 
a bifurcated graft as the Fontan baffle. A total of 17 patients, including a consecutive 
series of 15 patients at a single center, have received such a connection, successfully 
demonstrating its technical feasibility. However, the associated hemodynamics of these 
in vivo Y-grafts must be evaluated to determine the actual effectiveness of their use. 
This objective will be accomplished in two parts: a) characterize the hemodynamics of 
the 15 patient series and compare them to population averages established in SA1; b) 
use the same virtual surgery paradigm as SA4 to create virtual extracardiac TCPC 
controls for 5 of the Y-graft patients to directly compare hemodynamic outcomes as a 
function of connection. 
Aim 5- Analyze and compare longitudinal changes in VF and TCPC hemodynamics. 
Since most post-Fontan complications develop over the course of several years, a single 
snapshot of a patient’s functional status cannot be expected to present the whole 
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picture. Rather, multiple time points’ worth of data must be collected to observe the 
progression and dynamic change of these parameters. Therefore, in addition to the 
cross-sectional analyses conducted in SA1 and SA2, we propose a preliminary analysis 
of longitudinal changes in a small patient subsection (N=15) for whom CMR evaluations 
are acquired at multiple time points. Such an analysis will begin to elucidate the 
mechanisms of patient deterioration and failure. 
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Chapter 3.  BACKGROUND AND SIGNIFICANCE 
3.1 Normal Cardiovascular Anatomy and Function 
3.1.1 The Human Circulatory System 
The cardiovascular system is the primary means of inter-organ transport in human 
physiology. Among its many functions, it serves as the vehicle for gas exchange, 
delivering oxygen to cells and removing carbon dioxide; and it is the means by which 
nutrients from food are distributed and waste products removed.  
The driving force behind this system is the heart: a muscular structure divided into four 
functional chambers, two ventricles and two atria. The ventricles serve as the contractile 
blood pumps; whereas the atria serve as ventricular antechambers, and are integral in 
both the electrical conduction pathways of the heart and pumping function. As shown in 
Figure 3.1, the heart operates at the center of two distinct circulatory systems: the 
systemic and pulmonary circulations. Beginning in the right ventricle (RV), blood is 
pumped through the pulmonic valve into the pulmonary artery. Arteries are some of the 
largest blood vessels in the body serving the primary function of carrying blood away 
from the heart to the rest of the body. The pulmonary arteries carry blood from the RV to 
the lungs where, after successive vascular branching to a wide network of smaller 
arterioles and eventually capillaries, gas exchange occurs to increase blood oxygen 
content and extract carbon dioxide waste. The oxygenated blood is collected from the 
lungs by the venules, which eventually come together to form much larger veins. Veins 
are the vessels that return blood from the body tissues to the heart. In this case, the 
pulmonary veins deliver the blood into the left atrium before it passes through the mitral 
valve into the left ventricle (LV). The LV is the most muscular of the heart chambers 
since it must generate sufficient pressure to drive blood flow to the rest of the body 
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tissues (i.e., the systemic circulation). Blood from the LV passes through the aortic valve 
into the aorta, the body’s largest artery, before following a similar branching pathway as 
the pulmonary circuit: arteries-arterioles-capillaries. In the capillaries, the oxygen 
absorbed in the lungs is delivered to the local tissues to facilitate cellular respiration, and 
respiratory by-products (e.g., carbon dioxide) are removed. From there, blood returns 
through the venules-veins-vena cava to the right atrium, through the tricuspid valve and 
back to the RV, thus completing the circuit. In a healthy adult circulation, the ventricles 
contract approximately 70-80 times and circulate 5 liters of blood per minute. Figure 3.2 
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 Figure 3.1 Schematic of Human cardiovascular system comprised primarily of the heart 
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Figure 3.2 Cardiac anatomy inclusive of two ventricles, two atria, four valves, the aorta, 
pulmonary arteries, and veins. 
 
 
3.1.2 Ventricular Function 
The cardiac cycle can be broadly divided into two phases: systole (i.e., contraction) and 
diastole (i.e., relaxation) (see Figure 3.3). At the onset of systole, pressure increases 
within the ventricle and quickly surpasses the pressure of the atrium, closing the 
atrioventricular valve. A period of isovolumic contraction ensues in which ventricular 
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pressure continues to rise at a constant volume. Once the pressure surpasses that of 
the aorta (in the case of the LV), the aortic valve opens and blood is ejected from the 
ventricle into the aorta. The valve closes once ventricular pressure falls below that of the 
aorta, signaling the end of ventricular systole and the beginning of diastole. The ventricle 
relaxes isovolumically until the mitral valve opens and filling occurs. Near the end of 
diastole, the atrium contracts to force more blood into the passively filled ventricle just 




Figure 3.3 Ventricular Pressure-Volume Relationship over the cardiac cycle. Cycle is 
divided into systole and diastole by diagonal dashed line; opening and closing of valves is 
highlighted by blue arrows. 
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This function of the ventricles is highly specialized and responsive to the dynamic 
pressure and volume loads it encounters in the course of normal function. In particular, it 
is important to highlight three particular determining factors that help to govern cardiac 
functional output: preload, afterload, and contractility.  
Preload is the stretching force imparted on the cardiac muscle cells in the ‘relaxed’ state 
prior to systolic contraction. It is related to the volume and/or pressure of blood 
contained within the ventricle (relative to its native size) at the end of diastole. 
Afterload is the force opposing muscle cell shortening during systolic contraction. It is 
related to the resistance of downstream vasculature against which the heart is pumping. 
Contractility is the inherent intensity of the contractile force the heart is capable of 
generating (independent of preload or afterload) as a function of the underlying muscle 
fiber structure. 
Experimental muscle preparations2 have consistently demonstrated that these forces 
have direct effects on the force generation and contractile velocity of the heart. For 
example, with increasing afterload, the tension placed on the cardiac muscle cells 
increases; however, the extent and velocity of muscle fiber shortening decreases (Figure 
3.4). This inverse interplay is the so-called force-velocity relationship. Similarly, 
increasing the preload on the ventricle has a direct relationship with the force of muscle 
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Figure 3.4 Plots demonstrating the force-velocity relationships with varying Preload 
[middle] and Inotropy [bottom]. Velocity of shortening decreasing with increasing 
afterload (force), but increases in preload and inotropy increase the velocity for a given 
force. (Image credit- cvphysiology.com) 
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Figure 3.5 Frank-Starling curves relating cardiac output with preload with the effects of 
changing myocardial contractility and afterload. Cardiac output rises (falls) with 
increasing contractility (afterload) at a given preload condition. 
 
 
In recent years, the study of diastolic function has grown in popularity and importance 
given appreciation for its role in congestive heart failure3. Normal diastolic function can 
be sub-divided into four phases: 1) isovolumic relaxation, 2) early filling (~80% of filling 
volume4), 3) diastasis (~5% of filling), and 4) atrial systole (~15% of filling). The process 
of ventricular relaxation (particularly the isovolumic stage) is a combination of active and 
passive processes4, with the ultimate efficiency and effectiveness of ventricular filling 
dependent on mechanical properties, such as compliance, stiffness, and the end-
diastolic pressure-volume relationship.  
In summary, the biventricular heart is a highly specialized and functionally optimized 
muscle that has been evolutionally optimized, both in filling and ejecting, to respond to 
changing loads so as to maintain a stable homeostatic cardiovascular baseline.  
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3.2 Congenital Heart Disease 
Congenital Heart Disease (CHD) is the generic term used to describe anatomical 
abnormalities of the heart present at birth. These defects could be as simple as an atrial 
septal defect, or a complex combination of multiple defects of both the ventricles, valves, 
and the great arteries. Approximately 8-10 per 1,000 births in the United States annually 
have some form of CHD5, 6. Table 3.1 provides estimates for the incidence of some of 
the more common forms of CHD6. 
 
 
Table 3.1 Incidence of various CHD per 1,000 live births 
CHD Incidence 
Ventricular Septal Defect 3.6 
Patent Ductus Arteriosus 0.8 
Atrial Septal Defect 0.9 
Bicuspid Aortic Valve 13.6 
Pulmonary Stenosis 0.7 
Tetralogy of Fallot 0.4 
Hyploplastic Left Heart 0.3 
All cyanotic 1.4 
 
 
Some of the most severe forms of CHD are classified as ‘cyanotic’, which means that 
the delivery of concentrated, oxygen-rich blood to the systemic circulation is 
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compromised. For example, in Tetralogy of Fallot the combination of pulmonary 
stenosis, a ventricular septal defect, a mal-positioned aortic arch (over-riding the septal 
defect) and right ventricular hypertrophy leads to significant mixing of the oxygen-rich 
blood in the left ventricle (returning from the pulmonary circulation) and oxygen-poor 
blood from the right ventricle (returning from the systemic circulation). As a result, 
patients with cyanotic defects are typically born with blue-tinged skin (the color of de-
oxygenated blood) indicative of poor blood oxygen saturation in their extremities. These 
defects often require surgery; in fact, more than 50% of children born with CHD require 
at least one invasive surgery during their lifetime7. The success of these treatment 
strategies has gradually improved over the past decades as evidenced by the fact that 
there are currently more adults than children living with CHD8, but the long-term 
prognosis is still far from ideal in many cases. Cardiac-related morality 25 years post-
operatively has been reported to be as high as 17% for certain defects9. 
 
3.3 Single Ventricle Defects 
An important sub-class of CHD is characterized by the functional use of only a single 
ventricular pumping chamber, and are thus called single ventricle heart defects (SVHD). 
These defects occur in 7.7% of CHD1. SVHD is associated with an extremely high 
mortality rate without surgical intervention owing to: 1) hypoxic mixing of oxygenated and 
deoxygenated blood in the single ventricle, and 2) a likely imbalance of blood delivered 
to the systemic and pulmonary circuits (Figure 3.6). While the ultimate goal of surgical 
care is relatively consistent across SVHD (i.e., the restoration of a series configuration to 
the circulatory systems), this objective is often achieved in stages, which are very 
dependent on the underlying anatomic characteristics of the individual patient. The 
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following sections will therefore highlight some of the more common forms of SVHD and 
the common surgical treatment strategies. 
3.3.1 Hypoplastic Left Heart Syndrome (HLHS; Figure 3.7) 
HLHS is among the more common forms of SVHD and it is characterized by the severe 
under-development of left-sided heart structures (aorta, ventricle, etc), creating a 
significant deficiency of a systemic flow source after birth. In the neonatal period, the 
ductus arteriosus is medically kept patent to allow systemic flow to be shunted from right 
to left via the RV and pulmonary artery. However, within the first days to weeks of life, 




Figure 3.6 Electrical circuit analog diagrams of normal (left) and single ventricle (right) 
cardiovascular systems. For single ventricles, the pulmonary and systemic circuits are in 
parallel with each other rather than a healthy series circuit. 
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Figure 3.7 Anatomy of Hypoplastic left heart syndrome. (Image credit- Mayo Foundation) 
  
 
3.3.2 Tricuspid Atresia (TA; Figure 3.8) 
In this disease, the right atrioventricular valve (Tricuspid valve) is underdeveloped or 
absent, leading to an under-development of right-sided ventricular structures. Pulmonary 
blood flow at birth therefore depends on the presence of secondary defects (atrial and 
ventricular septal defects) to channel systemic venous flow from the right atrium to the 
pulmonary artery. The early palliative course for TA and other similar defects depends 
on numerous anatomic considerations, particularly the relative size of the great arteries 
and the ratio of pulmonary to systemic flow (Qp/Qs). For example, if Qp/Qs is too high a 
PA band may be introduced to restrict the pulmonary artery size and promote flow to the 
aorta. On the opposite extreme, if the PA is under-developed a systemic-to-pulmonary 
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shunt (as in HLHS) may be required. If Qp/Qs is naturally maintained in a healthy range, 




Figure 3.8 Anatomy of Tricuspid Atresia. 
 
 
3.3.3 The Norwood Procedure 
The Norwood involves (in many cases) a reconstruction of the hypoplastic aorta with the 
pulmonary artery (the Damus-Kaye-Stansel procedure) and a systemic to pulmonary 
shunt. If necessary, this procedure is performed within the first days or weeks of life 
(before the ductus arteriosus closes) to ensure adequate systemic and pulmonary blood 
flow. In the modern era, this shunt has taken the form of either the modified Blalock-
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Taussig shunt (BTS; right subclavian artery to right pulmonary artery connection)10, or 
the Sano procedure (right ventricle to pulmonary artery connection)11. The relative 
superiority between these options is a source of intense scrutiny since the Norwood 
procedure has among the highest mortality rates among common congenital heart 
procedures12. Comparative outcome results have been inconclusive: the first 
randomized, controlled study in pediatric cardiac surgery showed no difference in 
transplant-free survival after 12 months. 
3.3.4 The Glenn Procedure 
At 3 to 6 months of age, once pulmonary vasculature has developed and dropped 
vascular resistance from its high neonatal levels, the stage II procedure is performed. 
Here, the systemic to pulmonary shunt is removed and replaced by routing flow from the 
superior vena cava (SVC) to the pulmonary arteries (PA). The original Glenn procedure 
was a unidirectional connection of the SVC to the right PA; however, this has largely 
been replaced by several ‘bidirectional’ connection options: an SVC-PA end-to-side 
anastomosis (the Bidirectional Glenn; Figure 3.9 (left)) or a side-to-side anastomosis of 
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Figure 3.9 Varying surgical approaches to superior cavopulmonary anastomosis. Left: 
Bidirectional Glenn connection (end-to-side anastomosis of SVC to RPA). Right: Hemi-
Fontan connection (side-to-side connection of right atrium/SVC to pulmonary arteries). 
 
 
3.4 The Fontan Procedure 
First proposed in 1971, the Fontan procedure completely restores a series circuit 
configuration to the cardiovascular system by routing systemic venous flow into the 
pulmonary arteries13. The connection proposed by Fontan and Baudet called for 
separate unions of the SVC to RPA and the IVC (through the right atrium with implanted 
valve conduits) to the LPA (Figure 3.10a). Two years later, Kreutzer et al. proposed a 
valveless atrio-pulmonary connection in which the SVC remained natively connected to 
the right atrium, while the atrial appendage was connected to the pulmonary arteries14 
(Figure 3.10b). The atriopulmonary connection (APC) remained the standard for this 
operation for almost 20 years, despite noted issues of atrial thrombus and arrhythmias15, 
16, among other issues. In 1988, de Leval et al. proposed the total cavopulmonary 
connection (TCPC) on the basis of hydrodynamic efficiency compared to dilated APCs17 
(Figure 3.10c). The TCPC was shown to decrease the incidence of arrhythmias 
compared to APC18, and has since become the connection of choice for SVHD. 
 - 22 - 
 
Figure 3.10 The Evolution of the Fontan procedure. a) Unidirectional, valved end-to-end 
VC-PA connections originally proposed by Fontan and Baudet. b) Valveless 
atriopulmonary connection proposed by Kreutzer et al. c) Total cavopulmonary connection 
proposed by de Leval et al. which is the current standard. 
 
 
The actual connection described by de Leval was an intra-atrial lateral wall tunnel 
(Figure 3.11a) in which a synthetic patch was placed inside the atrium to direct IVC 
blood flow through the atrium to the pulmonary arteries (through the enlarged SVC-PA 
junction). An alternative TCPC design was proposed by Marcelletti et al.19 that instead 
routed a synthetic baffle around the atrium from the IVC directly to the RPA (i.e., an 
extracardiac conduit; Figure 3.11b). The relative benefits of intra-atrial vs. extracardiac 
connection approaches are still the subject of debate and research in the present day; 
often the decision is based on patient size at the time of Fontan (since the lateral tunnel 
is believed to be more accommodating for growth) and surgeon preference. Perhaps 
one of the most compelling arguments for one connection over the other came from a 
recent review of over 2700 Fontan patients in the Society of Thoracic Surgeons 
Congenital Heart Surgery database that found the rate of in hospital death or Fontan 
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revision/takedown to be low (2.7%), but patients with an extracardiac connection had an 
adjusted odds ratio of 2.2820. 
 
 
Figure 3.11 Two primary methods of total cavopulmonary connection: a) intra-atrial lateral 
tunnel; b) extracardiac connection. (Image courtesy Children’s Hospital Boston). 
 
 
It is important to point out that the Fontan procedure generally requires the surgical 
staging described in §3.3.3 and §3.3.4 (as opposed to a single operation at birth) 
because of high pulmonary vascular resistance (PVR) in the neonate. Since the lungs do 
not function in utero, PVR is very high at birth and decreases as the lungs develop. High 
PVR creates a preload limitation in the Fontan circulation, so neonatal resistances are 
not suitable for the Fontan and surgical staging is required. The use of mechanical 
circulatory support has been proposed as an alternative means to overcome high 
neonatal PVR21, but such technology is not available. 
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3.5 Clinical Experience with the TCPC 
Owing to significant advances in patient care and management, particularly with the 
development of effective surgical staging techniques, the short-term operative outcomes 
associated with the Fontan procedure are generally favorable. Patients are reaching 
adulthood with increasing frequency and with acceptable quality of life22, 23. Some acute 
issues may persist, such as sudden increases in central venous pressure leading to 
ascites, pleural effusions, decreased pulmonary compliance and increased pulmonary 
vascular resistance. Fontan takedown is one of limited options available in such 
instances24, but is associated with drastically increased mortality25.  
Conversely, long-term complications and chronic failure are more commonly noted26-29. 
Among the most commonly cited chronic complications are ventricular dysfunction (both 
systolic and diastolic), atrial arrhythmias, liver fibrosis and dysfunction, atrioventricular 
valve regurgitation, pulmonary arteriovenous malformations (PAVMs), diminished 
exercise capacity, protein losing enteropathy (PLE), somatic growth retardation, 
thrombotic complications, and poor neurodevelopmental outcomes27, 30, 31. While many, if 
not all, of these issues are complex and multi-factorial in nature, they primarily reflect 
dysfunction of both the ventricle and the vasculature (inclusive of the TCPC). 
3.5.1 Role of the Single Ventricle 
As defects in the ventricle are the root cause of disease, it should come as no surprise 
that the function of the ventricle is integral to the long-term health and functional status 
of patients. It has been the focus of a large body of research to characterize SV function 
and understand the risk factors of poor outcomes. Kirklin et al. identified ventricular 
hypertrophy as a risk factor for death following the Fontan procedure32. Fogel et al. 
found that ventricular mass, volume, and contractile “vigor” decreased two years 
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following Fontan33. Cavalcanti et al. compared functionally healthy Fontans to failing 
patients and found a 51% decrease in cardiac index34. Eicken et al. reported a significant 
drop in ejection fraction (EF), a load dependent measure of systolic function, in patients 
10 years post-Fontan (49.3% vs. 64.8% in a control group)35 and thus the gradual 
development of heart failure is expected over time36.  
At the same time, appreciation for the incidence and importance of diastolic dysfunction 
is quickly growing. Anderson et al. reported abnormal diastolic function in 72% of a 500 
patient cohort30. Cheung et al. reported ventricular relaxation times via echocardiography 
that were consistent with reductions in ventricular compliance37. 
The fact is that the physiology of SVHD is drastically altered from normal biventricular 
hemodynamics: the single ventricle must pump against increased afterload38 (the 
systemic and pulmonary circuits in series) with decreased preload39 (pulmonary driving 
pressure is decreased), which will inherently impair cardiac function (by the Frank-
Starling relationships). Such afterload and preload reductions were noted by Szabo et al. 
in a canine model40. Furthermore, in many cases the ventricle itself may not even be 
optimally suited to handle systemic loads41, particularly if it is a morphologically right 
ventricle. After years of working against these adverse conditions, it is perhaps not 
surprising that gradual attrition is the norm. 
The ventricle may also have an important role to play in exercise intolerance. Work by 
Senzaki et al. showed a limited inotropic response and worsening diastolic filling with 
increased HR39. Hence, in response to exercise physiology, single ventricles have 
limited capability to improve stroke volume and must primarily meet the demands for 
increased cardiac output through higher heart rates.  
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3.5.2 Role of the Vasculature 
To provide a theoretical framework for this discussion, it is first useful to review Guyton’s 
isolated venous theory42. This theory says that the vascular compliance elements play 
the key role in mediating ventricular filling and cardiac output by providing the elastic 
potential energy needed to drive blood flow back to the heart. As such, Guyton 
demonstrated that changes to venous resistance had a more primary impact on cardiac 
output than arterial resistance because the venous resistance falls downstream of the 
vascular compliance. These observations are particularly relevant to single ventricle 
physiology (systemic and pulmonary circuits in series) because the systemic venous 
resistance, the TCPC, and the pulmonary vascular resistance are all downstream of the 
systemic vascular compliance. Thus, the sum of these resistive elements is the mediator 
of central venous pressure and the filling and output of the single ventricle.  
Said another way, the differential of the central venous pressure (CVP) and the atrium is 
the sole driving force to move blood from the systemic veins back to the heart; any high 
resistors in that pathway will directly decrease the flow that can be achieved given that 
driving force. To maintain a reasonable cardiac output, chronic compliance remodeling 
(up to 400% decrease) occurs, which drastically increases CVP43, 44. de Leval best 
described this configuration as paradoxical: chronic systemic hypertension coupled with 
chronic pulmonary hypotension45. He also noted that the poor ventricular filling 
characteristics that result from this low driving pressure create a chronic preload-limited 
state analogous to mitral stenosis. In such an analogy, the degree of elevated PVR 
and/or TCPC resistance equates to the severity of the stenosis.  
The chronic high CVP/low output state of the Fontan circuit may also explain the 
incidence of gastro-intestinal diseases, such as PLE and cirrhosis46-48. Vasodilating 
agents, such as sildenafil, have achieved some success in relieving these symptoms of 
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liver failure49-51, but larger studies are needed to determine if it can effectively combat the 
50% mortality rate within 5 years of PLE diagnosis52.  
3.5.3 Role of the TCPC 
The importance of the TCPC in single ventricle hemodynamics is perhaps less 
straightforward and is still a source of controversy. It is important to recognize that the 
TCPC sits at a critical juncture of the single ventricle circuit at the transition of the 
systemic and pulmonary circuits such that all pulmonary flow (less collateral 
contributions) must first pass through the TCPC. Early experimental studies using 
idealized models of the TCPC demonstrated that the collision of caval flows at the 
junction was not optimally efficient for passive transport53, and a large body of research 
has since sought better alternatives54.  
Using a mathematical model of the Fontan circulation, Sundareswaran et al predicted 
decreasing cardiac output with physiologic increases in TCPC resistance55. Furthermore, 
Sundareswaran et al. and Whitehead et al. showed how TCPC-mediated hemodynamic 
losses can become exacerbated with higher flow/simulated exercise conditions55, 56. 
Conversely, the other vascular resistances (SVR, PVR) typically decrease in response to 
physiologic exercise demands to improve ventricular filling and ejection characteristics57. 
Thus, the relative importance of the TCPC is perhaps accentuated under such 
conditions.  
Finally, the TCPC has also been implicated for involvement in the development of 
pulmonary arteriovenous malformations (PAVM). These malformations are arterial-to-
venous shunts that may develop in the pulmonary vasculature creating progressive 
hypoxemia as increasing blood volume bypasses blood oxygenation pathways in the 
lungs. Although the exact mechanism is unknown, it is widely believed that liver-derived 
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proteins present in the hepatic venous blood can prevent or counter-act their formation58-
60. Duncan et al. reported that PAVMs develop in as many as 25% of patients following 
the Glenn procedure58, presumably because the hepatic venous flow (along with the rest 
of the IVC flow) is still connected to the ventricle and does not pass through the lungs. 
Post-Fontan, the incidence of PAVMs drops off significantly; however, sub-optimal (i.e., 
unilateral) pulmonary flow distribution through the Fontan baffle has been shown to 
foster PAVM development in the contra-lateral lung61. At particular risk for such a 
scenario are patients with interruption of the IVC pathway62, in which an enlarged azygos 
vein carries the majority of inferior venous blood flow to the SVC, and the hepatic veins 
natively drain into the atrium separately. With drastically decreased volume and flow 
momentum through the hepatic venous Fontan baffle, it can be particularly susceptible 
to poor distribution outcomes and is extremely sensitive to surgical positioning. 
In summary, the Fontan procedure and its evolution over the past decades have given 
life to many patients with complex CHD who previously had little hope for survival. Yet, 
Fontan physiology is an imperfect palliation that drastically alters ventricular loads and 
vascular hemodynamics and so puts these patients on a course of gradual functional 
deterioration and attrition. While the factors governing Fontan failure are complex and 
multi-factorial, isolating and understanding the contributions of the individual players (the 
ventricle, the vascular system, and the TCPC) may provide novel insights that empower 
caregivers to combat failure.  
3.6 Single Ventricle Function 
Generally speaking, single ventricle function (VF) can be characterized by both systolic 
and diastolic dysfunction, owing in part to altered venous and arterial hemodynamics 
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and contractile abnormalities. These factors will be investigated in more detail in the 
following sections.  
3.6.1 Systolic Dysfunction 
Traditional measures of ventricular systolic function (i.e., cardiac index, ejection fraction) 
are generally reported to be lower in Fontan patients compared to normal, age-matched 
controls33, 63-65. Akagi et al. reported decreased cardiac index compared to normals64. On 
average, cardiac index in single ventricles is approximately 70% of normal values66. 
Parikh et al used radionuclide angiography in 15 patients going from BT-shunt to 
atriopulmonary connections and found that ejection fraction (EF) decreased from 52% to 
39% over one year after surgery65. Similarly, Akagi et al used radionuclide angiography 
and found lower EF post-Fontan (50%) compared to controls (60%)64. However, in a 
contemporary cross-sectional study, EF was found to be normal in 73% of patients30, 
perhaps reflective of improvements made in patient management over the past 20 years. 
Yet, it is worth noting that a difference in systolic function was seen in the more recent 
work based on ventricular morphology, with single LVs having a better function than 
single RVs30. Also, myocardial fibrosis, occurring in approximately 30% of patients, has 
been associated with decreased ejection fraction and may be a discriminating factor in 
these differing results67.  
There is a fair amount of uncertainty regarding the source of this systolic dysfunction, 
and it is likely the result of a combination of multiple altered states. While many early 
studies presumed that decreases in functional metrics were indicative of inherent 
contractile shortcomings (which still may be true for single LV vs. single RV 
considerations), their dependence on ventricular loading conditions is an important 
confounder. For example, Senzaki et al invasively measured vascular impedance in 
Fontan patients compared to BTS and normals38, and found that elevated levels of 
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vascular impedance (i.e., afterload) caused by low frequency wave reflections were 
significantly correlated with decreased cardiac index. At the same time, Senzaki et al. 
used β-adrenergic stimulation to test the inotropic response of the single ventricle, and 
the expected (albeit limited) improvement in cardiac index was observed. Hence, the 
underlying contractile capabilities of the ventricle remain intact, but there was lack of 
sufficient reserve to augment output substantially, which is consistent with the fact that 
ventricular filling is more important than myocardial contractility in augmenting stroke 
volume68.  
Yet, it has been pointed out that a decrease in ventricular afterload in single ventricles 
(unlike in the normal circulation) will not increase cardiac output66. Instead, systemic 
resistance tends to increase to maintain blood pressure in chronically low output 
states40, suggesting that afterload may be a result, not a cause, of diminished cardiac 
index in single ventricles66. 
3.6.2 Diastolic Dysfunction 
In contrast to the 73% of patients with preserved EF, Anderson et al reported that 
diastolic function was abnormal in 72% of patients30. While that prevalence was an 
unexpected finding, it builds on a large body of literature demonstrating delayed69, 70 or 
decreased peak rates63, 64 of ventricular filling. Peak filling rates have been correlated 
with ventricular relaxation rate and atrial pressure at the onset of atrioventricular valve 
flow71; contributions of wall thickness and elastic properties (perhaps ‘supranormal’ 
compliance69), preload, and other extrinsic factors have also been suggested4. Again, 
progressive development of myocardial fibrosis, which has been correlated with 
increasing end diastolic volume, may play an important role in this process67. These are 
generally summarized as ‘impaired relaxation.’  
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Here again, the significance of these findings is controversial. Penny et al. suggested 
there may be a significant impact of this delayed filling phenomenon on ventricular filling 
capacity72. Senzaki et al. instead claim their results (from primarily left morphological 
ventricles) show such impairment has minimal impact on overall diastolic filling at rest39. 
Finally, Gewillig et al. argue that ventricular preload may be the cause of abnormal 
diastolic function and the primary mediator of cardiac output in single ventricles66, which 
suggests that Fontan failure may be as much a disease of the vasculature as of the 
ventricle itself. 
 
3.7 TCPC Hemodynamic Investigations 
Through the years, significant insights into the local fluid dynamics within the TCPC have 
been gained through combined use of experimental, computational, and clinical imaging 
methodologies. The primary focus of these works is traditionally related to the energy 
efficiency of the observed flow fields. The following sections provide a brief overview of 
some of the major contributions. 
3.7.1 In Vitro and Computational Models 
The study that arguably fathered this field of research was the groundbreaking work of 
de Leval et al.17 in which experimental investigations demonstrated the efficiency 
benefits of flow streamlining through straight pipes. This observation served as a primary 
motivator for the proposed switch from the dilated atriopulmonary connections to the 
TCPC. Many subsequent studies similarly used very simplistic models of the connection 
to isolate the impact of key geometric factors. Khunatorn et al conducted an in depth 
analysis of CFD flow fields and pointed to the secondary flow structures in the PAs as an 
important source of energy dissipation73. Sharma et al. experimentally demonstrated 
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improved efficiency through the introduction of a caval offset (i.e., lateral displacement of 
the central axes of the SVC and Fontan baffle; Figure 3.12)53. Gerdes et al. showed 
similar effects with the introduction of baffle curvature74, while Ensley et al. advocated for 
flaring of the caval connections to the PA junction75. DeGroff et al showed that even with 
simplified models and laminar flow, the presence of flow instabilities and secondary flow 
structures had important implications for the results of computational flow simulations 
and their agreement with experimental measures76. Wang et al later confirmed the 
presence of such instabilities in more complex, patient-specific models as well77. These 
early studies provided a valuable basis for understanding the connection dynamics; 
however, it was soon realized that simplified, uniform models did not sufficiently capture 
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Figure 3.12 Experimental comparison (via particle tracking (top) and particle image 
velocimetry vectors (bottom)) of idealized TCPC models with no offset (left) and a 1 
diameter caval offset (right). Introduction of caval offset helps avoid flow collision to 
improve hemodynamic efficiency. 
 
 
Since that time, emphasis has shifted significantly toward the use of patient-specific 
geometries and computational modeling. Subsequent studies continued to reveal tight 
coupling between the geometric design of the connection and the resulting fluid 
mechanics81, 82. Through analyses of individual case studies or small patient samples, 
researchers investigated the effects of factors such as simulating LPA angioplasty83, 
centrally positioning the Fontan between bilateral SVCs81, and the results of different 
connections between the Fontan baffle and PAs84.  
Additionally, the relative ease of increased sample sizes afforded by CFD modeling 
allowed for broader physiologic insights to be derived. Whitehead et al. used CFD in 10 
patients to demonstrate the non-linear increase in TCPC power loss that occurs with 
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simulated exercise flow conditions (Figure 3.13)56. Marsden et al. made similar 
observations in two patient-specific models with the inclusion of respiratory effects on 
time-varying flow conditions85. Sundareswaran et al showed potential linkages between 
CFD-derived power loss and cardiac output in 16 patients55.  
Other groups, such as Throckmorton et al86, Rodefeld et al87, and Lacour-Gayet et al88 
have leveraged the capabilities of CFD modeling to investigate mechanical support 
options for the single ventricle circulation. 
3.7.2 Phase Contrast Cardiac Magnetic Resonance 
A concurrent development in Fontan flow visualization and quantitative analysis is the 
increasing capabilities of medical imaging, particularly cardiac magnetic resonance 
(CMR), for making direct measurements of in vivo flow conditions. For CMR, such 
capabilities are achieved through the use of phase contrast sequencing, which are 
described in more detail in §4.1. Such methods are widely used to acquire cross-
sectional velocity information in specific blood vessels to inform computational boundary 
conditions; however, the images themselves can provide valuable hemodynamic insight. 
Be’eri et al. used planar, mutli-dimensional PC MRI to compare APC and TCPCs89. They 
reported regions of flow stagnation, reversal and recirculation in APC, while TCPC flows 
were less variable and more unidirectional. Conversely, Sharma et al. reported disturbed 
flow in the Fontan baffle90. 
Expansion of these imaging techniques into 4D provides improved visualization and 
analysis capabilities, as shown by more recent studies. Markl et al. demonstrated the 
feasibility of these volumetric techniques in 4 patients with an extracardiac connection91. 
Sundareswaran et al. used a novel interpolation scheme coupled with a stack of 4D 
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velocity slices in 16 patients to visualize differences between extra-cardiac and lateral 
tunnel connections (Figure 3.14)92. 
3.7.3 Lumped Parameter Modeling 
Lumped parameter modeling has proved to be an effective tool for studying Fontan 
physiology. The relative simplicity of lower order modeling allows for the inclusion of a 
broader scope of the domain (i.e., modeling the entire cardiovascular system rather than 
just the local TCPC district). Such an approach has been used for a wide range of 
research objectives from prescribing TCPC boundary conditions93-95, studying the effect 
of mechanical assist devices96, 97, or relating TCPC resistance to broader physiology55. 
Some of these represent landmark studies that have provided key insights and 
motivation into ongoing work. The study by Pekkan et al was the first to demonstrate that 
a cavopulmonary pressure rise of 3-5 mmHg through the use of a mechanical assist 
device would be effective in reversing the Fontan paradox96. Many investigators have 
used this insight to motivate investigations into low pressure/high volume pumps for the 
specific application of single ventricles, as opposed to the high pressure design of 
traditional left ventricular assist devices. The study by Sundareswaran et al predicted 
that increasing TCPC resistance would have deleterious effects on single ventricle loads 
and function, such as increased afterload and central venous pressure, and decreased 
preload and cardiac output55. These findings served as important motivation for an 
ongoing NIH-funded study into hemodynamics and patient outcomes (HL098252), as 
well as much of the work presented in this thesis. 
 
 
 - 36 - 
 
Figure 3.13 Power loss increases non-linearly with increasing bulk flow rate (left) owing to 
increasing viscous energy dissipation (right), particularly close the walls. (Images adapted 
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Figure 3.14 Representative velocity streamlines reconstructed from 4D PC MRI in patient-
specific lateral tunnel (left) and extracardiac (right) connections. Qualitative differences in 






3.7.4 Prospective Surgical Modeling 
The unifying theme of many of these previous studies is the search for an ‘optimal’ 
TCPC geometry. However, patient-specific analyses have conclusively shown that a 
single, broadly applicable optimal surgical approach is not possible. Instead, the use of 
CFD methods coupled with anatomical editing capabilities affords the opportunity to 
prospectively indentify the optimal surgical approach on a case-by-case, patient-specific 
basis. 
Surgical planning, by this definition, is the combination of 3D medical imaging, applied 
computer vision and computer-aided design capabilities to mimic and/or provide visual 
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guidance to surgical procedures. Since the first mention of such ideas almost 30 years 
ago98, surgical planning is now a routine part of interventions in the fields of 
neurosurgery99, 100, spine surgery101, abdominal interventions102, catheterization103, and 
orthopedics104. Translating this paradigm to cardiovascular interventions provides the 
benefits of not only these enhanced 3D visualization abilities, but also the potential to 
interface with physics-driven computational solvers (e.g., CFD) to predict the 
hemodynamic outcomes associated with a given interventional approach.  
Application of these principles to Fontan surgery began as theoretical exercises. Pekkan 
et al. showed a 50% improvement in energy efficiency through the virtual angioplasty of 
a diffuse left pulmonary artery stenosis in a patient-specific TCPC model83. de Zélicourt 
showed a 7% decrease in power loss and alleviation of flow stasis in a bilateral SVC 
TCPC by centrally positioning the Fontan baffle between the superior connections81. 
These studies provided valuable and useful insights, but did not tap into the fundamental 
promise of these techniques: to provide prospective clinical information. 
A major turning point toward the use of surgical planning tools came with the report of 
Sundareswaran and de Zélicourt et al. who were the first to describe a case study of 
their prospective deployment61. In that work, a patient with interrupted IVC and azygos 
vein continuation had developed PAVM after inclusion of the hepatic venous flow by a 
Fontan connection to the enlarged Kawashima junction. Analysis by both PC MRI and 
CFD demonstrated that the hepatic venous flow was unilaterally streaming to a single 
lung, consistent with the PAVM diagnosis to the contra-lateral side. Multiple surgical 
options were investigated, and revision to a hepatic-to-azygos connection was ultimately 
found to produce the most desirable hepatic flow distribution characteristics of the 
potential options. 
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de Zélicourt et al. followed-up with a series of 5 prospectively modeled studies for 
patients with interrupted IVC who were surgical treated for PAVM with the use of surgical 
planning105. Trends were elucidated with regard to differences in connection 
hemodynamics on the basis of superior caval anatomy. Also, the authors reported an 
improvement in arterial oxygen saturations post-operatively, which anecdotally verified 
the results of the computational modeling insofar as increased hepatic flow was 
assumed to be reaching the diseased lung and helping to resolve the PAVM present.  
These two studies represent critical proofs of concept for the potential of pre-operative 
modeling and planning. The linkage between PAVM and hepatic flow distribution is a 
rare instance in which the direct linkage between hemodynamics and disease is readily 
observable, making the application of these methods to that disease particularly 
straightforward. Critically, however, the lack of post-operative data has precluded the 
ability for more thorough validation of model predictions.  
At the same time, Migliavacca and colleagues have also been working toward a surgery 
planning model through the retrospective study of individual test cases. Their approach 
has primarily targeted method development rather than application93. For example, 
Baretta et al used a coupled multi-scale solver to simulate different Fontan connections 
for a patient-specific connection and demonstrated efficiency differences among the 
various options95. Pennati et al used the same model to compare simulated post-
operative physiology to actual acute patient measurements with mixed results, 
particularly with respect to the distribution of pulmonary flows94. 
3.7.5 Fontan Y-Graft 
Another novel insight that has come from the extensive engineering analyses of the 
TCPC is the proposal of completely redesigned connections. While small changes to 
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positioning or angle of the Fontan baffle incrementally improved losses compared to 
head-on collision, such designs still mediated a complex flow transition from caval veins 
to pulmonary arteries with high potential for dissipative secondary flow structures73. This 
prompted the proposal by Soerensen et al. for the ‘Optiflo’ connection (Figure 3.15, right) 
in which the cavopulmonary connections were both bifurcated to allow for a streamlined, 
efficient transition of flow into the pulmonary circulation106. The authors reported between 
23 and 40% decreases in power loss in a model with constant vessel cross-sections 
compared to the 1D offset TCPC model under increasing cardiac output conditions.  
In a subsequent study, Marsden et al. designed a ‘Y-Graft’ bifurcation (i.e., half of the 
Optiflo) applied to patient-specific models and reported improved efficiency compared to 
an offset TCPC control107. This latter study also brought to light the importance of the 
choice of graft sizing for this bifurcated connection. Two different designs were modeled: 
one in which the cross-sectional area was maintained (18x12x12 mm), and one in which 
the branch diameters were held constant (18x9x9 mm). The former graft was the most 
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Figure 3.15 Comparison of velocity fields via CFD for a 1D offset TCPC model (left) and a 
prototype of the Optiflo connection (right). The bifurcated design of the Optiflo is shown to 
streamline flow transition to the pulmonary arteries and avoid dissipative caval flow 
collision (arrow, left). 
 
 
Like surgical planning, the use of bifurcated grafts for the Fontan connection appears to 
a promising means of reducing the hemodynamic energy required to move blood from 
the systemic to the pulmonary circulations and thus improve circulatory function. 
However, the studies of Soerensen and Marsden did not address surgical feasibility, and 
so critical questions still remain as to the utility of this approach. 
3.8 Summary and Significance of the Proposed Approach 
Despite the relatively low incidence of single ventricle defects, the numerous 
complications have an impact on the whole healthcare system. With improved survival 
through their early care and operative course, single ventricle patients are living longer 
than ever before. In fact, there are now more adults than children living with congenital 
heart disease8, and the number of adults is estimated to be growing at 5% per year in 
the US alone108. However, despite over 50 years of surgical experience with single 
ventricle defects, there is not yet a solution; instead, high early mortality has been 
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replaced by gradual attrition and onset of cardiac and gastrointestinal dysfunction. Thus, 
the cost of caring for these patients is also disproportionately large given their numerous 
chronic health issues109.  
These facts dictate that it is no longer sufficient to advance these patients through the 
early stages of surgical care and medical management with the ‘simple’ objective of 
short-term survival. Rather, every effort should be taken to understand and consider the 
long-term implications of these actions to help offset the compounding effects of an 
aging and chronically ill adult congenital heart disease population. The TCPC, as a 
central component in single ventricle management, serves as a prime target for detailed 
characterization. Past research has suggested numerous plausible functional 
hypotheses, but corroboration with patient data have generally been lacking. 
For these reasons, the present study is designed to make several significant 
contributions to the field: 
1) Establish the functional importance of TCPC power loss. Many studies have sought 
to evaluate TCPC hemodynamics; none have possessed sufficient sample size to 
make statistically powered observations. To date, the largest investigation of TCPC 
flows have only included sample sizes of 1655, 92. Similarly, many studies have 
considered the TCPC and the single ventricle in isolation, but none have sought to 
relate them using functional patient data. The proposed work contains both the 
statistical power and combination of endpoints to elucidate the relationship between 
the TCPC and single ventricle function, as well as the evolution of such metrics with 
time. 
2) Shift the surgical paradigm for TCPC design. As a direct extension of the previous 
item, if, per the stated hypothesis, the magnitude of power loss is found to 
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significantly impact VF, then the use of pre-operative planning tools for TCPC design 
to minimize power losses will be justified. A recent National Heart, Lung, and Blood 
Institute working group on research in adult congenital heart disease recommended 
the development of technology to “support hemodynamic and functional modeling of 
individual patients to improve understanding of cardiac status, and to plan for future 
therapy”8. The framework for such a surgical planning system already exists61, 110, but 
it lacks two critical inputs: 1) an understanding of which hemodynamic measures are 
clinically relevant at what thresholds; 2) verification that the pre-operative models 
reflect the post-operative hemodynamic results. Both of these points are addressed 
through this thesis. 
3) Establish the efficacy of new TCPC designs. Again, with the importance of TCPC 
power loss established, the continued search for new means of systematically 
improving it would be justified. The Y-Graft/Optiflo paradigm is a theoretically 
promising one, but critical clinical questions (in vivo power loss performance, size 
selection) remain outstanding.   
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Chapter 4. MATERIALS AND METHODS 
4.1 Magnetic Resonance Imaging (MRI) 
The studies performed in this thesis are entirely dependent on the use of MRI to extract 
patient-specific anatomic and physiologic information to inform subsequent modeling 
and/or analysis. Thus, a brief overview of the physics behind MRI is first presented 
before detailing the specific sequences used and post-processing performed. 
4.1.1 Physics Background 
At a basic level, MRI produces an image by manipulating the rotation of water molecules 
(comprising between 70-90% of most body tissues) by subjecting them to a series of 
controlled magnetic spatial gradients superposed on a strong homogeneous magnetic 
field. As opposed to other medical imaging modalities such as X-ray, which are limited in 
their means of signal generation (e.g., attenuation of x-rays) and thus their means of 
generating contrast between adjacent tissues, there are any number of different 
sequences of magnetic field excitation that will each change the signal received. This 
characteristic is one of the primary strengths of the method and so will be explored in 
more detail in this section. 
Consider a single proton. This particle is naturally in constant rotational motion and thus, 
because of its positive charge, creates its own weak magnetic field. If placed in a strong 
external magnetic field, this proton will tend to align the main axis of its own magnetic 
field with the direction of the main field; however, quantum mechanical effects keep the 
proton from statically aligning and it instead precesses about the main magnetic field 
axis (B0; Figure 4.1). The angular speed of this rotation, ω0, is directly proportional to the 
magnetic field strength according to the Larmor equation: 
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       (Equation 4.1) 
 
where γ is a constant called the gyromagnetic ratio. Hence, in a given sample under the 
influence of the same magnetic field, all protons are precessing at the same frequency. 
The vector sum of these spins is the net magnetization vector of the sample (effective 









In order to yield a measurable signal from M0, it must be translated to the ‘transverse’ 
plane (90° from the direction of B0) by a secondary magnetic field. This field is 
temporarily created by the so-called radiofrequency (RF) pulse (B1, Figure 4.2) emitted 
by a separate transmitter coil. The angle swept by M0 under the influence of B1 depends 
on the duration of the RF pulse. For example, a “90° pulse” is timed to position M0 on the 
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transverse plane. Additionally, the RF pulse induces phase coherence of the precessing 
protons (i.e., they all point in the same direction on the transverse plane). This rotating 
field thus induces a voltage in a receiver coil that is sensitive to magnetization only in the 
transverse plane.  
 
Figure 4.2 A) Creation of RF pulse (B1) to B) translate effective magnetic moment, M0, from 





Once the RF pulse is turned off, small inhomogeneities in the local magnetic field and 
proton-proton interactions cause the loss of phase coherence in the transverse signal 
amplitude, M┴. In fact, the signal decays exponentially (as the spins “fan out”) in several 
milliseconds according to: 
 





   (Equation 4.2) 
 
 (note: this equation assumes a rotating reference frame), where T2 is the experimental 
constant known as the “spin-spin” relaxation time constant. At the same time, the 
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magnetization component parallel to the main magnetic field is gradually restored as the 
energy imparted by the RF pulse is dissipated (as thermal energy) into the surrounding 
lattice. This can be expressed as: 





        (Equation 4.3) 
 
where Mz is the magnetization component parallel to the main magnetic field, M0 is the 
equilibrium magnetization, and T1 is the experimental “spin-lattice” relaxation constant. 
As a general rule, T1 is much larger than T2, therefore its relaxation is much slower. 
Together, Equation 4.2 and Equation 4.3 form the Bloch Equation for the time rate of 







         
 
  
     (Equation 4.4) 
 
While this temporary pulse and decay does create a readable signal (from what is known 
as Free Induction Decay), practically speaking this is not a signal of interest in clinical 
imaging. Instead, most images are built using “echoes” in the magnetization signal. The 
most common are gradient and spin echo sequences. 
4.1.1.1 Gradient echo 
The Larmor equation dictates that angular frequency is dependent on magnetic field 
strength. While the frequency is therefore uniform under the sole influence of the main 
magnetic field, the superposition of a spatially-varying magnetic field will create 
heterogeneous frequencies within the sample as a function of position within the 
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smoothly varying field (Figure 4.3). As will be covered in a subsequent section, the ability 
to create these gradients is central to the spatial localization of images, but is also the 




Figure 4.3 Effect of local gradient superposition on proton spins. When the field was 
uniformly constant (left image), angular frequencies were the same. With spatially varying 






A visual description of this process is illustrated in Figure 4.4. Following the RF pulse, a 
negative spatial gradient is briefly turned on causing a rapid dephasing of the transverse 
magnetization. The gradient is then reversed so that instead of dephasing, the spins 
rephase and eventually come back together into a coherent signal, called an echo. The 
signal associated with this echo is read by the receiver coil to build the image. 
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4.1.1.2 Spin echo 
A schematic of this process is illustrated in Figure 4.5. In this case, the spins are allowed 
to dephase naturally (T2 decay) for a time following the RF pulse before a 180° pulse 
about the transverse plane is applied. With this latter pulse, the protons that had been 
dephasing faster (clockwise in the figure) are positioned “behind” the previously lagging 
protons, and vice versa. Thus, the natural dephasing will move the spins back toward 
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Figure 4.4 Schematic of gradient echo sequence. a) Sequence diagram depicting relative 
timings of b) RF pulse, c) negative gradient lobe dephasing, d) rephasing under function of 
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Figure 4.5 Schematic of spin echo sequence. a) Sequence diagram depicting relative 
timings of b) 90°RF pulse, c) natural spin-spin dephasing, d) 180° pulse, e) natural spin-
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4.1.1.3 Image acquisition and k-space  
Echoes are a key component in the methods of MR image acquisition, but they do not 
address the fundamental task of spatial localization. This process is achieved through 
the concerted application of multiple spatial gradients in addition to the “readout” 
gradient used to form the echo. This multi-dimensional gradient spectrum is ultimately 
what is built up, as “k-space”, to reconstruct the MR image using Fourier transforms. A 
generic representation of a 2D gradient echo-based image sequence is shown in Figure 
4.6; the following paragraphs describe these constituent components in more detail. 
The first step is slice selection: exciting a thin slab (for planar imaging) to image from the 
entire 3D volume of interest. This process involves two distinct components: a spatial 
gradient acting perpendicular to the desired slice (for an axial slice, this gradient would 
run from foot to head); and a specially tuned RF pulse with a narrow, specifically focused 
bandwidth corresponding (through the local gradient-induced Larmor frequency) to the 
location and thickness of the desired slice. The correspondence of these components 
with each other and the resulting slice selection is illustrated in Figure 4.7. The final step 
in slice selection is a rephrasing lobe (the negative portion of the slice selection signal in 
Figure 4.6). Just as the spatial gradient induces a spatial ‘spreading’ or spin dephasing 
in the creation of the gradient echo, the slice selection gradient has the same dephasing 
effect. The rephasing lobe therefore acts to refocus the spins to ensure a uniform 
distribution through the slice thickness. 
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Figure 4.6 Generic sequence schematic for gradient echo acquisition of a 2D slice with 
time positioned along the x-axis. GSS- slice selection gradient; GPE- phase encoding 
gradients (hashed lines denote coverage over sequential RF pulses); GFE- frequency 
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Figure 4.7 Interplay of RF pulse and slice selection gradient to isolate a thin localized 
image slice. The specific frequency of the pulse is tuned to correspond to the Larmor 
frequency of the region of interest after application of the slice selection gradient. The RF 





With the slice localized, the next challenge is to spatially encode the information within 
that slice, which is done with a combination of frequency and phase encodings. For the 
phase encoding (represented by line 3 of Figure 4.6 and visually illustrated in Figure 
4.8), a gradient is rapidly turned on and off in the phase encode direction. While the 
gradient is on, the frequencies vary spatially with the gradient such that, when the 
gradient is turned off and the spins are again precessing at a uniform frequency, the 
accumulated phase differences remain. This phenomenon is represented in Figure 4.8 
by the fact that the arrows in the last column are at different phase angles even though 
they all have the same instantaneous frequency. Finally, the frequency encoding is 
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performed in the direction orthogonal to the phase encoding as described in the gradient 
echo section: a continuous gradient induces a spatially varying frequency profile that is 




Figure 4.8 Visual demonstration of the effect of phase encoding gradients. While gradient 
is on (middle column) the varying spatial frequencies dephase signals as usual such that, 
once the gradient is turned off (last column) the spins return to a uniform frequency but 





The process just described above pertains to a single RF excitation, which is insufficient 
for completely resolving an entire image. In fact, in the image spectrum matrix being 
measured (i.e., k-space), this sequence corresponds to a single measurement line. As 
represented by the discrete bans of the phase encoding excitation in Figure 4.6, this 
process of RF-slice selection-phase encoding-frequency encoding is repeated numerous 
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times (with varying magnitudes of the phase encoding gradient) to completely fill in the 
k-space matrix. Once completed, k-space looks like the top image of Figure 4.9a (with 
the corresponding magnitude image on the bottom). Interestingly, Figure 4.9b and 
Figure 4.9c reveal the distinct information encoded in the different parts of k-space: the 
low frequency central region carries most of the bulk image information (seen in the 
‘burry’ bottom image), whereas the high frequency extremities of k-space carry most of 




Figure 4.9 Relationship of k-space to the resulting magnitude image. In b) only the low 
frequency center of k-space was used and the resulting image contains the bulk features 
but lacks edge definition. In c) only the high frequency regions of k-space were used and 
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Here it is worth noting that the spatial resolution of an MR image is dependent on the 
selections made regarding the frequency and phase encodings. At a basic level, the 
resolution depends on the size of the image and the number of sample measurements it 
contains. For a given field of view, the MR resolution depends on the matrix size, i.e., the 
number of frequency and phase encoded lines measured; the gradient magnitude 
(higher is better); and the sampling time (FE direction only; again, more is better). 
Conversely, decreasing the field of view at a constant matrix size requires increases in 
either the gradient strength or sampling time (FE direction). 
Finally, the techniques herein described for acquisition of a 2D slice can be easily 
extended to a 3D volume. By simply phase encoding the third orthogonal direction and 
methodically covering a range of phase values for that component in addition to the 
planar phase encoding direction, the acquired slice is extended to a 3D (or 4D, with 
time) volume. Of course, the tradeoff with such an acquisition is the increased time 
needed to cover an additional phase encoding range for each of the original phase 
encoded lines. 
4.1.1.4 Contrast and Signal-to-Noise  
In MR acquisitions, there is a finite signal available for each tissue in the field of view, 
which is dependent on the tissue properties and the sequence used. Ideally, a high 
contrast is achieved such that the tissue of interest generates a high signal while the 
signal from surrounding tissues is suppressed. This is done by leveraging inherent 
differences in tissue characteristics (proton density, T1, or T2) by manipulating sequence 
parameters such as repetition time (TR; the time between consecutive RF pulses) and 
the echo time (TE; the time from the RF pulse to the echo). Notably, the means of 
forming the echo (spin or gradient) does not matter as both can be used to generate T1 
or T2-weighted images. 
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As an example of tissue dependent property values, fluids like cerebrospinal fluid and 
blood have higher proton densities than bones or tendons. For T1, fluids (1500-2000 ms) 
have longer relaxation times than water-based tissues (400-1200 ms) or fat-based 
tissues (100-150 ms). The same is true for T2 relaxation, even though the values are 
much smaller: times for fluids (700-1200 ms) are higher than those of water-based (40-
200 ms) or fat-based (10-100 ms) based tissues111. 
For T1-weighting, T2 effects must be minimized to exploit only T1 differences between 
tissues. Hence, both TR and TE are kept short (less than 40 ms for TE). With a short TR 
(less than 750 ms), tissues with longer T1, such as blood, do not have enough time to 
completely relax before the 2nd RF pulse; thus, their transverse magnetization 
components are decreased compared to tissues with shorter T1 after the subsequent 
RF. For this reason, fluids (like blood) usually appear dark in T1-weighted images, unless 
they are flowing into the region of interest during the acquisition, which nullifies the effect 
of the short TR. When using gradient echo sequences to weight by T1, the choice of flip 
angle (i.e., the angle traced out between the B0 axis and the transverse plane as a 
function of the RF pulse) is also of profound importance as it will determine the 
component of magnetization that remains parallel to B0 (and therefore does not have to 
‘relax’ before the subsequent pulse. Hence, flip angles greater than 50° are generally 
required to achieve the desired T1 weighting. 
Conversely, T2-weighting seeks to minimize T1 effects using long TR (>1500 ms) and TE 
(>75 ms) values. For this reason, T2 scans typically take much longer as scan time 
directly relates to TR. Fluid volumes tend to produce the strongest signal in T2-weighted 
images, as the rapid dephasing of surrounding tissues is more apparent with longer TEs. 
This feature makes T2-weighting a common selection in analysis of fluid-based 
pathological specimen surrounded by other soft tissues. 
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The final basic option is proton density weighting, which (as the name implies) relies 
solely on a higher number of protons present in a given tissue to produce a stronger 
signal than neighboring tissues. For these scans, both T1 and T2 effects must be 
negated. Notably, effects of proton density differences cannot be corrected in T1- or T2-
weighted images and can act as a compounding factor, even though the relative proton 
densities of body tissues are fairly consistent. As may be guessed from the preceding 
paragraphs, long TR (to mitigate T1 differences) and short TE (to negate T2) scans are 
used to weight by proton densities. 
The signal generated by these techniques is offset partially by the presence of noise: 
random differences in pixel values. In MR, these differences arise from fluctuations in 
electrical currents: those in the MR coils as well as the electrically conductive body 
tissues (containing ion channels) being imaged. The ratio of the signal strength to the 
noise magnitude is known as the signal-to-noise ratio (SNR). SNR is generally 
maximized through the use of dedicated body coils specific to the region of interest.   
4.1.1.5 Steady-State Precession and Coherent Echoes  
The previous introduction of gradient echo and spin echo principles was very basic. In 
clinical reality, particularly in time-varying applications like cardiac imaging, time is 
limited and means of improving efficiency and speed of acquisition are highly sought. 
Perhaps the easiest way to cut down on scan times is to reduce TR. At short TR 
intervals, T1 relaxation is incomplete and the longitudinal magnetization component 
exposed to the RF is reduced. However, after several RF pulses this component 
equilibrates such that the transverse magnetization completely relaxes between pulses. 
Equivalently, the longitudinal magnetization reaches a ‘steady-state’ and no longer 
varies with each RF pulse.  
 - 60 - 
In many applications, TR may be reduced even below T2. In such cases, remnants of 
transverse magnetization remain at the time of the following RF pulse that create ‘partial 
echoes’ in addition to the natural FID during the subsequent pulse period. Without 
properly accounting for these extra echoes, severe image artifacts and incorrect contrast 
characteristics ensue. There are three common strategies to handle the partial echoes: 
1) “spoiling”, while removes these partial echoes; 2) “rewinding”, which uses them; and 
3) “time reversing”, which exclusively depends on their formation. 
Of these three, the rewinding option has become a predominant favorite for cardiac 
applications and Steady-State Free Precession (SSFP) sequences, which use this 
approach are considered a ‘workhorse’ of CMR owing to excellent contrast between 
blood and the myocardium. Figure 4.10 outlines a fully rewound, or ‘balanced’ SSFP 
acquisition. The defining characteristic of this pulse is that each gradient is reversed, i.e., 
the zeroth moment of all magnetization gradients about the RF pulse is 0. 
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Figure 4.10 Sequence diagram of a balanced, rewound steady-state gradient echo 
acquisition. It is noted that all gradients are reversed prior to the following RF pulse such 





4.1.1.6 Angiography and Phase Contrast Velocity Imaging  
An implicit assumption made in reconstructing MR images from the basic spatially-
varying phase encoding scheme is a lack of motion. In other words, changes in 
magnetization in a slice from pulse to pulse are expected to result only from changes in 
the phase encoding amplitude. Blood flow therefore presents an obvious violation of this 
assumption and in purely anatomical scans, it must be corrected for to avoid significant 
artifact formation. On the other hand, the signal disturbances resulting from blood flow 
can also be utilized to provide detailed functional information. This fact is another of the 
great strengths of MR in medical imaging and can be done in one of two ways: 
angiography (MRA) or phase contrast (PC MR). 
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Angiography is largely a qualitative approach to flow measurement, which relies on 
‘time-of-flight’ (TOF) effects to generate flow signals related to the bulk flow velocity. 
MRA can be done using either spin echo or gradient echo sequences; however, 
because gradient echo methods produce bright blood images (preferable for image 
processors) compared to dark blood spin echoes, we will presently only consider the 
gradient echo situation. Figure 4.11 visually demonstrates the principle behind these 
acquisitions. First considering a case where the blood velocity is low (near 0) and 
assuming TR<T1 for blood, the blood in the region of interest would become saturated by 
the short TR and produce little signal (Figure 4.11a). On the opposite extreme, if the 
blood is moving fast enough such that the volume in the slice is completely replaced 
(i.e., completely flows out of the volume) between successive pulses, the incoming blood 
would be unsaturated and produce a strong signal compared to the surrounding tissues 
(Figure 4.11c). In between (Figure 4.11b), the signal would be intermediate to these two 
cases as there would be a mixture of saturated and unsaturated blood signal within the 
volume. The critical velocity, Vc, distinguishing b from c is related to the slice thickness, 
z, and TR as:  
 
   
 
  
 (Equation 4.5) 
 
such that V≥Vc produces the maximal signal of case Figure 4.11c. 
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Figure 4.11 Relationship between flow rate and image intensity for gradient echo MRA 
acquisitions. For slow moving or stagnant fluid (a), the spins become saturated and no 
fluid signal is produced. For high velocities (c), the fluid in the volume of interest 
completely moves out of the volume between successive pulses and the new fluid volume 
produces a high signal on the next pulse. For moderate velocities (b), the signal produced 





By comparison, PC MRI is a quantitative means of measuring velocities in individual 
voxels in the region of interest. The underlying principle behind the method is that the 
phase shift acquired by moving spins under the influence of a bipolar gradient pulse is 
linearly related to the time rate of travel, i.e., its velocity, through a known dependency. 
The explanation is as follows. Phase is the time integral of precession frequency, 
       , which is spatially dependent on the main magnetic field and the local 
gradient strength:               . For spins moving at the constant velocity, ν, this 
 - 64 - 
relationship becomes:                    . Assuming a constant gradient, G, 
applied for a fixed time interval, T:  
 










      
 
 
     (Equation 4.6) 
 
where M1 is the “first moment” of the gradient. The negative gradient lobe creates a 
similar moment that cancels out all phase differences in stationary spins, but not the 
moving ones. Now, because phase contrast is usually imposed with gradient echoes, 
phase distortions due to local field inhomogeneities become important. It therefore 
becomes necessary to acquire a second image with the gradient lobes reversed to 
subtract the effect of the local distortions such that the only phase differences are the 
result of the desired motion:  
 
         (Equation 4.7) 
 
The relationship between the velocity and this magnetic moment must be encoded into 
the sequence prior to the acquisition, which is done by defining the velocity encoding, 
VENC, parameter. The VENC is the velocity that creates a 180° phase shift (π radians): 
 
     
 
   
 (Equation 4.8) 
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Thus, by selecting the gradient strength and duration that corresponds to the desired 
VENC, the velocity of each voxel can be calculated following acquisition.  
As is true with many of the sequences discussed in the prior sections, phase contrast 
acquisitions can be easily extended to cover three orthogonal directions and therefore 
resolve a three-dimensional velocity vector. An example of such a 3D PC MR acquisition 




Figure 4.12 Example of coronal slice acquisition of 3-component velocity vectors (plus 
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From this basic MRI background, several strengths and attributes of the technology 
should be apparent, which make it the preferred method for hemodynamic investigations 
of the TCPC. First, the imaging data can provide both anatomic and functional (e.g., 
flow) information, critical boundary conditions for computational modeling. These 
features are unique among other standard medical imaging techniques (i.e., 
echocardiography and computed tomography (CT)), which either cannot provide 
quantitative flow information (CT) or are anatomically limited by severe depth 
dependence (echo). Second, MRI does not require ionizing radiation (like CT), which 
improves feasibility in young patients who may require many examinations over their 
lifetime. Finally, it can image in any arbitrary orientation in 2, 3 (static or 2+time), or 4 
(3+time) dimensions and with reference to specific points of the cardiac cycle, if desired. 
For these reasons, and others, CMR was the cornerstone of these investigations. 
 
4.1.2 Challenges of Pediatric CMR 
Since the majority of subjects included in this thesis are pediatric patients, it is 
appropriate to make note of important challenges inherent to imaging pediatric patients. 
The most obvious issue is the smaller size of pediatric structures that necessitates 
greater spatial resolution compared to the same adult structures. Signal-to-noise ratio 
effectively sets a limit to how high this resolution can be set. 
An additional challenge is related to the generally high pediatric heart rates, which 
necessitates high temporal resolution. This need requires that tradeoffs be struck 
between high temporal resolution acquisition schemes (reading one line of k-space per 
RF pulse) and clinically manageable acquisition times (typically achieved in adult 
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imaging through k-space ‘segmentation’112: reading multiple k-space lines (typically 3-
64113) per cardiac cycle).  
In pediatrics, particularly for infants and young children, administration of sedation or 
anesthesia is often required to ensure the patient remains motionless throughout the 
study. The use of these drugs adds to the risk associated with performing the imaging 
study, which may limit the scan duration. Additionally, more clinical personnel are 
required to be present to administer these scans (e.g., cardiac anesthesiologist, 
cardiologist, etc.) and help avoid/address adverse events (at increased cost), and 
Institutional Review Boards (IRB) require stronger justification and direct patient benefit 
to offset the increased risk in cases where the scans are being performed for research 
purposes. 
Finally, respiratory compensation is a particular challenge in pediatrics. The motion of 
the diaphragm and lungs induces time-varying motion in the adjacent cardiac structures 
being imaged; this motion must be accounted for in image acquisition to avoid blurring. 
Typically, through the use of shortened segmented acquisitions, adult respiratory 
compensation is typically done via short voluntary breath holds. Because of the frequent 
use of sedation/anesthetics in pediatric imaging, breath holding is not an option. Instead, 
signal averaging can be used, at the cost of increased scan time, to compensate for 
respiratory motion while the patient is freely breathing.  
 
4.1.3 Acquisition Protocols and Image Processing 
The patient-specific data investigated in this thesis were collected according to basic, yet 
specific protocols. The data were then post-processed and analyzed using previously 
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established methods specific to the application. These applications can be sub-divided 
into 3 categories: 1) anatomic, 2) flow, and 3) functional investigations. 
4.1.3.1 Anatomic  
Patient-specific TCPC geometric information was primarily derived from a static axial 
stack of thin, ‘trueFISP’ (balanced SSFP) images (Figure 4.13). These acquisitions 
spanned the thorax region from diaphragm to upper torso in 35-50 images with 3-4 mm 




Figure 4.13 Sample images from axial trueFISP image stack of single ventricle patient. 
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These images provide excellent cross-sectional views of the caval veins and Fontan 
baffle, which run perpendicular to the slice. Complete representation of the pulmonary 
arteries presents more of a challenge as they generally run parallel to the slice. 
Depending on the size of the arteries and the slice thickness, the PAs may be captured 
in only a few slices and the reconstruction of the cross-sectional profile may be less 
accurate.  
The process for reconstructing the patient-specific anatomy from this image stack was 
as follows. To overcome the anisotropic resolution of the axial anatomic stack, the data 
were interpolated in the through-plane direction using adaptive control grid interpolation 
(ACGI)114. As can be appreciated in Figure 4.14, this technique smoothes the transition 
between slices, which helps to produce more realistic results (e.g., removing the 
appearance of piece-wise discontinuities). The interpolated stack was then semi-
automatically segmented using a scaffolded shape-element (or ‘bouncing ball’) 
method115. With this technique, a threshold is applied to the image to remove noise, and 
the regions of interest for a given slice are selected. The program fills in the entire 
connected region for the location selected (Figure 4.15) and creates a binary mask of 
the segmentation. A 3D level set surface evolution algorithm was then used to smoothly 
and coherently deform the masked data, using gradient ‘forces’ derived from the raw 
images, to create a point-cloud representation of the 3D segmentation (Figure 4.16). 
Finally, Geomagic Studio (Geomagic, Inc., Research Triangle Park, NC) was used to fit 
a surface to the point cloud, perform any necessary smoothing or de-noising, crop the 
vessels, and prepare the model for CFD simulation. 
 
 




Figure 4.14 Effect of ACGI on the anatomic data (in this case, shown as a ‘black blood’ 
image volume). The block on the left contains the raw data and the discrete, discontinuous 
steps between slices are apparent. The block on the right shows the interpolated data and 





Figure 4.15 Sequence of ‘bouncing ball’ segmentation. After shape-element initialization 
within the vessel (a), it moves within the vascular scaffold (b) until all the pixels internal to 
the structure are segmented (c). 
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While the trueFISP sequence was the standard input for anatomic reconstruction, 
several other methods were also employed, particularly from scans acquired at 
Children’s Healthcare of Atlanta. The two most common were isotropic 3D volume 
acquisitions, and gadolinium-enhanced angiograms. Gadolinium is an MR-specific 
contrast agent that enhances T1 relaxation and thus provides strong signal with short 
TR. The protocol for using these images was generally no different than the truFISP 
images, but the SNR and contrast characteristics varied. 
4.1.3.2 Velocity  
The other critical input for patient-specific computational modeling of the TCPC is local 
flow information at the vessel (or system of vessels) inlets and outlets. This was 
obtained using a series of through-plane (i.e., one velocity component) cine (time-
varying) PC MR slices. As shown in Figure 4.17, these planes were specifically 
positioned at the inlets (distal to relevant venous confluences) and outlets (proximal to 
major bifurcations) of the TCPC, as well as the ascending aorta to provide cardiac output 
information. Depending on patient heart rate, these data typically spanned the cardiac 
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cycle in 15-30 phases. The VENCs were tuned with consideration of patient-specific flow 
rates (often after a pilot acquisition), and generally ranged from 50 cm/s (in the VCs) to 





Figure 4.17 Positioning of the PC MR planes (in black) on the TCPC inlets and outlets 
relative to a patient-specific anatomy. 
 
 
The cross-sectional PC MR data were segmented with an in-house algorithm using 
active contours116. In this method, the user initializes a contour around the vessel of 
 - 73 - 
interest in a single magnitude image and that contour is then automatically evolved 
according to an image-based energy functional: 
 
   
 
 
         
  
 
          
 
               (Equation 4.9) 
 
where E is the total energy of the evolution; C(s) is a parametric contour as a function of 
arc length, s; α is a constant that weights the curvature of the contour; β is a constant 
that controls rigidity in the through-plane direction (set to 0 for 2D); and Eext is the 
‘energy’ of the image117. The image energy was defined using gradient vector flow 
(GVF)118, which diffuses the gradient of the image contours throughout the image to both 
provide insensitivity to initialization location and noise and naturally handle vessel 
concavities. Additionally, a hybrid image was created based on a cross-correlation of the 
magnitude and phase images119. This hybrid image is particularly helpful when the 
vessel of interest is in close proximity to another anatomic structure, such as the SVC 
and the aorta in Figure 4.18, because the local phase discontinuities (stemming from the 
internal velocity differences) distinguish the structures in the hybrid representation. The 
active contour functional was then implicitly evolved with a level set-based formulation120 
to extract the region of interest for each phase of the cardiac cycle. 
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Figure 4.18 Effectiveness of hybrid magnitude/velocity image energy functional for 
distinguishing different vessel structures in close proximity, such as the SVC (segmented 





Once the region of interest was segmented, a novel post-processing algorithm was used 
to filter the data and remove noise and spurious vectors. This approach is called Fuzzy 
Adaptive Vector Median Filtering116. Briefly, a median vector is defined from a subset of 
the sampled data and a set of fuzzy membership rules is used to determine if individual 
vectors are noise or true signal. If determined to be noise, the same filter selects a 
suitable replacement value based upon the same vector median. This methodology was 
previously shown to improve accuracy of segmented results116. 
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From the segmented data, characteristics of vessel area, flow and velocity over the 
cardiac cycle, pulsatility and resistance indices, and cross-sectional quadrant flow 
profiles were extracted119. Of these, the time varying and time averaged flow rate values 
were retained to provide the flow boundary conditions for CFD simulations (see §4.3.4). 
While the through-plane acquisitions were performed and analyzed in this way for the 
vast majority of patients enrolled in these studies, an additional 4D velocity protocol was 
acquired in a small subset to reconstruct of the full in vivo flow fields. These data were 
acquired as a coronal stack, usually comprising of 5-7 slices with 3 orthogonal velocity 
components acquired on each slice (as shown in Figure 4.12). VENCs were generally 
similar to through-plane values (as the velocities measured were the same). Because 
the data were acquired as anisotropic slices (as opposed to a volumetric slab91), an 
interpolation scheme was required to resolve velocities between slices. 
This interpolation scheme, developed and implemented through the PhD work of Dr. 
Sundareswaran119, is called Divergence Free Interpolation (DFI), and uses inherent 
properties of incompressible fluid flows (i.e., zero divergence,        ) to improve the 
accuracy of interpolating flow-based vector fields121. A brief description of this method 
will be provided here; the interested reader is directed to Dr. Sundareswaran’s thesis119 
for a more detailed derivation. 
Helmholtz’s theorem of vector calculus states that any sufficiently smooth 3D vector field 
can be resolved into the summation of irrotational (curl-free) and divergence-free vector 
fields. An experimentally measured incompressible 3D velocity field can therefore be 
thought of as the superposition of divergence-free (the true velocity field) and curl-free 
(noise) components. By projecting the measured data into a divergence-free space, the 
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true velocity field is recovered. It therefore becomes the challenge to define appropriate 
basis functions for this divergence-free space. 
The works of Narcowich and Ward122 and Lowitzch123 introduced the concept of 
divergence free spaces defined using radial basis functions. This space has the general 
form: 
 
                    (Equation 4.10) 
 
where I is the identity matrix,    is the Laplacian operator,   is the gradient operator, and 
Ψ is a scalar-valued, infinitely supported radial basis function. In the scheme proposed 
by Narowich and Ward122, Ψ(x) was based on the Gaussian function: 
 
       
      
 (Equation 4.11) 
 
which produces a smooth, positive definite basis. The interpolation model is thus: 
 
                               (Equation 4.12) 
 
where V is the interpolating function, (xj, j=1:P) is the set of stationary control points in 
the domain, Φ is the divergence free radial basis function and C is a vector valued set of 
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coefficients that are determined from a least squared error analysis from the measured 
velocity data. 
With the interpolating scheme in place, the primary practical challenge in applying this 
method to the coronal TCPC data is in segmentation of the flow domain. Typically the 
spatial resolution and coverage of the axial data used for the anatomic reconstruction is 
much better than what the coronal magnitude images provide. Thus, rather than 
performing a de novo segmentation of the coronal data, the segmentation and flow 
domain identification is performed through a registration of the single axial segmentation 
mask to the time-varying velocity data (Figure 4.19). The velocity data are then 
interpolated to the anatomic grid providing a time varying volumetric reconstruction. This 




Figure 4.19 Segmentation of coronal 4D PC MR data via A) registration with 3D anatomy 
reconstructed from axial stack and B) segmentation of vessel boundaries on each slice. 
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From the reconstructed 4D velocity fields, the quantitative endpoints of interest were 
power loss and IVC flow distribution. Since there is no pressure information available 
from the MR data to calculate power loss using the traditional control volume approach, 
power loss was instead approximated based on viscous dissipation: 
 















    
  
  






    +     +    +      (Equation 4.13) 
 
For flow distribution, the built-in temporal interpolation and particle tracking 
functionalities of the open-source ParaView data analysis and visualization application 
(version 3.12.0; paraview.org) was used. Credit for the development of this protocol 
belongs to Dr. Lucia Mirabella. Briefly, the procedure was as follows: 
1. Import the set of 4D velocity fields (usually arranged as one time point per file), 
with the first time point duplicated and appended to the end of the set. 
2. Perform temporal interpolation (Filters> Temporal Interpolator> Interval = 0.1) 
3. Scale time to match MR acquisition (Filters> Temporal Shift Scale> Scale as 
appropriate; 3 periods; select periodic and periodic end correction). 
4. Cache temporal data for particle tracking (Filters> Temporal Cache) 
5. Select emitter source plane (select interpolator data in pipeline browser, Use 
‘Slice’ Tool) 
6. Particle release (select cache in browser, Filters> Particle Tracer) 
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4.1.3.3 Ventricular Function  
In the patient subset for which ventricular function was quantified, a short axis stack (6-
12 slices) of cine SSFP (16-33 phases) images was acquired. The stack was positioned 
to span from ventricular apex through its base.  
Segmentation was performed using a variation of the 2D level set active contours used 
for the velocity cross-sectional segmentation. A contour was initialized on the first phase 
for a given slice and propagated through the rest of the cine set. Manual corrections 
were made as necessary to ensure a visually appropriate segmentation. Once the stack 
was entirely segmented, the volume of each cardiac phase was calculated using a 
Simpson’s rule approach.  
The following measurements were derived from the segmented volumes: 
 End diastolic volume (EDV) 
 End systolic volume (ESV) 
 Stroke volume (StV = EDV-ESV) 
 Ejection Fraction (EF = StV/EDV) 
 Maximum time rates of volume change (three point averaged) 
o Peak filling rate (PFR) 
o Peak ejection rate (PER) 
 Time to PFR (difference between phase at which PFR occurred and end systolic 
phase) 
 
4.2 CMR Patient Database 
As it serves as the primary data source for all studies conducted in this thesis, a brief 
description of the Georgia Tech Single Ventricle CMR database is warranted. This 
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resource is the result of over 10 years of a multi-center collaboration between Georgia 
Tech, the Children’s Hospital of Philadelphia (CHOP) and Children’s Healthcare of 
Atlanta (CHOA). The database is comprised of complete CMR studies, both 
prospectively and retrospectively collected, for single ventricle patients in various stages 
of palliation, with particular focus on Glenn-stage patients and patients late after Fontan. 
All told, it includes data for 303 patients (at the time of this writing) and represents the 
largest known CMR library for TCPC hemodynamics. The investigations performed in 
this thesis drew primarily from the CHOP patient contributions to the database, 
specifically 100 such patients with a completed Fontan connection. However, the 15 
patient Y-graft series from CHOA is also a notable component. 
 
4.3 Computational Fluid Dynamics (CFD) 
The CFD methods employed in this thesis are all based on the assumption of 




   (Equation 4.14) 
     
   
   
 (Equation 4.15) 
 
where ρ is the fluid density, P is the static pressure, τ is the shear stress tensor, u is 
velocity, and μ is the fluid viscosity. The unsteady 3D velocity vectors were iteratively 
calculated through the solution of the incompressible continuity equation (Equation 4.16) 
and Newtonian form of the Navier-Stokes equations (Equation 4.17): 
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        (Equation 4.16) 
  
   
  
                      (Equation 4.17) 
 
where f represents generic body forces (such as gravity), which were neglected. The 
numerical solver used extensively throughout this thesis was developed and 
implemented through the PhD work of Dr. de Zélicourt124. A broad overview of its details 
is provided here, but the interested reader is referred to her work for a complete 
description. 
4.3.1 Solver Description 
The fluid solver is fundamentally based on the hybrid Cartesian sharp-interface 
immersed boundary method of Gilmanov and Sotiropoulos125. Herein, the external 
surface of the fluid domain (e.g., the fluid in contact with the lumen of a blood vessel in 
the case of vascular flows) is meshed with unstructured triangular elements and 
registered within a structured Cartesian grid. The grid cells are thus classified into one of 
three groups (Figure 4.20): 1) the fluid cells internal to the boundary, 2) the wall cells 
external to the boundary, and 3) the immersed boundary (IB) cells immediately interior to 
the wall. From this classification, the Navier-Stokes equations were discretized and 
solved in the fluid cell; the wall nodes were excluded from the computation; and the 
velocity of the IB cells was reconstructed through quadratic interpolation, assuming a 
rigid no-slip condition on the wall. To further improve computational efficiency for 
complex vascular structures, which tend to be small with respect to the bounding 
Cartesian volumes, de Zélicourt et al recast the computationally expensive structured 
Cartesian data in an unstructured formulation by completely discarding the wall nodes126. 
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Figure 4.20 2-dimensional representation of Cartesian grid cell classification with respect 
to the Immersed Boundary. External (Wall) cells (white) are external to the boundary. 
Immersed boundary (IB) cells (yellow) are internal and immediately adjacent to the 





4.3.2 Spatial Discretization 
With the geometry represented with an unstructured Cartesian grid, spatial derivatives 
are calculated using a basic three-point central differencing scheme:  
 
   
  
 
         
   
 (Equation 4.18) 
 
where i denotes cell index, and Δx is the spacing between cell centers. While this 
scheme represents one of the simplest approaches, it is not without potential challenges 
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and instabilities. Most notable are known oscillations in the pressure field when the 
pressure and velocity data are collocated (i.e., stored at the same grid location) and 
symmetric differencing operators are used. The instabilities in this scheme arise from the 
fact that Pi depends on ui-1 and ui+1, which depend on Pi-2, Pi, and Pi+2. Thus, the adjacent 
grid points are de-coupled and may evolve independently of each other.  
The most common solutions to this problem are either the introduction of artificial 
damping terms or the use of a staggered grid arrangement; that is, storing pressure 
values at cell centers and velocity values at cell faces. To overcome challenges in 
synchronization of boundary condition prescription with this latter approach, Gilmanov 
and Sotiropoulos proposed the use of a hybrid staggered/non-staggered formulation in 
which the boundary conditions are imposed on a non-staggered layout, the velocity 
values are mapped to their staggered cell face locations, and the Navier-Stokes 
equations are solved in the staggered configuration125. Figure 4.21 visually demonstrates 
this varying variable storage scheme for a single cell domain. Away from vessel 
boundaries, the non-staggered velocity values (at the cell centers) are reconstructed 
from the staggered velocities using a QUICK interpolation scheme: 
 
           
   
     
 
 
     
                   
    
 
 
     
 
 Equation 4.19. 
 
 
 - 84 - 
 
Figure 4.21 Representation of the hybrid Staggered/non-Staggered variable storage 
scheme. Pressure (P) values are stored at cell centers while velocities (u) are stored at cell 
face centers. In the boundary condition prescription, velocities are interpolated to the cell 





4.3.3 Temporal Discretization 
Time advancement was accomplished using a fractional-step integration method, a 
widely used approach for incompressible flows127. The method is comprised of three 
steps: a prediction step, where the fluid momentum equations are solved without 
enforcing continuity; a pressure correction step, which iteratively solves for the pressure 
correction term based on the intermediate velocity field obtained in the first step; and 
projection into divergence free space, which enforces continuity and advances the 
‘predicted’ intermediate variables in time. The first step was performed using a 4th order 
explicit Runge-Kutta method to obtain the intermediate velocity prediction, u*, from: 
 
  
    
 
  
    
    
 




   
   
  
    
 
      
 (Equation 4.20) 
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It is important to note that the pressure, P, in Equation 4.19 is the known pressure field 
from time, n, and only u* is advanced in time through that calculation. Because u* is not, 
by definition, divergence free, a correction must be applied to recast the result back into 
divergence free space. To do so, the incremental pressure field must be resolved. It can 
be shown that this incremental pressure, δP, is related to u* as: 
 
       
 
   
      (Equation 4.21) 
 
The solution of this Poisson equation (Equation 4.20) is non-trivial and is iteratively 
performed using the Flexible Generalized Minimal Residual (FGMRES) solver with a 
multi-grid pre-conditioner124, 128. With δP determined, Pn+1 and un+1 can be simply 
computed as: 
 
           (Equation 4.22) 
        
 
   
      (Equation 4.23) 
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4.3.4 Boundary Conditions 
As previously mentioned, all simulations performed in this thesis assumed static and 
rigid vessels and a no-slip boundary condition along those walls. The handling of the 
inlet and outlet boundary conditions was more varied although was always based on the 
PC MR-derived flows, as described in §4.1.3.  
4.3.4.1 Velocity reconstruction at the Immersed Boundaries 
Velocity values in the IB cells are handled differently than for fluid cells: rather than being 
calculated from the Navier-Stokes equations, the velocities are reconstructed based on 
wall normal vector and proximal fluid cell velocity. Figure 4.22 helps to visualize this 
protocol. The normal vector (      ) from the center (F) of the closest triangular surface 
mesh element (s) connects the immersed boundary cell center (G) to its respective fluid 
element (H). The value at G is then reconstructed via quadratic interpolation based on 
the known values at H and F (the latter being 0 for no-slip boundary conditions). The 
selection of quadratic interpolation has been shown to improve the results compared to 
simple linear schemes125. 
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Figure 4.22 Reconstruction of the solution at an IB-cell center (G) by interpolating 
between its projection onto the closest immersed-boundary and fluid elements (points F 
and H, respectively) along the local normal to the immersed-boundary. The light gray 






4.3.4.2 Inlet boundary conditions 
At the inlets (typically, only the SVC and IVC), either time-averaged (“steady”) or time-
varying (“pulsatile”) flow conditions were imposed as either a flat, plug-like velocity 
profile or a fully-developed parabolic velocity profile. The preference was generally for 
time-averaged conditions (although each section will explicitly state which condition was 
used) based on the relative simplicity of simulation implementation, analysis, and 
communication of results. Recognizing this selection as a potential limitation, however, 
an explicit comparison will be conducted between the two boundary condition types in 
Chapter 5 to better characterize the bias introduced.  
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An example of retained steady (dotted line) and pulsatile (box markers) flow conditions 
from a patient-specific measurement is demonstrated in Figure 4.23. It is noted that the 
character of the time-varying flow curve varied significantly both by patient and vessel, 
so while the time-averaged value in the present example appears to be a poor 
representation of the dynamic curve, the steady flow assumption is commonly employed 
in TCPC CFD modeling. It is also apparent from Figure 4.23 that the MR-derived flow 
measures have very few sample points compared to the temporal resolution needed for 
CFD. Hence, the measured flow curve underwent Fourier decomposition and 
reconstruction to achieve sufficient temporal sampling for pulsatile simulations. A 
minimum of 2000 time steps per cardiac cycle were used for pulsatile simulations, giving 




Figure 4.23 Example of time-varying vessel flow curve (square markers) and associated 
time-averaged flow magnitude (dashed line) measured from through-plane PC MR and 
used to prescribe inlet flow boundary conditions for CFD. 
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With respect to the selected velocity profile, the preference was generally for plug-like 
flow based on past-precedent124, although the parabolic profile was selected in some 
cases based on good observed agreement with PC CMR measurements. 
4.3.4.3 Outlet boundary conditions 
At the outlets, flow boundary conditions were again enforced except, to ensure mass 
convergence (which factors such as Fontan fenestration flow, measurement noise, etc. 
tend to distort in the measured data), these flows were often imposed as the ratio of the 
outlet flows scaled to the inlet flow magnitude. That is: 
 
     
    
           
    (Equation 4.24) 
 
where QS is the sum of the measured caval flows. The velocities 
reconstructed/extrapolated at the outlet cell faces (vG) are scaled to enforce these 
desired flow conditions and ensure mass conservation as follows: 
 
                        (Equation 4.25) 
 
where ΔQ is the difference between the desired mass flow rate, Q0, and current value 
based on the extrapolated values, as: 
 
                             (Equation 4.26). 
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4.3.5 Preparation of TCPC CFD Domain 
A step-by-step guide for model creation was provided in the appendices of Dr. de 
Zélicourt’s thesis124 and so only a brief description is provided here. Beginning with the 
smoothed tetrahedral surface model discussed at the end of §4.1.3, each inlet and outlet 
vessel must be cropped to provide a flat surface for the prescription of the boundary 
conditions discussed in the preceding section. Traditionally, these cuts are placed 
perpendicular to the central axis of the vessel immediately distal to venous confluences 
(for the SVC, IVC) or immediately proximal to arterial branches (for the PAs). However, 
because of the proximity of the Glenn and Fontan connections to the branching of the 
right upper PA lobe, it was necessary in many cases to explicitly include that branch in 
the computational domain and crop both the main and upper PA branches distal to the 
bifurcation. Once cropped, the ‘Exact Surfacing’ functionality in Geomagic Studio is used 
to create a NURBS (Non-uniform rational B-spline) model of the geometry and export in 
.igs format to be read by the meshing software, GAMBIT (ANSYS, Inc.).  
In Gambit, the vessel inlets and outlets were extended (by 10 and 50 mm, respectively) 
to ensure flow stability, minimize recirculation at the boundaries, and to reduce the effect 
of the chosen boundary condition profile on the hemodynamics in the domain of interest. 
The surface (including extensions and extended boundary faces) was then meshed with 
unstructured triangular elements and exported in the .FDNEUT format to be read by the 
IB solver pre-processor. Notably, a second mesh was also created and exported without 
the vessel extensions to be used in the post-processing steps such that only that actual 
domain of interest was used for the hemodynamic calculations. 
Finally, the pre-processing step is performed to: a) read in the TCPC surface mesh; b) 
specify the Cartesian grid node density (typically 2% of IVC diameter for mesh 
independence126) and range; c) register the immersed boundary within the structured 
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Cartesian grid; d) classify the fluid, wall, and IB nodes; e) create the geometric ‘Restart’ 
files and boundary condition cell indices to be read by the solver. 
 
4.3.6 Hemodynamic Metric Quantification 
The primary quantities of interest to be derived from the CFD simulations were: 
 Pressure drop: difference between cell centered running average pressure 
values at inlets and outlets of CFD domain (without flow extensions). 










   
Equation 4.27 
 
where p is the same static pressure values retained for pressure drop calculation, 
dA is the differential area of the inlets and outlets, and ρ is fluid density (set to 
1060 kg/m3). Because of the known dependence of power loss on bulk flow rates 
and patient size, the use of an appropriate normalization framework for power 
loss is critical when performing across-patient comparisons. In this thesis, two 
such frameworks were used extensively.  
o Resistance: To create an analog to the common clinical measure relating 
pressure drop through a vascular bed to the local flow rate, a power loss-
based pressure drop (ΔPTCPC=
  
  
) was defined (here, Qs is the systemic 
venous flow rate in units of m3·s-1) to calculate the connection resistance 
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(  
      
      
) in Wood Units (WU; mmHg·min·L-1); here, Qs in units of 
L·min-1. 
o TCPC Energy Dissipation Index (TCPC-EDI): Based on the work of Dasi 
et al.129, 130, PL was indexed (
  
   
      
) to calculate the dimensionless 
TCPC-EDI, where Qs is the systemic venous flow (here, in units of L·s
-1), 
BSA is the body surface area [m2]. 
 Hepatic (IVC) flow distribution (time-averaged simulations only): the running 
average velocity field was imported into Tecplot and streamlines are seeded at 
every point in a selected IVC cross-sectional slice. The streamlines are 
segregated based on the PA in which they terminate (i.e., they are classified as 
either LPA or RPA streamlines) and the fluxes (i.e.,                  ) of the 
streamlines (p) are computed based on the velocity (u) of the IVC seed point and 
the differential area. The relative distribution (
    
           
) is then quantified and 
retained. 
 Particle residence time (pulsatile simulations only): Using the in-house particle 
tracking program developed by de Zélicourt124, post-processing of pulsatile 
simulations included an IVC particle tracking analysis. A cross-sectional slice at 
the base of the IVC was selected and uniformly seeded 50 times over 1 cardiac 
cycle85. A total of 5 cardiac cycles were then simulated to allow for particle 
advection through the connection. As with the streamline analysis, particles were 
categorized as either LPA or RPA particles depending on termination location, 
and the relative proportion of these particles were quantified to give the flow 
distribution. In addition, the ‘temporal probability’ output from the code was 
imported into Tecplot to quantify statistics about the particle residence times. The 
calculated values include:  
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o Minimum transit time (shortest time for a particle to reach an outlet) 
o Mode transit time (residence time of the highest number of particles) 
o Maximum transit time (longest time registered for more than one particle). 
Figure 4.24 visually represents these points with respect to the residence time 
histogram. The selection for maximum time may be counter-intuitive; however, it was 
selected primarily for its objective repeatability in identification. As can be appreciated in 
Figure 4.24, many particles have longer transit times than the point marked as the 
maximum; yet, it cannot be conclusively said that even the highest (i.e., furthest to the 
right) point registered is the maximum without running many more cycles to capture very 
slow moving particles. Hence, that definition would introduce operator variability on the 
basis of selected cycle number and is arguably not representative of the higher end 
transit time experienced by ‘most’ particles. The times reported in each case were re-
dimensioned by multiplication by the characteristic velocity (VIVC) divided by the 
characteristic length scale (DIVC) to give units in seconds. 
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Figure 4.24 Visual representation of retained particle tracking statistics (minimum, mode, 
maximum) from residence time histogram. 
 
 
4.4 Lumped Parameter Modeling 
To help in relating the local effects of the TCPC to the broader single ventricle 
physiology, an electrical circuit analog model of the cardiovascular system was 
employed. This lumped parameter model was based on the circuit used by Pekkan et 
al96 and Sundareswaran et al.55. In this scheme, the ventricle, arteries and veins are 
treated as time-varying compliance chambers while capillary beds are represented as 
lumped resistances. The TCPC is additionally modeled as a lumped resistance value in 
series between the systemic and pulmonary circuits. 
The instantaneous flow and pressure from compartment i to compartment j of this model 
are thus evaluated by iteratively solving the following set of differential equations until 
convergence: 
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     (Equation 4.28)  
       
  
            
 
    (Equation 4.29) 
 
where P, Q, and C are the pressure, flow and compliance in a given compartment; R, L, 
and S are the resistance, lumped impedance, and valves between compartments. 
Based on the needs of the studies considered in this thesis, the previously developed 
models were amended by considering the superior and inferior systemic compartments 
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Figure 4.25 Schematic of lumped parameter circuit for single ventricle cardiovascular 
system including separate compartments for the superior and inferior systemic circuits. 
MV- mitral valve; V- ventricle; AV- aortic valve; R- resistance; C- compliance; SA- systemic 
arteries; SV- systemic veins; CPC- cavopulmonary connection; PA- pulmonary arteries; 
PV- pulmonary veins 
 
 
4.5 TCPC Geometric Characterization 
Understanding that there is a tight coupling between the geometric characteristics of the 
TCPC and its hemodynamics, there is a concurrent need to measure these features and 
relate them to the CFD-derived hemodynamics to gain a more explicit knowledge of this 
relationship. To this end, the vascular modeling toolkit (VMTK; vmtk.org) was used to 
extract geometric features of the reconstructed TCPC CFD models. 
VMTK is an online and open-sourced collection of libraries and tools specifically tailored 
and designed to handle the 3D reconstruction, geometric analysis, mesh generation, and 
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surface data analysis for image-based models of blood vessels. It has been used 
extensively in the study of intra-cranial aneurysms131; however, many of the same 
principles apply to the study of the TCPC.  
The geometric analysis in VMTK is based upon the identification of vessel centerlines, 
defined as the result of a functional minimization such that the minimal distance of the 
line to the vessel lumen is maximized. With the centerlines of each vascular branch of 
the connection identified, the characteristics of their union (i.e., the centerline bifurcation 
vectors, b) can also be identified. An example of the computed centerlines and 
bifurcations for a given TCPC reconstruction is shown in Figure 4.26. A full step-by-step 
protocol and custom script for TCPC analysis in VMTK is provided in the appendices. 




Figure 4.26 Visual representations of angle definitions between (left) VC-PA connections, 
(top-right) the PA branches, and (bottom-right) vena cavae. 
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The features of interest retained from the centerline calculation were as follows: 
o At each point along the centerline, the maximum inscribed sphere radius was 
calculated by VMTK; the diameter (D) of each vessel was obtained by doubling 
this radius. The minimum, mean and maximum diameters were thus computed 
for all vessels. Additionally, the variation of diameter along vessel was defined as 
the stenosis index (SI): 
      
    
    
 (Equation 4.30) 
 
An SI of 0 represents an ideal, uniform cylinder, a value of ~1 would indicate that 
Dmin is ~0. 
o The angle (θ) between any 2 vessels (Figure 4.26) was quantified by computing 
the dot product of the corresponding bifurcation vectors (b): 
 
        
       
        
  (Equation 4.31) 
o Caval offsets (Figure 4.27 were computed by projecting the displacement 
between the IVC and SVC vector onto (1) the anterior-posterior axis (AP offset; 
negative when the IVC is anterior to the SVC), and (2) the right-left axis (RL 
offset; negative when the IVC is to the right of the SVC). The VC-PA offset was 
defined as the shortest distance between the two centerlines from IVC to SVC 
and from LPA to RPA. 
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Figure 4.27 Visual definition of caval offsets (left) in the anterior-posterior direction, 
(middle) in the right-left direction, and (right) with respect to the PA axis. 
 
4.6 SURGEM: Virtual Surgery Interface 
The ability the accurately recreate the surgical interventions to successfully model 
procedures is a critical requirement for the development of virtual surgery tools. Pekkan 
et al. detailed SURGEM as the solution to this need110. Developed through 
collaborations between Drs. Yoganathan and Rossignac (GT College of Computing), 
SURGEM provides an interface for a user to re-create virtual surgical connections based 
on patient-specific templates using independent 3D spatial control via PHANTOM Omni 
haptic devices (Geomagic Inc.) (Figure 4.28). In other words, the reconstructed anatomy 
from CMR can be loaded into the software and a virtual cylinder can be registered to the 
anatomy to mimic the positioning of the surgical baffle. 
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Figure 4.28 Virtually interfacing a virtual surgical baffle (red) with reconstructed patient-
anatomy (blue) using 3D haptic devices. youtube.com 
 
The realism of the output of this naturally depends on the proper constraint of the work 
space. For Fontan surgery, this means that simply visualizing a patient’s Glenn 
connection and proximal IVC ‘in a vacuum’ is unlikely to yield satisfactory results. 
Instead, it is regular practice to incorporate those elements as well as surrounding 
anatomical structures into the interface in order to properly orient the virtual connection 
to realistic landmarks. An example is shown in Figure 4.29 wherein the Fontan pre-
cursors (bilateral bidirectional Glenn and proximal IVC) are shown in blue, the 
surrounding anatomy (heart, aorta, pulmonary veins) are shown in orange, and the 
virtual Fontan baffle is shown in red. Control of the baffle is achieved at the three control 
points located distributed along its centerline, such that the cylinder can be elongated, 
shortened, or curved in any direction. Importantly, no material properties are introduced 
and the cylinder will contort to any shape imposed on the centerline.   
Even with the inclusion of surrounding anatomy, it is important to appreciate common 
surgical landmarks to accurately replicate what is done in the operating room. For 
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example, extracardiac Fontan connections are typically positioned close to the junction 
of the pulmonary veins and the atrium, as shown in the right side of Figure 4.29. Lateral 
tunnel connections are more challenging to emulate with the current software; however, 
the ‘inside-out’ viewing mode does facilitate visualization of internal structures as 
needed. Thus, the SURGEM software provides all the basic tools necessary to cover a 
broad range of modeled interventions. 
Alternative methods for virtual anatomic design have been proposed132; however, there 
are several key distinctions. SURGEM is user driven, as opposed to being an automatic 
framework, which makes it sub-optimal for robust optimization since the user would have 
to create each individual geometric alteration. However, this feature also means that the 
model designs are created visually, which is the way the surgery is performed, and so 
are more intuitive and natural than parametric representation of a curve, and can better 
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Figure 4.29 Patient-specific reconstruction of bilateral bidirectional Glenn connection 
(blue) with surrounding anatomy (orange) in the SURGEM interface. The virtual surgical 
baffle is shown in red and can be seen being positioned from IVC to the right Glenn 
connection in the image at right. 
 
 
4.7 Section Summary 
MRI is a diverse and robust clinical imaging modality whose numerous strengths made it 
an ideal basis for the acquisition of patient-specific anatomic and functional data for 
analysis in this thesis. Over the past decade, a diverse and powerful set of 
complementary tools have been developed in our group to make use of the potential of 
the MR images to extract valuable functional information at a patient-specific level and 
improve physiologic understanding. These include: TCPC anatomic reconstruction and 
geometric characterization; quantification of in vivo flows from PC MR, both in a single 
vessel and in a volumetric domain; and the computational simulation of local 
hemodynamics with very high temporal and spatial resolution.  
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The computational tools in particular represent a robust and valuable asset in the study 
of single ventricle palliation. Such methods, in addition to providing superior spatial and 
temporal resolution compared to CMR flow measurements (for improved quantification 
of metrics like power loss), CFD also allows for the parametric variation of specific 
variables to observe their individual impact. Such variables could be simple boundary 
condition adjustments, to model exercise physiology or changing pulmonary vascular 
tone, or could be complex modeling of entirely new patient-specific connections (as 
created with the SURGEM interface). These strengths are all leveraged in various ways 
throughout this thesis to better our understanding of TCPC hemodynamics and its role in 
single ventricle physiology. 
A schematic of how these methodologies fit together to produce the study metrics of 
interest is provided in Figure 4.30. For the first time, this thesis builds upon each of these 
prior developments and deploys them in unprecedented study sizes to provide the best 
opportunity to date to relate TCPC hemodynamics to patient functional outcomes. 
 
 
 - 104 - 
 
Figure 4.30 Schematic of methodology workflow from MRI to the various investigational 
methods employed in this thesis. 
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Chapter 5. SPECIFIC AIM 1: ANALYSIS OF TCPC 
HEMODYNAMICS IN A LARGE PATIENT COHORT 
5.1 Overview 
In the present era, operative mortality for the Fontan procedure is low22, 133, but gradual 
attrition is a significant problem29. The TCPC is known to mediate an adverse 
hemodynamic environment45 and in some cases, strong hypothetical connections can be 
drawn between these adverse hemodynamics and the cause or exacerbation of chronic 
morbidities. For example, poor exercise tolerance may be related to non-linear power 
loss increases across the connection134; poor distribution of hepatic factors to the lungs 
is widely believed to be related to the development of pulmonary arteriovenous 
malformations (PAVM58). For these reasons, the TCPC has been the focus of a large 
body of research54.  
Early optimization studies using idealized models identified modifications to reduce 
venous collision and improve flow efficiency such as a caval offset and vessel flaring75, 
135-137. However, it was soon realized that the 3-dimensional hemodynamics of patient-
specific connections can be much more complex than can be appreciated with such 
simplified models80. A majority of studies over the past decade have therefore used 
medical imaging and/or computational fluid dynamics (CFD)81, 85, 107, 134, 138, 139, 91, 92 to 
characterize TCPC flows at a patient-specific level. These investigations have been very 
successful in incrementally improving fundamental physiologic knowledge55 and 
providing surgical insights105.  
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There are inherent challenges to the use of patient-specific models. Considerable effort 
and resources are required to amass and analyze such data in significant quantities; the 
largest Fontan CFD study to date included only 16 patients55. Furthermore, the ability to 
draw generalizable conclusions based on small samples of patient-specific results is 
limited and must be approached with caution. If local dynamics and energetics of TCPC 
flows are an important determinant of patient functional health status and quality of life 
as they are hypothesized to be, larger sample sizes are needed to power the analysis of 
such outcome metrics.  
The NIH-supported GT CMR Fontan database is therefore a valuable resource, which 
can provide significant sample sizes for these detailed hemodynamic evaluations. By 
leveraging these data, this study provides an unprecedented patient population for being 
able to answer these questions. The broad objective was therefore to use the image-
based patient-specific data to perform numerical simulations and quantify hemodynamic 
parameters of interest. These parameters can then be used to: a) establish mean values 
for this population; b) statistically relate the findings to other functional measures, such 
as cardiac index or systemic venous flow; c) compare results across surgical (intra-atrial 
vs extracardiac) or anatomic (single RV vs. single LV) templates and observe biases. 
The basic outline for the chapter is as follows. First, the protocol used for patient 
selection, CFD simulation, and statistical analyses will be discussed. Next, an in depth 
comparison of selected computational results against 4D PC CMR-derived velocity fields 
will be performed to provide verification for solver accuracy (in addition to the formal 
validation studies previously conducted). An explicit comparison of results from steady 
vs. pulsatile flow boundary condition simulations will provide further indication of the 
impact of limiting assumptions employed in the modeling effort. Finally, moving to the 
core of our study, we will detail the results for the entire patient cohort study, including 
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3D CFD results and statistical analyses of key hemodynamic metrics, followed by the 
VTMK geometric analysis and, finally, the comparison of geometric and hemodynamic 
metrics in order to identify potential predictors of global TCPC performance.  
 
5.2 Study Protocols 
5.2.1 Patient Selection 
As discussed in §4.2, the GT Fontan CMR database contains results from over 250 
patients with a single ventricle. From these, 114 patients consecutive patients were 
selected on the bases of: a) having a completed Fontan connection (i.e., excluding 
patients at the Glenn stage); and b) having been imaged at CHOP. Patients were then 
excluded on the bases of severe CMR artifacts in the available data, lack of sufficient 
phase contrast velocity data, or diagnosis of Ebstein’s anomaly, reducing the number of 
investigated patients to 100. Basic demographic details for these 100 patients are 
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Table 5.1 Patient demographic details 





Body Surface Area 
(m2) 








IA- Intra-atrial; EC- Extracardiac; APC- Atriopulmonary; HLHS- Hypoplastic Left Heart 
Syndrome; Continuous data reported as mean ± st. dev.; See Table 12.1 in Appendix A. 
 
 
5.2.2 CFD Protocol 
Simulations were divided among several investigators, with the candidate completing 
over 50% of the total. Unless otherwise indicated, simulations employed time-averaged 
boundary conditions based on the phase contrast velocity data for each vessel. At the 
inlet extensions, a flat velocity profile was imposed based on the vessel-specific flow rate 
measured. The presence of a fenestration was generally ignored, although in more 
recently acquired data in which PC MR planes were acquired above and below the 
fenestration, the flow rate from the acquisition above the fenestration was retained (see 
Appendix A).  
Since the sum of the measured inflows usually exceeds the sum of the measured 
outflows (due in part to fenestration flow), imposing the measured pulmonary artery flow 
rates would typically violate conservation of mass compared the inlet flow rates. 
Accordingly, flow boundary conditions at the outlet extensions were not imposed based 
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on the measured outflow rates, but rather based on the ratio of these measured vessel 
flows to total pulmonary arterial flow. In a few selected cases, primarily when a stenosis 
was present in one branch pulmonary artery, the measured flow rate in the stenotic 
artery was retained for the simulation while flow through the contra-lateral branch 
pulmonary artery was assumed to be equal to the total caval return less the flow in the 
stenotic artery. It is known that connection 109nergetic are dominated by localized PA 
stenoses140 so the above-described practice prevented the artificial increase in imposed 
flow across the stenotic region. For geometries in which the right upper lobe branch 
artery was retained in the computational domain, the measured RPA flow split (taken 
proximal to the branch) was divided between the lower and upper branches based on 
the ratio of their respective areas. 
For all simulations, convergence at each time step was ensured by constraining the 
relative residuals of the Poisson solver to decrease by 8 orders of magnitude. Time was 
advanced (for steady simulations) until convergence of the running average to the 
instantaneous mean. This was assessed by tracking pressure and velocities at selected 
points within the computational domain, typically in the center of the connection and at 
proximal and distal (with respect to the artificial extensions) outlet points.  
5.2.3 Statistical analyses 
Statistical analyses were performed using Minitab (Minitab Inc., State College, PA). 
Continuous variables (e.g., TCPC-EDI, HFD) were tested for normality using the 
Anderson-Darling test. The Student’s t-test and Mann-Whitney test were used for 
comparisons between groups, as appropriate, while Pearson’s R or Spearman’s ρ tests 
were used for correlations. P-values less than 0.05 were considered statistically 
significant in all cases. Partial correlation was used, as needed, to correct for the 
confounding effects of other independent variables. The analysis presented here is 
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exploratory in nature, and thus no adjustments were made for potential inflation of Type I 
error (i.e., rejection of a potentially true null hypothesis) due to multiple comparisons. 
 
5.3 Modeling Verification 
5.3.1 Comparison of 4D PC CMR with CFD 
From the 100 patient CFD cohort, 8 patients had sufficiently high quality 4D PC CMR 
data (particularly in the PAs to allow for quantification of flow distribution) for a detailed 
cross-modality comparison. Such comparisons were performed to provide additional 
verification that the simulated results used for subsequent statistical and functional 
analyses are representative of the in vivo hemodynamics. Much of the credit for this 
section belongs to Dr. Kartik Sundareswaran who implemented the CMR interpolation 
scheme and reconstructed the flows for the 8 cases presented119. 
The following paragraphs present the analysis for the 8 patients; it is noted that multiple 
patient IDs are provided to reflect the identifiers in our three database entries; namely, 
the original bioengineering research partnership (BRP) grant database, the new 
designations of the 2010 R01, and surgical planning database (when applicable). It 
should also be noted that the power loss results from the CMR data are routinely an 
order of magnitude less than the CFD because the CMR values are calculated from 
viscous dissipation, thereby using velocity gradients, and their accuracy is hindered by 
the poor measurement resolution near the walls where gradients are typically the 
highest.  
For each patient, the velocity fields are visually represented with: A) velocity streamlines 
from the time-averaged CFD; B) a representative series of instantaneous velocity 
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streamlines from CMR; C) streamlines from the time average of the CMR data; and D) 
instantaneous snapshots from CMR particle tracking. 
5.3.1.1 CHOP068/CHOP064A (Figure 5.1) 
This patient had a lateral tunnel (LT) Fontan connection to a hemi-Fontan SVC 
anastomosis, resulting in a large ‘pouch’ anteriorly offset from the pulmonary arteries.  
Figure 5.1 shows a comparison of velocity encoded streamlines for the time-averaged 
CFD (A) and the instantaneous time points from the 4D PC CMR (B).  
Focusing on the CMR results first (Figure 5.1B, Figure 5.1C), the clear defining 
characteristic of this connection is the large, dynamic central vortex in the LT pouch 
region. Owing to the right offset of the SVC anastomosis compared to the LT, as the 
SVC flow enters the connection it collides with the IVC flow, which has a right-to-left 
directionality from the LT curvature, creating a rapid direction change in the SVC flow 
and further constraining the IVC flow along the left lateral wall. The combined flow 
streams traverse right-to-left and anterior-to-posterior through the connection (giving the 
appearance of the central vortex with the incoming SVC flow) before colliding with the 
posterior wall of the connection and dividing between the right and left pulmonary 
arteries. Figure 5.1D shows an instantaneous snapshot of IVC particle tracings providing 
improved visualization of the IVC dynamics within the connection. 
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Figure 5.1 CHOP064A (intra-atrial): Velocity streamlines from A) time-averaged CFD, B) 
instantaneous CMR reconstructions, and C) time-averaged CMR. D) IVC Particle tracing 
from CMR data. A large counter-clockwise recirculation is present in the center, formed by 
the right-to-left and anterior-to-posterior motion of the IVC and SVC flows at their collision 
point. The recirculation center is not as well defined in the CFD as in the CMR owing to 
differences in the cross-sectional velocity profile (best seen in the particle tracing). 
 
 
By comparison, the CFD streamlines (Figure 5.1A) demonstrate very similar 
characteristics. A counter-clockwise recirculation pattern is evident in the connection at 
the collision of the IVC and SVC flows and the local velocity magnitudes are in good 
agreement, despite the variations present in the time-varying results. There is a 
noticeable difference in the location of the center of recirculation, as well as the fact that, 
in the CFD, it is the SVC that is constrained along the right lateral wall more so than the 
IVC being constrained along the left wall. These minor differences likely reflect non-
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uniformities in the inlet velocities, i.e., rather than uniformly distributed and 
perpendicularly directed (with respect to the vessel cross-section) velocities at the inlets, 
the in vivo distributions and angles vary, leading to small differences in the location and 
dynamics of flow collision. 
Quantitatively, the flow distribution results were varied slightly (66% vs. 82% IVC to LPA 
for CMR and CFD respectively), likely reflecting the varied location of IVC-SVC 
interactions (more SVC flow exited the RPA in the simulations, consistent with the 
rightward constraint). Power loss quantities were 0.04 mW and 0.5 mW for PC MR and 
CFD, respectively. 
5.3.1.2 CHOP073/CHOP069A (Figure 5.2) 
As in the previous case, this patient had a lateral tunnel/hemi-Fontan connection and the 
local hemodynamics were again characterized by complex recirculation within the 
connection region. From the 4D PC CMR (Figure 5.2B and Figure 5.2C, results shown 
from a posterior perspective to facilitate visualization), the SVC flow is constrained to the 
right lateral wall upon entering the connection and primarily exits the RPA. The IVC flow 
appears to skew along the outer wall of the tunnel curvature and recirculate posteriorly 
and left to right within the connection (this is better seen in the instantaneous particle 
tracings in Figure 5.2D). The resulting IVC-to-LPA flow thus has a high degree of 
secondary flow apparent in the velocity streamlines. 
The CFD streamlines are similar with respect to the constrained SVC-to-RPA flow; 
however, the complexities of the IVC flow within the connection appear to be slightly 
altered with decreased secondary flow magnitudes. Again, differences in the inlet 
velocity profile may mediate this discrepancy. It is noted that the streamlines in the 
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proximal IVC/Fontan baffle are more disturbed in the PC CMR results than the uniform 
distribution imposed on the CFD. 
The flow distribution results compared favorably: 59% vs. 47% IVC-to-LPA (CMR vs. 
CFD). The reason for the slight difference is not immediately clear from the flow fields 
since the SVC flow appears to be entirely constrained to the RPA in both cases; small 
differences in volume flow rates to the respective vessels or limited PC CMR temporal 
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Figure 5.2 CHOP069A (intra-atrial): Velocity streamlines from A) time-averaged CFD, B) 
instantaneous CMR reconstructions, and C) time-averaged CMR. D) Sequential (from left 
to right) IVC particle tracings from CMR data. As best seen from the particle tracings, the 
IVC flow is skewed along the outer wall of the lateral tunnel and recirculates posteriorly 
from left to right. The SVC flow is constrained to the RPA and a portion of the IVC flow 
continues a 360° (or more) rotation to exit the LPA. Not all of this complexity was captured 
by the CFD because of non-uniformity of the IVC velocity inlet profile. 
 
 
5.3.1.3 CHOP078/CHOP074A (Figure 5.3) 
This patient has many of the same anatomic (LT) and hemodynamic features discussed 
in the previous two cases. Here, the PC CMR and CFD streamlines qualitatively reveal 
the same flow features: IVC flow is directed right-to-left, anterior-to-posterior as it enters 
the connection. Furthermore, the less “bulgy” nature of this connection compared to the 
previous examples, and more streamlined Fontan flow in the CMR data facilitated this 
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improved qualitative agreement. The posterior wall appears to act as a flow dividing 
point, splitting the IVC flow between the left and right PAs (Figure 5.3D). The SVC is 
entrained along the right lateral wall by the incoming IVC flow stream and exits entirely 
through the RPA. 
Reasonable agreement was seen in comparing the IVC flow distributions (73% vs 60% 




Figure 5.3 CHOP074A (intra-atrial): Velocity streamlines from A) time-averaged CFD, B) 
instantaneous CMR reconstructions, and C) time-averaged CMR. D) Sequential (from left 
to right) IVC particle tracings from CMR data. The IVC flow dominates local dynamics, 
constraining the SVC flow along the right lateral wall and forcing a local recirculation zone 
as the SVC flow is redirected toward the RPA. The qualitative velocity streamlines were 
well conserved between CMR and CFD. 
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5.3.1.4 CHOP089/CHOP082A (Figure 5.4) 
While the first three patients exposed above all had a lateral tunnel (LT), this patient and 
the 3 following ones featured the other common surgical approach to Fontan surgery; 
namely, an extracardiac conduit Fontan to a bidirectional Glenn SVC-PA anastomosis. 
In this patient, no offset was present between the inferior and superior caval 
connections, yielding direct collision of the IVC and SVC flows in the connection (as 
seen from both modalities, Figure 5.4A, B, and C). Despite the caval flow collision, flow 
in the PAs remains ordered and laminar with the IVC component fairly evenly distributed. 
Here, the IVC flow distributions were different by only 3% (60% vs. 57% to the LPA for 
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Figure 5.4 CHOP082A (extracardiac): Velocity streamlines from A) time-averaged CFD, B) 
instantaneous CMR reconstructions, and C) time-averaged CMR. D) Sequential (from left 
to right) IVC particle tracings from CMR data. With no lateral offset between the SVC and 
IVC anastomosis locations, the caval flows collide and appear to both divide relatively 
evenly and smoothly transition laterally into the PAs. The qualitative velocity streamlines 
were well conserved between CMR and CFD. 
 
 
5.3.1.5 CHOP090/CHOP083A (Figure 5.5) 
A slight caval offset is seen with the extracardiac Fontan baffle offset to the RPA with 
respect to the bidirectional Glenn connection. As a result (as can be seen in both 
modalities, Figure 5.5 A, B, and C), there is a noticeable bias of SVC flow to the LPA. A 
significant secondary flow pattern develops in the IVC flow as it enters the connection 
through interactions with SVC flow and the superior wall of the PAs before primarily 
exiting the RPA. 
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Figure 5.5 CHOP083A (extracardiac): Velocity streamlines from A) time-averaged CFD, B) 
instantaneous CMR reconstructions, and C) time-averaged CMR. D) Sequential (from left 
to right) IVC particle tracings from CMR data. The Fontan baffle was positioned with 
roughly a half-diameter offset toward the RPA and as a result, the caval flow collision 
directs all the SVC flow exclusively to the LPA while the IVC flow perfuses both PAs with a 
high degree of secondary recirculation. The qualitative velocity streamlines have excellent 
agreement between CMR and CFD. 
 
 
In addition to the excellent agreement of local velocity magnitudes between the CMR 
and CFD flow fields, good agreement was seen between the IVC flow distribution results 
(32% vs 48% to the LPA for CMR and CFD, respectively). The power loss comparison 
was particularly weak (0.17 mW vs. 5.7 mW), perhaps owing to significant CMR signal 
drop off in the LPA distal to the sub-aortic narrowing (site of significant convective 
acceleration), as evidenced by the loss of streamlines (Fig 5.5B) and the constraining of 
IVC particles along the inferior vessel wall (Fig 5.5D). 
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5.3.1.6 CHOP091/CHOP084A (Figure 5.6) 
As another extracardiac connection without a visible caval offset, this connection is 
characterized by a direct collision of SVC and IVC flows. In fact, a distinct stagnation 
point is apparent in all figures across modalities. As was the case in CHOP089, the 
result of this collision is an apparently laminar and ordered transition from caval to 
pulmonary flows. The lack of large scale secondary flow structures in the CMR particle 
tracking (Figure 5.6D) particular supports this observation. 
Quantitatively, the differences between CMR and CFD were on par with the prior cases: 
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Figure 5.6 CHOP084A (extracardiac): Velocity streamlines from A) time-averaged CFD, B) 
instantaneous CMR reconstructions, and C) time-averaged CMR. D) Sequential (from left 
to right) IVC particle tracings from CMR data. Despite curvature of the Fontan baffle, the 
hemodynamics do not demonstrate effects of a caval offset. Instead, the flows collide 
(forming a distinct stagnation point) and divide smoothly to the PAs. The qualitative 
velocity streamlines, particularly the stagnation point at the center of the connection have 
excellent agreement between CMR and CFD. 
 
 
5.3.1.7 CHOP095/CHOP088A (Figure 5.7) 
The dynamics of this connection resemble those of CHOP090 owing primarily to the 
presence of a slight Fontan-to-RPA offset. Specifically, caval flow collision directs the 
majority of SVC flow to the LPA, while flow through the Fontan baffle tended toward the 
RPA with time varying magnitude. The time variation is perhaps best seen in the particle 
tracings (Figure 5.7D) in which the IVC particles are initially confined toward the RPA 
 - 122 - 
(far left) before spreading through the connection and reaching both PAs (right two 
images). 
HFD values were again in good agreement across modalities (20% vs. 27% LPA, CMR 
vs. CFD, respectively). Power loss agreement was much weaker (0.12 mW vs. 4.2 mW), 





Figure 5.7 CHOP088A (extracardiac): Velocity streamlines from A A) time-averaged CFD, 
B) instantaneous CMR reconstructions, and C) time-averaged CMR. D) Sequential (from 
left to right) IVC particle tracings from CMR data. The Fontan baffle was again offset 
toward the RPA, directing the SVC flow exclusively toward the LPA. The CMR results do 
reveal significant time-varying features (both in velocity magnitudes and direction of IVC 
flow), yet the CFD streamlines do appear to capture the general features well. 
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5.3.1.8 CHOP170/CHOP143A/CHOP_M1 (Figure 5.8) 
This connection represents one of the most complex geometries and hemodynamic 
profiles in the GT database and was the focus of a recent manuscript discussing the use 
of surgical planning to correct pulmonary arteriovenous malformations61. This patient has 
a complex anatomical configuration characterized by interruption of the IVC with 
continuation of the azygos vein to the SVC. In other words, the inferior venous blood 
flow is carried not by the IVC but by an enlarged azygos vein, leaving only the hepatic 
veins natively connected to the inferior side of the right atrium. In addition, the 
connection of the innominate vein and the right SVC in this patient occurred at the level 
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Figure 5.8 CHOP143A (Interrupted IVC-extracardiac hepative venous connection): Velocity 
streamlines from A) time-averaged CFD and B) instantaneous CMR reconstructions. C) 
Sequential (from left to right) hepatic vein particle tracings from CMR data. Complex 
interactions among the superior (SVCs plus Azygos) venous flows preferentially direct 
hepatic flow to the RPA. The qualitative velocity streamlines, particularly in the complex 
patterns of the hepatic venous flow have excellent agreement between CMR and CFD. 





The local hemodynamics were equally complex. The majority of systemic venous flow 
exited the LPA (as witnessed by the very high velocities in that vessel), and based on 
the streamlines (from both modalities) the SVC, innominate vein, and azygos flows were 
the primary contributors to LPA flow at the exclusion of the hepatic venous flow. In fact, 
as best seen by the particle tracings (Figure 5.8C) the hepatic flow, despite a preferential 
right-to-left curvature of the Fontan baffle, became entrained in higher momentum 
superior venous flows at the distal end of the baffle and made a nearly 180° turn and 
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exited the RPA. These hemodynamic findings are consistent with the diagnosis of left 
lung PAVMs, as mentioned. 
Despite the complexity of these flow patterns, flow distributions across modalities were 
very well conserved: 13% vs. 12%, CMR vs. CFD, respectively. Power loss results in 
this case were very divergent (0.3 mW vs. 30 mW for CMR and CFD, respectively) 
because the high velocities through the stenosed LPA were not captured by the CMR 
data. 
 
5.3.1.9 Section Limitations and Summary 
The preceding section provided direct comparisons, both qualitative and quantitative, 
between TCPC hemodynamics separately derived from computational simulations and 
medical imaging reconstruction for a series of 8 patients. The objective of the 
comparison was to provide support, in addition to formal and successful past validation 
studies61, 124, 126, for the realism and validity of the computational results for capturing the 
in vivo hemodynamics characteristics. 
It is first important to point out the significant limitations inherent to comparing CMR and 
CFD in the context of the quantitative discrepancies seen. First, the specific comparison 
made was between dynamic, interpolated results acquired and averaged over numerous 
cardiac cycles and static simulations whose boundary conditions were obtained from a 
separate CMR acquisition. Thus, there is a significant dependence on the stability and 
repeatability of the patient’s cardiac and respiratory function to ensure consistency 
between both the through plane and coronal acquisitions and during the potentially 
lengthy coronal stack acquisition.  
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Another significant issue is the large inherent difference in the spatial scales of the two 
modalities, which has profound implications on the ability to assess power loss via CMR. 
Fontan 4D PC CMR studies have reported voxel sizes ranging from 5.8-17.5 mm3 91, 92, 
while the grid size for the solver in our study was on the order of 0.05 mm3. These 
differences have significant implications for the ability of each method to resolve 
velocities close to vessel boundaries and accurately evaluate spatial derivatives of the 
velocity fields, both of which are crucial for hemodynamic power loss evaluation. Table 
5.2 summarizes the relative merits of these two modalities for studying TCPC flows. 
 
Table 5.2 Relative merits of 4D PC CMR and CFD for studying patient-specific TCPC 
hemodynamics 
 4D PC CMR CFD 
PROS 
 Velocity fields include effects of 
respiration, cardiac cycle variation, 
and vessel motion/elasticity 
 No assumptions needed for 
inlet/outlet boundary conditions 
 No assumptions needed for blood 
rheology 
 High spatial and temporal  
resolution 
 Results naturally adhere to 
laws of fluid mechanics, 
including mass conservation 
 Needed input from imaging 
limited to short, basic 
sequences 
CONS 
 Requires specialized CMR 
sequences not universally 
available 
 Limited spatial and temporal 
resolution 
 Requires long scan times 
 Data acquired piece-wise and 
averaged over many cycles 
 Must prescribe boundary 
conditions at inlets and 
outlets 
 Typically neglect respiration 
and wall motion 
 Typically assume Newtonian 
rheology 
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Hence, the CMR power loss values were almost uniformly an order of magnitude lower 
than the corresponding CFD power losses (Table 5.3). It can therefore not be claimed 
that the CMR provides the desired verification in this aspect of the numerical results; 
however, this limitation is not unique to the present study and thus most prior power loss 
validation studies have relied on other experimental methods and produced much better 
matches to control volume computational analyses141. 
Rather than power loss, the appropriate focus is therefore on the qualitative velocity 
comparisons and the quantitative HFD differences. With respect to the former, the 
agreement was generally very strong, as evidenced from Figure 5.1, Figure 5.2, Figure 
5.3, Figure 5.4, Figure 5.5, Figure 5.6, Figure 5.7, and Figure 5.8. While some subtle 
variations and dependencies were noted as a function of the detailed inlet cross-
sectional velocity profiles (as in CHOP064A and CHOP069A), the defining flow 
characteristics of each connection were well conserved across modalities. Specifically, 
the three intra-atrial connections were all characterized by 3-dimensional vortical 
patterns (anti-clockwise and anterior-to-posterior recirculation) within the large 
connection regions based on the interactions of the SVC and IVC flows with relation to 
the PAs. For the extracardiac connections, the effects of caval offset were apparent and 
consistent between CMR and CFD: either creating a head-on collision of the incoming 
flows (as in CHOP082A and CHOP084A) or preferentially directing SVC flow to the LPA 
in the presence of a Fontan-RPA offset (CHOP083A and CHOP088A).  
This consistency translates into reasonably good agreement with respect to quantitative 
HFD calculations (Table 5.3). Keeping in mind that mass conservation is not present in 
the CMR-measured data nor globally enforced after divergence free interpolation (i.e., 
only the individual interpolating kernels are divergence free), the consistency with 
simulated results is promising (considering neither modality is a true gold standard for 
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this measurement). As seen in the Bland-Altman plot in Figure 5.9, the average 
difference is close to 0, despite the small sample size, and the maximum difference was 
on the order of 16%. While it is difficult to exactly dictate the accuracy needed for clinical 
utility of these methods (given the uncertainty surrounding the clinical thresholds of the 
metric itself), it is important to note that the hemodynamics of the patient who did 
experience an adverse flow distribution outcome in this series were consistently and 
properly characterized by both modalities. These findings therefore provide assurance 
that the simulated results analyzed through the rest of this aim and the rest of the thesis 




Table 5.3 Summary of CMR and CFD Quantitative Comparisons. 
 
HFD (%LPA) Power Loss (mW) 
CMR CFD CMR CFD 
CHOP064A 66 82 0.04 0.5 
CHOP069A 59 47 0.1 0.8 
CHOP074A 73 60 0.09 1.3 
CHOP082A 60 57 0.14 1.4 
CHOP083A 32 48 0.17 5.7 
CHOP084A 61 72 0.11 1.4 
CHOP088A 20 27 0.12 4.2 
CHOP_M1 13 12 0.3 30 
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Figure 5.9 Bland-Altman Plot of differences between CMR- and CFD-derived HFD values. In 
this small sample, the mean difference (gray horizontal line) was close to zero and 
maximum difference was 16%. 
 
 
5.3.2 Pulsatile vs. Time-Averaged Boundary Condition Results 
For a subset (n=35) of the 100 patient cohort, simulations were performed using both PC 
CMR-derived time averaged and time-varying (pulsatile) flow boundary conditions. 
Paired comparison of the results of this set of simulations thus provides an indication of 
the impact that the steady flow assumption has on the quantitative simulation results. 
The results are considered separately below based on metrics of interest. 
5.3.2.1 Power loss  
Table 5.4 summarizes the power loss findings as a function of imposed flow conditions. 
Of note, one of the patients (CHOP033A) was excluded from the power loss comparison 
because the RPA phase contrast measurement revealed flow reversal for a small portion 
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of the cycle that, because of the rigid wall assumption, created an unrealistic and 
unmeasured spike in LPA flow and inflated the pulsatile power loss result. In the 
remaining 34 patients, the pulsatile power losses were significantly higher on average 
(6.4 mW vs. 5.6 mW, p<0.01 by Wilcoxon signed rank test), which is consistent with the 
preliminary findings of de Zélicourt124. However, there were three cases in which the 
pulsatile power loss was less than the steady value. On an individual patient basis, this 
difference translated into a 16.2% average absolute error.  
 
 
Table 5.4 Summary of steady vs pulsatile flow power losses 
 
Steady flow  
power loss (mW) 
Pulsatile flow  
power loss (mW) 
Absolute  
error (%) 
Mean 5.6 6.4 16.2 
Standard Deviation 4.5 4.8 11.4 
Median 4.0 5.3 15.7 
See Table 12.8 in Appendix B. 
 
Figure 5.10 shows a Bland-Altman plot for these data demonstrating the agreement 
between the two simulation conditions. There is a positive bias in the mean differences 
(0.86 mW) and the top and bottom horizontal lines represent two standard deviations 
from the mean. The majority of data points fall within these standard deviation bounds, 
although there are two instances where the differences were greater: one steady flow 
over-estimate (CHOP080A) and one steady flow under-estimate (CHOP082B). In the 
former case, as will be discussed in more detail with regard to HFD in the next sub-
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section, the relative phase shift in the incoming pulsatile flows alter their interactions 
(particularly the IVC and RSVC). For CHOP082B, the reason for the under-estimatation 
is the large amplitude of the flow pulsations, which ranged from 1 L/min to 5.5 L/min, 
resulting in significantly altered flow dynamics and power losses compared to the time-
averaged conditions. Similar factors were present in many of the other cases with large 




Figure 5.10 Bland-Altman plot of power losses derived from pulsatile and steady boundary 
condition simulations. A positive bias is apparent (gray horizontal bar; pulsatile higher 
than steady), with 2 data points falling outside two standard deviations from the mean 
(black horizontal bars).  
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From these data, the steady flow assumption appears to consistently undershoot 
pulsatile power loss values by 15-20%. Here, two points are worth noting. Firstly, this 
difference cannot be viewed as difference from truth as the pulsatile flow models were 
still limited by significant assumptions, particularly the use of rigid vessel walls. Second, 
without a fundamental understanding of the clinically significant thresholds of TCPC 
power loss, it is difficult to know the significance of these error margins and thus draw 
any decisive conclusions regarding the significance of the steady vs. pulsatile flow 
assumption.  
5.3.2.2 HFD  
Table 5.5 summarizes the HFD findings from the steady and pulsatile flow simulations. 
The means of the two sets of simulations are nearly the same (43 vs. 44, steady vs. 
pulsatile, respectively) and there was no statistical difference between them (p=0.35 by 
Wilcoxon signed rank test); however, the average absolute deviation for a given patient 
was 5. In other words, a steady HFD to the LPA of 43% was, on average, 5 percentage 
points higher or lower under pulsatile conditions.   
 
 
Table 5.5 Summary of steady vs pulsatile flow HFD 
 






Mean 43 44 5 
Standard Deviation 18 17 4 
Median 43 45 4 
See Table 12.8 in Appendix B. 
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Figure 5.11 shows the Bland-Altman difference plot for these data. Unlike the power loss 
plots, the HFD differences are tightly grouped around zero with a mean bias of 1.1. All 
but two points fall within the two standard deviation bounds, and in fact they are all within 
a difference of 10.  
Notably, the two outlier points (CHOP080A, CHOP091A) are cases of bilateral SVCs 
with a right-sided Fontan connection in which the steady flow conditions under-predicted 
the IVC perfusion of the left lung, while the pulsatile flow conditions yielded much more 
balanced IVC distributions. These findings suggest that dynamic vessel flow rates for 
these cases played an important role. Figure 5.12 shows the imposed pulsatile flow 
curves over one cardiac cycle for those two cases. The superposed vertical lines are 
provided to help relate the timing of the peak IVC flow rate to the concurrent changes in 
PA flows. For CHOP080A (Figure 5.12A), an increase and peak of IVC flow rate is 
closely synced with the increase and peak of the LPA flow rate. It is also noted that the 
amplitude of LPA pulsatility is much greater than that of the LSVC. These two 
observations imply that the IVC flow is primarily responsive to changes in LPA flow 
dynamics since the LSVC is comparatively static and the RSVC is more dynamically 
synced to RPA flow. This results in a more balanced IVC distribution than is obtained 
from the steady flow simulations, which (as seen in Figure 5.13) instead produced 
greater mixing of IVC and RSVC flows and thus a greater contribution of RSVC flow 
(shown in red) to the LPA. For CHOP091A (Figure 5.12B), the peak of the highly 
pulsatile IVC flow nearly coincides with the peaks of both LPA and RPA flows, while both 
superior caval flow curves are nearly flat over the entire cycle. Hence, the IVC flow is 
dynamically responsive to changes in flows to both PAs, and is thus more balanced than 
predicted by the steady flow simulation.  
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Figure 5.11 Bland-Altman plot of flow distributions derived from pulsatile and steady 
boundary condition simulations. There was a slight positive bias in the measurement 
differences, with 2 data points falling outside two standard deviations from the mean 




Figure 5.12 Imposed pulsatile flow curves by vessel of one cardiac cycle for A) CHOP080A 
and B) CHOP091A. The vertical lines are provided as a visual correspondence between the 
pulmonary flows and the peak of the IVC flow rate. 
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Figure 5.13 Time-averaged velocity streamlines color coded by vessel of origin (blue- IVC, red- 
RSVC, yellow- LSVC) for CHOP080A. Mixing of IVC and RSVC flows within the large hemi-Fontan 
connection promotes distribution of RSVC flow to the LPA, which is apparently reduced with the 








Animation 5.1 Particle tracking for pulsatile simulation of CHOP080A. 
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Returning to the more important question at hand, Figure 5.11 suggests that the steady 
flow assumption has little impact on hepatic flow distribution results. Clinically speaking, 
there is very little (if any) difference between an HFD value of 60 vs. 50 or even 40 vs. 
30. Thus, considering the average values achieved and the average differences 
observed, the same information will be achieved using either set of flow conditions in 
TCPC simulations. That said, in more complex anatomic (such as the bilateral SVC 
outliers described) and physiologic (e.g., highly pulsatile or asynchronous flow curves) 
cases, it may be advisable to specifically select pulsatile flow boundary conditions. 
5.3.2.3 Section Summary  
Directly comparing the quantitative outcomes of pulsatile and steady flow simulations in 
a 35 patient subset provided insights into the potential impact of the use of time-
averaged boundary conditions for the cohort analysis. The impact with respect to 
IVC/hepatic flow distribution is clinically negligible as the average difference was close to 
0 and in absolute terms was ±5 percentage points, generally no more than 10. For 
power loss, the impact is more difficult to gauge as a) there was a definite, but consistent 
bias toward higher power loss values under pulsatile flow conditions (17% on average); 
b) the effect of assuming rigid walls on the energetic of pulsatile flows is unknown; and 
c) the clinically relevant power loss thresholds are unknown, so it cannot be determined 
if a 15-20% underestimation is meaningful or not. For the purposes of this study, these 
results do not suggest that the use of time-averaged flows is a bad assumption (again, 
pulsatile results do not represent truth in this case), so they will be retained in the cohort 




5.4 Cohort Results 
Much of the credit for the data presented in this section belongs to Dr. Diane de Zélicourt 
for implementing and validating the numerical scheme used, Maria Restrepo and Elaine 
Tang for considerable assistance in performing and analyzing the simulations, and 
countless other past students who contributed to the anatomic and velocity CMR 
segmentations. 
5.4.1 Flow Summary 
Flow data derived from the PC MRI acquisitions are summarized in Table 5.6. All values 
were indexed to BSA. The full case-by-case results are provided in Appendix A, where it 
can be seen that not all vessel measurements were available for all patients. The 
collateral flow was calculated as the difference between cardiac output and Qs, while 
fenestration flow was estimated based on the difference between Qs and pulmonary 
arterial flows. On average, fenestration flow was less than 10% of Qs. This low value is 
significant given that fenestration flow was systematically neglected in the computational 
simulations. It therefore appears this limiting assumption was acceptable. 
These numbers are in very close agreement with those reported by Whitehead et al 
although that was somewhat expected given the considerable overlap in the patients 
included in both works142. From that study, we learned that the IVC blood flow fraction in 
Fontan patients is a function of age and BSA; that the LPA fractional flow is 45% on 
average (consistent with the present data), and that this overall pulmonary flow 






Table 5.6 Average flow data [L/min/m
2
] by vessel from PC MRI 
Vessel Flow rate [L/min/m2) 
IVC 1.72 ± 0.55 
SVC 1.00 ± 0.53 
LSVC* 0.64 ± 0.35 
Azygos Vein* 0.92 ± 0.37 
Qs 2.89 ± 0.81 
LPA 1.21 ± 0.63 
RPA 1.38 ± 0.50 
Collateral 0.60 ± 0.78 
Fenestration 0.30 ± 0.54 




5.4.2 Population Averages and Correlations 
Hemodynamic findings from the CFD analysis are presented in Table 5.7. The mean 
HFD value was 44% (to the LPA) in close agreement with the average pulmonary flow 
distribution (45% LPA), and the two variables were significantly correlated (r= 0.36, 
p<0.001; Figure 5.14A). With respect to maximum pressure drop, the mean value was 
1.5 mmHg (~10% of normal central venous pressures), with an inner quartile range of 
0.5-1.9 mmHg. TCPC resistance (R) was 0.23 WU on average (~15-20% of normal 
pulmonary vascular resistance55) and TCPC-EDI was equal to 0.037 on average.  
Pearson correlations revealed significant relationships between BSA and R (r=0.28, 
p<0.05), BSA and TCPC-EDI (r=0.37, p<0.05; Figure 5.14B), and age with TCPC-EDI 
(0.26, p<0.05). Additionally, because the power loss normalizing scheme used to 
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compute TCPC-EDI includes normalization by the cardiac output, scaling in Q3, there is 
potential for a false positive correlation to develop between Q and Q-3. After correcting 
for this confounder with partial correlation, the natural logarithm of TCPC-EDI was still 
significantly correlated with both Qs (r= -0.31, p=0.001; Figure 5.14C) and CI (r= -0.21, 
p=0.04; Figure 5.14D). Interestingly, there was also a negative correlation between age 
and CI (r=-0.37; p<0.05), which may have been a confounding factor in the TCPC-EDI 
vs. CI correlation: using partial correlation to correct for age effects weakened their 
relationship (r=-0.18, p=0.087). However, the TCPC-EDI vs. QS partial correlation was 
still statistically significant (r=-0.23, p=0.023). 
 
 























Mean 3.47 2.89 45 44 1.5 0.23 0.037 
Standard 
Deviation 
1.11 0.81 12 21 1.3 0.17 0.028 
Median 3.43 2.85 43 44 1.1 0.19 0.031 
25th 
Percentile 
2.86 2.33 37 31 0.5 0.10 0.016 
75th 
Percentile 
3.85 3.36 52 57 1.9 0.28 0.047 
HFD- Hepatic Flow Distribution; ΔPMAX- maximum pressure drop; R- TCPC Resistance; 




Figure 5.14 Correlative relationships in cohort data between A) HFD and global pulmonary 
flow split, B) indexed power loss (TCPC-EDI) and BSA, C) TCPC-EDI and systemic venous 
flow (logarithmic), D) TCPC-EDI and cardiac index (logarithmic). 
 
 
5.4.3 Single vs. Bilateral SVC Connections (Table 5.8)  
The presence of bilateral superior vena cava connections to the PAs (N=15) significantly 
increased the percentage of pulmonary flow to the LPA compared to single SVC 
connections (52% vs. 43%; p=0.02), but HFD to the LPA was comparatively decreased 
(34% vs. 45%; p=0.03). These observations can be simply explained by assuming that 
the composition of the LPA flow is: all of the left SVC flow and some combination of IVC 
and right SVC flows. Hence, the relative contribution of the superior venous flows to the 
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LPA is increased compared to single SVC cases in which some combination of SVC and 
IVC flows perfuse both lungs. It is noted that there was still a correlation of the 
pulmonary flow distribution with HFD in the bilateral patients (ρ=0.59; p=0.02), with a 
very similar coefficient, but with a shifted regression line compared to single SVC cases 
(Figure 5.15).  












Age (years) 12.3 ± 6.7 10.1 ± 6.9 0.19 
BSA (m2) 1.24 ± 0.44 1.14 ± 0.54 0.35 
Cardiac Index 
(L/min/m2) 
3.49 ± 1.19 3.39 ± 0.59 0.81 
GFD (%LPA) 43 ± 9 52 ± 15* 0.02 
HFD (%LPA) 45 ± 20* 34 ± 26 0.03 
ΔPMAX (mmHg) 1.5 ± 1.3 1.4 ± 0.6 0.57 
R (WU) 0.23 ± 0.18 0.24 ± 0.10 0.21 
TCPC-EDI 0.036 ± 0.029 0.038 ± 0.022 0.30 
*Value significantly higher than other group; Data reported as mean ± st. dev.; See 








Figure 5.15 Correlations between HFD and global pulmonary flow distribution (GFD) for 
single SVC TCPCs (blue) and bilateral SVC TCPCs (red). The slopes of the linear 
correlations are similar, but the bilateral line is shifted lower (toward more RPA flow). 
 
 
5.4.4 Intra-atrial (IA) vs. Extracardiac (EC) Connections (Table 5.9) 
When comparing IA vs. EC (neglecting APC), IA patients were significantly older and 
had larger BSA, while there was a strong trend (p=0.07) toward higher CI in EC patients. 
Based on the negative relationship between age and CI noted in §5.4.2, these 
characteristics are likely coupled. There were no statistical differences in R or TCPC-EDI 
between groups (p=0.48 and 0.24, respectively); however, the flow distribution trends 
did show connection dependencies. The pulmonary flow distribution to the LPA was 
significantly higher in EC patients than IA, but there was a trend toward lower HFD to the 
LPA for EC (p=0.08). Finally, a breakdown of the pulmonary flow/HFD correlation noted 
in §5.4.2 revealed similar significant correlations for both connections (p<0.05), although 





Table 5.9 Comparison of Intra-atrial and Extracardiac Connections 
 IA (N=64) EC (N=33) p-value 
Age (years) 13.5 ± 6.5* 7.9 ± 4.8 <0.001 
BSA (m2) 1.33 ± 0.43* 0.96 ± 0.37 <0.001 
Cardiac Index 
(L/min/m2) 
3.30 ± 0.87 3.90 ± 1.41 0.07 
Systemic Flow 
(L/min/m2) 
2.89 ± 0.89 3.10 ± 0.91 0.33 
GFD (%LPA) 41 ± 9 51 ± 15* 0.001 
HFD (%LPA) 46 ± 18 37 ± 26 0.08 
ΔPMAX (mmHg) 1.5 ± 1.1 1.4 ± 1.6 0.52 
R (WU) 0.25 ± 0.19 0.20 ± 0.12 0.48 
TCPC-EDI 0.040 ± 0.031 0.030 ± 0.017 0.24 
*Value significantly higher than other group; Data reported as mean ± st. dev; See Table 




5.4.5 Single Left vs. Right Ventricles 
This section compares the TCPC hemodynamics between patients on the basis of the 
morphology of the single ventricle, excluding patients with mixed ventricular 
morphologies (N=17; e.g., complex heterotaxy syndrome or double outlet right ventricle). 
All physiological and hemodynamic comparisons are summarized in Table 5.10. There 
was no difference in cardiac index between the two groups, but there was a trend toward 
higher pulmonary flow percentage to the LPA for single LVs (p=0.10). The maximum 
TCPC pressure drop was significantly higher in single RV patients (1.7 vs. 1.1 mmHg; 
p=0.01) and there were also strong trends for higher R (p=0.10) and TCPC-EDI (p=0.07) 
in single RVs. These energetic differences are likely related to a significantly smaller 
(p=0.015) minimum PA diameter for single RVs than single LVs. 
Dasi et al recently reported that the size of the reconstructed aorta, which is more 
frequently required for single RVs than LVs, is related to diminished LPA diameter143. 
Other studies have demonstrated the importance of minimum PA diameter in 
determining the TCPC energy dissipation29. It was therefore hypothesized that the 
vessel size and power loss differences noted in Table 5.10 might be mediated by the 
aorta. The patients (N=83) were sub-divided based on the presence or absence of aortic 
reconstruction; however, the patients without aortic reconstruction were significantly 
older than the patients with aortic reconstruction, which would confound the analysis 
since TCPC-EDI varies with age. To instead obtain two groups with comparable ages, a 
subset of patients (N=65) was selected consisting of RV patients with aortic 
reconstruction and LV patients without it. Results are shown in Table 5.11. The 
difference in total LPA flow became significant (p=0.025) and ΔPmax was significantly 
higher for the group with RV and aortic reconstruction; however, R and TCPC-EDI were 
statistically no different between these groups (p=0.42 and 0.28, respectively). 
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Considering the non-difference in normalized power losses, it is interesting that the 
minimum PA sizes were significantly different between these groups (p=0.04). However, 
the mean values (of the minimum diameters) for both groups were higher than the 
corresponding measures in Table 5.10 (i.e., LV < LV without aortic reconstruction). 
Given that power loss increases non-linearly with decreasing minimum PA size140, it 
appears that this incremental diameter increase, particularly for the RV group, mediated 
enough of a decrease in TCPC-EDI to be statistically no different than the LV group.  
These findings indicate that the differences in TCPC power losses between single LVs 
and RVs, noted in Table 5.10, were not caused by the reconstructed aorta compressing 
the LPA primarily in single RVs. If that were the case, than the RV with aortic 
reconstruction would have had significantly higher TCPC-EDI compared to the LV 
without reconstruction, and possibly a lower minimum PA diameter compared to entire 
RV group (assuming that RVs without reconstruction would have had generally larger 
diameters). Instead, it is possible that the fundamental differences between the 
morphologies with regard to pulmonary flow source and characteristics leading up to 
bidirectional cavopulmonary anastomosis (e.g., Norwood, PA banding, no palliation) may 
mediate different PA growth patterns, which manifest in long-term differences in TCPC 








Table 5.10 Comparison of single left ventricles (LV) and single right ventricles (RV) 
 LV (N=38) RV (N=45) p-value 
Age (years) 12.3 ± 7.6 11.9 ± 5.8 0.95 
BSA (m2) 1.22 ± 0.44 1.24 ± 0.45 0.88 
Cardiac Index 
(L/min/m2) 
3.56 ± 1.02 3.30 ± 0.96 0.52 
Systemic Flow 
(L/min/m2) 
2.95 ± 0.71 2.91 ± 0.99 0.53 
GFD (%LPA) 45 ± 13 41 ± 10 0.1 
HFD (%LPA) 45 ± 24 41 ± 19 0.47 
ΔPMAX (mmHg) 1.1 ± 0.8 1.7 ± 1.2 0.01* 
R (WU) 0.20 ± 0.16 0.24 ± 0.16 0.10 
TCPC-EDI 0.032 ± 0.026 0.040 ± 0.029 0.07 
Minimum PA 
diameter (mm/m2) 
7.6 ± 2.4 6.5 ± 2.9 0.015* 








Table 5.11 Comparison of left ventricles (LV) without aortic reconstruction and single right 










Age (years) 12.8 ± 7.7 10.5 ± 4.9 0.19 
BSA (m2) 1.27 ± 0.43 1.16 ± 0.41 0.31 
Cardiac Index 
(L/min/m2) 
3.42 ± 0.87 3.28 ± 0.80 0.82 
Systemic Flow 
(L/min/m2) 
2.92 ± 0.74 2.82 ± 0.80 0.65 
GFD (%LPA) 46 ± 13 40 ± 10 0.03* 
HFD (%LPA) 47 ± 25 40 ± 18 0.21 
ΔPMAX (mmHg) 1.0 ± 0.8 1.7 ± 1.3 0.03* 
R (WU) 0.21 ± 0.17 0.21 ± 0.12 0.42 
TCPC-EDI 0.033 ± 0.027 0.035 ± 0.020 0.28 
Minimum PA 
diameter (mm/m2) 
8.1 ± 1.9 7.0 ± 2.3 0.04* 







5.4.6.1 Physiologic significance of TCPC power loss 
TCPC design is one of the factors amenable to interventional/surgical manipulation in 
the care of single ventricle patients. From these data, it is seen that this patient-to-
patient variation led to a two order of magnitude range in indexed power losses, so 
elucidating its role in patient functional status and outcomes is of practical relevance. A 
popular model of ventricular filling (i.e., diastolic function) and cardiac output says that 
resistance elements downstream of vascular capacitance have a drastic effect on 
limiting the ability of the ventricle to fill and thus provide adequate output42; in Fontan 
physiology the TCPC and pulmonary vasculature are two such resistive elements. 
Elevated power loss resulting from sub-optimal connection geometry may therefore 
contribute to restricted preload reserve39, 66 of the single ventricle, which may limit long-
term performance.  
The significant negative correlations of iPL with Qs and cardiac index do in fact suggest 
such a relevant effect of elevated TCPC losses. A similar linear correlation between 
TCPC resistance and cardiac index has previously been noted55. The mean values of R 
and iPL were 0.23 WU and 0.037, respectively. To put these measures into context, 
normal pulmonary vascular resistance ranges for Fontan patients have been reported 
between 1.3-1.8 Wood units27, 55, and Dasi et al. found that the Cardiovascular Energy 
Dissipation Index for single ventricles (i.e., indexed ventricular output power) based on 
published data ranged between 2.7 (for ~4.5 year old patients) and 8.1 (for ~11 year old 
patients)129. Since the TCPC and pulmonary vasculature are in series, the present 
results indicate that the TCPC resistance adds, on average, 15-20% to the total 
pulmonary vascular resistance, and that contribution is non-negligible. 
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5.4.6.2 Extracardiac vs. Intra-atrial Connections  
Despite significantly higher total LPA flow (51% vs. 41%), extracardiac connections had 
a strong trend (p=0.08) toward lower HFD to the LPA (38% vs. 47%). A recent study144 
found that HFD correlated with the total pulmonary distribution in intra-atrial connections 
but not in EC, presumably because of the more intense mixing of the caval flows within 
IA connections. Conversely, HFD in extracardiac connections only correlated with caval 
offset144. These observations agree well with the present findings. While HFD did 
correlate with the total flow distribution for extracardiacs, this correlation was weaker 
than for IA connections. Also, the significant influence of caval offset was still apparent 
as over 60% of IVC flow perfused the RPA (the predominant direction of caval offsetting 
for such connections) despite a nearly balanced total distribution (51% LPA). Most 
critically, the flow distribution results for EC and IA connections, representing the 
majority of Fontan patients, do not suggest an inherent risk factor for unilateral hepatic 
distribution and PAVM in either case58.  
Arguably the more interesting comparison between these connections is with regard to 
the energetics. Since the decision of one connection or the other is almost entirely at the 
discretion of the surgeon, determining the superiority of one approach over the other has 
been the subject of debate for a number of years82, 145-148. In this series, there were no 
energetic differences between connections. This finding is encouraging in that the 
selection of one connection or another, for reasons of either surgical preference or 
patient need, does not inherently bias the connection power loss. However, it is 
important to recognize that techniques and geometric details vary among centers and/or 
surgeons; since this was a single center study, extrapolating this finding to all patients 
may not be straightforward. 
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5.4.6.3 Cohort Summary 
From this largest computational analysis of the Fontan connection to date, several 
clinically relevant insights were gained. First, power loss varies widely (two orders of 
magnitude) among Fontan patients and may vary with age and development. Second, 
there is a significant correlation between indexed TCPC power loss and systemic 
venous flow, which supports the hypothesis that TCPC hemodynamics can impact 
diastolic ventricular function. Third, no energetic differences were observed between 
intra-atrial and extracardiac Fontan connections.  
 
5.5 Factors Influencing Power Loss 
In the absence of a meaningful difference between IA and EC energetics, but a 
physiologically meaningful impact of power loss, the critical question then becomes: 
what are the factors that discriminate among patients to create high losses in some 
cases, and negligible losses in others? The following sections will attempt to provide 
insight into that critical question through multiple means. First, hemodynamics of 
selected patients from both ends of the TCPC-EDI scale will be evaluated in detail to 
elucidate trends that distinguish efficient connections from inefficient ones. Second, 
results of a detailed TCPC geometric characterization will be presented and correlated 
with the hemodynamics. This latter investigation therefore builds upon the ‘classical’ 
engineering approach to studying the TCPC by extending the search for 
geometric/hemodynamic relationships to a broad patient-specific scale. 
5.5.1 Most and Least Dissipative Connections 
A total of 12 patients were selected from the 100 patient cohort on the bases of TCPC-
EDI and age. Specifically, the 7 patients with the highest power loss (all with TCPC-EDI 
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> 0.08; average age of 16.6 years) and 5 of the 10 patients with the lowest power loss 
(average age of 13.8) were retained for this analysis. Five patients from this latter group 
were discarded to make the two groups similarly sized and as close in age as possible 
given the correlations between age and both cardiac index and TCPC-EDI noted in 
§5.4.2. The demographics and hemodynamics of these 12 patients are summarized in 
Table 5.12. 
The hemodynamics of each patient will be considered on an individual basis in the 
following sub-sections starting from the highest power loss and ending with the lowest. 
Several different plots will be presented for each case: 1) standard velocity streamlines 
encoded either by local velocity magnitude or vessel of origin; 2) vortex iso-surfaces 
based on the Q-criterion (the second invariant of the deformation matrix)149; and 3) the 
magnitude of viscous dissipation (i.e., V
2 ; where µ is the viscosity and V the 
velocity). It is noted that the contour scaling of the viscous dissipation plots was held 










Table 5.12 Patient data and hemodynamic metrics for the least (7 top rows) and most 


















CHOP103A IA 22 1.86 2.65 2.46 3.0 0.72 0.134 
CHOP023A IA 12 1.22 3.19 2.43 2.3 0.66 0.122 
CHOP032A IA 18 1.64 3.55 2.84 3.0 0.76 0.120 
CHOP080A IA 17 1.91 2.91 2.28 2.4 0.54 0.107 
CHOP034A IA 14 1.89 4.35 2.67 2.7 0.61 0.103 
CHOP072A IA 14 1.65 2.78 2.81 3.1 0.63 0.100 
CHOP005B IA 19 1.51 3.01 3.03 3.3 0.58 0.087 
CHOP191A EC 16 1.25 3.13 1.88 0.2 0.05 0.011 
CHOP203A IA 16 1.93 3.45 2.69 0.3 0.06 0.010 
CHOP188A IA 17 1.51 3.49 2.21 0.4 0.05 0.010 
CHOP089A IA 10 0.93 3.12 3.45 0.5 0.08 0.010 





5.5.1.1 Comparison of Cardiac-Index and Flow Magnitudes 
Despite the orders of magnitude differences in connection energetics (pressure drop, 
resistance, and TCPC-EDI), it is first interesting to note that the cardiac indices (3.2 ± 
0.6 vs. 3.4 ± 0.3) and indexed systemic flow magnitudes (2.6 ± 0.3 vs. 2.8 ± 0.9) were 
not statistically different between high and low power loss groups, respectively. This 
finding runs counter to the noted correlation in Figure 5.14, which would instead predict 
that the higher power loss group would have lower systemic and cardiac flow rates. 
Assuming that the general correlation is true, this non-difference is likely the result of 
other confounding factors (e.g., PVR or underlying cardiac defect) and underscores the 
complexity and multi-factorial nature of these patients’ physiology. 
5.5.1.2 Detailed Presentation of the 7 Most Dissipative Connections 
CHOP103A  
The velocity and vorticity fields associated with the most dissipative TCPC encountered 
in this study, CHOP103A, are shown in Figure 5.16 and Figure 5.17, respectively. The 
Fontan pathway in CHOP103A (a lateral tunnel) has a significant narrowing, particularly 
approaching the distal end of the lateral tunnel and the PA junction, and significant 
anterior/posterior curvature. The LT narrowing leads to a significant convective 
acceleration, which is further exacerbated by the anterior/posterior curvature that 
confines the IVC flow along the anterior wall. As a result, the IVC flow accelerates from 
an average inlet velocity of 8-9 cm/s to over 50 cm/s at the PA anastomosis. The 
elevated velocities and confinement along the wall lead to important energy dissipation 
within the LT itself. At the connection site, the IVC flow impinges against the superior 
aspect of the anastomosis resulting in significant secondary flows, and the strength of 
these recirculations is enhanced by the high kinetic energy of the impinging IVC flow. 
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The vortex cores (Figure 5.17A) reveal that this recirculation extends across the entire 
length of the PA domain as a single coherent structure. As the area surrounding the core 




Figure 5.16 Velocity streamlines for CHOP103A color coded by A) velocity magnitude and 




Figure 5.17 A) Q-criterion vortex cores (Q=4000) and B) viscous dissipation contours for 
CHOP103A. Despite the expansive length of the vortex core in the PA, it only appears to 




This patient has an enlarged azygos vein (like CHOP_M1 as discussed in §5.3.1), but 
with no interruption of the IVC. Hence, the Fontan baffle (a lateral tunnel) still carries 
over 70% of the systemic venous return. The combination of apparent lateral tunnel 
stenosis, high Fontan flow rate, and enlarged hemi-Fontan connection result in a very 
high (~90 cm/s) IVC inlet velocity jet that is eccentrically oriented with respect the center 
of the connection (Figure 5.18). This jet induces extensive viscous dissipation within the 
lateral tunnel and at the entrance to the PAs (Figure 5.18C), then proceeds to impinge 
on the incoming SVC flow and create an extensive recirculation region within the 
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connection, leading to a very disturbed flow profile in the connection and PAs 
downstream. High viscous losses are also seen at the walls of the RPA, which is 




Figure 5.18 Velocity streamlines for CHOP023A color coded by A) velocity magnitude and 
B) vessel of origin. C) Contours of viscous dissipation show the adverse effects of the 







In this case, the IVC undergoes a significant size reduction as it passes into the intra-
atrial conduit, before again expanding within the hemi-Fontan connection. Thus, the IVC 
flow accelerates from ~10 cm/s to over 90 cm/s within the conduit (Figure 5.19). The 
Fontan connection was made posterior to the hemi-Fontan and thus the IVC flow 
impinges on the opposite superior PA wall (and partly into the SVC outlet) before 
inducing considerable secondary flow recirculation within the PAs. These recirculatory 
patterns are nicely demonstrated by the vortex cores (Figure 5.20A), which shows the 
posterior roll-up and extensive secondary recirculation into the LPA caused by the high 
velocity IVC jet. Viscous dissipation ‘hot-spots’ (Figure 5.20B) are evident along the 
lateral walls of the Fontan baffle, along the superior PA walls where the IVC jet 







Figure 5.19 Velocity streamlines for CHOP032A color coded by A) velocity magnitude and 
B) vessel of origin.  
 
Figure 5.20 B) Q-criterion vortex cores (Q=2000) and C) viscous dissipation contours for 
CHOP032A. IVC recirculation is largely contained on the left side of the connection, but 





In CHOP080A, another instance with an undersized intra-atrial Fontan conduit, many of 
the flow features resemble those of the previous case. IVC flow accelerates from an inlet 
average of 14 cm/s to over 60 cm/s before emptying into the large right-sided hemi-
Fontan pouch; this case is complicated by the presence of bilateral SVC connections 
(Figure 5.21). A significant number of coherent vortex structures are visible (Figure 
5.22A), particularly along the left lateral wall of the hemi-Fontan and through the mid-PA 
transition between the left and right SVC connections. The contribution of these 
structures to viscous dissipation within the connection is particularly evident in this case 
and shown by the overlay of the vortex cores on the viscous dissipation contours within 









Figure 5.22 CHOP080A: A) Q-criterion vortex cores (Q=2000) from anterior and right 
sagittal perspectives. B) Localization of vortex structures with high dissipation regions in 




This patient provides another example of a lateral tunnel connection with mild narrowing 
of the Fontan pathway, as evidenced by the local increase in velocity (Figure 5.23A) and 
viscous dissipation (Figure 5.23C) immediately proximal to the hemi-Fontan pouch. 
Impingement on the lower velocity SVC outlet flow and recirculation within the 
connection are again seen as in prior cases; however, it is the acceleration and mild flow 
separation through the mildly stenotic LPA that appears to yield the highest dissipation in 





Figure 5.23 Velocity streamlines for CHOP034A color coded by A) local magnitude and B) 
vessel of origin. C) Contours of viscous dissipation show ‘hot spots’ particularly 




This lateral tunnel connection is characterized both by a moderate narrowing and 
right/anterior curvature, the combined effects of which create a high velocity, asymmetric 
jet that skews along the lateral/anterior wall before recirculating left/posteriorly within the 
connection (Figure 5.24A). The characteristic dissipation streaks can be observed along 
the lateral walls at the throat of the narrowing (Figure 5.24C). However, the more 
significant dissipation zones appear to again be located in the PAs, which are both small 
compared to the venae cavae, and thereby feature high velocities and dissipation via 




Figure 5.24 Velocity streamlines for CHOP072A color coded by A) local magnitude and B) 
vessel of origin. C) Contours of viscous dissipation show ‘hot spots’ particularly 




Unlike the previous six high power loss cases, there is no evidence of significant Fontan 
pathway narrowing in this patient. Instead, the losses appear to be largely, if not entirely 
related to flow through the LPA. In this vessel, the combination of narrowing and 
curvature lead to high velocities (maximum value of 107 cm/s), significant flow 
separation along the inferior distal wall of the LPA (Figure 5.25A), and extensive 




Figure 5.25 Velocity streamlines for CHOP005B color coded by A) local magnitude and B) 
vessel of origin. C) Contours of viscous dissipation show extensive losses in the LPA 
related to the separations in the high velocity flow. 
 
 
5.5.1.3 Detailed Presentation of the Selected 5 Least Dissipative Connections 
CHOP191A 
This patient begins the series of lowest TCPC-EDI cases and represents the only 
extracardiac connection in either series (Figure 5.26). The most notable characteristic of 
this connection is its strong resemblance to the idealized caval offset glass models used 
in the early Fontan experimental investigations (Figure 3.15). Just as in those early 
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experiments, the use of a caval offset, here supplemented by a rightward angling of the 
SVC and a leftward flaring of the Fontan baffle, created a streamlined hemodynamic 
profile with little caval flow collision and a smooth cavopulmonary flow transition. 
Between these connection features and the generally large pulmonary arteries, very few 




Figure 5.26 Velocity streamlines for CHOP191A color coded by A) local magnitude and B) 







The remaining ‘most efficient’ cases are generally unremarkable in their geometric and 
hemodynamic features, which perhaps is what led to low power losses in each case. 
Thus, the results will be presented together and common features highlighted. The figure 
correspondences are as follows: CHOP203A in Figure 5.27, CHOP188A in Figure 5.28, 
CHOP089A in Figure 5.29, and CHOP128A in Figure 5.30. 
Velocity magnitudes in these patients were in general lower and more uniform through 
the Fontan baffle than what was observed in the high loss group, although the total (non-
normalized) systemic flows were also lower on average (3.6 vs. 4.4 L/min, respectively). 
While secondary flow patterns and coherent vortex structures were present in most 
cases, their associated energy dissipation was much lower in magnitude than the high 
loss cases (see Figure 5.28D). Although, in some instances coincidence of vortex cores 
with higher viscous dissipation zones suggests that further improvements in power loss 
may have been achievable with more streamlined flow. In Figure 5.29D, for example, the 
anterior offset of the IVC with respect to the PAs induced a vortex to form along the 
inferior/posterior PA wall that, at least in some regions, was highly dissipative. 
Redesigning the Fontan connection would have induced a different dynamic that may 








Figure 5.27 Velocity streamlines for CHOP203A color coded by A) local magnitude and B) 





Figure 5.28 Velocity streamlines for CHOP188A color coded by A) local magnitude and B) 
vessel of origin. C) Q-criterion vortex cores (Q=2000) and D) Contours of viscous 







Figure 5.29 Velocity streamlines for CHOP089A color coded by A) local magnitude and B) 
vessel of origin. C) Q-criterion vortex cores (Q=4000) and D) Contours of viscous 
dissipation overlaid on the vortex cores. Despite the low power loss associated with this 
connection, it appears that better streamlining (i.e., removal of complex secondary 







Figure 5.30 Velocity streamlines for CHOP128A color coded by A) local magnitude and B) 
vessel of origin. C) Contours of viscous dissipation do show minor losses associated with 
secondary flow at the RPA outlet. 
 
 
5.5.2 TCPC Geometry and Hemodynamic Correlations 
The 96 TCPCs of the 100 patient cohort (excluding 3 APC and 1 Y-Graft connection) 
were geometrically characterized using a centerline analysis with VMTK. There were two 
general measurements of interest: 1) vessel diameters and 2) relative connection 
orientations. These features and their relationships with TCPC hemodynamics, namely 
power loss and HFD, will be described in the following sections. Much of the credit for 
this work belongs to Elaine Tang for developing the VMTK protocol for TCPC analysis, 
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as well as Elaine and Maria Restrepo for performing the analysis on a large percentage 
of the TCPCs in the cohort. 
 
5.5.2.1 Vessel Diameters 
For each vessel (IVC/Fontan baffle, SVC, LPA, RPA; neglecting the azygos, LSVC, and 
right upper lobe PA), there are four measurements of interest: mean, minimum, and 
maximum diameters (D), and stenosis index (SI;   
    
    
). An SI of 0 represents an 
ideal, uniform cylinder, a value of ~1 would indicate that Dmin is << Dmax. The diameter 
values were all normalized by BSA0.5.  
Table 5.13, Table 5.14, Table 5.15, and Table 5.16 present the results for the 
IVC/Fontan, SVC, LPA, and RPA respectively. Notable trends include: IVC/Fontan 
pathway mean diameter was largest, followed by SVC, RPA, and LPA; LPA Dmin was 
significantly less than RPA Dmin (Mann-Whitney, p<0.001); and SI for LPA was 
significantly greater than all other vessels (ANOVA with Tukey post-hoc). 
With respect to correlations with TCPC-EDI, all diameter dimensions (with the exception 
of the RPA Dmax) were significantly correlated in the form of a Power Law relationship, 
similar to what Dasi et al. found for minimum PA size130. The strongest relationship in 
each case was with respect to the vessel minimum, as shown in Table 5.17 and Figure 
5.31, except for the LPA in which case the mean diameter produced the same 
correlation coefficient as the minimum. For SI, only the IVC was significantly correlated 




Table 5.13 IVC/Fontan pathway Diameter Results 
 Dmean Dmax Dmin SI 
Mean 18.1 22.1 15.2 0.30 
Standard Deviation 4.2 6.1 4.2 0.13 
Median 17.9 21.4 14.9 0.30 
25th Percentile 15.1 18.6 12.2 0.20 
75th Percentile 20.1 23.4 17.2 0.39 
 
 
Table 5.14 SVC Diameter Results 
 Dmean Dmax Dmin SI 
Mean 13.7 16.5 11.9 0.26 
Standard Deviation 3.0 3.9 2.8 0.14 
Median 13.5 15.8 11.9 0.26 
25th Percentile 12.0 14.5 10.0 0.14 
75th Percentile 15.3 17.9 13.7 0.35 
 
 
Table 5.15 LPA Diameter Results 
 Dmean Dmax Dmin SI 
Mean 11.0 16.4 7.9 0.49 
Standard Deviation 2.5 4.5 2.3 0.19 
Median 10.9 16.3 7.4 0.53 
25th Percentile 9.1 14.0 6.4 0.35 
75th Percentile 12.5 18.7 9.5 0.63 
 
 
Table 5.16 RPA Diameter Results 
 Dmean Dmax Dmin SI 
Mean 12.0 15.8 9.9 0.35 
Standard Deviation 2.5 4.2 2.2 0.17 
Median 11.7 15.4 9.7 0.36 
25th Percentile 10.4 13.2 8.5 0.21 
75th Percentile 13.3 17.5 11.4 0.47 
 











IVC Dmin -0.59 <0.001 -1.30 <0.001 
SVC Dmin -0.37 <0.001   
LPA Dmin -0.51 <0.001 -1.11 <0.001 





Figure 5.31 Power law correlations of each TCPC vessel minimum diameter with TCPC-




Focusing in more detail on the PA relationships, it is important to note that the 
hemodynamics are agnostic with respect to which PA is smaller. Thus, the TCPC-EDI 
correlation was repeated using the absolute minimum PA size for each patient (i.e., 
min[RPA Dmin, LPA Dmin]), and the strength of the correlation increased (r= -0.60, 
p<0.001). Finally, since the distribution of pulmonary flow can help to offset the effects of 
a stenosis on a single side, it was hypothesized that the average of the minimum 
diameters would be more descriptive. In fact, this comparison produced the strongest 
univariate correlation with TCPC-EDI (r= -0.66, p<0.001). These power law curves are 




Figure 5.32 Statistically significant power law correlations between (left) minimum PA 
diameter (either RPA or LPA) with TCPC-EDI and (right) average of PA minima with TCPC-




In a multivariate regression model with the four minimum vessel diameters, the IVC, LPA 
and RPA were all predictors of TCPC-EDI (r=0.78, p<0.001); the SVC was not significant 
and was thus not included in the multi-variate column of Table 5.17. The coefficients of 
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these values in the model are provided in Table 5.17, although it is noted that these 
coefficients correspond to the linearized form of the power law equation and so instead 
represent the exponents of the diameters. 
With respect to HFD (represented as %LPA), only the mean (r=0.26, p=0.011) and 
maximum (r=0.21, p=0.045) LPA diameters were significantly correlated (linearly) with 
HFD. While it is not surprising that the caval sizes did not relate to this end point, it is 
interesting that an opposing trend was not seen with respect to RPA size. This suggests 
that, because the LPA was generally smaller, its size is a limiting and deterministic factor 
with respect to flow distribution. 
 
Relative Connection Orientation (Angles and Offsets) 
As shown in Figure 4.26 and Figure 4.27, there were six angles and three offsets of 
interest: the angles each VC makes with both PAs, the angle between the VCs, the 
angle between the PAs, the caval offsets in the right-left and anterior-posterior 
directions, and the shortest distance between the VC and PA axes. The offsets were all 
normalized by the mean IVC diameter given the traditional approach to describing the 
caval offset in terms of diameter (e.g., one-diameter offset or half diameter offset). 
Because the Fontan baffle could either be offset to the right or left of the SVC, the RL 
offset value is presented both in absolute and directional (positive when IVC to the right 
of the SVC) terms. 
Table 5.18 presents the results for connection angles. Recall from Chapter 4 that a large 
angle denotes improving alignment of the vessel centerlines; a 180° angle would denote 
a straight cylinder. It is also important to recall that what is measured is a 3-dimensional 
angle between the centerlines of the respective vessels as opposed to the angle of the 
2-dimensional coronal projection that may form the basis of the reader’s visualization. 
Analysis of variance among the VC-PA angles (with a Tukey post-hoc) showed that the 
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IVC-RPA angle was significantly smaller than all the others; the IVC-LPA angle was also 
significantly larger than the SVC-RPA connection. None of these angles related to power 
loss results; instead, there were meaningful correlations with HFD. Specifically, the IVC-
LPA, SVC-LPA (negatively), and SVC-RPA angles were all significantly correlated to 
HFD to the LPA, as shown in Figure 5.33. Interestingly, the correlation coefficients were 
higher for the SVC angles (-0.31 and 0.34 for the LPA and RPA angles, respectively) 
than the IVC-LPA angle (0.23), which suggests that the connection of the SVC may be 
as important in determining the flow distribution characteristics of a given connection as 
that of the Fontan connection.  
 
 
Table 5.18 Summary of Vessel Connection Angles 
 IVC-LPA IVC-RPA SVC-LPA SVC-RPA IVC-SVC LPA-RPA 
Mean 110 88 105 100 131 107 
St. Dev. 16 15 15 15 23 27 
Median 113 89 106 100 132 108 
25th Percentile 102 78 94 91 119 89 
75th Percentile 121 97 115 109 145 127 






Figure 5.33 Statistically significant linear correlations between (left) IVC-LPA angle, 
(middle) SVC-LPA angle, and (right) SVC-RPA angle with HFD. SVC correlations were 
stronger than the IVC. 
 
 
Table 5.19 Summary of Vessel Offsets (mm/mm) 
 RL RL (abs) AP VC-PA 
Mean 0.09 0.23 0.05 0.27 
Standard Deviation 0.41 0.35 0.13 0.23 
Median 0.08 0.14 0.03 0.28 
25th Percentile -0.01 0.05 0 0.02 
75th Percentile 0.20 0.25 0.10 0.43 
See Table 12.12 in Appendix C 
 
For vessel offsets (Table 5.19), the population averages present several interesting 
insights. First, the mean of the right-left caval offset position was close to 0, while the 
absolute offset distance mean was 0.23, indicating that there is nearly equal preference 
for placing the Fontan baffle to the left (positive) or right (negative) of the SVC. 
Furthermore, it is apparent from these mean values that the 1-diameter to 1.5-diameter 
caval offset advocated by Sharma et al. is not a routine part of clinical practice53, 135. Yet, 
the lack of any correlation between RL offset and power loss (Figure 5.34A) indicates 
that its use may not be of critical importance. In fact, the only offset parameter that 
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related to power loss was the VC-PA distance (r=0.25, p=0.015) with higher offset 
related to higher losses (Figure 5.34B). This measure is effectively an indication of the 
size of the connection (e.g., the anterior extent of the hemi-Fontan connection), and the 
influence of the large, dissipative connections discussed in §5.5.1 (the points toward the 
top right of Figure 5.34B) is apparent. Flow distribution trends included positive 
significant relationships between HFD and SVC-AP (r=0.35, p<0.001; more posterior 
Fontan related to higher IVC-to-LPA flow) and SVC-RL (r=0.38, p<0.001; leftward 
Fontan baffle related to higher IVC-to-LPA flow). The AP trend is particularly interesting 
because it is counter-intuitive, but further analysis reveals that the AP offset is 
significantly correlated with a larger IVC-to-LPA angle (r=0.40, p<0.001 after neglecting 
CHOP_M7 and CHOP057A because they represent non-standard connections), which 




Figure 5.34 A) No relationship between RL caval offset and TCPC-EDI. B) Significant linear 





5.5.3 Section Summary 
The preceding sections provided several important insights as to what factors mediate 
undesirable TCPC hemodynamics. The geometric characterization with VMTK showed 
the primary importance of vessel sizes, particularly the minimum diameter dimension in 
determining the connection power loss. The form of all of these relationships was a 
power law fit, which is consistent with the findings of Dasi et al.130, and demonstrates 
that the impact of vessel size increases exponentially as it gets smaller. The collective 
effect of all of these dimensions (in the multivariate model) captured a large percentage 
of the power loss variation (r=0.78). By comparison, the finer details of connection 
angles and offsets were not found to be related to power loss (with the exception of 
distance of the caval axis from the pulmonary arterial axis) at a population level. This 
finding seems to contradict the earlier work of Sharma and Ensley75, 135 that showed 
benefits associated with offsets and connection flaring; however, it is more likely that the 
influence of other patient-specific factors, such as vessel sizes (which were generally 
uniform in idealized models) is more important than caval offset. The fact that 
CHOP191A, which had a clear caval offset present, was among the lowest power loss 
cases in the cohort supports this idea that caval offset is not a poor concept, only a lower 
priority/lower impact feature. 
The analysis of the most and least efficient patient cases provided strong visual support 
for quantitative trends elucidated by the geometric data. Specifically, the diameter of the 
Fontan baffle had a clear influence on the disturbed patterns seen in the high power loss 
patients (Figure 5.16-Figure 5.24). More precisely, the presence of a contraction or 
narrowing along the length of the baffle (i.e., the stenosis index) caused significant 
convective acceleration prior to collision with the SVC flow and transition into the PAs. A 
large cavopulmonary connection (as in the characteristic hemi-Fontan pouch; Figure 
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5.18, Figure 5.21) distal to such a narrowing appeared to exacerbate this phenomenon 
by facilitating large-scale recirculation of this high velocity flow. Still, the pulmonary 
arteries remain the predominant location of energy dissipation. Even in cases with 
elevated mixing within the dilated junction, the dissipation occurring at the edge of the 
vortex cores was still significantly lower than that occurring via friction against the 
pulmonary walls. It was only when the vortex cores extended into the narrower PAs 
where the recirculation created higher gradients that the dissipation became substantial. 
This PA-localized dissipation appears to be a confirmation of the work of Khunatorn et 
al73 who noted increased power loss in idealized models with increased secondary flow 
in the PAs. Cross-referencing with the VMTK data shows that both PAs were relatively 
undersized in these patients given their leftward position in the average minimum PA 
size plot (Figure 5.32, right), a factor that would help to explain to concentration of losses 
in those regions.  
With that said, there is an important distinction to be made here. The natural explanation 
for higher losses with smaller vessels is the result of increased velocity gradients and 
wall shear stresses assuming a Poiseuille-like flow profile; the presence of complex 
secondary flows does not factor into the this strictly geometric characteristic. In fact, 
what these particular cases represent is the superposition of negative geometric (small 
IVC and PAs) and hemodynamic (complex flow structures and recirculation) features; 
neither factor alone tells the whole story. So while vessel sizes alone may provide an 
excellent approximation of power loss (through the multivariate model) there is still 
significant room for variation due in large part to the local hemodynamics, which vessel 
dimensions alone cannot easily capture or anticipate.  
A final observation of the patient analyses: although there were no statistical differences 
between intra-atrial and extracardiac Fontan connections in the broader cohort, it is 
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apparent from the makeup of these sub-groups that intra-atrial connections may provide 
an increased risk factor for variations in Fontan pathway diameter. While lateral tunnel 
connections provide the potential for growth with the patient by incorporating atrial tissue 
into the pathway, asymmetric growth of that pathway has the potential to create either 
stenoses or extreme dilations, which can adversely affect hemodynamics in various 
ways. Furthermore, intra-atrial conduit grafts tend to be smaller than extracardiac 
conduits (Figure 5.19 and Figure 5.21) and may be even more inclined to mediate high 
Fontan velocities. Thus, while extracardiac connections may not mediate improved 
hemodynamics as a general rule, they provide protection against adverse 
hemodynamics insomuch as they are less inclined to become stenosed. 
Finally, the flow distribution trends deserve consideration. Perhaps the most interesting 
finding was the relationships between the SVC angles to the PAs and the HFD to the 
LPA. Briefly, the greater the angle between the SVC and RPA, the more the IVC flow 
tended to the LPA (presumably because SVC flow is primarily directed to the RPA). 
Conversely, a favorable (with respect to low flow resistance) SVC-LPA angle 
suppressed IVC to LPA flow. By comparison, the IVC angle relationships were weaker 
and the RPA angle was not significantly correlated. The most likely explanation for these 
trends is the fact that the SVC volume fraction is much lower than the IVC and it is 
therefore more likely to be unilaterally directed to a single lung, as was seen on 
numerous occasions in the comparison of CMR and CFD results in §5.3.1. These 
findings suggest that the general HFD trends are largely within surgical control at the 
times of the Glenn and Fontan procedures: by either angling the SVC preferentially to 





5.6 Chapter Summary and Significance 
5.6.1 Method Verification 
Before highlighting the important physiologic findings, it bears repeating that the results 
presented in this chapter were based on computational simulations, which are subject to 
significant limitations such as assuming rigid vessel walls, time-averaged flow 
conditions, ignoring respiration and fenestration, etc. Computational validation is a 
critical component of any analysis although validation of patient-specific in vivo 
conditions is a significant challenge with no perfect gold standard. Hence, considerable 
effort was spent in providing support and verification (not necessarily ‘validation’) for the 
results obtained based on the best means available. First, a subset of 8 patients, 
covering several different connection templates and geometric complexity ranges, were 
selected for detailed comparisons of CFD and 4D CMR flow results. CMR is not bound 
by the numerical limitations: factors such as wall motion, breathing, and flow pulsatility 
are naturally incorporated into the results, thus providing an effective (although not 
conclusive) means to observe their impact. In light of the inherent limitations of CMR 
flow reconstruction itself (poor spatio-temporal resolution, the need for averaging of 
many cardiac cycles), the results of the comparison were very favorable both with 
respect to qualitative flow features and quantitative flow distribution outcomes, although 
there were instances where the lack of dynamic, time-varying data in the CFD posed 
potential limitations. In order to better quantify the error introduced by the time-averaged 
boundary conditions, we thus conducted a detailed, explicit comparison of time averaged 
vs. time varying boundary conditions. As expected, the use of pulsatile boundary 
conditions yielded higher quantitative values for power loss by about 15-20% 
consistently; flow distribution results were relatively unchanged. While this difference 
may one day prove untenable, our present understanding of the relationship between 
the absolute magnitude of power loss and clinical outcomes is not advanced enough 
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(even through the knowledge gained in this study) that the value itself is meaningful. 
Instead, conservation of relative relationships among patients with respect to other 
functional metrics of interest is presently the more important insight in initial attempts at 
elucidating physiologic impact. As such, while the retention of time averaged boundary 
conditions for the present aim was not ideal, it is an acceptable and pragmatic 
simplification that greatly facilitated subsequent aspects of the analysis, such as the 
most/least efficient connection comparison, that would have otherwise been much more 
difficult to carry out. 
5.6.2 Physiologic Significance 
TCPC design is one of the factors amenable to interventional/surgical manipulation in 
the care of single ventricle patients, elucidating its role in patient functional status and 
outcomes is therefore of practical relevance. In this specific aim, both the TCPC surgical 
geometry and local flow dynamics were explored from multiple scales: at the patient-
specific level as well as a population level, with the emphasis and novelty primarily 
focused on the latter aspect. Most prior investigations into TCPC hemodynamics have 
focused on only a few patients with the goal of providing an incremental advance in 
general knowledge of the geometry/hemodynamic coupling through that relatively 
narrow focus. In contrast, the present work sought to leverage a large patient sample to 
provide statistical power for objective correlations and then allow for retrospective 
selection of individual patient cases to elucidate the functional mediators of the observed 
trends. As a result, we have gained new functional insights, as well as important 
explanations regarding their governing factors. 
A popular model of ventricular filling and cardiac output says that resistance elements 
downstream of vascular capacitance have a drastic effect on limiting the ability of the 
ventricle to fill and thus provide adequate output42; in Fontan physiology the TCPC and 
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pulmonary vasculature are two such resistive elements. It is therefore reasonable to 
expect that elevated levels of TCPC power loss resulting from sub-optimal connection 
geometry contribute to restricted preload reserve39, 66 of the single ventricle, which may 
limit long-term performance. In fact, this trend was observed in the relationships between 
TCPC-EDI and cardiac index and Qs, in strong confirmation of the prior findings of 
Sundareswaran et al.55 This finding, while far from a final answer to the problem, justifies 
past and continued investigations into TCPC hemodynamics at a time when some have 
claimed it is no longer an issue in single ventricle care66.  
The logarithmic shape of the modeled relationship between TCPC-EDI and flow (both QS 
and CI) deserves specific attention. Table 5.7 shows that 75% of the TCPC-EDI values 
fall below 0.05 and Figure 5.14 reveals a large spread of flow values associate with that 
lower range of power losses; much of the strength of the correlation comes from its fit 
with the higher loss values. Contrastingly, the logarithmic curve dictates that the flows 
should be increasing in this lower range, and in most cases that is happening. However, 
it is important to keep in mind that the problem at hand is multi-factorial and perhaps 
these other factors (e.g., PVR, ventricular function) are more prominent at these low 
power loss levels. Correlation of these hemodynamics to patient outcomes is needed to 
determine if this observation is consistent with a meaningful threshold. 
With confirmation of a physiologically meaningful relationship between TCPC power loss 
and systemic function, the question returned to the traditional engineering pursuit of 
what the important geometric factors are and how to optimize TCPC hemodynamics. 
Unequivocally, the most important factor in determining connection efficiency (from both 
the quantitative geometric analysis and the qualitative evaluation of patient flow fields) is 
vessel size, particularly the minimal dimension of each vessel in the connection. Even 
the one significant offset correlation observed (VC-PA distance) effectively reflects the 
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size of connection as opposed to the true offset in the mold of what Sharma et al.135 
proposed. No other geometric feature (IA vs. EC Fontan type, single or bilateral SVCs, 
connection angles or offsets, etc.) had a significant relationship, seemingly in contrast to 
the findings of many earlier studies. However, there is an important distinction to be 
drawn with past works. Parametric studies of singular variables, as many other works 
have done82-84, 136, 146, artificially inflate the importance of the variable being studied (akin 
to selection bias) because all other variables are inherently held constant. In this study, 
by observing trends on a large patient cohort level the results obtained represent the 
effects strong enough to overcome the ‘noise’ patient-to-patient variability. The lack of 
significant relationships for other factors, like caval offsetting or flaring, does not 
invalidate those ideas nor preclude their prospective evaluation for use in a specific 
Fontan candidate, but suggests that their utility is sensitive to other geometric variables; 
there is no one-size-fits-all solution to the optimal TCPC design. This finding, in 
consideration for the role of power loss described in this aim provides excellent 
motivation for the continued development of patient-specific surgical planning methods, 
as will be discussed in greater detail later in this thesis. 
Finally, as would be expected, there were significant relationships between connection 
angles and resulting flow distribution. The distribution of IVC flow to the PAs is of 
particular interest based on the importance of hepatic blood (assumed to be evenly 
distributed within the IVC blood) in the vascular health and development of the 
pulmonary circuit58. Three of the four cavopulmonary angles (IVC-LPA, SVC-RPA, and 
SVC-LPA) were significantly related to HFD, but more interesting is the fact that the 
respective SVC relationships were stronger (higher correlation coefficient) than the IVC 
angle correlation. This finding suggests that the SVC angle is a primary determinant of 
IVC flow distribution, which is not necessarily intuitive and suggests that for cases in 
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which HFD is a primary concern, proper planning of the Glenn connection is just as, if 
not more important that planning the Fontan connection. 
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Chapter 6. Specific Aim 2: Assess single ventricle 
function and relate it to TCPC hemodynamics 
6.1 Overview 
In the present era, operative mortality of the Fontan procedure for single ventricle heart 
defects is low22, 133, but gradual attrition is a significant problem29. Among the most 
commonly cited chronic complications are ventricular dysfunction (both systolic and 
diastolic), atrial arrhythmias, liver fibrosis and dysfunction, diminished exercise capacity, 
protein losing enteropathy (PLE), thrombotic complications, and poor 
neurodevelopmental outcomes27, 30, 31. While these issues are complex and multi-
factorial in nature, extensive research in this field has pointed to the combined 
involvement of single ventricle function33, 63, 150, the characteristics of the vasculature43, 44 
and the hemodynamics of the total cavopulmonary connection (TCPC)55, 56. While these 
factors are frequently considered in isolation, few studies have sought explicit 
connections, particularly with regard to the TCPC. 
The NIH-supported Georgia Institute of Technology-Children’s Hospital of Philadelphia 
cardiac magnetic resonance (CMR) Fontan database provides an excellent resource for 
investigating these functional connections. In this study, TCPC hemodynamics and 
ventricular function are characterized in a group of single ventricle patients late after the 
Fontan procedure. The results for these measures are first considered separately, with 
particular emphasis on the diastolic filling characteristics of the single ventricle given the 
prevalence of diastolic dysfunction in the single ventricle population30. Subsequently, 
TCPC hemodynamics and ventricular function will be correlated to observe functional 




6.2 Study Protocols 
6.2.1 Patient Selection 
A subset of forty-four consecutive functional single ventricle patients from the 100 patient 
cohort investigated in chapter 5 were selected for analysis on the basis of the 
retrospective availability of a ventricular short axis cine image stack for quantification of 
ventricular function (VF). Four of the patients were excluded on the basis of either 
severe image artifacts (3) or an inconsistent number of cine phases within the stack (1). 
In four other cases, the VF data were not available from the CMR scan included in 
chapter 5, but were present for a later scan for those patients; the VF and TCPC 
hemodynamics results from those later scans were used in those cases. The 
demographics of the remaining forty patients are shown in Table 6.1, while imaging 
details are provided in Table 6.2. 
 
Table 6.1 Demographic Details for (40) Patients in Function Analysis 
Age (years) 13.0 ± 5.0 
Body Surface Area 
(m2) 
1.36 ± 0.42 





*LV- left ventricle, RV- right ventricle, M- ‘mixed’; data presented as mean ± st. dev.; See 
Table 12.13 in Appendix D. 
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6.2.2 Segmentation Protocol 
Details on the ventricular segmentation protocol and end point calculation were 
presented in §4.1.3.3. All analyses were performed at Georgia Tech. A sample output 
from the analysis showing two segmented volume phases and the time curves of 
ventricular volume and diastolic time rate of volume change is shown in Figure 6.1. It is 
noted that the ‘atrial kick’ was not always visualized in the filling curves. 
To verify the precision of the segmented volumes, inter- and intra-user variability were 
assessed on a select number of patient data sets. For inter-user variability, another 
expert user separately segmented the end diastolic and end systolic phases for eight of 
forty patients using a modified version of the segmentation program. For intra-user 
variability, segmentations for five patients were repeated by the same user 7-8 months 
following the initial analysis. In either case, the errors associated with volume 










Table 6.2 Imaging Detail (mean ± st. dev.) for Ventricular Function CMR data 
Slices 7.9 ± 1.2 
Slice Thickness 
(mm) 
8.4 ± 1.4  
Phases 25.5 ± 4.0 
Phase dt (s) 0.03 ± 0.01 
Spatial Resolution 
(mm) 
1.35 ± 0.36 
See Table 12.14 in Appendix D. 
  
6.2.3 Statistical Analysis 
Statistical analyses were performed using Minitab (Minitab Inc., State College, PA). 
Continuous variables were tested for normality using the Anderson-Darling test. The 
Student’s t-test was used for comparisons between groups to test the null hypothesis of 
no differences in volume or function. Pearson’s r was used for correlations between 
functional variables. P-values less than 0.05 were considered statistically significant in 
all cases. Partial correlation was used, as needed, to correct for the confounding effects 
of other independent variables. The analysis presented here is exploratory in nature, and 
thus no adjustments were made for potential inflation of Type I error (i.e., rejection of a 





Figure 6.1 Sample output from semi-automatic ventricular segmentation. Left: segmented 
overlays for two phases corresponding to EDV and ESV for CHOP033A (morphologic left 
ventricle). Right: Matlab-generated plots from ventricular segmentation showing (top) 
instantaneous volume curve over time and (bottom) three-point averaged time rate of 




This section is organized as follows: First, the summary of the entire forty patient sample 
will be presented with particular emphasis on dynamic functional measures; next, the 
single left and single right morphological ventricle groups will be compared; then the 
TCPC hemodynamic results (specifically TCPC-EDI given the physiologic relevance of 
that metric illustrated in the previous chapter) will be correlated with the ventricular 
function; finally, a multi-variate regression model will be constructed to predict cardiac 




6.3.1  Ventricular Function (VF) Data 
The traditional VF metrics for all forty patients are presented in Table 6.3. The volumes 
have all been normalized to BSA. The dynamic variables measured through the 
segmentation of cine data are summarized in Table 6.4. The peak filling and ejection 
rates (PFR, PER) are presented normalized to both BSA (PFRB, mL/s/m
2) and EDV 
(PFRV, EDV/s). Time to PFR was both presented as measured (s) and normalized to 
cardiac cycle time and reported as a ‘Time Ratio’. There are fewer published studies to 
provide comparisons for these data. Akagi et al. reported that PERV and PFRV (via 







































Mean 77 35 42 55 75 3.1 
Standard 
Deviation 
16 11 10 9 16 0.8 
Median 80 35 43 55 76 3.1 
25th 
Percentile 
62 25 35 49 62 2.6 
75th 
Percentile 
90 42 48 59 88 3.4 



























Mean 2.87 220 2.73 209 0.16 0.20 
Standard 
Deviation 
0.64 59 0.72 66 0.04 0.06 
Median 2.87 227 2.69 202 0.16 0.20 
25th 
Percentile 
2.41 179 2.15 165 0.13 0.16 
75th 
Percentile 
3.24 248 3.23 262 0.17 0.24 
See Table 12.16 in Appendix D. 
 
To provide a visual comparison, Figure 6.2 shows an example of volume vs. time and 
diastolic time rate of volume change vs. time for a normal left ventricle from a healthy 
volunteer. Of particular note is the characteristic shape of diastolic filling: rapid early 
phase, diastasis, and late atrial filling. 
Figure 6.3 qualitatively compares a representative sampling of ventricular volume curves 
for nine patients. Several different modes were discernible: a) a ‘normal’ diastolic profile 
characterized by significant early filling, diastasis, and late active filling; b) a ‘parabolic’ 
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diastolic profile with a short or absent diastasis period; or c) uniquely abnormal 
characteristics with prolonged or slowed relaxation/filling. 
Table 6.5 summarizes the correlative relationships between PER/PFR and ventricular 
volumes. Both PERB and PFRB were significantly correlated to EDV and SV; however, 
none of these relationships were significant when EDV (preload) was instead used as 
the normalization factor. PERV was found to significantly correlate with ESV and EF, 
while PFRV only correlated with EF. There was also a strong relationship between PERV 
and PFRV and after using partial correlation to remove this effect, there was no longer a 
significant correlation between PFRV and EF. Finally, the EDV and peak filling time ratio 




Figure 6.2 Volume (top) and dVdt (bottom) curves for a normal LV from a healthy volunteer 





Figure 6.3 Representative sampling of volume vs. time and time rate of volume change 
(diastole only) vs. time for nine patients. Red vertical lines on the volume curves denote 
the starting point of the associated dV/dt curve. Qualitatively, these samples either (top 
row) reflected a normal ventricular diastolic profile of early filling, diastasis, and late active 
filling; (middle row) had a parabolic filling profile with little to no diastasis; (bottom row) 
had an abnormal pattern characterized by either prolonged isovolumic relaxation or a 









Table 6.5 Statistical Correlations coefficients between PFR/PER and ventricular volumes 
 EDV ESV StV EF 
PERV (EDV/s) NS* -0.66 NS 0.74 
PERB (mL/s/m
2) 0.53 NS 0.82 0.49 
PFRV (EDV/s) NS -0.42 NS 0.47 
PFRB (mL/s/m
2) 0.47 NS 0.62 NS 
*NS- not significant 
 
 
6.3.2 Single Left vs. Single Right Ventricles 
The subset of patients with either a single left or single right morphological ventricle 
(excluding six cases with a ‘functional’ single ventricle in the form of two undersized 
ventricles) was analyzed to observe potential differences between groups. Table 6.6 
shows the results of this comparison while Figure 6.4 visually demonstrates the volume 
differences. All variables were normally distributed based on the Anderson-Darling test, 
so the two-sample t-test was used for all comparisons. 
None of the variables was significantly different between groups. This finding is in 
contrast to the findings of Anderson et al. who reported larger RV volumes (EDV, ESV, 
StV)30, although the discrepancy appears to be largely related to RV results as the 
present LV volumes are statistically no different from the cross-sectional data reported 
therein (via Z-test). However, other investigators have similarly reported no differences 




Table 6.6 Comparison of Single LV and Single RV function 
 Single LV (N=16) Single RV (N=18) p-value 
Age (years) 14.3 ± 5.1 
12.2 ± 4.4 
0.22 
BSA (m2) 1.37 ± 0.38 
1.36 ± 0.43 
0.94 
EDV (ml/BSA) 79 ± 15 76 ± 19 0.68 
ESV (ml/BSA) 34 ± 10 35 ± 14 0.72 
StV (ml/BSA) 45 ± 10 41 ± 10 0.28 
EF (%) 57 ± 8 55 ± 9 0.46 
PERV (EDV/s) 3.05 ± 0.72 2.79 ± 0.61 0.27 
PFRV (EDV/s) 2.91 ± 0.79 2.60 ± 0.67 0.23 
Peak filling time 
ratio 




Figure 6.4 Comparison of ventricular volumes and ejection fraction between single left and 
single right ventricle patients. There were no significant differences between groups in 
this analysis. See Table 12.17 in Appendix D. 
 
 
6.3.3 Relationship to TCPC Hemodynamics 
TCPC power loss (reported here as TCPC-EDI) was concurrently quantified for all 
patients using CFD with time-averaged flow boundary conditions as discussed in chapter 
5. The average of this sub-group was statistically no different than the rest of the cohort 
(0.040 ± 0.028 vs. 0.037 ± 0.028). Table 6.7 shows the correlations of TCPC-EDI with 
VF. Significant results include correlations between the natural log of TCPC-EDI and 
EDV, ESV, and StV (p=0.054), and (linearly) with the time ratio to PFR. Table 6.7 also 
presents the linear regression coefficients between ventricular volume measurements 
and ln(TCPC-EDI) showing that the power loss relationship with EDV (Figure 6.5) was 
much stronger than for the other two measures. In fact, it was hypothesized that the 
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associations of TCPC-EDI with ESV and StV were secondary to the EDV/TCPC-EDI 
relationship. After using partial correlation to remove the effect of EDV, TCPC-EDI was 
no longer associated with ESV (r= -0.03; p=0.85) or StV (r=0.02; p=0.90). 
6.3.4 Relationship to CI 
The VF and TCPC hemodynamic variables were all individually compared to cardiac 
index with the results shown in Table 6.8. Notably, Figure 6.6 shows the logarithmic 
form of the EDV vs. CI relationship, which resembles the characteristic shape of the 
Frank-Starling relationship (see Figure 3.5). In addition, a multi-variate model was 
constructed by selecting the first four variables (limit for N=40) into a forward stepwise 
regression. The variable inputs to the regression were based on the significant uni-
variate relationships; however, StV and PFR were left out because of co-linearity with 
















Table 6.7 Correlations of TCPC-EDI with Ventricular function measures and results of 









Age [years] 0.15 NS   




























0.20 NS   
PFRV 
[EDV/s] 
-0.1 NS   
Time ratio to 
PFR 
0.32* 0.044   
HR  (bpm) 0.11 NS   
 
 
Table 6.8 Correlation results with CI 
 Correlation 





Age [years] -0.28 0.08   
BSA [m2] -0.21 0.19   
ln(TCPC-
EDI) 
-0.09 NS   
ESV [mL/ 
BSA] 
0.05 NS   
EF [%] 0.36* 0.025   
ln(EDV) [mL/ 
BSA] 
0.44* 0.004 2.8 <0.001 
StV [mL/ 
BSA] 
0.61* <0.001   
PERV [EDV/s] 0.52* 0.001 0.73 <0.001 
PFRV 
[EDV/s] 
0.47* 0.002   
HR  [bpm] 0.46 0.003 0.027 <0.001 






Figure 6.5 Statistically significant correlation between the natural logarithm of indexed 




Figure 6.6 Logarithmic relationship between EDV (as a surrogate of preload) and CI, 





6.3.5 Results Verification 
Inter- and Intra-user variabilities were assessed through segmentations of 8 patients by 
two different individuals and 5 patients by the same operator on two separate occasions, 
respectively, to verify the precision of the reported results. The inter-user reliability was 
assessed using a two-way random intra-class correlation (ICC) model and combining the 
independent measures of EDV and ESV for the respective comparisons. The results are 
summarized in Table 6.9 as the average absolute errors among the various results. As 
expected, the EDV comparisons yielded the lowest error (since denominator is biggest), 
while the StV comparisons had the highest errors (compounding effects of individual 
errors in EDV and ESV). The inter-user variability was higher than desired, however it is 
reiterated that a different protocol was used and the segmented images are not available 
for review to understand the source of the differences. Conversely, the intra-user volume 
differences (from analyses 8-9 months apart) were all within 10% and provide greater 
confidence in data fidelity. The dynamic PER and PFR measurements both had an 
average error of 13%. The ICC coefficient for both measures was >0.9, indicating good 
reliability in the results. 
 
 
Table 6.9 Results precision/reliability analysis (Absolute % error) 
 
EDV ESV StV PERv PFRV 
ICC 
coefficient 
Inter-user (n=8) 10 12 17 N/A N/A 0.935 
Intra-user (n=5) 4 8 10 13 13 0.993 




6.4.1 Systolic Function 
The ability to make conclusive statements regarding the functional status of the patients 
in this study is significantly hampered by the fact that this was a retrospective, 
observational study with no control group. Therefore, inferences must be drawn based 
on comparisons to past published data. It must be noted that ejection fraction and 
cardiac index are poor measures of ventricular function given their dependence on 
preload, afterload, heart rate, and contractility; yet, with limited measures available from 
this retrospective analysis, they must serve as a primary reference.  
Ejection fraction (55 ± 9%) was on average lower in these patients than normal. Akagi et 
al. reported an EF of 60 ± 8% for controls, while Ingul et al. reported values of 64% and 
57% for lean vs. obese healthy subjects, respectively151. In previous single ventricle 
studies (not age-matched to the present data), Parikh et al and Eicken et al both 
reported decreased ejection fraction post-Fontan compared to control35, 65. Finally, even 
though the PHN cross-sectional study reported preserved systolic function in 73% of 
patients (based on a Z-score for EF > -2), they similarly noted that the population mean 
(59% by echocardiography) was lower than that of normal subjects30.  
However, this decreased ejection fraction did not translate to suppressed cardiac index 
(3.1 ± 0.8 L/min/m2). By comparison, Laird et al. reported a similar value (3.1 L/min/m2) 
for healthy 14 year old subjects152, while the results of Ingul et al. were between 2.6 and 
3.0 L/min/m2 for lean and obese normals, respectively151. These findings contrast with 
those of Akagi et al. and Senzaki et al. who reported suppressed CI in single ventricles 
compared to normals, although those studies were all done in much younger subjects38, 
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64, 150. Perhaps age differences are significant in this regard with Fontan CI depressed 
early after surgical palliation, but normalizing by early adolescence. 
Finally, PER provides another load-dependent assessment of systolic function. Akagi et 
al. quantified PERV via radionuclide angiography
63, 64 and without the use of three-point 
averaging, both of which preclude a direct comparison of the measured values. 
However, those authors noted a non-significant increase for single LVs compared to 
single RVs, with only the RV patients being significantly reduced from controls64. A 
similar non-significant difference on the basis of ventricular morphology was seen in this 
study (Table 6.6). Previous studies have shown an increase in ventricular afterload in 
single ventricle physiology38, so a decreased PER with preserved ventricular 
contractility66 likely reflects this adversity. Additionally, the strong correlation between 
PERV and EF is consistent with the findings of Rathod et al. who reported negative 
effects of myocardial fibrosis on ejection fraction in single ventricles67. In that study, 
patients with fibrosis had markedly decreased EF (45% vs. 56%), therefore a mean EF 
of 55% in the present study anecdotally suggests preservation of elastic properties. 
 
6.4.2 Diastolic Function 
With regard to diastolic function, it is more difficult to rely on other studies for comparison 
as diastolic dysfunction is typically assessed using echocardiographic measures of filling 
velocities (i.e., E-wave vs. A-wave). The qualitative comparison of rate of volume change 
vs. time profiles in Figure 6.3 provides anecdotal evidence of altered diastolic 
mechanics. Additionally, there are numerous reports of ‘delayed’, ‘altered’, and/or 
‘impaired’ ventricular relaxation/filling37, 69, 70, 72, 150 building upon the report of abnormal 
diastolic function in 72% of patients in the PHN cross-sectional study30.  
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Broadly speaking, there are several factors that govern the diastolic filling of the 
ventricle: the driving head pressure (for single ventricles, that is the CVP), the ventricular 
compliance, and the cumulative resistance of the pathway between those two elements. 
Collectively, these factors determine the filling characteristics and ultimately the 
ventricular preload (the wall stress at end diastole). In the absence of ventricular 
pressure information, end diastolic volume can be used as a surrogate of myocardial 
stretch, and thus preload. The resemblance of the EDV/CI relationship (Figure 6.4) to 
the characteristic Frank-Starling relationship between preload and output (see Figure 
3.5) supports this assumption. For single ventricles, the resistance between the CVP 
and the ventricle is the integration of the TCPC, the pulmonary vasculature, the atrium, 
and the AVV valve. Of these, the pulmonary vascular resistance is assumed to be the 
primary mediator, but the finding of a significant correlation between indexed TCPC 
power loss and EDV (Figure 6.5), the first time such a relationship has been explicitly 
shown, indicates that TCPC hemodynamics are also an important component of the 
pathway.  
It is worth briefly considering an alternative interpretation of this relationship between 
TCPC-EDV. Poor ventricular compliance leading to decreased ventricular filling and 
transpulmonary flow rate in these patients could artificially increase the indexed power 
loss and produce a similar correlation between these variables. The data available 
cannot conclusively determine causality, so future studies will need to ultimately 
distinguish between these possibilities. 
For the dynamic variables, the filling rate demonstrated inherent preload dependence as 
PFR was correlated to EDV when normalized by BSA; but after correcting for the 
preload dependence (normalizing by EDV), there were no longer relationships between 
with those variables. The PFR relationship to stroke volume was also preload dependent 
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by the same logic. Finally, the time ratio to PFR was significantly (negatively) correlated 
with EDV. This measure can be thought of as the percentage of the cardiac cycle 
required to accelerate atrio-ventricular flow to its peak rate and so the relationship to 
preload is reasonable. Furthermore, the (positive) correlation of this time ratio with 
indexed TCPC power loss is further evidence that the TCPC can contribute to decreased 
ventricular filling pressures. 
Once corrected for preload, PFRV is partly a surrogate for ventricular relaxation. Ishida et 
al. showed that PFR (non-normalized) was associated with ventricular relaxation rate (τ, 
time constant of iso-volumetric pressure decline) and the atrial pressure at the onset of 
mitral flow in an animal model (head pressure)71. Senzaki et al. used PFRV to denote 
relaxation and found that, despite ‘delayed filling’ and decreased PFR, there were no 
chamber volume differences between single ventricles and controls150. A similar finding 
is noted here by the lack of a correlation between PFRV and ventricular volumes, 
particularly EDV.  
Past studies have indicated that single ventricle mechanics are inherently altered from 
two ventricle hearts153, 154, so altered or ‘incoordinate’72 relaxation is not an unexpected 
phenomenon. One potential hypothesis is, with decreased circumferential strain in single 
ventricles (with respect to both magnitude and uniformity)153, 154, there is less elastic 
potential energy stored during systole to facilitate rapid diastolic filling through untwisting 
and “suction.”155, 156 However, the present findings and those of Senzaki et al.150 suggest 
that secondary adaptations help to preserve the ultimate volumetric dimensions of the 
ventricle. The nature of those secondary changes is difficult to infer from the present 
data, but are perhaps related to resting heart rate or diastolic duration (i.e., allowance for 
extended filling time to overcome altered early filling mechanics). 
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Finally, the relationship between PFRV and PERV is a strong indication that the filling 
mechanics are not uniquely related to relaxation mechanics. Instead, that correlation is 
suggestive of a broader dependence on ventricular elastic/compliance properties4, which 
have also been reported to be altered in single ventricles67, 69. No direct comment can be 
made on the ‘normality’ of the present data. 
6.4.3 Predictors of Cardiac Index 
A recent review by Gewillig pointed out that the factors mediating cardiac output for 
single ventricles are not entirely understood66. While output could be estimated in normal 
ventricles by some combination of heart rate, contractility, preload and afterload, the 
same is not true for single ventricles. Since cardiac index is a generic way of assessing 
overall cardiac function (while being very non-specific)4, relating the present results to 
cardiac index through a multi-variate analysis is a worthwhile exercise. 
Three variables were found to be predictive of CI: EDV, HR, and PER. Many parallels 
can be drawn from this list to the ‘normal’ predictors. EDV again serves as a surrogate 
for ventricular preload, while PERV represents some combination of afterload and 
ventricular compliance. While the findings of this model are perhaps academically 
interesting, from a clinical standpoint, the only worthwhile interventional target identified 
is the ventricular preload (EDV). While HR could theoretically be boosted by adrenergic 
stimulants, past experience has shown that single ventricle preload reserve limitations 
restrict the effectiveness of such therapies150. There is some disagreement regarding the 
importance of afterload, with Senzaki et al. finding negative relationships between low 
frequency arterial impedance and cardiac index38 and Gewillig instead arguing that 
afterload increases as a consequence of low output (to maintain systemic arterial 
pressures) and is not a cause of it66. Regardless, there is far more evidence indicating 
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the importance of preload that it should be the primary target for increasing CI, either 
through PVR reduction or an efficient Fontan pathway. 
 
6.5 Chapter Summary 
Numerous studies have focused on single ventricle mechanics and function as a means 
to better understand and manage Fontan physiology. The general consensus from these 
works is that single ventricles post-Fontan experience both systolic and diastolic 
myocardial dysfunction concurrent with altered arterial and venous hemodynamics and 
potential disruption of electrical conduction4. While there was no control in this study to 
provide ‘normal’ bases for comparison, the quantitative findings were generally 
consistent with past observations and thus add to that body of literature.  
The novelty of this study is instead focused on the relationship of the TCPC to the 
ventricle. While it has frequently been hypothesized that an inefficient TCPC could 
negatively impact the function and long-term cardiovascular health of the single 
ventricle, evidence to support such ideas has been lacking. This study therefore 
represents an important contribution as the first concurrent characterization and 
comparison of ventricular function and TCPC hemodynamics in single ventricle patients. 
Important findings include inverse relationships, as hypothesized, between TCPC power 
losses and ventricular volumes, most notably EDV as a preload surrogate. The 
correlation between power loss and the time ratio to the PFR provides additional 
evidence for the role of the TCPC in diastolic function. These findings are significant 
given the fact that the single ventricle output is largely mediated by preload (as 
confirmed by the multi-variate regression model), which is typically reserve limited150, as 
well as the prevalence of diastolic dysfunction among the single ventricle population30.  
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While it is not suggested that the TCPC is the primary factor or mediator of these 
problems, TCPC hemodynamics can be controlled via surgical intervention, thus 
providing at least one way to actively pursue better long term outcomes. In fact, as will 
be discussed in Chapter 7, the patient-specific hemodynamics could even be pre-
selected through imaging-based surgical planning to minimize the need for re-
intervention for hemodynamic optimization and further leverage these hemodynamic 




Chapter 7. Specific Aim 3: Investigate the utility and 
reliability of prospective Fontan surgical planning for 
a wide array of single ventricle patients 
7.1 Overview 
Single ventricle patients following Fontan palliation with a TCPC are subject to gradual 
attrition with numerous morbidities. For a handful of these complications, there is strong 
evidence suggesting a link between the specific characteristics of blood flow through the 
TCPC and the cause or exacerbation of the complication. The most prominent example 
of such relationships is the development of pulmonary arteriovenous malformations 
(PAVM) (causing progressive hypoxia) because of the maldistribution of hepatic factors 
produced by the liver to the pulmonary vasculature58. Another example is impaired 
exercise capacity157, 158 due in part to non-linear increases in the energy dissipated 
through the TCPC pathway with increased cardiac output39, 55, 134. Furthermore, in 
Chapters 5 and 6 of this thesis, statistically significant correlations were observed 
between TCPC power losses (TCPC-EDI) and systemic venous flow rate and end 
diastolic volume. Collectively, these findings suggest that ensuring an efficient TCPC 
design with a balanced hepatic flow distribution (HFD) may yield long-term benefits for 
patient health and quality of life. 
A potential solution to this need may be found in the fact that it is currently possible to 
“virtually” mimic surgical interventions on patient-specific anatomies to assess the 
feasibility of a specific intervention or to explore various surgical approaches under 
consideration.16,19 In addition, fluid-dynamic numerical solvers have progressed in 
complexity to the point of being able to accurately reflect in vivo function126. Together, 
these capabilities present a revolutionary way of approaching cardiac surgery in that the 
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functional implications of anatomic surgical decisions can be assessed and 
parametrically investigated preoperatively. Virtual surgical planning of the Fontan 
procedure has thus been proposed to help achieve desired flow characteristics on a 
patient-specific basis110. The potential for these methods is far-reaching across the field 
of cardiothoracic surgery, and single ventricle patients provide an ideal starting point for 
their development and evaluation for several reasons: (i) there is relative homogeneity in 
operative course and timing, while the surgical implementation details can vary widely; 
(ii) there is large variability in patient outcomes; (iii) an established and accurate 
computational model already exists; and (iv) our group has a large amount of preliminary 
data suggesting that the surgical decisions about Fontan geometry and connections 
directly impact outcome. 
Previous reports have detailed the prospective use of such techniques for a limited 
number of single ventricle patients, primarily focused on addressing PAVM. In particular, 
the PhD dissertation of Dr. de Zélicourt included an evaluation of these methods toward 
the treatment of patients with interrupted IVC and azygos vein continuation124. The 
efficacy evaluations in these earlier studies were largely based on measures such as 
arterial oxygen saturations, which are clinically meaningful yet inconclusive for 
confirming modeled predictions because oxygen saturation levels are not explicitly 
included in the models105, 159. Thus, while a key assumption of these methods is the 
accuracy of preoperative predictions with respect to postoperative hemodynamic 
outcomes, detailed quantitative comparisons between pre- and post-operative 
hemodynamic metrics have not yet been reported.  
Hence, the objectives of this specific aim are twofold: 1) expand the use of surgical 
planning for the Fontan procedure to include larger patient numbers, different anatomic 
characteristics, and different clinical end points of interest; and 2) use post-operative 
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follow-up CMR data to evaluate the efficacy and reliability of the surgical planning 
predictions. The hypothesis is that Fontan surgical planning can successfully delineate 
among the hemodynamic characteristics of various surgical options for a wide variety of 
patients with sufficient realism to recreate the post-operative physiologic state and thus 
assist in clinical decision making. 
 
7.2 Study Protocols 
This chapter consists of three primary sections. First, a retrospective review of the GT 
Fontan database was conducted to identify serial patient studies that could be used to 
provide preliminary insights, as the understanding of post-Fontan physiologic changes 
that are relevant to prospectively modeling the surgery (i.e., vena cava and pulmonary 
artery flow changes) is generally poor. Lumped parameter modeling was used to 
supplement these limited data sets. Second is the presentation of findings from 
prospective patient-specific surgical planning case studies. Finally, post-operative data 
collected for a limited number of these prospective cases will be characterized and 
compared to pre-operative models to assess the accuracy and reliability of these 
surgical planning methods. 
7.2.1 Patient Selection 
7.2.1.1 Serial Flow Study 
From a retrospective review of the Georgia Tech Fontan CMR database, 11 patients 
were identified based on the availability of CMR evaluations both prior to and shortly 
following their Fontan palliation. Three patients had interrupted IVC with azygos vein 
continuation and were excluded from this analysis. An additional patient was also 
excluded based on suspected obstruction of the RPA. 
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Clinical characteristics of the seven included patients are summarized in Table 7.1. 
Patient designations are provided with respect to the BRP patient designations due to 
the use of both CHOP and CHOA patients. Five patients had a bi-directional Glenn 
(BDG) procedure (including two with bilateral bi-directional connections), 1 had a hemi-
Fontan, and 1 had a “one and a half ventricle” repair (i.e., the main pulmonary artery 
outflow was intact). The Fontan completion was performed using an extra-cardiac 
conduit in 5 cases and a lateral tunnel in the remaining 2 cases. The time from the 













































CHOP055 4.7 .63 35 
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DORV with LV 
Hypoplasia CHOP148 4.1 .65 224 
  










Pulmonary Stenosis CHOP_M5p 2.0 .58 227 
  










Hypoplasia CHOA027 2.4 .58 153 
 
 











CHOA042 2.3 .46 10 
1.5V = One and a half ventricle repair; BDG = Bidirectional Glenn; DORV = Double 
Outlet Right Ventricle; ECC = Extracardiac Conduit; HF = Hemi-Fontan; HLHS = 
Hypoplastic Left Heart Syndrome; LT = Lateral Tunnel; LTGA = Levo Transposition of 





7.2.1.2 Prospective Surgical Planning Studies 
Patient selection was performed at the clinical level; that is, patients were referred by 
their cardiologist and/or cardiac surgeon to Georgia Tech for surgical planning on the 
basis of clinical need. No additional screening or inclusion/exclusion criteria were applied 
beyond that initial referral.  
 
7.2.2 Procedures 
7.2.2.1 Serial Flow Study 
An in-house program in Matlab (The Mathworks, Natick, MA) was used to process the 
MR images (see §4.1.3.2). An edge-based active contour algorithm was implemented for 
semiautomatic segmentation of the vessel of interest over all cardiac phases. An 
automatic noise removal algorithm was subsequently used to improve the accuracy of 
these velocity values. All flow rates were normalized by the patient body surface area at 
the time of the scan (i.e., the ascending aorta flow rate is reported as the cardiac index).  
To supplement the patient data with theoretical baseline predictions, a lumped 
parameter model of the single ventricle circulation was used, which was based on the 
design of Peskin et al.160 Details on the structure and formulation for this specific model 
were described in detail by Sundareswaran et al.55 
One significant alteration that was made to the existing model design was to separate 
the systemic venous returns into superior and inferior sections. This change allowed for 
the creation of a BDG circuit configuration to complement the TCPC model. A schematic 






Figure 7.1 Schematic describing the lumped parameter models used in this study. In the 
Glenn Stage model, the interior systemic circulation connected to the common atrium 
(green line, BDG). To simulate Fontan surgery, that connection was replaced by an IVC to 
PA connection (blue line, TCPC). AV = aortic valve; C = compliance; CPC = cavopulmonary 
connection; MV = mitral (atrioventricular) valve; PA, SA = pulmonary, systemic arteries; 
PV, SV = pulmonary, systemic veins; R = resistance; V = single ventricle. 
 
 
The modeling procedure for the lumped parameter study was as follows. The BDG 
model was run first to emulate the desired pressures and flows of typical Glenn-stage 
physiology (i.e., the simulations were not intended to be patient-specific as no pressure 
data were available). Subsequently, the TCPC model was run, using the BDG pressure 
and flow outputs as initial conditions, to characterize the physiologic response to the 
surgical reconfiguration. Both simulations were run for 200 cycles to ensure cycle-to-
cycle consistency of the results. The model parameters (Table 7.2) were the same in 
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both cases (with the exception of BDG vs. TCPC resistance values) and were selected 
such that the BDG output represented typical Glenn-stage hemodynamics. These values 
of interest included: an approximate 45/55 SVC/IVC flow split (present data); SVC and 
IVC pressures of ~10-15 and ~6 mmHg, respectively (representative catheterization 
data); cardiac output ~2.7 L/min (from the average cardiac index value of the present 
data); stroke volume of 40 mL36, 39 (and present data); ejection fraction between 50-
60%39, 153, 154, 161; a maximum time rate of single ventricle pressure change (i.e., 
max(dP/dt)) of ~1350 mmHg/s38; and mean arterial pressure ~80 mmHg (representative 
catheterization data). The value for BDG resistance was derived from the results 
reported by Pekkan et al.145, while the TCPC resistance was selected as the 
approximate midpoint of the range reported by Sundareswaran et al.55 It is worth noting 
that the reported values for compliance of the systemic and pulmonary venous beds 
differ from earlier publications using this model55, 96. Since compliance is not a global 
physiologic parameter but a local one44, the total compliance was prescribed based on 
the values of Kelly et al.43, but those values were halved to account for the explicit 
representation of the superior/inferior, left/right circuits. Finally, all resistances are 
reported in Table 7.2 in terms of Wood units (WU ≡ mmHg*min/L). 
The primary metrics of interest were the changes from Glenn to Fontan in the 











CSV, ml/mmHg  332.5 (Total) 
CSA, ml/mmHg 0.5 
RSSV, WU 50 
RISV, WU 45 
CPV, ml/mmHg 80 (Total) 
CPA, ml/mmHg 4.12 
RRPV, WU 6 
RLPV, WU 7 
RCPC, WU 0.1 (Glenn)   
1.0 (Fontan) 
  
RMV/AV, WU 0.01 
CV(min), ml/mmHg 0.05 
CV(max), ml/mmHg 6.5 
C = Compliance; CPC = cavopulmonary connection; 
MV, AV = mitral, aortic valves; PA = pulmonary arteries; 
PV = pulmonary veins; R = Resistance; 
SA = systemic arteries; SSV, ISV = superior, inferior 
systemic veins; V = ventricle; MV, AV = mitral, 
aortic valves; RPV, LPV = right, left pulmonary veins; 
WU = Wood Units 
 
 
7.2.2.2 Prospective Surgical Planning 
The basic surgical planning procedure consists of a number of steps, which were 
followed for all cases. 
 Anatomic Reconstruction: As for the general CFD procedure described in 
§4.1.3.1, the patient-specific cavopulmonary vasculature is reconstructed from 
CMR images. However, there are additional requirements for these cases given 
the need to include surrounding anatomical landmarks (i.e., ventricle, atrium, 
pulmonary veins, and aorta) and, in some cases, the native IVC/hepatic veins 
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into the reconstruction to provide important inputs into the virtual surgery 
interface. 
 Velocity Segmentation: This procedure was described in §4.1.3.2. 
 Virtual Surgery: As described in §4.6, the state-of-the-art SURGEM software 
provides a robust interface to effectively mimic the Fontan procedure and 
investigate any number of patient-specific surgical options110. Following anatomic 
reconstruction, the engineering and clinical teams consult to discuss the 
particular details and challenges of a given case and formulate a modeling plan: 
what options are being considered for surgery and what other potential options 
exist. The patient anatomy is then loaded into SURGEM and the discussed 
options are created. 
 “Stitching”: One of the current limitations of the SURGEM software is the inability 
to automatically mate the virtual Fontan baffle to the underlying patient anatomy. 
Instead, the baffle creation step must currently be followed by a stitching step to 
manually perform this mating process using the Geomagic Studio software. 
Stitching can add considerable time to the model creation process as well as 
introducing an element of user dependence; it is important to ensure that the final 
result resembles typical Fontan connections (as from the database) and does not 
taken on unrealistic characteristics through the stitching process. 
 Boundary Condition Prescription: Following the stitching phase, the CFD 
evaluation proceeds the same as in previous chapters with one important 
distinction. That is, the flow conditions at which the TCPC should be evaluated 
are not necessarily the same as what was measured with pre-operative PC 
CMR. In fact, the exact boundary conditions of interest are unknown given the 
generally poor understanding of post-operative physiologic changes, which is the 
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underlying motivation for the serial patient flow analysis. As such, the procedure 
for prescribing the boundary conditions of interest varied slightly from patient to 
patient, as will be detailed in the appropriate sections, but were based on the use 
of pre-operative measurements with hypothesis-based deviations.  
In general, time-averaged flow conditions were used for patients undergoing their initial 
Fontan procedure since the measured pulsatility in the IVC was assumed to be largely 
dictated by its pre-operative connection to the atrium; cases requiring surgical revision 
were typically modeled with pulsatile flow boundary conditions. The PA split was 
parametrically varied (for the PAVM cases) based on the assumption that PAVM 
regression would increase resistance to the affected side and thus shift flow to the 
opposite lung. The effect of the Fontan baffle design on the internal connection 
resistance (insofar as it determines the PA split) was generally ignored; however, in 
select cases in which it was thought to be potentially non-negligible, a post-hoc 
resistance analysis was performed to estimate potential flow split changes. 
7.2.3 Statistical Methods 
Since this specific aim was primarily focused on small sample sizes and individual 
patient case studies, statistical evaluations were limited and generally descriptive in 
nature. Where appropriate, Pearson correlations and t-test comparisons were used to 




7.3 Serial Flow Study Results 
7.3.1 Patient Results 
A statistically significant decrease in CI was observed (5.27 vs. 3.35 L/min/m2; Figure 
7.2). Figure 7.3 shows the averaged flows in each component of the Fontan pathway 
before and after TCPC. Consistent with the decrease in CI, significant decreases in both 
IVC (2.48 vs. 1.59 L/min/m2) and SVC flows (2.07 vs. 1.35 L/min/m2; after removing the 
patient with 1.5 ventricle repair) were observed. There was also a decrease in the IVC 
percentage of total caval flow in these patients (right side of Figure 7.3), although this 
difference was not statistically significant. With respect to pulmonary arterial flow, a 
significant increase in LPA flow was observed (0.88 vs. 1.40 L/min/m2), while there was 




Figure 7.2 Mean (± standard deviation) cardiac index values from phase contrast CMR 





Figure 7.3 Mean (± standard deviation) flows (left side of the figure), normalized by body 
surface area, through each of the vessels of the Fontan connection before and after 
surgery. A significant increase was seen in the LPA, while IVC flow change approached 
significance. Mean (± standard deviation) of the IVC percentage of total caval flow (right 
side of figure). 
 
 
To better assess the serial differences of caval flow distribution to the lungs, Figure 7.4 
shows the changes in LPA percentage of total pulmonary flow for all 7 patients. The 
slope of each line is indicative of the degree of change for each patient with large slopes 
corresponding to large changes. Large variations across patients were seen in this 







Figure 7.4 Change in percentage of LPA flow (to total pulmonary flow) for each patient. 
Only one line appears to be flat, denoting changes in the left/right pulmonary flow 
distribution of all other cases. 
 
 
7.3.2 Lumped Parameter Results 
The results of the lumped parameter simulations are presented in Table 7.3 and Table 
7.4. The comparable values from the patient results are reported where appropriate. As 
with the patient data, there was a large (42%) decrease in cardiac output between the 
Glenn and TCPC models as a result of the altered ventricular loading conditions. This 
fact is most evident by the change in end diastolic volume, which decreased by 25%. By 
comparison, the end systolic volume decreased by ~6%. These results (i.e., near 
constant end systolic volume with decreasing end diastolic volume) agree well with the 
findings of Fogel et al.33 The altered cardiac function resulted in decreases in caval 
flows- 44/40% for the IVC/SVC, respectively, while increases in both LPA and RPA flows 
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(27/26%, respectively) were observed. The percentage of IVC flow decreased from 
54.2% to 52.6%, while the percentage of LPA flow was little changed (46.0% vs. 46.2%). 
Table 7.3 and Table 7.4 also show that pressures throughout the system (except in the 
IVC) decreased. It is important to note that no changes were made to the systemic 
arterial properties of the model from the BDG to TCPC configurations. Thus, while it is 
recognized that these pressure values are non-physiologic and not directly consistent 
with clinical observations, they are consistent with an increased circulating blood volume 
in the TCPC circuit162, and the need for significant fluid loading in the acute post-
operative period. Numerous other adaptive mechanisms are also likely to be involved. 
 
 
Table 7.3 Summary of ventricular function changes predicted by the mathematical model 
Cardiac 
Function 
Glenn TCPC % Difference 
% Difference 
(Patient Data) 
CO (L/min) 2.99 1.73 -42.1% -31% 
 
ESV (mL) 32 30 -6.3% (NA)* 
EDV (mL) 69 52 -24.6% (NA) 
SV (mL) 37 22 -40.5% (NA) 
EF (%) 53.6 42.3 -21.1% (NA) 
Ao Pmax 98.1 61.8 -37.1% (NA) 
Ao Pmin 58.9 39.1 -33.7% (NA) 
Ao Pmean 79.5 50.9 -36.0% (NA) 
max(dP/dt) 1360 813 -40.2% (NA) 




Table 7.4 Summary of TCPC hemodynamic changes predicted by the mathematical model 
*NA- data not available 
 
7.3.3 Section Discussion and Summary 
The insights provided by the novel combination of serial patient data with lumped 
parameter modeling in this study are twofold: 1) we see the mechanism by which the 
creation of the completed Fontan series circuit affects and impairs cardiac function; and 
2) we see for the first time how such changes in cardiac output and ventricular function 
impact blood flow at the level of the TCPC. In the first case, it has been hypothesized 
that the altered ventricular function after the Fontan procedure is the result of significant 
changes to ventricular loading conditions, especially decreased preload40, 55, 163, despite 
the fact that the single ventricle is already considered to be “unloaded” at the Glenn 
stage. The findings of lower end diastolic volume and stroke volume (model results) and 
the subsequent reductions in CI noted in both the patient and model results support this 
hypothesis. It also stands to reason based on this mechanism that the severity of these 
responses will be dependent on the resistance to flow through both the TCPC and the 
Fontan 
Hemodynamics 
Glenn TCPC % Difference 
% Difference 
(Patient Data) 
QIVC (L/min)  1.62 0.91 -43.8% -36% 
QSVC (L/min)  1.37 0.82 -40.1% -35% 
QLPA (L/min)  0.63 0.80 27.0% 58% 
QRPA (L/min)  0.74 0.93 25.7% -18% 
PIVC (mmHg)  6.6 10.0 50.2% (NA)* 
PSVC (mmHg)  11.2 9.9 -11.1% (NA) 
PPA (mmHg)  11.0 9.5 -13.7% (NA) 
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pulmonary circuit, which supports the use of surgical planning or other hemodynamic 
optimization strategies for the TCPC to minimize its contributions in this regard.  
With respect to TCPC flow changes, both caval flow rates significantly decreased, 
consistent with decreased cardiac output. Further, both the patient and modeling results 
suggest a redistribution of caval flow balance (with higher SVC percentages), which 
would be expected to have an impact on the local hemodynamics. The likely mechanism 
mediating this effect is the increased afterload resistance to IVC flow posed by the 
TCPC and pulmonary vasculature (just as they altered preload resistance to the 
ventricle).  
For the pulmonary arteries, the additional source of flow (from the IVC) translated into a 
significant increase in LPA flow post-operatively; however, the finding of decreased RPA 
flow in the patient data is puzzling. The model results (showing an increase) agree with 
intuition in this case as there is no apparent reason that RPA flow should behave so 
differently from the LPA, nor why the percentage of LPA flow increased post-operatively 
in each case. Absent any geometric bias, uneven sampling of inherently large variations 
(i.e., type II error) could be a primary contributor. Alternatively, in a large patient series 
using the same acquisition protocol, Whitehead et al. noted challenges with RPA flow 
measurement related to the proximity of the measurement plane to the caval junction 
and right upper lobe branch point142. However, despite these potential uncertainties, it is 
difficult to completely dismiss the observed heterogeneity in PA flow distribution changes 
as an actual effect because of the possibility of complex physiologic adaptation to 
surgery or hemodynamic changes. Potential explanations include the confounding 
effects of residual pleural effusions or PAVM, or potential changes in right lung 
resistance post-Glenn. More research is needed to better understand these trends.  
In large part, the significance of this work lies in how the results can be used to improve 
the accuracy of surgical planning results, given the rising interest in implementing such 
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methods. Until now, such changes have been neglected in prospective modeling 
studies, but the present data show that the relevant physiologic changes are not 
insignificant. Chief among such observations is the variation of PA flow distribution pre- 
and post-operatively (Figure 7.4). A similar observation was made in a recent study94, 
but only in a single patient. These variations will obviously have a significant impact on 
the both dynamics of flow through the Fontan pathway as well as the distribution of the 
flow, particularly of the IVC (and thus hepatic) to the respective PAs105. Critically, the 
study by Pennati94 also demonstrated, as is confirmed by the present results, that 
lumped parameter modeling may not be able to capture the entirety of pulmonary arterial 
adaptation following surgery because of the multi-factorial complexity of the response. 
Hence, while coupling CFD solvers to lower dimensional models95, 164 is a positive 
strategy for anticipating some of the physiologic response to TCPC surgery and 
undoubtedly a necessary next step for the development of these surgical planning 
techniques, it is not entirely self-sufficient; user input, guided by past patient/clinical 
experience, is still required to ensure the surgical options are evaluated over the 
appropriate range of possible outcomes.  
 
7.4 Prospective Patient Case Studies 
7.4.1 Overview 
In total, ten patient cases will be presented: seven patients from CHOP, two patients 
from Children’s Healthcare of Atlanta (CHOA), and one from Boston Children’s Hospital 
(CHB). The prospective Fontan surgical planning experience to date includes the 
contributions of multiple researchers among whom the work has been divided; the ten 
cases presented here (unless otherwise credited) represent the contributions of the PhD 
candidate (CMH) with no additional selection criteria. Furthermore, there is not yet a 
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formally established protocol for patient enrollment in surgical planning; instead, the 
recruitment is performed in the respective clinical centers on ad hoc, as needed basis. 
Details on the cases presented, including their ‘M’ designations in the surgical planning 
database are provided in Table 7.5. In half the cases, the planned surgery represented a 
revision of an existing Fontan connection, while for the other half it was the primary 
Fontan procedure. As discussed in §7.2.2.2, this factor played a primary role in dictating 
the boundary condition assumptions made for the study. A minimum of three surgical 
options were considered in each case (with one exception), with a maximum of eight. 
This number was primarily dictated by the number of viable options as well as the time 
available to perform the modeling study. 
The data presented in the table as well as in the results sections indicated are in 
chronological order of the modeling studies, which were performed between August 
2010 and June 2012. This order is not necessarily consistent with the applied numbering 
scheme of the patient identifiers. For a general summary of the surgical planning 












Table 7.5 Details for Surgical Planning Patients 







CHOA_M2 18 F Post-Fontan PAVM Right 7.4.2 
CHOP_M9 2 M Kawashima PAVM Right 7.4.3 
CHOP_M10 3 F Kawashima PAVM Left 7.4.4 
CHOP_M12 2 M Bilateral BDG PAVM Left 7.4.5 
CHOP_M13 2.5 F Bilateral BDG PAVM Left 7.4.6 
CHOP_M8 8 M Post-Fontan PAVM Left 7.4.7 
CHB_M1 8 M Post-Fontan PLE N/A 7.4.8 
CHOA_M5 12 F Post-Fontan PAVM Right 7.4.9 
CHOP_M16 2 M Bilateral BDG PAVM Right 7.4.10 




This patient was an 18 year old female with interrupted IVC and azygos vein 
continuation to a ride-sided SVC who had developed right-lung PAVM even though the 
hepatic venous flow had previously been directed to the pulmonary arteries with a lateral 






Figure 7.5 Pre-operative anatomy for CHOA_M2 shown from anterior (left) and right 
sagitttal (right) perspectives. 
 
 
A significant challenge faced with the pre-operative modeling for this patient was the fact 
that the CMR images were not optimized for CFD modeling: the axial slice thicknesses 
were 10 mm. Additionally, there was significant signal dephasing at the PA junction, 
making it difficult to accurately resolve some connection features. Thus, the 
reconstruction shown in Figure 7.5 actually represents a manual combination of several 
different imaging acquisitions (i.e., axial, 4-chamber ventricular view, and a small sagittal 
‘Fontan’ stack), which is far from optimal. These factors may have also contributed to the 
fact that the pre-operative simulations were never able to successfully recreate the 
unilateral hepatic flow-to-LPA streaming that would be consistent with the right lung 
PAVM diagnosis. Instead, as shown in Figure 7.6 the hepatic flow (yellow streamlines) 
was evenly divided between the LPA and RPA (50/50). This limitation was taken into 
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Figure 7.6 Velocity streamlines color-coded by vessel of origin for pre-operative anatomy 
of CHOA_M2. 
 
The PC CMR-measured vessel flow rates are summarized in Table 7.6. The hepatic 
venous contribution to systemic return was low (17%), as expected, while the RPA 
carried 77% of the total pulmonary flow, which is consistent with right-sided PAVM given 





Table 7.6 Measured pre-operative flow rates for CHOA_M2 
 Flow Rate (L/min) Relative Distribution (%) 
Hepatic Vein 0.57 17 
SVC 0.7 21 
Az 1.61 49 
Innom. Vein 0.43 13 
LPA 0.97 -23 
RPA 3.3 -77 
 
 
A total of four different surgical options were modeled: three prospective designs and a 
fourth that was retrospectively considered (and constructed by modifying the post-
operative anatomic reconstruction). For the three prospective designs, the rationale was 
that by either repositioning the Fontan connection ‘centrally’, anteriorly/centrally, or 
bifurcating the hepatic venous flow using a Y-graft, the HFD to the RPA would be 
improved while still maintaining an adequate distribution to the LPA. The final 
retrospective design was a hepatic-to-azygos connection, motivated by the studies of de 




Figure 7.7 Virtual surgical options investigated for CHOA_M2 representing two different 




To evaluate the prospective surgical options, three different simulations were performed 
with varying outflow boundary conditions, while maintaining constant inflow rates and 
using time-averaged conditions: 
1. Pre-operatively measured conditions (23% LPA; Table 7.6) 
2. 35%/65% LPA/RPA  
3. 50%/50%. 
Conditions 2 and 3 were intended to simulate a scenario in which the right lung PAVM 
regressed and the relative resistance through that lung increased, leading to a local 
redistribution of flow. In such a scenario, it is important to insure that a desirable flow 
distribution outcome can still be achieved over that range of possible conditions. 
Figure 7.8 shows the results for the two EC options. As expected from prior 
experience105, 124, the seemingly small change in baffle placement yielded very different 
quantitative outcomes because of the low flow momentum carried by the hepatic baffle 
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as compared to the superior venous returns. By moving the connection closer to the 
RPA, hepatic flow was biased toward the RPA; in fact, for two of the simulations 
performed for option A (without anterior curvature), the entirety of hepatic flow was 
directed to that lung. Introducing the anterior curvature to the baffle (option B) improved 
flow distributions slightly by removing the ‘head-on’ flow collisions with SVC flow; yet, the 
RPA bias was still present. Given this extreme sensitivity of results to baffle placement, 




Figure 7.8 Velocity streamline results from simulations under pre-operative BC (Sim. 1) for 
the extracardiac options for CHOA_M2. Hepatic venous flow is shown in blue. Tables at 





By comparison, Figure 7.9 shows the results for the virtual Y-Graft option. In this case, 
by placing the bifurcated branches on either lateral side of the SVC-Azygos connections, 
the hepatic flow (shown in blue) was predicted to distribute fairly evenly to both PAs 
(38% to the LPA under pre-operative flow conditions). For this reason, this approach 
was deemed to have improved stability and robustness compared to the extracardiac 




Figure 7.9 Qualitative and Quantitative results for Y-Graft surgical Option for CHOA_M2. 
CFD predicted good HFD balance and low power losses. 
 
 
Finally, the result of the retrospective hepatic-to-azygos connection is shown in Figure 
7.10, with the pre-operatively measured boundary conditions considered. This design 
promoted robust mixing of the inflows within the connection, leading to an HFD result 
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that was in close match to the global pulmonary flow split. While additional outflow splits 
were not explicitly modeled, this trend would be expected to lead to increased HFD-to-
LPA flow with increased to total volume to that branch, making this connection 
potentially favorable. The two potential drawbacks are: higher power losses (3x higher 
than what was seen for the other options considered in Figure 7.8 and Figure 7.9), and 
potentially increased surgical complexity because of the posterior positioning of the 




Figure 7.10 Result from retrospectively considered hepatic-to-azygos connection for 




This patient was a two year old male with Hypoplastic Left Heart Syndrome and 
Interrupted IVC who had an existing Kawashima connection, but did not have a Fontan 
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connection of the hepatic veins to the PAs. As a result, right lung PAVM had developed 
and the patient was referred for surgical planning to evaluate the possible operative 
options with respect to HFD. The anatomic reconstruction of the Kawashima connection 




Figure 7.11 Anatomic reconstruction for CHOP_M9 pre-operative connection with (left) and 
without (right) the surrounding structures (in blue). 
 
Table 7.7 PC CMR-measured pre-operative flow rates for CHOP_M9 
 Flow Rate (L/min) Relative Distribution (%) 
Hepatic Vein 0.44 18 
SVC 1.31 54 
Az 0.68 28 
LPA 0.5 -34 




A total of 9 surgical options were considered for this patient: three extracardiac conduits, 
two Y-grafts, three ‘flow divider’ options (one per extracardiac design), and one hepatic-
to-azygos connection (retrospectively modeled). The first two extracardiac models 
employed a 20 mm conduit to the SVC and varied slightly by offset, with one option 
being positioned slightly closer to the RPA. A 5 mm cylindrical hole was created in the 
middle of the distal end of each of these baffles to create the first two flow divider 
options. The Y-graft was modeled as a 20x10 mm aorto-iliac graft. After this first round 
of options was modeled, it was determined that the 20 mm graft design was too large for 
this patient given that the hepatic venous baffle typically carries much lower volume than 
a typical Fontan. A second round of options was thus created using 14 mm grafts 
(including 14x7 mm Y-graft) and using a triangular-shaped insert for the flow divider 
option to minimize flow stagnation/separation points as would be expected with a circular 
profile insert. These options are shown in Figure 7.12. 
As with CHOA_M2, the 20 mm-based options were all evaluated at a series of different 
pulmonary flow splits (34%, 50%, and 60% LPA; assuming regression of right PAVM) for 
a constant set of time-averaged inlet flow conditions based on the pre-operative 
measurements (Table 7.7). The second round of smaller options (14 mm-based) were 
only run under the pre-operatively measured conditions because of limited time 




Figure 7.12 Surgical options created and evaluated for CHOP_M9 encompassing 
extracardiac connections of different sizes (20 mm or 14 mm) and positions, flow dividers 








The results for the 20 mm extracardiac options with and without circular flow dividers are 
shown in Figure 7.13. Qualitatively, the flow in the hepatic baffle was very disturbed: the 
combination of low hepatic flow volume, large baffle size, and relatively high momentum 
SVC flow led to SVC penetration into the baffle and significant mixing. From the included 
plot it can be seen that even with a seemingly small difference in baffle placement 
between EC option 1 and EC option 2, the two options yielded HFD values at opposite 
extremes. Interestingly, the introduction of the flow dividers to both cases improved the 
HFD performance of both connections (i.e., moved the results closer to 50%), despite a 
similar qualitative appearance of disturbed flow within the Fontan baffle. While the 
mechanism for this improvement is not obvious from the visual results, it is likely that the 
presence of the divider actually helped to reduce SVC flow penetration into the baffle 
and subsequent constraining of hepatic flow preferentially to one side. Regardless, both 
options were extremely sensitive to placement and, considering the interactions with 
SVC flow, were extremely unpredictable.  
By comparison, Figure 7.14 shows the results for the 14 mm extracardiac models. The 
smaller baffle improved hepatic flow momentum and reduced (but did not remove) SVC 
flow penetration. By virtue of a slight left offset, the non-divider option resulted in 73% 
hepatic flow to the left (measured flow conditions). Interestingly, the divider in this case 
did not moderate HFD as in the prior models (i.e., move it closer to 50/50). Instead, the 
flow characteristics changed completely because the SVC flow restricted passage 
through the left side of the divider and the distribution simply changed from one extreme 






Figure 7.13 Results for 20 mm extracardiac options for CHOP_M9 with and without flow 
dividers inserted. For these particular models, the presence of the flow dividers improved 
HFD performance for all investigated flow conditions. 
 
 
Figure 7.14 Results for 14 mm extracardiac option for CHOP_M9 with (left) and without 
(right) a (triangular) flow divider (outlined in black). The flow divider result is additionally 
shown from the left (far right) to highlight the flow dynamic with the SVC. Rather than 
improving flow distribution in this case, the divider drastically changed qualitative 




The results of the two Y-Graft sizes investigated are shown in Figure 7.15. Because the 
SVC and azygos vein join the PAs at a single location, positioning the branches laterally 
to either side was deemed to be surgically feasible. For both options, SVC interaction 
with flow through the left branch is apparent (as with the left side of the flow divider in 
Figure 7.14), but appears to be more extensive with the larger (20-10) graft size. For the 
larger graft, increasing LPA flow also increased HFD to the LPA, a trend that was 
assumed would hold true for the 14-7 design. For these reasons, the 14-7 mm Y-Graft 




Figure 7.15 Results from the 20-10 mm Y-Graft (left) and the 14-7 mm Y-Graft (right). HFD 






As a brief addendum, a hepatic-to-azygos connection was retrospectively modeled for 
this patient under pre-operatively measured flow conditions (as for CHOA_M2), with the 
result shown in Figure 7.16. The HFD result was comparable to the Y-Graft options, but 









This patient was a 3 year old female with pulmonary atresia with interrupted IVC and 
azygos vein continuation. Like CHOP_M9, she had a previous Kawashima connection 
but hepatic flow still drained into the atrium and left-sided PAVM had developed. 
Surgical planning was requested to investigate the flow distribution characteristics of the 
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available options. Reconstructed patient anatomy is shown in Figure 7.17 and measured 




Figure 7.17 Reconstructed Kawashima connection (in blue) and surrounding heart and 
vessels (in red) for CHOP_M10. 
 
 
Table 7.8 PC CMR measured pre-operative flow conditions for CHOP_M10 
 Flow Rate (L/min) Relative Distribution (%) 
Hepatic Vein 0.35 18 
SVC 1.09 56 
Az 0.49 26 
LPA 1.37 -76 






Six options were considered for this case, as shown in Figure 7.18: two extracardiac 
options, two Y-Grafts (18x9 mm and 14x7 mm), a hepatic-to-azygos, and a hybrid Y-
Graft to azygos connection (‘H-Graft’). In addition to the pre-operatively measured flow 
conditions (76% to the LPA), each of these options was also evaluated at 65/35% and 
55/45% LPA/RPA flow splits (assuming regression of left-sided PAVM) with a constant 




Figure 7.18 Surgical options considered for CHOP_M10 encompassing two extracardiac 
models, two Y-Grafts of different sizes (18x9 mm and 14x7 mm), a hepatic-to-azygos and a 




Results for the two extracardiac options are shown in Figure 7.19. As with CHOP_M9, 
flow through the hepatic baffle is seen to be adversely affected through direct collision 
with higher momentum superior flows, particularly for EC1 (Figure 7.19, left). Both 
options favored HFD to the LPA at all investigated flow splits (and were relatively 
consistent with respect to each other) despite the fact that attempts were made with the 
first option to introduce no offset of the baffle with respect to the SVC. Yet again, this 
finding underscores the placement sensitivity of extracardiac conduits in cases of 




Figure 7.19 Velocity for the two extracardiac options for CHOP_M10 and associated HFD 





The Y-graft results are shown in Figure 7.20 and despite the size and (slight) positioning 
disparities, the velocity streamlines and HFD measures are very similar across options. 
Furthermore, the HFD values are nearly perfectly balanced and show relative 
insensitivity to changing global flow split. For these reasons, the 14x9 mm Y-graft was 




Figure 7.20 Velocity for the two Y-Graft options (18x9 mm and 14x7 mm) for CHOP_M10 
and associated HFD performance over a range of PA flow splits. Images shown 
correspond to 76% LPA GFD condition. 
 
 
Finally, Figure 7.21 shows the results for the H-Graft and hepatic-to-azygos connections. 
The H-Graft was by far the worst performer of the investigated options with respect to 
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HFD as all the hepatic flow (even the portion diverted through the azygos vein) was 
constrained to the RPA. However, it is worth noting that if the design had been reversed 
such that the PA-directed branch was connected on the left rather than the right, this 
option may have been more favorable with hepatic flow delivered to both lungs. 
However, these benefits would likely have been negligible as compared to the standard 
Y-Graft options. The hepatic-to-azygos connection again performed well, but was more 
sensitive to PA flow split and arguably more surgically challenging than the Y-graft, and 




Figure 7.21 Velocity for the H-Graft and hepatic-to-azygos (H2A) options for CHOP_M10 
and associated HFD performance over a range of PA flow splits. Images shown 





7.4.5 CHOP_M12  
It is noted that the credit for completing the study for this patient goes to Maria Restrepo 
(Georgia Tech); brief details are included here because of relevance to the later analysis 
for post-operative data. 
This patient was a two year old male with bilateral bidirectional Glenn connections who 
had developed bilateral PAVM prior to Fontan completion. The patient-specific anatomic 
reconstruction is shown in Figure 7.22, while the measured flow conditions are in Table 
7.9. 
Figure 7.23 shows the four virtual options created for this patient consisting of two 20 
mm extracardiac conduits and two 20x10 mm Y-Grafts. Differences of angles and offsets 
between like options were intentionally small based on the desire to evaluate option 




Figure 7.22 Anatomic reconstruction of the bilateral bidirectional Glenn (in blue) and 
surrounding anatomy (in grey) for CHOP_M12. 
 
Table 7.9 PC CMR measured pre-operative flow conditions for CHOP_M12 
 Flow Rate (L/min) Relative Distribution (%) 
IVC 1.27 56 
RSVC 0.57 25 
LSVC 0.42 19 
LPA 0.61 -62 






Figure 7.23 Surgical options for Fontan surgery considered for CHOP_M12 consisting of 
two extracardiac connections and two Y-Graft connections varying primarily by baffle 
angles and offsets. 
 
 
Figure 7.24 shows the results for the extracardiac connections revealing very subtle 
qualitative differences in flow features. EC2 was positioned slightly further to the left but 
less angled to the left and as a result, its HFD-GFD curve is shifted up (note the location 
of the first point) relative to EC1. However, the slopes of the respective responses to 









Differences between Y-Graft options (Figure 7.25) were qualitatively more apparent as 
Y2 exhibited much more complex mixing patterns both within the baffle itself because of 
the high degree of curvature as well as within the connection. By comparison, Y1 
appeared to have a much more laminar profile in that the flow through the right Y-branch 
exited the RPA and vice versa. Thus, the HFD response for Y1 was relatively flat with 
respect to changing GFD; whereas, the response of Y2 varied considerably across 






Figure 7.25 Velocity streamline and HFD results for the two Y-Graft options for CHOP_M12. 
 
 
Finally, the summary of power loss measures across the range of investigated options is 
shown in Table 7.10. Values were generally consistent among the different connections, 
although a 55% difference was seen between the two Y-Graft options at the 40% LPA 







Table 7.10 Power loss summary for each option across investigated flow conditions. 
%LPA 40 50 62 70 
EC1 3.9 2.9 2.3 2.1 
EC2 3.6 2.7 2.3 2.2 
Y1 3.1 2.7 2.3 2.4 
Y2 4.8 3.1 2.5 2.2 
 
 
In conclusion, because of the potential complexity and sensitivity of implementing a Y-
Graft for a case of bilateral SVCs combined with the apparent stability and predictability 
of the extracardiac models, the surgeon opted for an extracardiac connection, which was 
implemented in April 2011. 
 
7.4.6 CHOP_M13 
This was an approximately 2 and a half year old female with the diagnosis of single 
ventricle in the form of heterotaxy syndrome, dextrocardia, malaligned atrio-ventricular 
canal (AVC), total anomalous pulmonary vein connections (TAPVC), infradiaphragmatic, 
double outlet right ventricle (DORV) with pulmonary stenosis (PS) after bilateral 
bidirectional Glenn reconstruction, TAPVC repair and main pulmonary artery (MPA) 
ligation and division. The patient was referred for surgical planning of the Fontan 
procedure with suspected PAVM in the left lung. Anatomic reconstruction is shown in 
Figure 7.26 where it can be seen that the case was complicated by the presence of 
separate IVC and left hepatic venous connections to the left atrium. PC CMR measured 
flow rates are listed in Table 7.11. In addition to those measured flow conditions, 
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simulations were also performed at pulmonary flow splits of 80/20 and 55/45 (LPA/RPA), 
and another assuming a 30% decrease in cardiac output (based on the finding of 





Figure 7.26 Anterior (left) and left sagittal (right) views of anatomic reconstruction of 








Table 7.11 Measured flow conditions for CHOP_M13 
 Flow Rate (L/min) Relative Distribution (%) 
IVC 0.56 24 
HepV 0.1 5 
RSVC 0.61 27 
LSVC 1.0 44 
LPA 0.93 -68 
RPA 0.44 -32 
 
 
A total of 8 options were investigated, as shown in Figure 7.27. The design breakdown is 
as follows: one option investigates two separate, bilateral baffles for the IVC and Hepatic 
vein, respectively (a). The next three options are intra-atrial baffles with the hepatic vein 
connecting in an end-to-side fashion to the IVC baffle inside the atrium. The distinction 
between the options is with respect to PA location: (b) sub-RSVC, (c) mid-PA, (d) sub-
LSVC. The remaining options are variations of Y-grafts: (e) has a similar Hep-IVC 
connection and spans the two SVCs with the Y branches, (f) investigates the effect of 
offsetting the right Y branch of the previous option more centrally. The final two primarily 
vary the way in which the IVC and HepV are ‘captured’ by simulating part of the IVC 
baffle being sutured to the atrial ‘floor’ around the two venous entrance points and 
extending (g) left in an extracardiac approach and (h) right for an intra-atrial tunnel 
(using the same connection points as option e). 




Figure 7.27 Eight surgical options evaluated for CHOP_M13 representing (a) bilateral 
conduits for IVC and left hepatic vein, (b-d) intra-atrial conduits of varying connection 




The HFD and power loss results for each option are detailed in Table 7.12 and Table 

















The first option that was eliminated from consideration was option (a) for the reason that 
significant concern was raised about the thrombus risk that the design posed given the 
extremely low flow rate present in the left hepatic veins. This would be especially 
exacerbated by the high velocity in the LSVC (44% of venous returns), which would be 
located opposite to the connection of that left hepatic baffle, and create significant 
resistance to forward flow. From the velocity plot in Figure 7.28, the difference in 
velocities (and thus momentum) between the LSVC and the IVC is readily apparent, 




Figure 7.28 CFD results for option (a). On the left, the streamlines are colored by vessel, 





Next considering the various Y-graft designs, it is evident from Figure 7.29 that for each 
of the 3 different Y-graft placements investigated (since e and h were the same with 
respect to placement), significant obstruction and disturbance of the flow in one branch 
occurred. Hence, even though some options produced reasonable flow distribution 
values (Table 7.12), the connections did not direct flow as intended, indicating energy 
inefficiencies. Furthermore, there was significant sensitivity to branch placement without 
a great indication from the modeled designs if an optimal placement could even be 





Figure 7.29 CFD results for options (e-h). In each case (denoted by the arrows) one of the 
branches was significantly affected/obstructed by the superior caval flows, primarily the 








Finally, the intra-atrial tunnel designs (b-d) are shown in Figure 7.30. Perhaps owing to 
the fact that the bilateral SVCs were medially angled (i.e., forming a ‘V’), these options 
(with the possible exception of option d) were consistently the best performers. There 
were significant interactions apparent between the Fontan and either of the SVC flows, 
particularly as the Fontan baffle moved left toward the dominant LSVC flow, but these 
interactions appeared to promote bidirectional flow distribution (Table 7.12), rather than 
unilateral (with the exception of option (d) when LPA flow was 80% of Qp). By far the 
lowest power losses simulated in this study (Table 7.13) were seen in option b, which 
also had one of the most balanced flow distribution characteristics of any option. Thus, 
the recommended surgical approach was for a single, combined IVC-Hepatic intra-atrial 
baffle to be positioned medially with respect to the bilateral SVC, but closer to the RSVC 
than the LSVC. It was noted that positioning too far to the right would likely constrain the 
IVC flow primarily to the RPA, and so it was advised to err on the medial side rather than 





Figure 7.30 CFD results for options (b-d). The major difference among these options was 
the position of the Fontan baffle, but the effect that difference has is noticeable by the 
smooth, streamlined look of b compared to the disturbed recirculation regions present in 
the latter two. Presumably this again owes to the fact that the IVC interactions with the 
LSVC are minimized in (b), which also provides energetic benefits. 
 
 
With respect to the means of connecting the left hepatic veins and IVC, a (roughly) direct 
comparison is possible with options e and h (Figure 7.29; although these are Y-graft 
models and not straight baffles). Of these two, there was minimal difference in the flow 
distributions; however, the power loss of option h (the one inclusive of the atrial wall) 
was considerably lower than option e. There is not an immediate visual clue as to why 
this is the case, although perhaps this configuration allows for a more natural 
streamlining of this combination rather than a blunt end to side connection. However, 
since this connection was never previously considered in these modeling studies, its 
geometric ‘realism’ was difficult to guarantee. Thus, no recommendation on that aspect 
of the connection was made.  
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Based on these findings, the surgeon opted to connect Fontan graft toward the left SVC 
in November 2011. 
 
7.4.7 CHOP_M8 
This was an 8 year-old patient with bilateral SVCs and interrupted IVC with azygos vein 
continuation to the left SVC. PAVMs were reported in the left lung even with an existing 
Fontan connection to include hepatic venous flow to the right SVC. The pre-operative 
reconstruction is shown in Figure 7.31. This case represents the most complex surgical 
modeling study to date. 
This patient had previously been referred for CFD analysis as a risk assessment for 
PAVM development.124 At that time, it was concluded there was a significant risk of left-
sided PAVM because of a predicted imbalance in hepatic venous flow, as shown in 
Figure 7.32. As predicted, left lung PAVM developed and the patient was again referred 










Figure 7.32 Qualitative CFD results from original risk assessment study of CHOP_M8 to 











 Flow Rate (L/min) Relative Distribution (%) 
IVC 0.31 9 
RSVC 0.72 22 
LSVC 1.04 32 
Az 1.21 37 
LPA 1.48 -55 
RPA 1.23 -45 
 
 
Repeating the baseline simulations using the updated pulsatile flow conditions concurred 
with those previous findings, as there was still a significant lack (<1%) of hepatic flow 
reaching the LPA (Figure 7.33, Animation 7.1). Two important observations: 1) As 
before, there was a significant amount of pulsatility noted, particularly in the hepatic 
venous flow (see Figure 7.33; a significant portion of the cycle actually had flow 
reversal), so all simulations were done under pulsatile flow conditions; 2) There is a 
significant imbalance in left vs. right venous returns with the (average) sum of the LSVC 
and azygos accounting for 69% of the venous returns. This fact implies that simply re-
positioning the Fontan connection medially between the bilateral connections is not 






Figure 7.33 Left- Instantaneous velocity streamlines based on most recent pre-operative 
CMR and PC MRC reconstructions for CHOP_M8 (HepV flow in blue). Right- time-varying 












Animation 7.1 Time-varying velocity streamlines for pulsatile simulation of post-operative 





The six options considered for this patient are shown in Figure 7.34. Because of they are 
all non-standard and complex designs, a more thorough description of each is provided 
below.  
 Option1: Intra-atrial graft routed to the LPA via the left atrial appendage. 
 Option 2: Routing the LSVC around the aortic arch to the RSVC (as a normal 
innominate vein); no change to the existing Fontan connection. 
 Option 3: Same as option 2 except the existing Fontan baffle was replaced with a 
Y-Graft. 
 Option 4 (non-surgical): Based on an intervention that had previously been done 
for a similar patient (CHOP_M3), this option simulated a scenario in which a 
series of stents were deployed inside the MPA: one to dilate the whole segment, 
a covered stent to route hepatic flow through the first stent to the left side of the 
connection, and a third creating a space between the covered stent and the first 
stent to allow backflow to the RPA. Because this stent-in-stent design is not 
easily translatable to the design of the immersed boundary solver, this 
connection was instead simulated by connecting the hepatic baffle to the superior 
section of the left-sided Glenn connection and dilating the connection between 
left and right. The arrows drawn in Figure 7.34 denote the intended blood flow 
pattern through this design.  
 Option 5: An extended Y-Graft design in which the left branch is routed through 
the atrium to the left side. 
 Option 6: A Y-Graft in which the RSVC-MPA connection was ligated and 




Figure 7.34 Six surgical options modeled for CHOP_M8 to address LPA PAVM. Options 
included an intra-atrial connection to the left (1), re-routing the LSVC to the right without 
(2) or with (3) revising the Fontan baffle, a complex MPA stenting approach (4), and two 
potential Y-Graft approaches (5,6). 
 
 
A brief aside is now necessary regarding the handling of PA outflow conditions. As is 
standard, connection performance was assessed over a range of different outflow 
conditions because of the potential for future remodeling. However, the implicit 
assumption with these methods (since flow boundary conditions are imposed at the 
outlets) is that the surgical modifications do not significantly alter internal connection 
resistance. In other words, the flow split primarily dictated by the downstream pulmonary 
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vascular resistances, which are assumed to remain constant, would not be appreciably 
altered by the new connection. Given the anatomic complexity involved in this case, 
including the significant resistance imposed by the stenosed mid-PA segment, this 
assumption is very unlikely to hold true. Using option 2 in Figure 7.34 as an example, re-
routing the LSVC flow to the right side of the connection would be expected to increase 
RPA flow because the relative pressure on the right side of the connection would 
increase, while the pressure on the left would decrease.  
These concerns were addressed as follows: Using the original CFD results from the 
most recent scan, it was assumed that the hepatic venous pressure was 10 mmHg 
(value taken from cath report from CHOP_M3 prior to stent insertion). Then, using the 
CFD-derived differential pressure values through the connection, an estimate was 
obtained for the pulmonary vascular resistances (PVR) of each PA assuming a constant 
downstream atrial pressure. Based on the selection of 10 as the hepatic pressure, these 
values resulted in 2.2 mmHg·m2·min/L total PVR, with independent L/R values of 4.5/4.6 
mmHg·m2·min/L as reference values. Assuming a constant hepatic venous pressure, 
this procedure was repeated for the surgical option results to retrospectively estimate 
branch PVR and compare to the references to estimate the likely PA flow splits following 
that intervention. That is, the pulmonary split for the subsequent surgical options that 
produced PVR values closest to the reference were assumed to be the likely post-
operative result. To be clear, the simulations were still performed with flow boundary 
conditions; the PVR calculations were performed as a post-hoc assessment. 
In addition to the 55% average LPA distribution measured pre-operatively, the 
alternative time-varying profiles for the PA splits were determined by: switching the 
measured left and right profiles (giving a 45% LPA condition), and by taking the LPA as 
272 
 
the instantaneous difference of the venous inflows and the RPA outflow (as there was a 
0.6 L/min disparity in the measured values; giving a 63% LPA condition). 
Finally, since time-varying flow conditions were used rather than time-averaged, the 
means of quantifying HFD were modified. Using the particle tracking algorithm described 
in §4.3.6, a hepatic baffle cross-section was seeded with particles at 50 evenly spaced 
time points across the cardiac cycle107. These particles were then advected through the 
time-varying velocity fields until they had been completely washed through the 
connection, at which time the relative distribution of particles to the left and right were 
summed. Additionally, instantaneous visualization of particle motion provides a more 
appropriate indication of the motion of blood elements as compared to instantaneous 
static streamlines. 
For the first option (intra-atrial connection to the LSVC), results (Figure 7.35) indicate 
this design over-corrects: 99% of the hepatic flow goes to the LPA. While this would take 
care of the short-term problem, it is not a desirable long-term solution given the lack of 
hepatic flow to the RPA in that configuration. Further, such an approach is likely to be 
extremely sensitive to the exact positioning of the baffle with respect to the azygos and 
LSVC junction because of the momentum mismatch between the flow carried by these 










The results for option 2 (re-routing the LSVC) are shown in Figure 7.36 and Animation 
7.2. From both the instantaneous streamlines and particle tracking, a qualitative 
improvement in hepatic flow to the LPA is seen. Effectively, this option redirected LSVC 
flow to the RPA rather than the LPA, allowing the hepatic flow to cross through the MPA 
to make up the difference. The quantitative results, as well as those of the pre-operative 
baseline connection, are shown in Table 7.15. HFD values ranged from 20-75% LPA 
across the various PA splits tested. Based on the estimated PVR values, LPA global 
flow percentage would be expected to decrease slightly from 55% as the calculated 
resistance (4.9 Wood unit PVR) was higher than the LPA reference (4.5 WU). However, 
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the change would not be drastic since the 45% LPA GFD condition produced a much 





Figure 7.36 Results for Option 2 (re-routing the LSVC). Top- instantaneous velocity 
streamlines at pre-operative flow conditions color-coded by vessel of origin (hepatic flow 
in blue). Bottom- A sequential series (from left to right) of hepatic particles traversing the 













Animation 7.2 Hepatic particle tracking for re-routed LSVC option (#2) 
 
 
Table 7.15 HFD and Power loss results for CHOP_M8 Baseline (pre-operative) and Option 2 





BASELINE 0 6.2 4.5/4.6 
    
45% LPA 20 11.1 5.4/3.7 
55% LPA 44 11.4 4.1/4.9 





Results for option 3 are shown in Figure 7.37 and Animation 7.3, and quantified in Table 
7.16. As with option 2, improved HFD to the LPA was seen; however, expected 
additional improvements through bifurcating the hepatic baffle with a Y-Graft were not 
realized through this particular design. Instead, the results for the 55% LPA flow 
condition were fairly consistent between options 2 and 3 (HFD= 44 vs. 45%, 
respectively) with the primary difference being the more stable response of option 3 to 
changing PA splits (results ranged from 33-52% to the LPA). Still, based on the 
estimated PVR values, the expected ~50/50 post-operative PA split would still yield 
approximately 40% HFD to the LPA. The intentionally conservative design of the graft 
branches (i.e., short length, positioned close to the RSVC connection) contributed to 
these sub-optimal results as evidenced by the residual interaction between the hepatic 
flow through the left branch (blue) and superior venous flows (red) in Figure 7.37. 
Providing greater spatial separation at the left anastomosis (not investigated due to time 





Figure 7.37 Results for Option 3 (re-routing the LSVC + Y-Graft). Top- instantaneous 
velocity streamlines at pre-operative flow conditions color-coded by vessel of origin 
(hepatic flow in blue). Bottom- A sequential series (from left to right) of hepatic particles 
traversing the connection with time from first release provided. 
 
 
Table 7.16 HFD and Power loss results for CHOP_M8 Option 3 





45% LPA 33 11.1 4.9/4.1 
55% LPA 45 12.2 4.0/4.9 










Animation 7.3 Hepatic particle tracking for re-routed LSVC with Y-Graft Fontan option (#3) 
 
 
For option 4, because there was little confidence in the geometric realism of the model, 
going into extensive detail of its quantitative output would not have been a meaningful 
exercise. Instead, this option was treated simply as a proof of concept: that routing the 
hepatic flow to the left-sided LSVC and secondarily directing flow from left-to-right 
through the MPA could deliver hepatic flow to the left. This semi-quantitative assessment 
is shown in Figure 7.38 and, in fact, it is confirmed. Like option 1, this design would be 
expected to increase total LPA flow such that the result could fall in the range of the 
included table.  The only potentially concerning finding from the results is that there was 
very little apparent mixing of hepatic flow with the LSVC/azygos flows, so depending on 
the geometry of the stented openings it is possible that the hepatic flow could traverse 
the MPA and be immediately redirected back to the right without reaching the LPA. 
Without accurate representation of that final geometry, the risk of this happening cannot 




Figure 7.38 Results for Option 4 (MPA stent) shown from the posterior perspective. 
Instantaneous velocity streamlines shown correspond to pre-operative flow conditions. 
HFD results provided in included table. 
 
 
Option 5 simulated a bifurcated design in which the left branch was routed through the 
atrium to the LSVC-Az junction. While promising in theory, the placement of the left 
branch (in opposition to the entrance flow of the LSVC+Az) impeded flow through that 





Figure 7.39 Representative instantaneous velocity streamlines for the intra-atrial Y-graft 
option investigated for CHOP_M8. 
 
 
Option 6 simulated a Y-Graft design in which the MPA connection to the RSVC was 
mobilized and connected end-to-end to the left branch of the Y-graft. Evaluating such a 
connection exploits a weakness of using flow outlet conditions, as previously discussed, 
since the flow direction through that end-to-end connection is entirely dependent on the 
selected outlet conditions. It is clear that, with 69% of venous return coming from the 
LSVC and Az, if the in vivo flow split (55%) was imposed at the LPA, there would be a 
net flow from left to right through the connection (as in the original configuration) with the 
Y-branch simply taking the place of the MPA. Instead, an LPA flow split of 75% was set 
(which is enough to encompass all of the LSVC+Az flows, plus approximately half the 
281 
 
average contribution of the hepatic flow). To check the feasibility of this condition, the 
values of downstream PVR needed to produce these flow spits were computed, 
obtaining 2.7 Wood units for the LPA and 10.3 Wood units for the RPA. Both these 
values represent significant departures from the baseline values, meaning that the LPA 
resistance would have to drop considerably while the RPA resistance would have to 
increase considerably for this connection to produce the desired hemodynamic outcome. 
Since this is an unlikely scenario, this option was ruled out. 
Ultimately, these results were not utilized as it was deemed that none of the modeled 
options was surgically feasible and a hepatic-to-azygos connection, which had been pre-
operatively ruled out for feasibility concerns (see position of descending aorta in Figure 
7.31), was implemented. 
 
7.4.8 CHB_M1 
Patient was a 9 year old male with an existing lateral tunnel Fontan and bilateral superior 
venous connections. He presented with suspected protein-losing enteropathy (PLE), 
fatigue, poor exercise tolerance, and frequent respiratory illness with desaturations into 
the mid-70s. He was referred for modeling for the dual purposes of 1) identifying if any 
streaming biases were present related to the desaturations; and 2) evaluate connection 
efficiency with respect to PLE and poor exercise tolerance, and determine if surgical 
revision might provide therapeutic benefit. The existing TCPC reconstruction is shown in 
Figure 7.40. 
To complement the standard axial SSFP and through plane PC CMR data typically 
obtained, a coronal stack of 4D PC CMR data was also acquired to reconstruct the in 
vivo velocity fields and provide verification for the CFD results. A comparison of 
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instantaneous velocity streamlines between the two modalities is shown in Figure 7.41. 
Animation 7.4 shows the dynamic CMR results. Notably, it can be seen that the 
computational domain was extended inferiorly to explicitly include the distal IVC and 
hepatic veins before their confluence. This detail was added to the model based on the 
PC CMR findings to improve the qualitative match of the velocity profile entering the 
lateral tunnel. 
From both analyses, the local hemodynamics were found to be very complex, 
particularly with respect to large-scale recirculation taking place within the dilated (up to 
50 mm diameter) connection. However, both PAs were of good size, with no evidence of 
significant convective acceleration; thus, the connection power loss was low (2.7 mW). 
Furthermore, the IVC flow distribution was well balanced (65/35% LPA/RPA), which 




Figure 7.40 Reconstructed TCPC anatomy for CHB_M1 shown from anterior (left) and left 





Figure 7.41 Qualitative comparison of instantaneous velocity streamlines derived from 4D 



















Animation 7.4 Time-varying velocity streamlines from 4D PC CMR acquisition for CHB_M1. 
 
 
At the request of the clinical team, virtual surgery was performed to simulate a revision 
from the dilated lateral tunnel to a 22 mm extracardiac conduit, as shown in Figure 7.42. 
Comparison of resulting power losses under baseline and simulated exercise between 
the existing connection and virtual extracardiac model is shown in Table 7.17. Owing to 
the large PA size, there was no difference in power loss between connections, 
suggesting that surgical revision in this case would not yield meaningful benefit. On the 
surface, this finding is somewhat surprising in that it seems to contradict the work of de 
Leval that motivated the switch from atriopulmonary Fontan to TCPC17, although 
important distinctions exist between the atriopulmonary connection and this lateral tunnel 
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connection, even with its dilated appearance (e.g., there is no collision and mixing with 
SVC within the connection for the lateral tunnel). The logical explanation for the finding, 
leveraging the geometric results presented in §5.5.2.1, is that vessel minimum and mean 
diameters are the strongest predictions of power loss for a given connection, not the 
maximum dimension. Hence, because the PAs for this patient are large, the resting 
power losses for the both the in vivo and virtual extracardiac connections were very low. 
With that said, this case may also exploit inherent shortcomings in the computational 
method related to the rigid wall assumption and the use of the same inlet flow conditions 
in the evaluation of the two surgical models. Revisiting this case in the future with such 




Figure 7.42 Virtual extracardiac connection created and evaluated for CHB_M1 shown from 





Table 7.17 Power loss (in mW) results at baseline and exercise for the two connections 
evaluated. 
 Baseline 2x exercise 
Current connection 2.7 12.5 
Virtual Extracardiac 2.7 12.6 
 
 
Finally, with limited hemodynamic resistance produced by the TCPC, we sought to 
quantify the potential therapeutic benefit of targeting/lowering PVR to relieve the high 
CVP (via Sildenafil use, for example). For this, the lumped parameter model (§4.4) was 
selectively tuned to approximate known values of this patient’s physiology from 
catheterization (cardiac output - 3.2 L/min, PVR – 2.5 WU, arterial pressure 95/55 
mmHg, atrial pressure 10 mmHg, CVP, 18.2 mmHg). With these baseline values 
established, the PVR parameter was arbitrarily decreased in steps of 0.5 units to 
observe the effect on CVP. Results are shown in Table 7.18. 
 
 
Table 7.18 Results of parametric lumped parameter analysis of PVR in CHB_M1 
 From Cath. Modeled 
Baseline 
   
C.O. (L/min) 3.2 3.17 3.4 3.67 3.98 
PVR 
(mmHg/L/min) 
2.5 2.5 2 1.5 1 
CVP (mmHg) 18 18.2 17.8 17.3 16.7 
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It was found that each step down in PVR dropped the CVP by increments of ~0.5 
mmHg, as well as increased the cardiac output. For the extreme case tested (PVR =1) a 
maximal decrease of 1.5 mmHg was predicted along with a 0.8 L/min increase in cardiac 
output (which, again, is based on a non-specific model of the ventricle function). 
Based in part on these findings, the patient was started on a Sildenafil regimen to 
attempt to lower PVR and CVP; however, at last follow-up, no change in baseline 
hemodynamics had been noted. Finally, it is worth noting that this patient was the focus 
of additional investigation and analysis by Mirabella et al165. 
 
7.4.9 CHOA_M5 
Patient was a 12 year-old female with an existing lateral tunnel Fontan. Arterial oxygen 
saturations were in the low 90/high 80% range, but PAVM were diagnosed in the right 
lung on the basis of systemic venous bubble injections in the cath lab- patent bubbles 
observed in the pulmonary veins denote AVM as they would have been filtered out 
otherwise.  
Most recent catheterization report was from 2009 at which time 2 Amplatzer ASD 
devices were inserted to close the fenestration. Pre-closure hemodynamics showed 
systemic saturation of 82%, systemic BP 100/67 with a mean of 79 mmHg, mean Fontan 
pressure 14 mmHg, LVEDP 11 mmHg, calculated Qp 1.71 L/min/m2, calculated Qs 2.23 
L/min/m2, Qp:Qs 0.76:1, PVR 1.76 Wood units, SVR 29.11. Post-closure no further 
hemodynamics were performed except that the systemic saturation rose from 82 to 88%. 
The CMR scan that served as the basis for this surgical planning evaluation was 
performed on 12/8/2011. No axial SSFP or cine sequences were acquired; however, 
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MRA data acquired in conjunction with lower extremity gadolinium injection were found 
to be sufficient for anatomic reconstruction. The results are shown in Figure 7.43; the 
defining characteristic is an apparent stenosis of the connection of the lateral tunnel to 
the PAs. As usual, phase contrast planes were acquired in both caval veins and 











Table 7.19 Pre-operative vessel flow rates from PC CMR for CHOA_M5 
 Flow Rate (L/min) Relative Distribution (%) 
IVC 1.36 52 
SVC 1.26 48 
LPA 1.12 -43 





The results of simulating the pre-operative hemodynamics with time-varying boundary 
conditions are shown in Figure 7.44 and Animation 7.5. It is evident that the stenosed 
Fontan-PA attachment, which has a slight left offset with respect to the SVC, acts to 
direct the majority of the Fontan flow to the LPA; however, the acceleration (through the 
stenosis) and collision of Fontan flow against the posterior PA wall act to promote mixing 
and left/right division of Fontan flow such that there is a non-negligible fraction of that 
flow that appears to perfuse the right lung. By particle tracking over the cardiac cycle, 
this distribution was calculated to be 65/35% LPA/RPA. On the surface, this distribution 
does not appear to be consistent with the PAVM diagnosis, but perhaps neglecting wall 
motion through the lateral tunnel for this particular patient is a weak assumption. 
Energetically, both PAs were well-sized (with the possible exception of a small narrowing 
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of the sub-aortic section of the PA), so despite the large Fontan pathway and the 
stenosed junction, the total resistance was low- 0.30 Wood Units. 
 
 
Figure 7.44 Representative results from time-varying simulation of the pre-operative 









Animation 7.5 Pulsatile IVC particle tracking for pre-operative simulation for CHOA_M5. 
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All simulations for the surgical options were also performed by imposing time-varying 
flow conditions at the model inlet/outlets with rigid vessel walls. Because of significant 
compliance effects in the dilated lateral tunnel (peaks of ±10 L/min over the course of the 
cardiac cycle), the IVC flow conditions were imposed as the instantaneous difference 
among the other inlets/outlets. In addition to the measured flow conditions, two other 
scenarios were investigated for most options: an alternate PA outflow condition (65/35 
RPA/LPA), and an alternate caval inlet distribution (65/35 IVC/SVC; with Qs held 
constant). The rationale for this latter condition was that changing QS with constant 
vessel distributions (as was done for CHOP_M13) does not generally alter the results; 
whereas, changing the relative distributions (simulating increased IVC flow percentage 
with increasing BSA142, for example) represented both a likely physiology scenario and a 
different data point at which the connection could be evaluated. HFD was quantified 
using the same particle-based method employed for CHOP_M8. 
Given the relative simplicity of the patient anatomy compared to the previous cases 
presented, only two basic surgical revision approaches were envisioned: either an 
extracardiac conduit or a Y-Graft. However, as was done for CHOP_M12 (§7.4.5), 
multiple implementations of these two options were investigated to identify potential 
pitfalls and evaluate the robustness of each approach. These designs are shown in 
Figure 7.45. Briefly, three Y-Graft designs were tested: one ‘ideal’ implementation with 
both branches positioned laterally away from the Glenn anastomosis, and one option 
each with the left or right branch medially positioned with respect to the SVC (shown in 
red in Figure 7.45). The two extracardiac options explored the effects of no caval offset 





Figure 7.45 Five surgical options investigated for CHOA_M5 representing three Y-Graft 
designs and two different placements of an extracardiac conduit. The medial Y-Graft 
designs are shown in red to highlight the difference with respect to the ‘ideal’ case. 
 
 
The results for the ‘ideal’ Y-Graft option are presented in Figure 7.46 and Table 7.20. 
Flow distribution results were well balanced (51/49% LPA/RPA) and presumably an 
improvement over the pre-operative condition (even though the simulated results were 
not particularly poor). Changes in imposed flow conditions did little to change these 
results. Connection resistance was equivalent to the pre-operative value (0.30 WU), 
likely because neither case relieved the slight narrowing of a sub-aortic PA stenosis. 
Positioning the left branch further to the left than what was modeled may have improved 
performance in this regard. Additionally, the convective acceleration through the 
293 
 
undersized Y-Graft branches likely reduced efficiency improvements, as evidenced by 




Figure 7.46 Velocity streamlines for the ‘ideal’ Y-Graft option under pre-operative flow 
conditions. The left image shows the streamlines colored by vessel of origin while the 
right image shows the local velocity magnitude for the IVC flow. 
 
 
Table 7.20 HFD and power loss (resistance) results for the ‘ideal’ Y-Graft option  
 Pre-operative 65/35 R/L split 65% IVC flow 
Flow Distribution 
(R/L) 
51/49% 52/48% 51/49% 
Connection 
Resistance (WU) 





In comparison to the case where the branches were laterally positioned, Figure 7.47 
shows the qualitative outcomes if either branch was instead placed medially. The 
quantitative data are provided in Table 7.21. As expected, medial offsets of the Y-graft 
limbs led to 1) slightly higher resistances; and 2) slightly higher flow distribution to the 
contra-lateral lung (as compared to the ‘ideal’ case). Fortunately, the outcomes with 




Figure 7.47 Velocity streamlines (colored by vessel of origin) for the two medial Y-branch 
placement options. Interaction of the medial branch flow with the SVC flow is apparent, yet 








Table 7.21 HFD and power loss (resistance) results for the two medial Y-Graft options. 

















Results for the extracardiac models are shown in Figure 7.48 and Table 7.22. With 
respect to flow distribution, both extracardiac options investigated produced favorable 
outcomes although 1) they demonstrated much greater sensitivity to the outflow splits 
than the Y-graft options (as expected); and 2) the introduction of a right offset biased 
flow much more to the right lung than any of the other options, which is again an 
expected outcome. Also noteworthy is the fact that these models were predicted to be 




Figure 7.48 Velocity streamlines for the (left two images) no offset extracardiac and (far 
right) right caval offset extracardiac options under pre-operative flow conditions. 
 
 
Table 7.22 HFD and power loss (resistance) results for the two extracardiac options 







52/48% 60/40% 52/48% 
Connection 
Resistance (WU) 




69/31% 77/23% N/A 
Connection 
Resistance (WU) 





Since this procedure was a Fontan revision (i.e., the patient was older than a normal 
Fontan recipient) and the small branch size in the 20x10 mm Y-Grafts was suspected to 
be a limiting factor in the lack of efficiency improvements compared to the virtual 
extracardiac and pre-operative connections, a final Y-Graft model with a 22x11 mm graft 
was created using the ‘ideal’ branch placement design. The results for this option are 
shown in Figure 7.49. Flow distribution results were still well balanced between LPA and 
RPA, although with a slightly greater preference for the RPA than the 20x10 graft. More 
importantly, the power loss was the lowest of any of the investigated options because of 
the decreased velocities through the branches owing to the larger graft size. Hence, this 
option was recommended (along with the suggestion that efforts be made to connect the 




Figure 7.49 Results from a 22x11 mm Y-Graft option with ‘ideal’ branch placement under 






Patient was a 2 year-old male with heterotaxy syndrome of asplenia type status post 
bilateral bidirectional Glenn. PAVM were suspected in the right lower lobe and there was 
also a history of significant systemic-pulmonary collaterals.   
The CMR scan that served as the basis for this surgical planning evaluation was 
performed on 8/8/2011. The imposed flow conditions for the computational simulations 
were taken directly from the MR report (included in the patient files) as there were some 
inconsistencies in the file labeling with regard to the acquisition VENC in the CMR 
dicoms. 
The 3D anatomic reconstruction is shown Figure 7.50 (anterior and posterior views) in 
blue with the surrounding anatomy in gray. The IVC is located on the left, behind the 
heart, while the pulmonary veins primarily connect to the right atrium. The flow 






Figure 7.50 Anatomic reconstruction of the bilateral bidirectional Glenn connection (blue) 
and surrounding anatomy (gray) for CHOP_M16. 
 
 
Table 7.23 Flow rates from clinical CMR report for CHOP_M16 
 Flow Rate (L/min) Relative Distribution (%) 
IVC 1.09 55 
RSVC 0.58 29 
LSVC 0.32 16 
LPA 0.22 -22 







All simulations were performed by imposing time-averaged flow conditions at the model 
inlet/outlets with rigid vessel walls. In addition to the measured flow conditions, two other 
scenarios were investigated: an alternate PA outflow condition (55/45 RPA/LPA) to 
simulate eventual PAVM regression and pulmonary redistribution; and a decreased IVC 
flow rate (0.68 L/min vs. 1.27 L/min) in anticipation of decreased cardiac output post-
operatively. For this latter condition, the measured SVC flow rates were held constant to 
maximize the ‘adversity’ of this scenario, such that the IVC contribution dropped to 40% 
of the venous return. It is noted that these numbers (46% decrease in IVC flow pre- to 
post-operatively) were roughly based on the post-operative experience with CHOP_M12 
(§7.4.5), which was anatomically very similar and had similar pre-op flow measures. 
A total of 6 options were investigated. The first 5 modeled intra-atrial connections 
through the left atrium to the left/medial aspect of the connection based on the perceived 
difficulty of passing in front of the descending aorta. However, at the suggestion of the 
surgeon, a 6th option was added simulating an extracardiac conduit running underneath 
the right atrium and up the right side of the heart, as per a normal connection. These 





Figure 7.51 Six surgical options investigated for CHOP_M16 including 5 intra-atrial 
approaches to the LSVC (#1-5) and an extracardiac connection to the right (#6). 
 
 
The characteristics of the 5 left-sided options were all very similar with respect to both 
flow distribution and resistance. The only design that clearly performed poorly was the Y-
graft (Figure 7.52). The significant curvature imposed on the proximal (i.e., inferior) 
section of the conduit because of the IVC positioning (in addition to the angles of the 
SVCs) is not advantageous for angling the branches at the PA anastomoses. In the 
particular design modeled, for example, the left branch is angled to the right, away from 
the LPA rather than streamlining flow to that vessel; whereas the right branch runs 
inferior to the LSVC and (while this condition was not simulated) would have likely been 
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inhibited by LSVC flow at lower IVC flow conditions. The end result is a very chaotic flow 
profile that would intuitively not be very stable and robust and had the highest 




Figure 7.52 Results for the intra-atrial Y-Graft connection investigated for CHOP_M16. 
 
 
For the remaining left-sided options, Figure 7.53 demonstrates that the results were all 
very consistent and there are very few qualitative distinguishing characteristics. Because 
of the medial angle of the LSVC, all four designs achieved approximately 60% HFD to 
the RPA (the side with suspected PAVM) at the pre-op MR flow conditions because both 
the LSVC and RSVC were carried across to the right side of the connection (Table 7.24). 
That is, the majority of LPA flow was IVC contribution. As a result, as the total LPA flow 
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increased, the IVC-to-RPA contribution dropped off quickly, with a bit more intra-option 
variation (Table 7.25). Furthermore, under lower IVC flow conditions, this behavior could 
be more problematic for getting IVC flow across the connection to the RPA as a larger 
percentage of the IVC flow will be required to meet LPA demands. For example, running 
option 1 at the ‘low-IVC’ conditions dropped the HFD from 59% RPA to 45% RPA. 
Depending on how severely the IVC flow decreases post-operatively, this difference 






Figure 7.53 Velocity streamlines (for the pre-operatively measured flow rates) for options 








Table 7.24 Quantitative results for options 1-4 at the pre-operative flow conditions. 
 HFD (%LPA) R (WU) 
Opt1 41 0.15 
Opt2 40 0.20 
Opt3 40 0.16 
Opt4 39 0.17 
 
 
Table 7.25 Quantitative results for options 1-4 for GFD=45% LPA 
 HFD (%LPA) R (WU) 
Opt1 71 0.3 
Opt2 N/A N/A 
Opt3 62 0.27 
Opt4 64 0.26 
 
 
As compared to the left-sided options, the right-sided extracardiac connection (Figure 
7.54) placed the Fontan in closer proximity to the RPA, leading to much high HFD-to-
RPA values (which is the more immediate need with right-sided PAVM). Furthermore, for 
the design evaluated (conduit placed as far medially as visually possible) the Fontan 
flow does pass through the connection to the LPA suggesting that, as shown with the 
45% LPA result, there does not appear to be a high risk of unilateral flow to the right. 
Finally, under low IVC flow conditions, the proximity of the baffle to the RPA provides a 




Figure 7.54 Results for the right extracardiac model investigated for CHOP_M16. Velocity 
streamlines shown correspond to the pre-operative flow conditions. 
 
 
The conclusion of this study was that, while none of the evaluated options except the Y-
graft was a bad choice, the safest bet for ensuring distribution of flow through the Fontan 
baffle reached the RPA (assuming it is surgically feasible) was an extracardiac 
connection to the right. This design succeeds in perfusing both lungs, with a preference 
for the RPA obviously, and is more robust to decreases in IVC flow, as expected post-
operatively. This option was selected and surgically implemented in June 2012. 
 
7.4.11 CHOP_M17 
Patient was a 14 year-old male with heterotaxy syndrome and a hypoplastic left 
ventricle. There was IVC interruption with azygos vein continuation to a left SVC. He had 
an existing Fontan connection of the hepatic veins to the RPA. He had progressing 
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systemic hypoxia because of substantial left lung PAVM with reported saturations in the 
upper 60s. 
The patient was scanned via CMR on 6/8/2012 for surgical planning evaluation. 
Because of coil artifacts in the upper right chest, anatomic reconstruction was performed 
(by M. Restrepo, Georgia Tech) using a combination of SSFP and GRE sequences. The 










Table 7.26 Time-averaged flow data for CHOP_M17 measured from PC CMR. 
 Flow Rate (L/min) Relative Distribution (%) 
HepV 0.30 11 
Az 1.40 50 
LSVC 1.10 39 
LPA 1.80 -62 
RPA 1.10 -38 
 
 
Simulations were run with pulsatile inflow conditions based on the measured vessel 
inflow conditions for hepatic vein, LSVC, and azygos vein. The HFD was quantified 
based on a pulsatile particle tracking method- massless particles were seeded across a 
specified cross-section of the hepatic venous inlet 50 times over 1 cardiac cycle and 
advected through the connection over the subsequent 4 cycles. Connection energetics 
are reported as power loss. 
To confirm the diagnosis of left lung PAVM (by visualizing unilateral hepatic flow the 
right), the current patient-specific anatomy was simulated under the measured MR flow 
conditions. Representative flow streaming results are shown in Figure 7.56. Consistent 
with the clinical diagnosis, the hepatic flow (shown in blue) was entirely constrained to 
the right lung because of its extreme offset position with respect to the azygos and left 






Figure 7.56 Velocity streamlines for pre-operative Fontan connection of CHOP_M17. 
 
 
There was one minor inconsistency with these findings and other clinical reports- a 
catheterization report from 8/11 noted a 3 mm pressure drop between the azygos vein 
and LPA (18 mm Hg vs. 15 mm Hg). On average, there was only about 0.5 mm drop in 
simulations between those vessels- a 3 mm drop would require a severe obstruction or 
much higher flows, neither of which are present. The cath report also noted only a 1 mm 
drop from the azygos to the RPA (compared to 0.9 average drop from simulations). It is 
unclear how the distal vessel could have a smaller drop than the proximal one (again, 
without a severe obstruction present), so the LPA discrepancy is not overly concerning 
with respect to the model verification as it suggests a potential error in the data recorded 
in the catheterization report. 
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A total of 3 options were investigated, as shown in Figure 7.57. The first was simply an 
attempt to move the hepatic baffle to the site of the kawashima connection (as opposed 
to the current right offset). Next was a hepatic-to-azygos connection, which has been 
shown to be successful in past cases on interrupted IVC with a single SVC. Finally, an 




Figure 7.57 Three surgical options investigated for CHOP_M17 representing (left) 
repositioning the hepatic venous baffle, (middle) hepatic-to-azygos connection, (right) and 








Simply re-positioning the hepatic baffle to the left did improve hepatic flow to the left 
slightly, as shown in Figure 7.58. However, the hepatic flow to the left was still only a 
small percentage of total hepatic flow volume (21% based on the pre-operative flows) 
and past experience (see §7.4.3) dictates that these connections are not very robust. In 
other words, they are extremely sensitive to baffle placement and the relative vessel 




Figure 7.58 Velocity streamlines for the re-positioned hepatic baffle (opposite the LSVC 






The hepatic-to-aygos connection performed better for this patient given the natural 
tendency for azgos flow (green) to stream to the LPA (see Figure 7.59). Under the pre-
operatively measured flow conditions (Qp= 62% LPA), this led to HFD = 84% to the LPA 
(the side with PAVM). To evaluate this performance under varying outflow conditions, 
the PA splits were set to Qp =55% and 45% to the LPA in subsequent simulations to 
simulate progressive regression of left sided PAVM. HFD and power loss results for all 




Figure 7.59 Velocity streamlines from pre-operative flow conditions for the hepatic-to-





Table 7.27 Quantitative results for the hepatic-to-azygos connection at various boundary 
condtions 
Imposed Qp Split HFD (%LPA) PL (mw) 
62% LPA (measured) 84 2.5 
55% 76 2.1 
45% 64 1.5 
  
 
As total flow to the RPA increased, so did the hepatic flow, which was expected. 
Therefore, despite the fact that this connection biased hepatic flow to the left, pulmonary 
remodeling subsequent to PAVM regression would be expected to recruit hepatic flow to 
the RPA and so avoid future PAVM development in that lung. With respect to power 
loss, this connection is slightly less efficient than initial Fontan, consistent with prior 
findings regarding hepatic-to-azygos connections, although the magnitude still appears 
to be acceptably low. 
Finally, to evaluate the impact of changing systemic venous returns in the acute post-
operative period, one final simulation was performed with altered (time-averaged) inflow 
distributions. The new values were chosen based on measurements made from an 18 
year old patient with similar venous anatomy (CHOA_M2) such that the total flow 
decreased from 2.8 to 2 L/min, and the relative distributions for the hepatic vein, svc, 
and azygos were set at 11%, 62%, and 27%, respectively. Despite these changes, 
100% of hepatic flow was predicted to perfuse the LPA under those conditions, 
confirming the robustness of this connection design. 
Since the hepatic-to-azygos option did bias flow to the LPA, one final option was 
considered that had potential to provide slightly better balance for HFD. However, as 
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seen Figure 7.60, the hepatic-to-RPA connection was energetically more favorable than 
the hepatic-to-azygos connection, so this option still favored hepatic flow to the right 








The present results, in conjunction with past experiences, made this case rather 
straightforward. An extracardiac connection (further to the left) to the Kawashima 
junction was not a robust approach and could yield unpredictable outcomes. The left-
sided SVC with a left-sided hepatic vein makes a ‘traditional’ Y-graft approach 
impossible, and the modified H-graft approach did not achieve the same flow distribution 
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effects. Therefore, the best approach was the hepatic-to-azygos connection, which was 
predicted to significantly improve hepatic flow to the left in a robust fashion with respect 
to expected physiologic remodeling. At the time of this writing, no information has been 
provided regarding the final surgical implementation. 
 
7.4.12 Section Discussion and summary 
7.4.12.1 Approach for Patients with Interrupted IVC and Azygos vein continuation 
Based on early experience of surgical planning for the Fontan procedure, de Zélicourt et 
al. proposed strategies for approaching the most anatomically complex single ventricle 
patients: those with interrupted IVC and azygos vein continuation105. These guidelines 
were separated based on superior venous anatomy with different advice for single 
versus bilateral SVC cases. Since the work presented in this thesis expands that 
experience considerably, it is worth revisiting those guidelines. 
Figure 7.61 visually summarizes the conclusions reached for single SVC cases105. 
Namely, it was determined that the flow distribution within the connection was dictated 
by the directionality of the superior venous flows (SVC + azygos). Thus, standard 
extracardiac connections are very susceptible to unilateral distribution bias unless they 
are perfectly aligned with the center of momentum for the superior flows. Instead, the 
hepatic-to-azygos connection was suggested as a good default, an idea that has been 
independently advocated by others in the field62. The Y-Graft design has potential utility 
for these patients but is still susceptible to poor outcome in some cases (seen in the top 




Figure 7.61 HFD for selected TCPC options for the 3 patients with a single SVC, including 
intra-atrial or extracardiac options with (A) an offset to the LPA or (B) aiming to the center 
of the Kawashima connection, (C) bifurcated Y-grafts, (D) intra-atrial or extra-cardiac 
options combined with an AZ-to-HepV shunt, and (E) HepV-to-AZ shunts. Percentages 
indicate HFD to the left lung. Superimposed black arrows show the main flow direction of 
the superior inflows. Dashed lines denote vessel axes. Orientation axis: S ¼ superior; I ¼ 
inferior; L ¼ left; R ¼ right. AZ, Azygous; HepV, hepatic veins; N/A, not available; CO, 





The conclusions regarding extracardiac connections were reaffirmed by the current 
experience; it is the guideline with respect to Y-Graft usage that must be revisited. Of the 
series of patients prospectively modeled in this thesis, four had this single SVC with 
interrupted IVC anatomy. Three received a Y-Graft hepatic baffle connection; a hepatic-
to-azygos was recommended for the fourth. Clearly, the Y-Graft design is a good fit for 
this configuration. 
The earlier hesitation for the Y-Graft was based largely on the experience with 
CHOP_M1159 (see §5.3.1.8). In that case, a Y-Graft design was attempted despite an 
extremely large Kawashima connection and a dominant left-to-right directionality of the 
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superior venous flows. As a result, the Y-Graft option failed to effectively span the 
superior connections and thus deliver hepatic flow to both PAs. That patient was the first 
prospective Fontan surgical planning case and thus weighed heavily in the collective 
interpretation of the early cases; however, additional experiences have shown the 
connection geometry to be exceptionally complex even among other interrupted IVC 
cases. Putting aside the CHOP_M1 experience, the remaining single SVC cases are 
marked by relatively narrow and well-defined connections of the SVC and azygos to the 
PAs. Therefore, since the primary criterion for the Y-Graft to be successful in this 
configuration is the ability to laterally span the superior flows, having this narrow, 
focused center point is conducive for the Y-Graft.   
None of these observations is to say that the prior conclusions regarding hepatic-to-
azygos connections are invalid. To the contrary, these options continue to produce 
positive flow distribution results in all cases (including the retrospective modeling 
performed for CHOA_M2 and CHOP_M9 in this series). However, the caveat for these 
options remains the poor energetic performance: routing the hepatic flow through the 
extensive length of the azygos vein routinely created the highest power losses among 
the options modeled for each case (directly increasing hepatic pressures). Thus, if parity 
with respect to HFD can be achieved between hepatic-to-azygos and Y-Graft 
connections, it seems prudent to opt for the Y-Graft approach to reduce potential 
pressure build-up in the liver. 
Unlike the case for single SVCs, for which we have strong evidence to suggest there are 
at least two viable surgical approaches, bilateral SVC connections in conjunction with 
interrupted IVC continue to present a significant challenge. de Zélicourt et al. proposed 
different strategies depending on the balance of flows between the left and right sides of 
the connection105; however, it would seem unlikely that the flows would be balanced (for 
the long term especially) with two inlets on one side of the connection and only one on 
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the other. The flow distribution results for CHOP_M7124 and CHOP_M8 bear this out. For 
this scenario, H-Graft connections (which are extremely sensitive to flow split) or multi-
step azygos-to-hepatic connections (questionable surgical feasibility) were 
recommended. Only one bilateral patient was modeled in this thesis, so conclusive 
statements cannot be made in this regard, except to say that the suggested approaches 
were not sufficient for that case. Instead, it is possible (and perhaps likely) that balanced 
HFD in these complex cases is simply not possible and the decision must be made as to 
which lung is in the most immediate need of hepatic flow unless other possible 
approaches (e.g., systemic to pulmonary shunts) are shown to be effective. 
7.4.12.2 The Y-Graft Fontan 
Soerensen et al106 were the first to propose the use of flow bifurcation in constructing the 
TCPC to optimize flow efficiency. The model they investigated was both highly idealized 
and called for the bifurcation of both the IVC and SVC connections to form the ‘Optiflo’. 
The Y-Graft patients presented in this study (CHOA_M2, CHOP_M9, CHOP_M10) were 
among the first to have this theory translated into practice, and the use of virtual 
modeling and patient-specific surgical planning were integral in that process. 
Furthermore, the success of these early cases motivated the use of the Y-Graft as a 
surgical standard for a consecutive series of Fontan patients at CHOA, which will be 
detailed in SA 4. 
The fundamental motivation for the Y-Graft was to improve efficiency by 
reducing/removing caval flow collisions. Its merits in this regard will be explored in the 
next chapter; however, its use as a hepatic baffle for patients with interrupted IVC 
utilizes different strengths of the design based around the same concept: avoidance of 
flow collision allowing a greater degree of control over pulmonary flow distribution. Its 
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use for this purpose is irrespective of its energetic performance and should be widely 
considered moving forward in these complex cases, as discussed in §7.4.12.1.  
There are two caveats based on the modeling experiences presented in this section. 
One is the issue of lateral placement away from superior anastomosis sites that has 
already been discussed. The second is the need to avoid significant lateral curvature. 
Reviewing the results for cases like CHOP_M12, CHOP_M13 (particularly option g), and 
CHOP_M16 showed that whenever a significant left-right curvature was imposed on the 
Y-Graft, the results were sub-optimal. Some of these results are compiled in Figure 7.62 
as a reminder. There are multiple reasons for this observation, but the two factors most 
likely mediating the result are: a) the fact that the two branches are pointing in the same 
lateral direction at the anastomosis site rather than directing flow in opposite directions; 
and b) the curvature skews the velocity profile prior to the bifurcation such that the two 
branches no longer evenly divide the flow. Hence, it is advisable to avoid using a Y-Graft 
(regardless of whether there is IVC interruption or not) in cases where high lateral 






Figure 7.62 Compilation of Y-Graft results for the specified cases in which significant 
lateral curvature limited Y-Graft effectiveness. 
 
 
7.5 Post-Operative Analyses166 
The previous section as well as the work of de Zélicourt et al.105 detailed the prospective 
use of surgical planning for a heterogenous group of single ventricle patients and based 
the estimation of their effectiveness on measures such as improving arterial oxygen 
saturations, which are clinically meaningful yet inconclusive for confirming modeled 
predictions105, 159. Thus, while a key assumption of these methods is the accuracy of 
preoperative predictions with respect to postoperative hemodynamic outcomes, detailed 
quantitative comparisons between pre- and post-operative hemodynamic metrics have 
been lacking. 
The following section compares the pre- and post-operative hemodynamics for a small 
subset of cases for whom such data were available, and subsequently details 
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preliminary efforts to quantify the impact of the numerous unknown variables inherent to 
prospective surgical modeling (e.g., geometric agreement, adaptation of input and output 
boundary conditions) to assess the predictive power of the virtual surgery paradigm. In 
all cases, post-operative imaging occurred in the hospital prior to discharge (5-10 days 
following surgery). 
 
7.5.1 Post-operative results 
7.5.1.1 CHOA_M2 
Figure 7.63 shows a qualitative comparison of the post-operative TCPC compared to the 
virtual surgical model for CHOA_M2. In this case, the match was weakened by the fact 
that the pre-operative CMR data had a large slice thickness (10mm), while the post-
operative CMR had only black blood images available for anatomic reconstruction, which 
provide different signal characteristics with regard to the vessel boundaries. Hence, 
there are significant visual differences between the two results, particularly with respect 
to the size (volume) of the SVC-Azygos-PA connection site. 
Yet, the qualitative streaming results for these two connections (Figure 7.64) are 
remarkably similar. The flow through the Y-Graft, as predicted, is directly laterally to 
either side of the superior anastomoses and exits through the respective PAs. The 
quantitative results do show some disparity, although still within acceptable ranges: 
connection resistance was higher but still less than population means, while HFD was 






Figure 7.63 Qualitative comparison of virtual model (blue) and post-operative 
reconstruction (red) for CHOA_M2. 
 
 
Figure 7.64 Velocity streamlines and quantitative measures from the time-averaged pre-
operative simulation (left) and time-varying post-operative simulation (right; representative 
















For this patient, post-operative arterial oxygen saturations improved from 85% to 95% 
16.5 months after surgery. As argued by de Zélicourt et al., this finding suggests the 
surgical intervention was successful in addressing the PAVM. 
Visual comparison of the pre-operative model and post-operative TCPC for CHOP_M9 is 
shown in Figure 7.65. There is a visible difference in the placement of the right graft 
branch (being more medially positioned in the actual connection), but the features of the 
connections are otherwise well-conserved.  
The post-operative scan included a 4D PC CMR sequence, the results of which are 
shown in Figure 7.66 and Animation 7.7. The pre-dominance of RPA flow is apparent; 
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yet, bilateral hepatic distribution through the Y-Graft can be seen through most phases 
of the cardiac cycle. In fact, quantifying the particle tracking produced an HFD result of 




Figure 7.65 Qualitative comparison of virtual model (blue) and post-operative 






Figure 7.66 4D Velocity data for post-operative reconstruction for CHOP_M9 derived from 
coronal PC CMR data with divergence free interpolation. Top row- instantaneous 




















Figure 7.67 compares the simulated velocity streamlines between the virtual model and 
post-operative result. Realized connection resistance was lower (likely because of less 
total flow to the LPA post-operatively), while HFD to the LPA was higher because the left 
branch of the Y-Graft was positioned further laterally than modeled. Still, the desired 






Figure 7.67 Velocity streamlines and quantitative measures from the time-averaged pre-
operative simulation (left) and time-varying post-operative simulation (right; representative 




Post-operative arterial oxygen saturations had improved from 61% to 72% one month 
after surgery, with no updated report available since then. It is therefore difficult to 
conclude anything regarding the success of the surgery based on saturations over that 
short interval. 
Anatomical comparison for CHOP_M10 is shown in Figure 7.68. The biggest difference 
is seen with respect to the placement of the right graft branch, which is more medial, 
anterior and superior in the actual connection compared to what was modeled. 
Otherwise, the models are very similar. 
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4D CMR data were again acquired and the results shown in Figure 7.69 and Animation 
7.8. There is an appreciable bias of the superior flows for the LPA, and significant 
acceleration occurs as the SVC and azygos flow combine within the connection. Still, as 
particularly seen from the particle tracking images, hepatic flow is bilaterally distributed 
to both sides of the connection (76% to the LPA based on the particles). 
 
 
Figure 7.68 Qualitative comparison of virtual model (blue) and post-operative 






Figure 7.69 4D Velocity data for post-operative reconstruction for CHOP_M10 derived from 
coronal PC CMR data with divergence free interpolation. Top row- instantaneous 























Figure 7.70 shows the simulated velocity streamlines for the virtual and actual models, 
and a significant disparity can be seen. Owing to the difference in the placement of the 
right graft branch, hepatic flow through that pathway was markedly different between 
models, with significant collision with the superior venous flow simulated in the actual 
post-operative connection. However, that interaction was not apparent in the 4D CMR 
velocity fields, possibly because of a difference in cross-sectional velocity profile 
between what was numerically imposed (uniform profile) and what exists in vivo (with a 




Figure 7.70 Velocity streamlines and quantitative measures from the time-averaged pre-
operative simulation (left) and time-varying post-operative simulation (right; representative 




Arterial oxygen saturations had improved from 86% to 96% 8 months after surgery for 
this patient, suggesting a successful intervention with respect to PAVM. 
The connection comparison for CHOP_M12 is shown in Figure 7.71. There is a clear 
difference in location of the Fontan connection as the model was medially positioned 
between the bilateral SVCs, while the actual connection was made further to the right 





Figure 7.71 Qualitative comparison of virtual model (blue) and post-operative 
reconstruction (red) for CHOP_M12 
 
 
Despite this anatomic difference, Figure 7.72 and Animation 7.9 show the reconstructed 
4D CMR velocity data, in which the majority (75%) of IVC flow tends to the LPA despite 
a generally non-uniform and disturbed cross-sectional profile. By comparison, Figure 
7.73 shows the simulated velocity fields (based on a uniform IVC inlet profile), which 
predict a more balanced IVC flow distribution from the post-operative connection in close 




Figure 7.72 4D Velocity data for post-operative reconstruction for CHOP_M12 derived from 
coronal PC CMR data with divergence free interpolation. Top row- instantaneous 























Figure 7.73 Velocity streamlines and quantitative measures from the time-averaged pre-
operative simulation (left) and time-varying post-operative simulation (right; representative 




The anatomic comparison for CHOP_M13 is shown in Figure 7.74. The connection 
location to the PAs is consistent between the models (close to the LSVC); however, the 
curvature of the baffle was different. In the virtual model, the baffle was positioned in a 
straight path, resulting in a slight right-to-left bias. The actual surgical connection, by 
comparison, started further to the left and angled back toward the center of the 
connection. 
Unlike the prior cases, the post-operative velocity results for this case did not show a net 
forward flow through the Fontan baffle (because of high fenestration flow). Hence, the 
results based on these data would not have been informative and no post-operative 
simulations were performed. Instead, longer term follow-up in this patient will be needed 






Figure 7.74 Qualitative comparison of virtual model (blue) and post-operative 




Geometric comparison of the virtual model and post-operative connection for CHOA_M5 
is shown in Figure 7.75. While the general connection approach advocated by the model 
was used (22x11 mm Y-Graft), very little other similarities are present. The virtual model 
did not include much anterior-posterior displacement, while the actual surgery introduced 
significant anterior curvature before bilateral connection to the PAs. Also of note is the 
fact that the post-operative CMR data did not provide a clear enough signal to 
reconstruct the upper lobe branch of the RPA. 
The simulated velocity and hemodynamic output results are shown in Figure 7.76. 
Resistance was higher than predicted, likely because of a decrease in RPA diameter, 
while HFD to the LPA was lower. Some interaction and cross-over can be seen with the 
flow through the left Y-branch, however, the absence of the upper RPA lobe is the bigger 
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reason for the HFD difference as the SVC flow was primarily directed to the LPA rather 




Figure 7.75 Qualitative comparison of virtual model (blue) and post-operative 





Figure 7.76 Velocity streamlines and quantitative measures from the time-averaged pre-
operative simulation (left) and time-varying post-operative simulation (right; representative 
streamlines) for CHOA_M5. 
 
 
7.5.2 Sensitivity Analysis  
The previous section showed that, while agreement between pre-operative models and 
post-operative results (both simulated and imaged) was generally favorable, there were 
important differences in most cases. The objective of this study is to quantify the impact 
of the numerous unknown variables inherent to prospective surgical modeling (e.g., 
geometric agreement, adaptation of input and output boundary conditions) to assess the 
predictive power of the virtual surgery paradigm.  
Because both patient-specific anatomy and flow conditions were variables in this 
analysis, multiple simulations were performed for each patient to isolate their effects. 
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Specifically, in addition to the time-averaged pre-operative analysis, which is simulation 
(1a), four simulations were run for each patient after the surgery: 
1) The retained surgical planning model under: 
a) time-averaged pre-operative BCs  
b) pulsatile post-operative BCs 
c) time-averaged pre-operative inflows and time-averaged post-operative PA 
outflow split BCs 
2) In vivo post-operative anatomy under:  
a) time-averaged pre-op BCs 
b) pulsatile post-op BCs (i.e., actual outcome) 
Comparison of 1a vs. 2b was performed for each case in §7.5.1, and provides an 
assessment of the surgical planning predictive power with respect the primary planning 
endpoint of hepatic flow distribution. A comparison of 1c vs. 2b is instead used to assess 
connection resistance in order to remove the confounding effects of varying flow through 
a stenotic vessel (e.g., the LPA of patient 2). Comparing 1a vs. 2a and 1b vs. 2b 
provides insights into the impact of geometric variation; 1a vs. 1b vs. 1c and 2a vs. 2b 
was used to isolate the impact of the varying inflow and outflow BCs.  
7.5.2.1 Hemodynamic Changes from Geometric Variation 
To isolate the hemodynamic impact of the observed surgical variations and image 
reconstruction differences, both the surgical planning and post-operative geometries 
were simulated under time-averaged, pre-operative boundary conditions (simulations 1a 
and 2a). The results (Figure 7.77, Table 7.28) demonstrated that the effects of geometric 
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mismatch (both surgically-mediated and image-processing related) can be significant. 
Previous studies have shown strong correlations between minimum PA size and power 
loss across the TCPC140, and the present changes in power loss directly corresponded 
to variations in the minimum reconstructed PA sizes in each case. As a result, the errors 
in power loss values because of geometric differences ranged between 18-68% with an 
average of 39%. For HFD, differences ranged between 2-18%, with surgical baffle 
mismatch mediating the largest discrepancies (as for CHOP_M10 and CHOP_M12).  
 
Table 7.28 Geometry-Related Differences: Hemodynamics under Pre-Operative Flow 
Conditions (Comparison of Simulations 1a and 2a) 
Patient  












CHOA_M2  23 / 14 
AZ flow impinging 
on Rt branch 
outlet 
1.9 / 3.2 
Pouch and PA size 
differences  
CHOP_M9 25 / 27  7.7 / 5.1 Different PA size  
CHOP_M10 58 / 72 
Medial placement 
of right Y-branch  
1.1 / 1.3 Different PA size 





Figure 7.77 Comparison of pre- and post-operative connections under steady, pre-
operative flow conditions.  Streamlines are color-coded by vessel of origin 
 
 
7.5.2.2 Post-operative flow conditions 
Table 7.29 shows the phase velocity CMR-derived flows by vessel, plus the cardiac 
output (measured in the aorta) for each patient. Cardiac output decreased after surgery 
in 3 of the 4 cases. With respect to TCPC flows, the relative percentage distributions of 
each vessel were different following surgery; the magnitude of those changes ranged 
anywhere from 2 to 22%. Notably, the PA changes were all in favor of higher flow 
percentage toward the lung with PAVM. 
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Table 7.29 CMR-derived flow rates 




HepV/IVC Right SVC Left SVC AZ LPA RPA 
CHOA_M2 
Pre 3.3 17 34  49 -23 -77 
Post 2.4 21 52  27 -18 -82 
         
CHOP_M9 
Pre 2.9 18 54  28 -34 -66 
Post 1.8 30 47  23 -13 -87 
         
CHOP_M10 
Pre 3.2 18 56  26 -76 -24 
Post 3.7 16 72  12 -85 -15 
         
CHOP_M12 
Pre 2.6 56 25 19  -62 -38 
Post 1.8 58 20 22  -69 -31 
 
 
7.5.2.3 Hemodynamic Changes from Flow Rate Variations 
Figure 7.78 shows representative, instantaneous streamlines for the CFD-derived post-
operative flows (simulation 2b) for each patient. Despite the noted quantitative flow 
differences, the results for patients 2 and 3 are qualitatively very similar to their 
corresponding steady pre-operative flow results (simulation 2a) from Figure 7.77. For 
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patients 1 and 4, the impact of (decreased) azygos and (increased) IVC flow changes, 




Figure 7.78 Representative instantaneous velocity streamlines (color-coded by vessel of 
origin) from the time-varying post-operative flow simulations on the actual post-operative 





The hemodynamic results as a function of imposed flow conditions are reported for the 
surgical planning models and the post-operative anatomies in Table 7.30 and Table 
7.31, respectively. To isolate the effect of varied PA splits from the total change in TCPC 
flow conditions, Table 7.30 also provides the results of combining post-operative outflow 
splits with pre-operative inflow conditions (simulation 1c). The HFD differences ranged 
between 3-19% (mean of 13%) and 8-21% (mean of 17%) for the virtual models and 
post-op anatomies, respectively.  
 
 
Table 7.30 Effect of Boundary Condition Variations: Surgical planning models (comparison 
of simulations 1a,1b,1c) 
Pt 





















CHOA_M2 23 19 40  0.26 0.28 0.19 
CHOP_M9 25 17 28  0.77 0.27 0.2 
CHOP_M10 58 58 77  0.18 0.21 0.24 






Table 7.31 Effect of Boundary Condition Variations: Post-operative Anatomy (comparison 




(Pre BC / 






(Pre BC / 
Pulsatile Post 
BC)  
CHOA_M2  14 / 35 
Varied venous 
flow distributions 
0.44 / 0.22 
CHOP_M9  27 / 35 
Varied venous 
flow distributions 
0.51 / 0.32 
CHOP_M10 72 / 91 
Varied venous 
flow distributions 
0.22 / 0.35 
CHOP_M12 34 / 54 
Increased Total 
LPA Flow  
0.14 / 0.18 
 
 
Connection energetics in Table 7.30 and Table 7.31 are reported as resistance to 
partially correct for the noted changes in bulk flow rates. Generally minor variations were 
seen as a function of PA split (Table 7.30) owing to differences in vessel size. This effect 
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was substantial for CHOP_M9 because of the relatively small size of the LPA. 
Neglecting PA size effects and comparing only the 5th and 6th columns, the efficiency 
errors as a function of systemic flow variations ranged from 14-32% with an average of 
24%. 
7.5.2.4 Predictive Accuracy 
The explicit comparison of surgical planning predictions to simulated post-operative 
hemodynamics is shown in Table 7.32. For HFD, the predictive difference (pre-operative 
value vs. post-operative result) ranged between 2-33%, with a 90% confidence interval 
of 14.3 ± 4.3%. For connection resistances, the predictive comparisons (pre-operative 
inflows with post-operative PA splits vs. post-operative simulation) ranged between 0-
40% error with a 90% confidence interval of 19.5 ± 4.8%. 
 
 
Table 7.32 Predictive Accuracy Summary 
 















CHOA_M2 23 35 12  0.28 0.22 22 
CHOP_M9 25 35 10  0.27 0.32 16 
CHOP_M10 58 91 33  0.21 0.35 40 
CHOP_M12 52 54 2  0.18 0.18 0 
90% #CInt.   14.3 ±4.3    19.5 ± 
4.8 




7.5.3 Section Discussion and summary 
This study compared the results from pre-operative virtual surgery modeling of the 
Fontan procedure to the simulated hemodynamic outcomes following the surgical 
implementation of those models in four patients. While the agreement was not exact, it is 
important to note that the hemodynamic outcomes with respect to what the patients 
ultimately needed (i.e., hepatic perfusion of the diseased lung) were achieved in each 
case, which is not a guarantee in such complex anatomical configurations. The 
improved/improving arterial oxygen saturation values further support this observation as 
they suggest the PAVMs are regressing and more blood is being properly routed through 
the lungs. Ultimately, that is the desired clinical endpoint. 
These results suggest that the virtual models mimicked the interventions with sufficient 
realism to provide relevant insights to the cardiovascular surgeon and help in the 
decision-making process. The fact that these Y-graft patients were the first for either 
surgeon in this study provides strong testament that the modeling results were taken into 
account in their surgical strategy. Furthermore, providing the first assessment of 
prospective modeling comparisons is a milestone in the development of tools for 
engineering-based modeling of cardiothoracic surgery because it demonstrates the 
ability of the modeling to approximate the acute surgical result. Of equal importance, 
however, was the identification of key variables that dictate the error margins of the 
approximations. Such information will be critical to both prioritize and further motivate 
future developments to address these limitations.  
HFD: As seen in Table 7.32, the confidence interval of pre-operative HFD predictions to 
post-operative results was 14.3 ± 4.3%. This finding is positive for several reasons. HFD 
is a primary consideration in patients with PAVM diagnoses based on the assumption 
that achieving desired flow streaming would successfully alleviate the immediate disease 
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state. However, there is a poor clinical understanding with regard to the critical values of 
HFD that mediate PAVM formation or regression, with the only clearly negative outcome 
being complete exclusion of hepatic flow from one lung. Interventional target values are 
therefore broad, ill-defined, and nearly impossible to dictate a priori. Providing a means 
to achieve a specific outcome, even with up to 19% uncertainty, thus represents a 
significant refinement of the current approach.  
Surgical/model geometrical agreement is a critical mediator of flow streaming predictions 
and thus represents an important need to improve results. Unfortunately, surgical 
mismatch is currently an unavoidable factor of the process as consistently exact 
agreement would require: a) registered, simultaneous visualization of both the patient 
anatomy and virtual model in the operating room; b) a lack of intra-operative adjustments 
from the pre-determined plan by the surgeon; and c) simulation of the geometric 
changes that occur post-operatively (e.g., from chest closure or restoration of normal 
thoracic pressures). While none of these is impossible for future work to incorporate, 
they are not currently feasible. Rather than addressing this limitation on the surgical 
side, however, it would be easier to take preventative measures on the virtual design-
side to minimize its impact. Such considerations were subjectively included in these 
present cases (see §7.4), but only on an ad hoc basis. Low sensitivity of desirable 
hemodynamic values to possible variations in exact implementation (i.e., option 
robustness) can also be mathematically formalized into a separate evaluation criterion to 
strengthen the analysis167.  
Connection Resistance: Prospective resistance predictions were not as strong as for 
flow distribution (19.5 ± 4.8%). Yet, even though the clinically relevant thresholds of 
TCPC power loss are currently unknown, it is assumed that the resistance values found 
in all cases were acceptably small. In fact, the low magnitudes (~0.3 WU) contributed to 
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the error magnitudes given the relatively small absolute differences observed (~0.1 WU 
or less). It is unlikely that the difference between 0.28 and 0.22, for example, would be 
clinically significant given that, from the work of Sundareswaran et al., a 3- or 4-fold 
increase in resistance would be required to drop cardiac output by ~12%55. Furthermore, 
power loss was only a secondary consideration in the decision making process for these 
patients (as seen from the pre-operative analyses) and only came into play when two 
options had similar flow distribution characteristics. In fact, the efficiency differences 
between the options for which power loss was a discriminator exceeded the 24% mean 
error margin, so it was still a useful metric in those pre-operative analyses. That said, the 
secondary importance of connection efficiency is not a permanent fixture, particularly 
given the physiologic impact of power loss demonstrated through the previous chapters; 
there are likely patients and disease states (e.g., poor exercise intolerance, high central 
venous pressure, severe diastolic dysfunciton) for which such metrics are of primary 
concern. Thus, while the present findings from this initial series provide a viable starting 
point, they are not sufficient for the ultimate promise of such analyses.  
Based on the present data, one focal point for making improvements is minimizing the 
deviation of reconstructed vessel sizes, particularly of the small PAs, which were a 
primary contributor to predictive errors of efficiency. Uncertainties in vessel sizes were 
related to three primary sources: a) finite sampling of medical images; b) the possibility 
of actual changes occurring in the vessel sizes, as in response to changing flow 
conditions or surgical manipulation; and c) the reconstruction protocol itself (smoothing 
and surface fitting algorithms tend to shrink the segmented volume). Continuous 
advancements in imaging (particularly the growing use of 3D anatomic sequences) and 
image processing techniques will help address points (a) and (c); the effects of (b) will 
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need to be studied through future work with larger sample sizes, and may require fluid-
structure interaction models to resolve if deemed critical to the result. 
Flow boundary condition uncertainty: While surgical agreement and reconstruction errors 
were each found to impact pre-operative predictions in an isolated fashion (i.e., either 
HFD or power loss), changes in flow conditions was seen to mediate changes in both 
metrics of interest and thus deserves particular attention. Decreases in cardiac output 
post-Fontan have previously been noted by Fogel et al.33 and in the work presented in 
§7.3. No similar report exists with respect to post-operative physiology of interrupted IVC 
patients. In this limited series, output decreased in 3 of 4 patient cases by as much as 
1.1 L/min. Power losses are directly dependent on the total flow rate, so normalizing to 
express as a resistance better accounted for most of these changes, as evidenced by 
the similar orders of magnitude in the comparisons of Table 7.30, Table 7.31, and Table 
7.32. Dynamic interactions among the various inlets, dictated by their relative flow rates, 
would have also contributed to the hemodynamic efficiency of the connection.  
Relative vessel flow rates also impacted HFD. It is known that HFD is generally 
positively correlated to the pulmonary outflow split144, so this finding was expected. In 
CHOP_M12, for example, pre-operatively varying the outflow split (Table 7.30) improved 
agreement with the result of the post-operative BC simulation. CHOA_M2 and 
CHOP_M9 (both with Y-graft conduits) diverged from this trend, which suggests that the 
inlet fluid momentum in bifurcated grafts may supersede the outlet conditions under 
certain conditions. More importantly though, the physiologic factors governing post-
operative adaptation of pulmonary splits are not well characterized, and so parametric 
sensitivity studies should be a critical component of any surgical planning analysis. 
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Coupling lumped parameter models to 3D fluid solvers has been proposed and 
evaluated in hypothetical surgical planning studies as a means to mathematically predict 
physiologic changes and better account for such effects94, 95, 164. This is potentially a very 
powerful paradigm and certainly represents the future for these techniques. However, 
there is currently a lack of data in the literature characterizing patient-specific pre- and 
post-operative physiology for the models to be properly validated. Furthermore, the 
difficulty in obtaining the data needed to make such models truly patient-specific (e.g., 
explicit compliance characteristics throughout the various vascular beds) can be 
challenging. Perhaps the best approach for future protocols would be for these multi-
modality approaches to be complemented by clinical experience of serial patient 
changes (both acute and chronic) to ensure the models have simulated all the relevant 
conditions. While this development continues, the controlled and hypothesis-driven 
deviation of the investigated outflow splits as part of our surgical planning analysis is 
worthwhile approach that, based on the presented findings, should be augmented and 
complemented with similar variations of the inlet BCs to ensure robust solutions with 
respect to physiologic changes. 
 
7.6 Chapter Summary 
In this specific aim, we have expanded our patient-specific Fontan surgical planning 
experience with respect to patient numbers, anatomical complexities, and physiologic 
indications. These techniques continue to be a promising and exciting new approach to 




Additionally, the unique contribution of this thesis is the preliminary investigations into 
post-operative outcomes through both theoretical lumped parameter modeling as well as 
detailed analyses of imaging data acquired after prospectively planned surgeries to 
compare the results to prospective virtual model predictions. This latter component in 
particular is a critical step for the advancement of the paradigm as it provides a first look 
at the fidelity of the modeling and its usefulness in representing the post-operative state. 
The results are promisingly positive while also indicating that more work is needed to 
ultimately achieve the desired utility. It was found that model predictions for flow 
distribution were within the range of clinically acceptable error margins (±14%), 
especially considering the fact that there are no existing means to quantify these 
measures without computational modeling, so the information provided is still better than 
what is otherwise available. On the other hand, the error margins for power loss 
predictions are on the order of the expected inter-option differences that surgical 
planning is expected to identify (this topic will be revisited in Chapter 10). Hence, 
continued advancement in the methods is needed to provide necessary confidence to 
make meaningful power loss assessments. 
The largest need is clearly for a more robust means of arriving at the relevant post-
operative boundary conditions to simulate, presumably through calculation with a 
coupled lumped parameter model. However, that alone is not sufficient since it is only 
providing a single result in what will be a transient physiology; the connection modeled 
needs to last a lifetime, not just in the acute post-operative period. Therefore, concurrent 
with the technological advancements is the need for continued medical research and 
longitudinal patient follow-up to understand how the physiology changes with time and 




Chapter 8. Specific Aim 4: Evaluate the clinical 
feasibility of the Fontan Y-Graft for Improving TCPC 
Hemodynamics 
8.1 Overview 
While representing an energetic improvement over previous designs (APC), the TCPC 
creates an adverse hemodynamic environment due to the collision of the caval flows53, 85, 
168. The idea of using a flow bifurcation in the Fontan connection was first proposed by 
Soerensen et al.106 (“Optiflo”; U.S. Patent #7811244). The motivating concept was that 
by dividing and rerouting one or both of the vena caval flows, the inefficient collision and 
mixing at the PA junction can be avoided.  
Subsequent studies have analyzed and sought to optimize the design of the Fontan Y-
graft (half of the Optiflo) using virtually rendered models107, 169. However, the recent work 
of Kanter et al.170 represents the first clinical report of Y-graft usage in a consecutive 
series of Fontan patients. Post-operative imaging data from these patients provide the 
unique opportunity to evaluate the hemodynamic outcomes of this series and compare 
them to what could have been realized with possible surgical alternatives.  
We hypothesize that the use of a Y-Graft for the Fontan connection improves Fontan 
hemodynamics by both reducing power losses and providing a better balance of IVC 
flows to the left and right PAs. This hypothesis is evaluated in this section in two parts: 1) 
the results from a set of 15 consecutive Y-Graft patients will be presented and compared 
to the overall cohort as well as a sub-set of age-matched controls; and 2) five of the 
fifteen patients will be selected for more thorough numerical evaluation under resting 
and simulated exercise flow conditions, and comparing these performance 
characteristics to extracardiac TCPC models virtually created for the same patients.  
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8.2 Study Protocols 
8.2.1 Patient Selection 
Between August 2010 and July 2012, 15 consecutive patients receiving their Fontan 
connections under the care of Dr. Kirk Kanter at Children’s Healthcare of Atlanta 
received a commercially available bifurcated aorto-iliac polytetrafluoroethylene (PTFE) 
graft (Goretex; W.L. Gore; Flagstaff, AZ) as their Fontan baffle. All patients were imaged 
post-operatively for clinical evaluation of their Fontan pathway and consented for the 
data to be used for research purposes. These patients are the focus of this study and 
their demographic information is summarized in Table 8.1. Two patients were excluded 
from the hemodynamic analyses: in one case (CHOA_Y7) the post-operative (3T) CMR 
data was not sufficient for anatomic reconstruction, while for the second (CHOA_Y15) 
the flow through the fenestration (as measured by PC CMR) was greater than the IVC 
flow such that net flow through the Y-Graft was negative, thus no CFD simulations were 
performed. Finally, it is noted that there is overlap between these patients and those 
presented in Chapter 8: CHOA_M2 was the first in this series (‘CHOA_Y1’), while 










Table 8.1 Patient demographic detail for Y-Graft patient series 
Pt. Age (yrs) BSA (m2) Y-Graft 
size (mm) 
Other comments 
CHOA_M2 (Y1) 18 1.49 18 x 9 
Surgical revision; 
Interrupted IVC 
CHOA_Y2 5 0.72 20 x 10 Post-op CT 
CHOA_Y3 2 0.53 18 x 9  
CHOA_Y4 3 0.72 20 x 10 Surgical revision 
CHOA_Y5 2 0.47 20 x 10  




CHOA_Y7 2 N/A 20 x 10 Poor CMR quality 
CHOA_Y8 14 1.53 20 x 10  
CHOA_Y9 3 0.51 20 x 10  
CHOA_Y10 2 0.58 18 x 9  
CHOA_M5 (Y11) 12 1.40 22 x 11 Surgical revision 
CHOA_Y12 2 0.47 20 x 10  
CHOA_Y13 4 0.6 20 x 10  
CHOA_Y14 2 0.58 18 x 9  
CHOA_Y15 2 0.5 18 x 9 
No net Fontan 
flow measured; 
bilateral SVCs 
Average 5.5 ± 5.2 0.78 ± 0.38   
 
 
8.2.2 CFD Protocol 
The computational simulation protocols were generally the same as has been used in 
the preceding chapters. Primary end points included TCPC power loss (TCPC-EDI) and 




1. There was a preference for using time-varying flow boundary conditions in this 
study. The lack of CMR-measured velocities or the lack of a smoothly time-
varying profile measured (from CMR) prevented their use in some instances. 
Hence, the BCs used (either time-averaged or pulsatile) will be noted during the 
presentation of the individual cases. 
2. For the second half of the study involving the in depth analysis of five patient 
cases compared to extracardiac controls, simulated exercise boundary 
conditions were used per the method of Whitehead et al56. Specifically, the 
measured cardiac output was doubled (for “2x”) or tripled (for “3x”) with the 
difference imposed as an increase in IVC flow rate (simulating lower limb 
exercise). All of these exercise simulations were done using time-averaged flow 
values. 
3. As seen for two cases in Table 8.1, only post-operative CT anatomic data were 
available to reconstruct the patient anatomy and no concurrent PC CMR 
measurements were available. Flow conditions to be used for the computational 
simulations therefore had to be derived from alternate sources. 
a. For CHOA_Y2, a pre-operative (Glenn-stage) catheterization report was 
used converting the QP/QS ratio into the IVC and SVC flow rates (SVC= 
QP; IVC=QS-QP) and setting the pulmonary flow distribution on the basis 
of vessel sizes. 
b. CHOA_Y6 was a surgical planning patient (CHOA_M3; study performed 
by M. Restrepo) who had a pre-operative CMR performed; thus, the pre-





8.2.3 Statistical Analyses 
Statistical analyses were performed using Minitab (Minitab Inc., State College, PA). 
Continuous variables were tested for normality using the Anderson-Darling test. The 
Student’s t-test and Mann-Whitney test were used for comparisons between groups. P-
values less than 0.05 were considered statistically significant in all cases. 
 
8.3 Results 
8.3.1 Hemodynamic Summary 
The TCPC reconstructions for the 13 included patients are shown in Figure 8.1. It is 
noted that the sizes shown are scaled consistently among the connections. There are 
two clear generations of surgical implementation that can be seen. The first 5 patients all 
exhibit relatively short branches with little curvature and generally connect to the PAs at 
right angles. Starting with the sixth case, branch lengths are all considerably longer and 
have greater curvature in an attempt to better direct flow smoothly into the PAs. It is 
clear, particularly considering patients 8-14, that achieving such an angle is easier for 
the left branch than the right. In fact, in many cases the right branch is angled away from 
the RPA outlet at the anastomosis, presumably because its proximity to the right lung 









A summary of the (non-normalized) flow rates used for each patient in the computational 
simulations is provided in Table 8.2. The flow rates were generally low, with 7 patients 
having cardiac outputs ≤ 2 L/min. Additionally, in most cases the IVC flow rate was lower 
than the SVC. Both of these observations are consistent with both the generally young 
age of the patients and the fact that the imaging studies were conducted in the acute 
post-operative period.  
 
 
Table 8.2 Vessel flow rates retained for each patient 
Pt. CO [L/min] IVC [L/min] SVC [L/min] LPA [L/min] RPA [L/min] 
CHOA_M2 (Y1) 5.0 0.5 (Hep) 1.9 (+Az) 0.4 2.0 
CHOA_Y2* 2.7 1.5 1.2 1.3 1.4 
CHOA_Y3 2.0 0.3 0.5 0.2 0.3 
CHOA_Y4 2.5 0.6 0.8 0.3 0.6 







CHOA_Y8 4.1 2.1 1.3 1.6 1.7 
CHOA_Y9 1.5 0.5 0.9 0.4 0.9 
CHOA_Y10 1.5 0.5 0.9 0.4 0.7 
CHOA_M5 
(Y11) 
4.1 1.0 1.5 0.8 0.9 
CHOA_Y12 1.1 0.4 0.7 0.8 0.2 
CHOA_Y13 1.0 0.4 0.8 1.1 0.3 
CHOA_Y14 1.8 0.6 1.0 0.5 0.7 




Representative velocity streamlines for all patients are shown in Figure 8.2 and Figure 
8.3. General trends include low velocities (except in cases like Y3, Y9, Y10 with very 
small PAs); patient-specific variation in the dynamic interactions with SVC flow (recalling 
that SVC anastomosis angles were shown in Chapter 5 to be related to flow 
distributions); and IVC flow division between the two Y-Graft branches, as expected. 
Regarding this last point, however, static streamlines can be visually misleading in this 
regard, and Figure 8.4, Animation 8.1, and Animation 8.2 show that these dynamics 
varied among patients with some cases preferentially favoring IVC flow through one 









Figure 8.2 Representative velocity streamlines color coded by local velocity magnitude for 










Figure 8.3 Representative velocity streamlines color coded by local velocity magnitude for 






Figure 8.4 Sequence of IVC particle tracking images for CHOA_Y9 (top) and CHOA_Y10 
(bottom) contrasting cases in which branch velocities are approximately equal (Y10) and 





















Animation 8.2 Pulsatile particle tracking for CHOA_Y10 
 
The summary of the hemodynamic end points of interest derived from the computational 
simulations (as well as the type of BCs imposed for each case) is presented in Table 
8.3. With respect to flow distribution, there is only one case that exhibits a significantly 
biased HFD result: CHOA_Y9 (7% LPA). Incidentally, this is the case highlighted in 
Figure 8.4 as having a significant bias for higher velocities through the right Y-branch. 
The LPA in that patient appears significantly stenosed and the SVC flow appears to add 
additional resistance to IVC flow tending to the left branch. Furthermore, the LPA carries 
only 30% of total pulmonary flow, so having a low hepatic contribution is expected. 
For power loss (TCPC-EDI), there were three values > 0.090, which corresponds to the 
losses of the patients in §5.5.1 as being the highest power loss cases. In fact, CHOA_Y3 
(0.244) has a value greater than any of those prior cases. All three of these patients are 
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marked by very small LPA diameters, which is the reason for the elevated energy 
dissipation.  
 
Table 8.3 Summary of CFD-derived hemodynamic data 
Pt. BCs TCPC-EDI GFD (%LPA) HFD (%LPA) 
CHOA_M2 (Y1) Time-averaged 0.027 18 35 
CHOA_Y2 Time-averaged 0.018 48 70 
CHOA_Y3 Pulse 0.244 33 28 
CHOA_Y4 Pulse 0.021 34 45 
CHOA_Y5 Pulse 0.029 74 34 
CHOA_M3 (Y6) Time-averaged 0.041 68 49 
CHOA_Y8 Pulse 0.052 49 38 
CHOA_Y9 Pulse 0.095 30 7 
CHOA_Y10 Pulse 0.133 35 41 
CHOA_M5 (Y11) Time-averaged 0.059 46 25 
CHOA_Y12 Time-averaged 0.027 80 62 
CHOA_Y13 Time-averaged 0.021 80 41 
CHOA_Y14 Pulse 0.034 46 52 
 
 
8.3.2 Statistical Comparisons 
The results in Table 8.3 were compared to those presented in Chapter 5 for the TCPC 
cohort to statistically evaluate the performance of this small Y-Graft series. With regard 
to HFD, Table 8.4 shows that the results were no different (p=0.49) with a mean of 44% 
LPA in both groups. Similarly, TCPC-EDI was statistically no different with respect to the 
median values (Mann-Whitney test; p=0.12) although the Y-Graft mean value was 
skewed considerably higher because of the high values reported in several cases. 
366 
 
Table 8.4 Comparison of Y-Graft hemodynamics to TCPC cohort results 






Mean ± SD 
44 ± 21 44 ± 20 0.49 
    
TCPC-EDI 
Mean ± SD (Median) 
0.037 ± 0.028 
(0.032) 





8.4 Comparison to Patient-Specific Controls139 
The cohort comparison for Y-Graft power loss is not necessarily the most appropriate 
because the Y-Graft patients were all imaged in the acute post-operative period, while 
the cohort data largely represent hemodynamics late after the Fontan procedure. 
Instead, a more appropriate way to evaluate the merits of an alternate Fontan 
connection (the Y-Graft) is to vary only the connection, while holding all other variables 
constant. This approach was the focus of the following section. 
8.4.1 Methods 
To provide this alternate basis for comparison, SURGEM was used to create two virtual 
extracardiac TCPC models for each of five Y-Graft patients (Y2-Y6) representing the 
possible alternative connections they may have received instead of a Y-graft110. This 
analysis was conducted early in the patient series, so the patients selected were those 
who had been recruited to that point. CHOA_M2 (Y1) was excluded from this analysis as 
the simulation of exercise physiology in the context of an interrupted IVC would not have 
evaluated the Y-Graft connection, as desired, but would instead increase azygos vein 
flows. The two extracardiac designs varied slightly in caval offset, and are thus 
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designated as the ‘t-junction’ and ‘offset’ models. Baffle diameters matched the diameter 





Figure 8.5 Patient Y-Graft connections (top row; with photo of bifurcated PTFE graft) and 






In addition to baseline (resting) flows, simulated exercise conditions were also 
investigated. Exercise limitations are a known chronic issue with Fontan patients157, 158 
and previous studies have shown that the non-linear increases in TCPC power loss with  
increased flow rates may be an important contributor55, 134. Further, since small 
inefficiencies under resting conditions may be amplified and exacerbated with higher 
flows, these simulations are a means to assess the hemodynamic characteristics and 
robustness for a given connection geometry. Per standard practice, simulated exercise 
conditions of two and three times baseline (‘2x’ and ‘3x’) were numerically imposed by 
respectively doubling and tripling the measured cardiac output and imposing that 
difference as additional (time-averaged) IVC flow (approximating lower limb exercise)107, 
134. The pulmonary flow splits were maintained constant across these varied conditions 
as suggested by previous studies171. 









 ;  where ΔP is pressure drop, QVC is the sum of caval inflows, 
and BSA is the body surface area)55. Additionally, the IVC flow distribution to the PAs, 
(HFD) was quantified144. Further, to facilitate qualitative hemodynamic comparisons, the 
magnitude of viscous dissipation (i.e., V2 ; µ is viscosity, V is velocity) and 3D vortex 
core visualization (via iso-surfaces of the second invariant of the deformation matrix, 
Q)149 were also used, where appropriate. 
 
8.4.2 Results 
The resistance and HFD results are detailed in Table 8.5 and Table 8.6, respectively, 
and summarized in Figure 8.6. For resistance, the Y-Graft group had the lowest average 
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value. This trend was skewed by a single case (CHOA_Y2) for whom there was a 
significant improvement in efficiency with the Y-Graft. For the remaining patients, there 
were only minor differences. The non-linear response to simulated exercise was 
consistent among the connections (Figure 8.6A).  
 
Table 8.5 Connection Resistance Summary [mmHg*min/L] at Rest and Exercise 











Y2 0.33 1.26 1.21 0.74 2.57 2.29 1.22 3.95 3.43 
Y3 1.6 1.6 1.5 2.63 2.42 2.60 3.93 3.83 3.83 
Y4 0.17 0.15 0.23 0.40 0.32 0.46 0.68 0.51 0.62 
Y5 0.2 0.19 0.19 0.57 0.55 0.67 0.89 0.90 1.08 
M3 0.33 0.33 0.32 1.80 1.50 1.62 3.56 2.54 2.81 












Table 8.6 HFD Results [%LPA] 











Y2 70 65 42 51 56 38 47 52 42 
Y3 32 16 4 30 14 9 30 24 20 
Y4 49 57 28 45 47 42 44 43 41 
Y5 52 46 35 58 56 60 66 65 69 
M3 49 31 100 58 56 82 62 60 76 
Mean 51 43 42 49 46 46 50 49 49 
St. 
Dev 




Figure 8.6 Mean, maximum, and minimum values of connection resistance (A) and flow 
distribution (B) for each connection (YCPC (Y-Graft), TCPC, Offset) and flow condition (1x, 
2x, 3x) investigated. 
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With respect to HFD under baseline conditions, the Y-grafts had the smallest range and 
standard deviation among all patients (Figure 8.6B). By comparison, the TCPC offset 
models had a range of almost 100%, denoting significant patient-to-patient variation. 
Additionally, while there is no accepted ‘optimal’ value for HFD, the mean Y-Graft value 
(rest conditions) was closest to 50%, denoting desirable left/right balance. 
 
8.4.3 Detailed Hemodynamic Analyses  
As seen in Table 8.5 and Figure 8.6A, the resistance values varied considerably among 
patients. Thus, rather than focusing on the absolute magnitude of power loss, we seek to 
identify the factor(s) that mediated energy dissipation differences for a given patient 
across connection types, to then identify possible means for improvement. Two trends 
were discernible: dissipation through local vessel constrictions (Figure 8.7), and 






Figure 8.7 Comparison of Y-Graft and TCPC hemodynamics for patients 1 (CHOA_Y2; A), 2 
(CHOA_Y3; B), and 5 (CHOA_M3; C). The resting velocity streamlines (top row), 3x velocity 







Figure 8.8 Velocity streamlines (a,d), vortex core isosurfaces (Q=800 (top), 13000 (bottom)) 
(b,e), and viscous dissipation contours localized to the vortex isosurfaces (c,f) for Patients 
3 (CHOA_Y4; top, rest) and 4 (CHOA_Y5; bottom, 3x). 
 
 
Figure 8.7 shows the resting (top) and 3x (middle) velocity streamlines, as well as 
resting viscous dissipation contours (bottom) for the Y-Graft and one TCPC option for 
CHOA_Y2, Y3, and M3. For CHOA_Y2, there was a section of the LPA that was mildly 
stenotic, which resulted in significant convective acceleration and dissipation of LPA flow 
for both connections, even under resting conditions. However, the position of the left 
branch of the Y-graft helped to augment the size of the vessel, bypass the throat of the 
constriction, and reduce flow separation in the distal LPA (particularly with exercise), as 
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compared to the t-junction results. These characteristics resulted in a significant 
reduction of the viscous losses (bottom row). 
For CHOA_Y3 (Figure 8.7B), an acute stenosis in the LPA was again observed, except 
in this case it was distal to the Y-graft anastomosis. As a result, this patient consistently 
had among the highest resistance values in the study, irrespective of IVC baffle design 
(Figure 8.7, bottom row).  
CHOA_M3 was unique in this series based on the presence of bilateral SVCs, and the 
use of numerical modeling to pre-operatively plan the procedure105 and suggest surgical 
revision to a Y-graft. As seen in Figure 8.9a, the previous TCPC exhibited severely 
unbalanced HFD (blue) to the PAs (and thus right lung PAVMs developed) because of 
the unequal distribution of RSVC/LSVC flows (55% Qs vs. 21% Qs, respectively). In 
contrast, Figure 8.9b shows that the Y-graft delivers IVC flow to both PAs. However, the 
extended length of the Y-graft conduit caused significant acceleration and flow 




Figure 8.9 Streamlines color coded by vessel of origin (red-SVC/LSVC, blue- IVC) for a) the 




For the remaining two patients (CHOA_Y4- top; CHOA_Y5- bottom), Figure 8.8 shows 
velocity streamlines (a) and coherent vortex cores (b), to facilitate appreciation of the 
complex flow recirculation. In these patients, both branches of the Y-graft were 
connected nearly perpendicularly to the PAs, resulting in significant flow recirculation at 
the anastomoses (arrow, Figure 8.8a). The vortex cores (Figure 8.8b) provide improved 
visualization of these rotational flow structures and show their expansive size. Rather 
than being local, contained phenomena, these vortices bilaterally originated in the high 
shear wake region distal to the IVC bifurcation and extended downstream into the PAs. 
As a result, Figure 8.8c shows that local regions of relatively high energy dissipation 
(from the color contours) were created at multiple downstream locations adjacent to 




8.4.4 Section Summary 
This study, in conjunction with the clinical report of Kanter, et al.170, clearly demonstrates 
that the surgical implementation of the Fontan Y-graft is feasible. The additional 
contribution of this work is the identification and elucidation of the hemodynamic 
implications associated with the characteristics of the surgical design. In other words, the 
use of a Y-graft does not necessarily imply that it is as optimally efficient as in idealized 
studies106, 107. The following sections will analyze the numerically-derived 3D velocity 
fields in the context of the causative geometric design characteristics. 
Hemodynamic Efficiency 
The theoretical benefits of flow bifurcation in the cavopulmonary pathway originated with 
the experimental and numerical work of Soerensen et al.106, in which the multiple 
bifurcations of the Optiflo were shown to outperform an idealized TCPC model. Rather 
than requiring a collision and 90° redirection of caval flows, the Optiflo efficiently 
redirected flow, ensuring a smooth and streamlined transition to the PAs. Marsden et al. 
followed with a numerical investigation in patient-specific models, focusing only on the 
bifurcation of the IVC107, demonstrating again the potential for energetic improvements.  
These hypothetical gains were not realized in the present in vivo implementations. In 
four of the five cases, Y-graft resistance was approximately equal to the resistances of 
the virtual TCPC controls. Clearly, since this is the first attempt at systematic, Y-graft use 
for the Fontan procedure, a learning curve to optimize the surgical implementation 
should be anticipated. In that regard, it is promising that there is no evidence in this 
series of diminished early outcome. These results suggest that the YCPC may be 
‘forgiving’ enough to still be energetically equivalent to the TCPC when the design is 
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theoretically sub-optimal. Yet, there is also clear evidence from at least one case, that 
the energetics can be better than the TCPC.  
In that case (CHOA_Y2), the decreased resistance is attributable to the fact that the Y-
graft position augmented and bypassed an acute stenosis in the LPA that was otherwise 
a significant resistive element. Given the recent report showing the prevalence of sub-
aortic PA stenosis143 in single ventricle patients (particularly those with hypoplastic left 
heart syndrome), this potential strength of the Y-graft is something to consider for 
targeted use. However, this specific application does not tap into the fundamental 
characteristics of the Y-graft that theoretically make it efficient. 
One possible reason for the efficiency differences compared to idealized models is the 
size selected for the Y-graft branches. Larger branches allow for lower fluid velocities 
and shear stresses, which would reduce losses. In fact, Soerensen explicitly evaluated 
Optiflo models of varying sizes, including a case in which the branch diameters summed 
to the base total as in the Gore grafts being used (20-10-10), and found higher power 
losses compared to the design in which the branch diameters equaled the base diameter 
(20-20-20, for example)172. Marsden et al reported similar findings comparing virtual 
models of 18x9 mm Y-Grafts vs. 18x12 mm Y-Grafts (constructed ad hoc)107. However, 
larger branches also impose increased spatial constraints, and are not available “off the 
shelf,” as the current grafts are. Without a pre-fabricated graft, the bifurcation must be 
constructed ad hoc, which creates an additional set of design variables and possible 
failure modes (e.g., thrombosis formation along additional suture lines). As such, a more 
pragmatic question to ask is, can the efficiency results be improved with the existing 
graft design to remove the need for pursuing size and construction alternatives?   
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A recent study by Yang et al. sought to parametrically optimize the Y-graft design (e.g., 
branch placement, angle, size, etc.)169. While, in theory, such an analysis would be 
helpful in directing surgical decision-making, insufficient mathematical constraint of the 
design variables limits the ability to translate those results into quantitative guidelines for 
surgical implementation. However, the demonstrated importance of tangential alignment 
of the bifurcation branches with the PA axis is a relevant message that was implicit in the 
original Optiflo design concept and provides an interesting perspective for the present 
results. 
In this light, there were two primary shortcomings in these patient connections that 
limited hemodynamic efficiency and should be surgically addressed in future cases. The 
first was the near perpendicular angle of approach in most of the connections. This 
perpendicular connection creates a scenario in which the IVC flow enters the PA, 
impinges on the opposite (e.g., superior) vessel wall, and must undergo significant 
secondary recirculation to align with the PA axis of flow. As shown in Figure 8.8, this 
recirculation may create dissipative secondary flow structures that can extend to 
significant lengths downstream and decrease overall connection efficiency. By 
introducing an anterior curvature to the baffle may facilitate better angulation than a 
straight t-junction approach would allow. Beveling the distal ends of the graft is also 
suggested to achieve the efficiency benefits of a flared connection75. These features, 
particularly the anterior curvature, have been incorporated into the later patients in the Y-
Graft series (as noted for Figure 8.1) and have generally helped to streamline flow 
through the left Y-Graft branch.  
The second shortcoming was the close proximity or even medial (to the SVC) placement 
of the Y-Graft branches, which allows for continued interaction and mixing between the 
caval flows. In the extreme case where one branch was positioned exactly opposite the 
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SVC (as in CHOA_Y2 (Figure 8.7A) and CHOA_Y5 (Figure 8.8, bottom)), there is direct 
caval flow competition and the associated energy dissipation that a bifurcated design 
was intended to avoid. Placing the right branch distal to the right pulmonary upper lobe 
and the left branch immediately posterior to the ascending aorta provides the best 
means to avoid that scenario. Furthermore, positioning of the SVC at the Glenn stage 
could be adjusted in future Y-graft candidates to provide additional lateral space for the 
branches. 
Importantly, these design factors are independent of graft size and, in fact, smaller 
branches would facilitate placement according to these guidelines. This provides 
additional support for the present choice in Y-graft design, and indicates that future 
studies should pursue these design optimization modifications in conjunction with 
parametric sizing studies to practically determine the best approach for Y-Graft 
implementation.  
In addition to diameter, the length of the Y-Graft branches is another important variable 
with implications for its energy efficiency. Clearly, a length that is too short does not 
allow for lateral separation between the branches and instead approaches an 
extracardiac baffle with a cylindrical hole through the middle (see CHOA_Y5). On the 
other extreme, it is clear from basic fluid mechanics (Poiseuille flow) that pressure drop 
will increase linearly with the length of cylinder which, in conjunction with the longer 
length of higher wall shear dissipation with smaller diameter grafts, will contribute to 
increased power loss. Cases like CHOA_M3 and CHOA_Y8 show some of these 
deleterious effects of extensive graft length.  
Clearly, there should be an optimal length in between these two extremes. A parametric 
evaluation could help to identify that solution; however, given the potential number of 
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variables involved (e.g., how discretely the range of lengths is sampled, the potential for 
anterior and/or lateral curvature), a basic parameter sweep could be computationally and 
time intensive. Instead, this type of question may be an ideal application for the 
surrogate management framework169, or a similar optimization scheme assuming that 
the inputs are properly constrained within physiologic limits.  
With regard to the originally posed hypothesis, this work shows that the Fontan Y-Graft 
can be effectively used in certain scenarios. Yet, this fact neither proves nor disproves 
the hypothesis with respect to energy efficiency because the question remains: can the 
suggested modifications ensure that the ‘optimal’ Fontan Y-graft is consistently realized 
under anatomic size constraints? The answer is likely to be patient-specific in that the 
position and size of the PA, pulmonary veins, SVC, and aorta are sure to be the critical 
determinants of whether or not the desired shape and position of the Y-Graft is 
achievable. Herein lies a potential application for patient-specific simulation-based 
surgical planning techniques for Fontan surgery105, 159, which could be used to both 
select candidates for favorable Y-Graft implementation and visually provide the target 
landmarks for branch placement. 
Caval Flow Distribution 
Balanced HFD is an important consideration to prevent the formation of PAVM58. There 
is a lack of evidence to indicate the minimum thresholds to prevent PAVM formation; 
however, a split at or around 50/50 is a desirable target. In considering the HFD values 
of the various connections evaluated in this series, there was no clinical significance in 
the mean differences (Y-Graft vs. t-junction vs. Offset), as 40% vs. 50% HFD would not 
impact the patient outcomes. However, the smaller variance across the Y-Graft results is 
noteworthy because it demonstrates improved consistency and stability of that design. 
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By comparison, there were three instances with TCPCs that exhibited severely 
unbalanced HFD. So while, on average, the Y-graft may not significantly improve IVC 
flow distributions, these data suggest it could reduce the occurrence of outliers with poor 
streaming performance. Such outliers are far more prevalent in specific groups, such as 
cases of interrupted IVC62, suggesting that these are additional patients who may benefit 
from targeted Y-Graft use over extracardiac baffles105, 159.  
In summary, the detailed hemodynamics of the Fontan Y-graft in an in vivo setting were 
investigated under a variety of relevant flow conditions and with direct comparison to 
patient-specific TCPC controls. Desirable IVC-PA flow distribution characteristics were 
found; however, the flow efficiency performance fell short of the outcomes predicted by 
previous models. A beneficial comparison was found when the Y-graft was able to offset 
the effects of acute PA stenosis, making such situations a potential for targeted usage. 
Further, detailed analysis of the surgical Y-graft implementation with respect to the 
resulting flow fields was used to identify strategies for improving performance on a 
broader scale.  
 
8.5 Chapter Summary 
This chapter provides an in depth hemodynamic analysis of a novel approach to Fontan 
surgery in a preliminary set of single ventricle patients. Motivated by fundamental 
engineering principles106, the Y-Graft connection is hypothesized to improve the energy 
efficiency of the TCPC junction by avoiding caval flow collision and helping to streamline 
the transition from systemic to pulmonary flows.  
Because of the need to two distinct connection sites instead of the one required for 
traditional Fontan connections, there were first concerns related to surgical feasibility 
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that needed to be addressed. As this series demonstrates, the Y-Graft can be surgically 
implemented with good short term outcomes170. The next important question was then: 
how do the hemodynamics compare of this connection compare to traditional 
approaches? 
In Chapter 7 of this thesis, several cases were presented at length in which a Y-Graft 
connection was used to achieve a beneficial flow distribution result. Those anecdotal 
findings in addition to the balanced HFD reported in this series (44% LPA on average) 
demonstrate the ability of the connection in this regard. However, it is worth noting that 
balance did not represent an improvement over the average TCPC patient, so the need 
for the Y-Graft connection for that purpose is limited. 
For power loss, results were much less conclusive as comparisons to the TCPC cohort 
as well as patient-specific controls both showed no difference with the Y-Graft. The size 
of these particular grafts are certainly a limiting factor107, 172, but larger grafts may present 
a trade-off of improved efficiency at the expense of surgical feasibility. Detailed analysis 
of five patients prompted suggestions of modifications to surgical implementation, and 
those suggestions were incorporated in the latter series of recipients with respect to the 
placement of the left branch with respect to the LPA. Placement of the right branch still 
remains a significant challenge and potential limitation. 
Ultimately, long term follow-up is needed to make strong conclusions from this 
experience. Issues such as PA growth and post-operative physiologic baseline 
hemodynamics are going to be critical mediators of the local connection hemodynamics 
that short-term follow-up does not capture. Additionally, a randomized clinical trial of the 
Y-Graft against extracardiac TCPCs, reminiscent of the recent single ventricle 
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reconstruction trial of the BT-shunt vs. the Sano shunt, would be another excellent 





Chapter 9. Specific Aim 5: Compare longitudinal 
changes in VF and TCPC hemodynamics 
9.1 Overview 
In the first two specific aims (Chapters 5 and 6), the physiologic importance of TCPC 
power loss was indicated by significant correlative relationships with cardiac index, 
indexed systemic venous flow, and ventricular volumes (particularly end diastolic 
volume- a surrogate of preload). These findings are a confirmation of the long-held 
hypothesis regarding the potentially confounding role of the TCPC in broader single 
ventricle physiology. Concurrently, baseline ventricular function was characterized in a 
small patient subset.  
These results, while novel and significant, represent only an instantaneous snapshot of 
each patient’s functional status. By comparison, Fontan ‘failure’ is a gradual and 
progressive process, which often develops over the course of several years. The natural 
follow-up questions to ask are thus, how do these functional characteristics change with 
time, and what do the changes suggest about the mediators of Fontan failure? 
The answers to such questions obviously require the use of serial patient analyses. 
While conclusive determinations would require extensive studies in a large patient 
sample, the lack of any such data (serial hemodynamics and function) means that a 
preliminary pilot study could provide novel insights to help inform and guide future, larger 
efforts. The aim of this chapter is to conduct such a preliminary analysis based on the 
availability of serial CMR data for a small subset of patients discussed in Chapters 5 and 
6. It is hypothesized that TCPC power losses increase with time, ventricular function 




9.2 Study Protocols  
9.2.1 Patient Selection 
Fifteen patients were selected from the 100 patient cohort analysis on the bases of 
having more than one CMR scan post-Fontan and having a ventricular short-axis cine 
acquisition as a part of at least one of those scan protocols. A total of thirty-three CMR 
scans were thus included for those fifteen patients (one patient having 4 different scans 
and another having 3) and TCPC hemodynamics were characterized from each. Twenty-
six scans included ventricular function (VF) data; however, inconsistent cine phase 
numbers across slices invalidated three data sets and poor signal quality excluded two 
others. As a result, seven patients had serial VF data while only one did not have 
sufficient quality VF data at either time point. Table 9.1 summarizes the patients and VF 
data included and the time between scans in this analysis. The patient designations of A, 
B, C, etc. denote the sequential scans for a given patient (A being the first scan, B the 
second, etc.). The ‘A’ scans for some patients were excluded from this analysis on the 
basis of either the data being incomplete (missing VF or axial dicoms) or the presence of 
artifacts. 
9.2.2 Statistical Analysis 
Paired t-tests and Wilcoxon matched pairs tests were used to test for serial changes in 
hemodynamics and ventricular function. In the cases for which hemodynamics and 
function were characterized at multiple time points, Pearson correlations were used to 






Table 9.1 Summary of Patients and data included in Serial Analysis 
Patients 





CHOP005 (B,C) 19 2 yrs, 1m VF x2 
CHOP008 (B,C) 16 2 yrs, 3m VF x2 
CHOP017 (B,C) 15 6 yrs, 4m VF excluded 
CHOP018 (A,B,C) 7 3 yrs; 4 yrs VF for C 
CHOP019 (A,B) 14 7 yrs, 6m VF x2 
CHOP021 (A,B) 11 3 yrs, 10m VF for A 
CHOP022 (A,B) 7 3 yrs, 9m VF for A 
CHOP033 (A,B) 10 7 yrs, 6m VF x2 
CHOP036 (A,B) 11 3 yrs VF for A 
CHOP052 (B,C,D,E) 10 
1 yr, 2m; 7m; 2 yrs, 
10m 
VF x2 (B,E) 
CHOP065 (A,B) 16 2 yrs, 4m VF for A 
CHOP080 (A,B) 17 5 yrs VF x2 
CHOP082 (A,B) 7 5 yrs, 8m VF for B 
CHOP088 (A,B) 8 5 yrs, 8m VF for B 







9.3 TCPC Changes 
The average age at first scan for these patients was 12.4 ± 4.3 years and the average 
follow-up duration was 4.8 ± 1.9 years. 
The results are organized as follows: first, case-by-case comparisons of TCPC 
geometric and hemodynamics changes will be presented followed by a summary and 
analysis of the combined trends. Next, the serial VF results will be analyzed for the 
seven eligible patients. Finally, an exploratory analysis will be conducted between the 
hemodynamic and functional data to understand if any preliminary trends or 
relationships are apparent from these data. 
 
9.3.1 Patient-by-Patient Investigations 
For each patient detailed in the following sub-sections, four primary comparisons are 
drawn: 1) a visual review of TCPC reconstruction differences; 2) a quantitative analysis 
of the geometrical results (obtained with VMTK analysis) by vessel; 3) quantification of 
changes in systemic and pulmonary flow rates and distributions; and 4) comparison of 
hemodynamic end points from serial CFD. For the visual TCPC comparisons, two points 
are noted: first, the registration was performed using the automatic registration features 
in Geomagic; second, the earlier geometry will be presented in blue in each figure with 
the more recent reconstruction surface provided as a translucent overlay. In most cases 
(unless more than one time point is presented) anatomic views are presented from both 
anterior (on left) and posterior views (on right). For the VMTK data, results are presented 
both non-normalized (in mm) and normalized to BSA0.5 [mm/m] since that normalization 
scheme has been shown to be appropriate for vascular and valve diameters173. Based 
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on the strong hemodynamic correlations of the minimum and mean vessel diameters 
with power loss seen in Chapter 5, only those values will be reported. 
9.3.1.1 CHOP005 
Figure 9.1 shows the resulting surface reconstructions while Figure 9.2 provides the 
VMKT results. The vessels generally increased in size with the notable exception of the 
LPA, which saw decreases in both the mean and minimum diameters. 
 
 





Figure 9.2 Actual (top) and BSA-normalized (bottom) vessel minimum and mean diameters 
for CHOP005. The BSA values at each time point are provided in the color legend. 
 
 
The changes in vessel flow rates are shown in Table 9.2. For this patient the RPA 
measurements were not consistent and were discarded. The total cardiac output 
decreased in time leading to a subsequent decrease in IVC flow. The resulting time-
averaged CFD flow fields are shown in Figure 9.3 and quantitative comparison in Table 
9.3. High velocity LPA flow is seen at both time points. Fontan flow was decreased in 
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scan C through the combined effects of increased vessel size and decreased flow rate, 
thus the dynamics of the SVC/Fontan flow interactions were altered slightly, as 
evidenced by the change in HFD (increased in the later scan). The pressure drop and 
power loss decreased between scans (owing to the decreased flow rate); however, after 
indexing (as TCPC-EDI), the power loss was actually elevated at the later time point. 
 
 
Table 9.2 Measured flow rates (in L/min) for CHOP005 scans B and C. 
 Ao IVC SVC LPA RPA 
B 4.5 3.6 1.0 2.6 - 


















B 68 3.3 17.9 0.58 0.087 




Figure 9.4 and Figure 9.5 compare the surface reconstructions and vessel sizes, 
respectively, for CHOP008B and CHOP008C. All vessels decreased in diameter slightly, 
but the changes in the LPA and IVC/Fontan pathway are most visually apparent. 
Table 9.4 provides the comparison of CMR-measured flows at the two time points. The 
total systemic flow remained constant despite minor shifts in cardiac output and 
superior/inferior distribution. The pulmonary flow split similarly varied slightly from 43% 
to 39% LPA, perhaps in response to the changes in vessel sizes. These minor flow 
changes did not create significant visual differences in the resulting flow fields (Figure 
9.6); however, the quantitative results were very different, presumably owing to the small 








In fact, the values for maximum pressure drop (>8 mmHg) and resistance (>1.1 WU) 
appear to be unphysiologically high, while the TCPC-EDI is more than double the 
highest value reported in Chapter 5. These findings suggest that because the minimum 
LPA diameter and through-plane spatial resolution of the anatomic CMR acquisition 
were of approximately the same dimension (both ~5 mm), the uncertainty in the vessel 
size may be large compared to the reconstructed dimension. If this size also 
corresponds to the high curvature region of the diameter/power loss Power Law 
relationship (Figure 5.31), which it likely does, then this uncertainty can produce large 




Figure 9.5 Actual (top) and BSA-normalized (bottom) vessel minimum and mean diameters 
for CHOP008. The BSA values at each time point are provided in the color legend. 
 
 
Table 9.4 Measured flow rates (in L/min) for CHOP008 scans B and C. PA percentages are 
shown in parentheses. 
 Ao IVC SVC LPA RPA 
B 6.7 3.8 0.8 1.8 (43%) 2.4 (57%) 






Figure 9.6 Time averaged CFD velocity streamlines for CHOP008 B(left) and C(right). 
 
 










B 50 3.2 8.2 0.34 0.065 




Figure 9.7 and Figure 9.8 show that the TCPC vessel sizes for CHOP017 were little 
changed between scans B and C. The most notable change was the slight decrease in 
LPA dimensions, which were already smaller than the other vessels. Table 9.6 shows 
the measured flows were also consistent between scans- cardiac output decreased (by 
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8%) but systemic venous return increased (by 5%) and total pulmonary flow (magnitude 








Figure 9.9 shows the resulting CFD velocity fields, which were very consistent between 
time points: the SVC flow is pushed preferentially to the LPA, with a small portion 
recirculating and exiting the RPA, while the Fontan flow is primarily constrained to the 
RPA. Quantitative velocity differences (i.e., higher velocities in the later scan) in the 
Fontan baffle and LPA reflect increased IVC flow contribution and decreased LPA 
diameter, respectively. These changes, particularly in the LPA, led to a serial increase in 




Figure 9.8 Actual (top) and BSA-normalized (bottom) vessel minimum and mean diameters 
for CHOP017. The BSA values at each time point are provided in the color legend. 
 
 
Table 9.6 Measured flow rates (in L/min) for CHOP017 scans B and C. PA percentages are 
shown in parentheses. 
 Ao IVC SVC LPA RPA 
B 5.1 2.5 1.3 0.6 (16%) 3.1 (84%) 





Figure 9.9 Time averaged CFD velocity streamlines for CHOP017 B(left) and C(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










B 0 0.8 3.4 0.18 0.035 









Figure 9.10 Comparison of TCPC surface reconstructions for CHOP018A (blue, left) vs. 
CHOP018B (clear, left) and CHOP018B (blue, right) vs. CHOP018C (clear, right). 
 
 
From the three reconstructed TCPC geometries shown in Figure 9.10, significant growth 
and evolution can be observed in this patient across the series of 3 CMR scans. Moving 
from AB resulted in appreciable increase in all vessel diameters (as also seen in 
Figure 9.11), although the fact that the A scan was reconstructed from black blood 
images is a confounding factor in this comparison, particularly the length of the Fontan 
pathway. Moving from scans BC produced slightly smaller increases, although growth 
of the LPA and an increased size of the lateral tunnel (particularly where the native 
atrium is along the right lateral wall) are apparent. Despite the visible changes in size, on 
a BSA normalized basis (Figure 9.11bottom), the changes were much smaller and even 
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negative for some cases. The measured flows (Table 9.8) also increased, but only 
modestly over time (from 2.7 L/min to 3.3 L/min for QS); hence, connection velocities 
(Figure 9.12) were generally low and maintained a similar qualitative structure over time. 




Figure 9.11 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 






Table 9.8 Measured flow rates (in L/min) for CHOP018 scans A-C. PA percentages are 
shown in parentheses. 
 Ao IVC SVC LPA RPA 
A 3.1 1.4 1.3 0.9 (42%) 1.3 (58%) 
B 2.5 1.5 1.5 0.9 (51%) 0.9 (51%) 




Figure 9.12 Time averaged CFD velocity streamlines for CHOP018 A (left), B (middle) and C 
(right). Inset images show streamlines color coded by vessel of origin (blue- IVC, red- 
SVC). 
 










A 67 0.4 1.4 0.06 0.008 
B 63 0.9 1.5 0.07 0.010 




Figure 9.13 and Figure 9.14 show the surface reconstructions and vessel measures, 
respectively, for CHOP019A and CHOP019B. Growth in the lateral tunnel pathway and 
proximal LPA is visually apparent and only the RPA was found to marginally decrease in 
size between scans. Table 9.10 shows that, even though measured aortic flow 
decreased slightly, both systemic and pulmonary flow magnitudes increased with time, 
while keeping fairly consistent distributions. 
As a result of the increased vessel dimensions, Figure 9.15 shows that the local TCPC 
velocity magnitudes generally decreased with time, with the possible exception of the 
RPA. The decreased magnitudes, in turn, correspond to decreased (normalized) power 
losses and pressure drop (Table 9.11). The dynamics with respect to the IVC/SVC flow 








Figure 9.13 Comparison of TCPC surface reconstructions for CHOP019A (blue) and 
CHOP019B (clear) The RUPA was included in the second scan, but cannot be readily seen 




Figure 9.14 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 




Table 9.10 Measured flow rates (in L/min) for CHOP019 scans A and B. PA percentages are 
shown in parentheses. 
 Ao IVC SVC LPA RPA 
A 5.5 3.5 1.4 1.9 (41%) 2.8 (59%) 





Figure 9.15 Time averaged CFD velocity streamlines for CHOP019 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










A 52 1.8 7.4 0.23 0.034 















Size comparisons for CHOP021A and CHOP021B are shown in Figure 9.16 and Figure 
9.17. Visually (and with respect to non-normalized dimensions) all vessels increased in 
size between scans. After correcting for BSA change, the lateral tunnel/IVC and RPA 
were relatively unchanged, but the LPA and SVC still demonstrated large increases. 
CMR-measured vessel flow rates (Table 9.12) all increased, with the biggest relative 
change being an increase in RPA percentage of total pulmonary flow from 62% to 70%. 
The CFD results (Figure 9.18) again show generally decreased velocity magnitudes, 
although significant acceleration and flow separation in the LPA is still apparent. As a 
result, the raw power loss value (Table 9.13) increased, but normalized values both 
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decreased (24% in the case of TCPC-EDI). HFD to LPA decreased, likely reflecting the 




Figure 9.17 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 







Table 9.12 Measured flow rates (in L/min) for CHOP021 scans A and B. PA percentages are 
shown in parentheses. 
 Ao IVC SVC LPA RPA 
A 3.7 2.2 0.9 1.2 (38%) 1.7 (62%) 
B 4.5 3.2 1.3 1.5 (30%) 3.5 (70%) 
 
 
Figure 9.18 Time averaged CFD velocity streamlines for CHOP021 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










A 49 2.3 7.3 0.42 0.076 










Figure 9.19 and Figure 9.20 show the reconstruction and vessel sizes for CHOP022A 
and CHOP022B, which was a case with bilateral SVC connections. After correcting for 
BSA change, most dimensions were seen to decrease with time, particularly the 
minimum LPA dimension. The visual differences in the length of the bilateral SVCs are 
the result of segmentation differences and not an actual meaningful change, but such 
differences are expected to have minimal affect on power loss differences (only the 
additional pressure drop associated with moving blood through that additional length). In 
conjunction with across the board increases in local flow rates (Table 9.14), these 
changes resulted in substantial increases in local velocity magnitudes, as seen in the 
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CFD results in Figure 9.21. All energetic measures (Table 9.15) also increased 





Figure 9.20 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 







Table 9.14 Measured flow rates (in L/min) for CHOP022 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LSVC LPA RPA 
A 3.4 1.3 0.8 0.5 1.1 (49%) 1.1 (51%) 




Figure 9.21 Time averaged CFD velocity streamlines for CHOP022 A(left) and B(right). Inset 

















A 33 0.8 1.7 0.10 0.016 









For CHOP033 (Figure 9.22 and Figure 9.23), the change in caval dimensions kept pace 
with overall BSA change, while both PAs relatively decreased in size after normalizing. 
The flow rates (Table 9.16) increased, although local velocity magnitudes (Figure 9.24) 
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appear largely unchanged. Power losses increased by over 100% with respect to TCPC-
EDI (Table 9.17), likely owing to decreases in PA diameter. The relative SVC-IVC 




Figure 9.23 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 






Table 9.16 Measured flow rates (in L/min) for CHOP033 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LPA RPA 
A 3.4 2.3 1.5 1.7 (52%) 1.6 (48%) 




Figure 9.24 Time averaged CFD velocity streamlines for CHOP033 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 










A 63 0.5 2.5 0.10 0.016 











Vessel sizes for CHOP036A and CHOP036B were largely unchanged, particularly after 
BSA-normalization (Figure 9.25 and Figure 9.26), with the exception of a decrease in the 
lateral tunnel dimension. Interestingly, the vessel flow rates (Table 9.18), particularly the 
IVC, decreased between scans; thus, even with minimal size changes, the local velocity 
magnitudes from CFD (Figure 9.27) generally decreased. Furthermore, the large drop in 
IVC flow led to a large shift in HFD measures (Table 9.19) with the increased SVC 
fraction taking a larger proportion of the RPA flow with very little change in the qualitative 
flow dynamics. Finally, despite a decrease in the raw power loss and pressure drop, 





Figure 9.26 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 




Table 9.18 Measured flow rates (in L/min) for CHOP036 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LPA RPA 
A 5.6 3.3 1.9 2.3 (55%) 1.8 (45%) 





Figure 9.27 Time averaged CFD velocity streamlines for CHOP036 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 










A 71 1.2 7.6 0.15 0.016 












Figure 9.28 Comparison of TCPC surface reconstructions for CHOP052B (blue, left) vs. 
CHOP052C(clear, left) and CHOP052C (blue, middle) vs. CHOP052D (clear, middle) and 
CHOP052D (blue, right) vs. CHOP052E (clear, right). 
 
 
CHOP052 is a very rare case in which four serial scans were available for analysis. The 
surface comparisons are shown in Figure 9.28 while the quantitative comparisons are 
shown in Figure 9.29. Unfortunately, small inconsistencies throughout the numerous 
scans limit some of the power of these rare data, but the picture is generally consistent 
with the other patients presented in this chapter. Geometrically, the inconsistencies are 
apparent in the PA reconstructions- IVC (extracardiac) and SVC dimensions were fairly 
consistent, and progressively decreased in size compared to BSA increases. By 
comparison, PA sizes fluctuated considerably between scans (particularly LPA min from 
scan D), and it is likely that limitations in through plane resolution impacted these results. 
Measured flow conditions (Table 9.20) were not much better: IVC and SVC magnitudes 
418 
 
were not properly encoded for scan C, while no aortic measure was available for scan E. 
Total pulmonary flow, which provided the most consistent measure, increased from 2.9 




Figure 9.29 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 







Table 9.20 Measured flow rates (in L/min) for CHOP052 scans B-E. PA percentages are 
shown in parentheses 
 Ao IVC SVC LPA RPA 
B 5.8 2.1 1.2 1.4 (49%) 1.5 (51%) 
C 6.5 - - 1.5 (43%) 2.0 (57%) 
D 5.9 1.9 1.5 1.7 (50%) 1.7 (50%) 
E - 2.4 1.6 2.0 (52%) 1.9 (48%) 
 
 
The anatomic nuances are perhaps more apparent with respect to the CFD results 
(Figure 9.30) where, even though the presence of a right caval offset created a fairly 
consistent flow profile in each case, differences in the size and shape of proximal LPA 
have an appreciable impact, and the takeoff of the upper right lobe is seen to vary 
slightly based on limited contrast in the ‘E’ scan. Local velocity magnitudes stayed fairly 
consistent with the possible exception of acceleration through the sub-aortic PA in scan 
E. Quantitatively, (Table 9.21) TCPC-EDI increased marginally from scans B-D with a 





Figure 9.30 Time averaged CFD velocity streamlines for CHOP052 B(far left), C(middle left), 
D(middle right) and E(far right). Inset images show streamlines color coded by vessel of 
origin (blue- IVC, red- SVC). 
 
 










B 21 0.9 3.5 0.16 0.022 
C 26 0.7 3.1 0.15 0.025 
D 30 0.5 2.7 0.15 0.027 















Figure 9.31 and Figure 9.32 provide the serial geometric comparisons for CHOP065A 
and CHOP065B. Visually, very little growth was apparent from the surface 
reconstructions (i.e., Figure 9.31 shows mostly the blue elements from the A scan), 
despite the large increase (35%) in BSA between scans. That observation is generally 
borne out in the quantitative results and thus, after normalization, all diameter values 
were lower in the latter time point. For CMR-measured flows, (Table 9.22) despite 
constant cardiac output, the systemic and pulmonary flow magnitudes increased, 
including a shift toward much higher LPA flow in the latter time point, suggesting a 
decrease in the collateral flows between scans. The resulting CFD velocity fields (Figure 
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9.33) were therefore only visually different in the LPA magnitudes, and power losses 




Figure 9.32 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 






Table 9.22 Measured flow rates (in L/min) for CHOP065 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LPA RPA 
A 3.3 1.9 0.5 0.8 (35%) 1.5 (65%) 
B 3.3 2.2 1.1 1.8 (55%) 1.5 (45%) 
 
 
Figure 9.33 Time averaged CFD velocity streamlines for CHOP065 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










A 39 0.1 0.5 0.05 0.013 










This patient, CHOP080, was covered with the ‘least efficient’ cases in Chapter 5, thus 
providing some additional motivation for characterizing serial change. Regarding vessel 
sizes (Figure 9.34 and Figure 9.35), both PAs increased diameter substantially, as did 
the right SVC and right-sided hemi-Fontan connection. The Fontan connection, which 
was a major source of inefficiency at the first time point, visually appears to increase in 
size; however, as seen in the CFD results (Figure 9.36) there is still an obvious 
narrowing at the base of the connection that created significant acceleration through the 
pathway. Of course, the flow rates (Table 9.24) also increased between scan 
substantially, so the higher IVC velocities are also largely affected by that change. 
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Despite the higher flows and velocities, TCPC-EDI (Table 9.25) was basically 




Figure 9.35 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 







Table 9.24 Measured flow rates (in L/min) for CHOP080 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LSVC LPA RPA 
A 5.6 2.6 1.3 0.5 2.1 (53%) 1.9 (47%) 




Figure 9.36 Time averaged CFD velocity streamlines for CHOP080 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










A 29 2.4 11.8 0.54 0.110 







Figure 9.37 Comparison of TCPC surface reconstructions for CHOP082A (blue) and 
CHOP082B (clear). The RUPA was not included in the A reconstruction. 
 
 
For this patient, CHOP082, the combination of minimal changes in vessel sizes (overall 
decreases on a normalized basis; Figure 9.37 and Figure 9.38), and significant 
increases in local flow rates (Table 9.26) yielded appreciable changes in TCPC 
velocities (Figure 9.39) and roughly 3-fold increases in pressure drop, resistance, and 




Figure 9.38 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 




Table 9.26 Measured flow rates (in L/min) for CHOP082 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LPA RPA 
A 2.7 1.6 1.0 0.8 (40%) 1.2 (60%) 





Figure 9.39 Time averaged CFD velocity streamlines for CHOP082 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










A 57 0.4 1.4 0.08 0.012 















Here, all diameter measures increased between scans (Figure 9.40 and Figure 9.41), 
but on a normalized basis, only the RPA increased. Despite the general increase in total 
volume flow rate through the connection (Table 9.28), that change (thanks in part to the 
fact that the RPA percentage increased substantially) was enough to mediate a 
decrease in normalized power losses (Table 9.29) as peak PA velocities (Figure 9.42) 




Figure 9.41 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 




Table 9.28 Measured flow rates (in L/min) for CHOP088 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LPA RPA 
A 3.4 1.8 0.9 1.6 (52%) 1.5 (48%) 





Figure 9.42 Time averaged CFD velocity streamlines for CHOP088 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










A 27 1.2 4.2 0.33 0.068 















For CHOP091, poor signal quality prevented a complete segmentation of the lateral 
tunnel pathway (Figure 9.43), but the serial reconstructions are otherwise quite similar 
with marginal increases in most normalized vessel dimensions (Figure 9.44). Flow rates 
(Table 9.30) were also generally consistent, but with a notable shift toward higher LPA 
flows. As a result, the qualitative CFD results (Figure 9.45) were very similar, and power 




Figure 9.44 Actual (top) and BSA-normalized (bottom) vessel minimum and mean 




Table 9.30 Measured flow rates (in L/min) for CHOP091 scans A and B. PA percentages are 
shown in parentheses 
 Ao IVC SVC LSVC LPA RPA 
A 5.0 3.5 1.0 0.7 2.2 (46%) 2.6 (54%) 





Figure 9.45 Time averaged CFD velocity streamlines for CHOP091 A(left) and B(right). Inset 
images show streamlines color coded by vessel of origin (blue- IVC, red- SVC). 
 
 










A 33 0.4 5.3 0.18 0.031 








9.3.2 Summary and Analysis 
Systemic Flow Rates (Table 9.32)  
Both the IVC and SVC flows increased significantly (p<0.05) over time (using pair-wise 
comparisons). However, after normalizing by BSA, there were no significant differences 
in IVC, SVC, nor total Qs flow rates. 
 
Table 9.32 Summary (mean ± standard deviation) of serial systemic flow rate changes 
 First scan Last scan p-value 
QIVC (L/min) 2.5 ± 0.9 3.0 ± 0.8 <0.05* 
QSVC (L/min) 1.2 ± 0.4 1.4 ± 0.4 <0.05* 
Norm. QIVC (L/min/m
2) 1.8 ± 0.4 1.8 ± 0.4 0.65 
Norm. QSVC (L/min/m
2) 1.0 ± 0.4 0.9 ± 0.3 0.28 
QS (L/min/m




As a first point, it is noted that the choice of BSA0.5 as a normalization scheme for vessel 
dimensions was not entirely obvious. The ascending aortic diameter, for example, 
provides a logical alternative reference for Fontan vessel sizes in that it accounts for 
similar changes in alternate vascular structures. Sluysmans and Colan demonstrated 
that BSA0.5 was linearly related to vascular and valvular diameters in normal children 
between 4 months and 20 years of age173. How that relationship translates to single 
ventricle anatomy or to patients over 20 (at which point the development of 
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cardiovascular structures could be expected to be completed while BSA could fluctuate 
with weight) is unknown. To verify that these choices of normalization would not provide 
independent information, Figure 9.46 shows that BSA0.5 and ascending aortic diameter 
(in mm; assessed using the segmented phase contrast CMR cross-sectional slice, when 
available) were linearly correlated in these patients. Hence, we can conclude that the 




Figure 9.46 Linear relationship between ascending aortic diameter and square root of BSA. 
See Table 12.20 in Appendix E 
 
 
Table 9.33 summarizes the BSA and normalized vessel diameter changes between 
serial scans. For the cases with more than two scans, the first and last were used in this 




Table 9.33 Summary (mean ± standard deviation) of serial BSA and vessel diameter 
changes 
 First scan Last scan p-value 
BSA (m2) 1.38 ± 0.42 1.7 ± 0.33 <0.001 
Dmin IVC (mm/m) 13.9 ± 2.9 12.8 ± 2.7 0.059 
Dmean IVC (mm/m) 16.6 ± 2.7 15.6 ± 3.3 0.08 
Dmin SVC (mm/m) 11.3 ± 2.3 10.8 ± 1.5 0.18 
Dmean SVC (mm/m) 12.9 ± 2.2 12.5 ± 1.4 0.34 
Dmin LPA (mm/m) 8.0 ± 2.5 7.1 ± 2.0  0.018 
Dmean LPA (mm/m) 10.7 ± 2.5 10.3 ± 1.7 0.42 
Dmin RPA (mm/m) 9.6 ± 1.9 9.3 ± 1.6 0.48 






Table 12.21 in Appendix E 
 
Two significant changes were observed in the serial comparisons (as highlighted in gray 
in the table): BSA increased and the normalized minimum LPA diameter decreased. 
There was also a strong trend (p<0.1) toward decreasing (normalized) diameters (both 
mean and minimum) for the Fontan pathway, reflecting the fact that all (for extra-cardiac) 
or part (for lateral tunnel) of that pathway is synthetic material. The remaining vessels 
grew at pace with the BSA0.5. 
Hepatic Flow Distribution 
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Results demonstrated there were significant changes in serial HFD values: the absolute 
differences between time points were greater than zero (9.8 ± 8.1; p<0.001). However, 
there was no directional bias to this change (i.e., the HFD did not preferentially increase 
to one PA or the other) since a (signed) paired t-test found no mean difference 
(p=0.112).  Instead, as might be anticipated from the correlation noted in §5.4.2, HFD 
changes were more responsive to changes in the total pulmonary flow distribution. 
Figure 9.47a shows this relationship. Thus, the total pulmonary flow displayed very 
similar trends: the absolute pulmonary distribution differences were greater than zero 
(6.5 ± 5.2; p<0.001), but there was again no directional bias (means were 44.1 vs. 45.1 
for first and second scans, respectively; p=0.68 via paired t-test). The inclusion of more 
patients for this analysis would be beneficial given the relatively small effect sizes to 




Figure 9.47 Significant correlations between a) HFD differences and PA flow differences 
and b) % change in TCPC-EDI with average percent change of mean PA diameter. See 






In ten cases, TCPC-EDI increased between CMR scans (range: 29-249%); it decreased 
in the remaining five (range: 4-57%). Thus, a Wilcoxon paired ranks test found no 
significant difference in medians for TCPC-EDI between scans (estimated median 
change= 0.011; p=0.10). The primary determinant of this change was the geometric 
growth/change in each patient.  
For these geometric growth changes, the magnitude of PA growth played a critical role. 
Figure 9.47b shows the very strong (r=-0.80, p<0.001) correlation between the averaged 
percentage change in PA mean diameters (i.e., average(% change Dmean LPA, % 
change Dmean RPA)) and the percentage change in TCPC-EDI. It is interesting to note 
that the y-intercept of the linear correlation is ~60%, which would suggest that in the 
absence of PA growth, TCPC-EDI will still tend to increase. Conversely the x-intercept 
value suggests that the PAs must increase their diameter by ~12% on a BSA-normalized 
basis to hold TCPC-EDI constant.  
A similar negative correlation was present between normalized mean IVC/Fontan 
percentage diameter change vs. percent TCPC-EDI change (r=-0.52, p=0.047). 
However, in a multiple regression model with IVC and PA dimensions, only the PA 
change was a significant predictor for power loss change (Coeff=-4.7, t(12)=-4.13, 
p=0.001). 
A natural question to then consider from these findings is: what factor(s) mediates, or is 
at least related to, the change in PA size and is thus also related to changes in TCPC-
EDI? PA growth in the context of congenital heart defects is dependent on flow174-176. 
Figure 9.48a supports this idea based on a positive correlation from these data between 
serially averaged vessel flow rates (i.e., average(QLPA scan 1, QLPA scan 2)) and the 
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percent change in normalized vessel mean diameter (r=0.46, p=0.012). It is also 
interesting to note that this association was much stronger for the LPA (Figure 9.48b; 
r=0.59, p=0.021) than the RPA (Figure 9.48c), for which the correlation was not 
significant (r=0.37, p=0.2). This difference could be related to the confounding issues of 
the right upper lobe branch: the measured RPA flow is not necessarily what is present at 
the site of the diameter measurement because of the upper lobe take-off. Further study 




Figure 9.48 a) Significant correlation between %change in PA diameter and serially 
averaged flow rate for all PAs. That correlation was asymmetric with respect to PA, 
however, given the stronger relationship for the LPA (b) than the RPA (c). See Table 12.24 





Pulsatility is another factor that could be expected to play an important role in PA 
size/growth. Time varying characteristics of pulmonary flows in SV patients are 
traditionally thought to be low compared to normal biventricular physiology with a 
pulsatile right ventricle. Yet, the combined effects of cardiac and respiratory variations do 
impart an appreciable pulsatile component to PA flows177. Figure 9.49 shows the 
comparison of serially averaged indexed pulsatility (PI) with serially averaged mean 
diameter and % diameter change by vessel. PI defined from phase contrast CMR 
measurements as: 
   
         
      
 
where the maximum and minimum were defined from the instantaneous measures and 
mean is the time average. First considering the relationship of PI and vessel size, very 
divergent responses were seen by vessel with the LPA (Figure 9.49a) having a strong 
(r=0.63) positive correlation and the RPA (Figure 9.49b) having no relationship to PI. 
Similarly for the %change in diameter, the trends were very different for the two vessels: 
the LPA % change (Figure 9.49c) had a strong negative (r = -0.78) logarithmic 






Figure 9.49 Relationship between mean diameter and pulsatility index for the a) LPA and b) 
RPA, for which only the LPA had a correlation. Also, relationship between the % change in 
mean diameter vs. PI for c) LPA and d) RPA, for which the LPA correlation was negative 
and logarithmic while the RPA demonstrated no relationship. See Table 12.24 and Table 
12.25 in Appendix E. 
 
 
This LPA % change response (Figure 9.49c) was unexpected and counter-intuitive and 
therefore deserves additional consideration. First, from a physiologic standpoint, it is 
important to understand if this trend is ‘real’ (e.g., are the vessels actually decreasing in 
size) or if it is an artifact of data normalization. To this end, Figure 9.50 recasts the 
relationship shown in Figure 9.49c using non-normalized vessel diameters, 
demonstrating the same negative trend, inclusive of negative diameter changes. Hence, 
the relationship is ‘real’, at least with respect to the data available. This finding in 
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conjunction with the positive correlation noted in Figure 9.49a raises several potential 
explanations:  
1) Varying pulsatility levels may mediate different vessel growth rates such that 
vessels with high pulsatility reached a ‘peak’ value quickly, while lower pulsatility 
vessels grow at a slower rate. This explanation is physiologically sensible, but 
there was no relationship between age and either pulsatility or LPA diameter to 
support it.  
2) Rather than being linked by an intrinsic mechanism (i.e., the pulsatility directly 
mediating vessel size), extrinsic factors may be involved. For example, a large 
over-riding aorta could impact (e.g., increase) pulsatility levels within the LPA 
while simultaneously impeding its growth143. The fact that the LPA and RPA 
responses were very different supports this possibility.  
Further investigation is warranted to determine which of these explanations, or perhaps 






Figure 9.50 Negative correlation between LPA pulsatility index and raw (non-normalized) 
LPA diameter serial change. See Table 12.24 in Appendix E. 
 
 
9.4 Ventricular Function Changes 
9.4.1 Cardiac Index 
While ventricular short axis data were not collected for all patients, phase contrast data 
were serially collected in the ascending aorta for all cases (N=15) (with one exception: 
CHOP052E). Table 9.34 provides a summary of the changes with respect to this metric. 
There was no significant pair-wise difference between the results from the first and 
second scans (p=0.46). Instead, the number of instances in which the index decreased 
(8) was nearly equal to the cases in which it increased (7) such that the average 
absolute change (20%) was much higher than the signed average (-4%). There was one 
interesting trend with respect to CI changes, and that was with age at first scan. In 
Figure 9.51, a distinct bi-modal pattern (reminiscent of a 4th order polynomial function) 
can be observed between these variables; yet, with so few data points, it is difficult to 
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conclusively determine if this is an actual trend or noise in the signal. More patients are 
certainly needed to better investigate this interesting trend. 
 
 
Table 9.34 Summary of Serial Cardiac Index Changes 
Cardiac Index, 1st scan (L/min/m2) 3.3 ± 0.9 
Cardiac Index, 2nd scan (L/min/m2) 3.1 ± 0.6 
Average change (%) -4 
Average absolute change (%) 20 
See Table 12.26 in Appendix E 
 
 
Figure 9.51 Relationship between serial percent change in cardiac index and age at first 
scan from the 15 patient subset. A bimodal (i.e., 4
th
 order polynomial) pattern can be 





9.4.2 Volume Analysis 
Serial volume data were available for only seven patients, again underscoring the 
preliminary nature of this analysis. Table 9.35 summarizes the volume changes and the 
EDV and ESV results are visually represented in Figure 9.52. As with the cardiac indices 
in the preceding section, the results were mixed: EDV increased in three cases (average 
of 27.7%), decreased in three others (average of 8.3%), and was virtually unchanged in 
one. ESV generally followed the same trends. It is worth noting that in 2 of the 3 cases 
for which volume increased with time (CHOP019 and CHOP091), more slices were 
acquired for the short axis stack in the later scan, which may have contributed to the 































   
 
CHOP005B 12 92.7 46.4 45.7 50 
CHOP005C 6* 84.0 41.3 42.0 50 
  -9% -11% -8%  
  
   
 
CHOP008B 9 75.3 41.8 33.5 45 
CHOP008C 8 99.0 53.8 45.2 46 
  32% 29% 35%  
  
   
 
CHOP019A 7 45.8 17.9 28.0 61 
CHOP019B 10 60.9 19.6 40.8 68 
  33% 10% 46%  
  
   
 
CHOP033A 8 75.0 39.4 35.6 47 
CHOP033B 8 82.6 50.6 32.0 39 
  1% 17% -10%  
  
   
 
CHOP052B 7 87.7 37.7 50.0 57 
CHOP052E 8 90.6 51.9 38.8 43 
  -3% 37% -23%  
  
   
 
CHOP080A 6 58.6 22.5 36.1 61 
CHOP080B 6 51.1 20.7 30.4 59 
  -13% -8% -16%  
  
   
 
CHOP091A 7 41.8 19.7 21.6 52 
CHOP091B 9 49.3 24.4 24.9 50 
  18% 22% 15%  




Figure 9.52 Serial changes in EDV (top) and ESV (bottom) for the 7 patients with VF data 
from two CMR scans.  
 
 
Table 9.36 presents the results for PERV, PFRV, and time ratio to PFR. As for the volume 
results, responses varied with both increasing and decreasing trends among patient 
cases. Most interesting was the statistically significant correlation (r=0.86, p=0.013) 
between the percentage change in PFRV and the percentage change in EDV, as shown 














CHOP005B 2.09 2.06 0.15 
CHOP005C 2.87 1.75 0.28 
 37% -15% 84% 
  
  
CHOP008B 2.36 1.97 0.24 
CHOP008C 2.42 2.37 0.25 
 3% 20% 4% 
  
  
CHOP019A 3.23 2.88 0.16 
CHOP019B 4.22 3.30 0.28 
 31% 15% 73% 
  
  
CHOP033A 2.16 2.47 0.14 
CHOP033B 1.74 2.14 0.14 
 -19% -13% -4% 
  
  
CHOP052B 3.90 3.05 0.20 
CHOP052E 2.99 3.31 0.21 
 -23% 9% 3% 
  
  
CHOP080A 3.14 1.92 0.31 
CHOP080B 2.29 1.52 0.28 
 -27% -21% -9% 
  
  
CHOP091A 2.64 2.45 0.23 
CHOP091B 2.72 2.55 0.20 
 3% 4% -15% 
 
 
As discussed in §6.4.2, PFRV has previously been described as a surrogate for 
ventricular relaxation rate, independent of preload39, 71. The relationship between serial 
changes in PFRV and changes in EDV (a surrogate of preload) would therefore suggest 
one of two possibilities: 1) normalization by EDV is not sufficient to remove preload 
451 
 
dependence from the measurement of PFR; or 2) the trend reflects a general increase or 
decrease in ventricular function, likely related to changes in ventricular compliance. The 
fact that no correlation was observed between the actual values of PFRV and EDV (see 
Table 6.5) and was only present between their respective percentage changes suggests 
that the first point is not accurate. Conversely, the similarly strong correlations between 
StV/EDV (Figure 9.53C) and CI/EDI (Figure 9.53D) provide strong support for the 
second conclusion. Serially improving single ventricle function would be surprising given 
the general understanding of a gradually deteriorating functional state, but such 




Figure 9.53 Relationships of percentage changes in PFRV (A) and PERV (B) to percentage 
changes in EDV. The linear PFR/EDV relationship was statistically significant. Similarly 
strong correlations were observed for stroke volume (SV)/EDV changes and CI/EDV 
changes. See Table 12.27 in Appendix E. 
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9.5 Serial TCPC Hemodynamics vs. Ventricular Function 
9.5.1 Cardiac Index and Systemic Venous Flow 
Serial CI and QS data are available from PC CMR for all 15 patients included in the serial 
hemodynamics analysis. Therefore, we will first consider and compare CI vs. power loss 
and QS vs. power loss. There are two questions to consider: 
 1) Are the relationships between variables consistent from scan to scan? 
2) Are the observed changes between variables related (consistent with the analyses 
performed in the preceding sections)? 
Figure 9.54 addresses the first of these points. The left column shows the correlation 
between CI and TCPC-EDI for the first (top) and last (bottom) scan for each patient; the 
right column mirrors that comparison for QS vs. TCPC-EDI. Two trends are apparent: 
first, the relationship between TCPC-EDI and QS is stronger than that of CI, which is 
consistent with the findings in Chapter 5. Second, the respective trends were both 
stronger (based on the R2 values) for the earlier time point than the latter. Since there 
were no constraints placed on patient age at enrollment or follow-up duration, it is 
unlikely that this observation has meaningful implications for physiologic evolution in 
these patients (e.g., that TCPC power loss becomes less important over time). Instead, 




Figure 9.54 Comparison of CI vs. TCPC-EDI (left column) and QS vs. TCPC-EDI (right 
column) for the first (top row) and last (bottom row) CMR scan for each patient in the serial 
analysis. All regression lines follow a logarithmic function, as discussed in Chapter 5, with 
R
2
 values as shown. None of the correlations were statistically significant. See Table 12.28 
in Appendix E. 
 
 
Figure 9.55 shows the comparison of TCPC-EDI changes with CI (top) and QS (bottom) 
changes. No correlations were observed in this present data set; however, continued 
analysis with additional patients is required to conclusively determine potential 






Figure 9.55 Relationships of % change in TCPC-EDI with change in CI (top) and change in 
QS. No correlations were observed in this limited sample; however, a larger sample size is 
needed. See Table 12.28 in Appendix E. 
 
9.5.2 Ventricular Volumes 
Table 9.37 shows a patient-by-patient comparison of the preliminary serial EDV vs. 
TCPC-EDI data. The ‘% change’ columns are color-coded as either positive (green) or 
negative (red) to facilitate visual comparison by readily identifying cases that are 
increasing or decreasing in the respective columns. Based on the working hypothesis, 
the expected trend from this table is that red values for one measure correspond to 
green values in the other. This was observed in only three of seven cases, with large 
changes in TCPC-EDI being again related to un-expected VF changes. Further study will 














CHOP005 93 84 -9 0.087 0.116 33 
CHOP008 75 99 31 0.065 0.228 251 
CHOP019 46 61 33 0.034 0.030 -12 
CHOP033 75 83 10 0.016 0.038 138 
CHOP052 88 91 3 0.022 0.045 105 
CHOP080 59 51 -13 0.110 0.106 -4 





9.5.3 Note about lumped parameter modeling 
The original proposal for this SA called for the use of lumped parameter modeling to 
supplement the trends identified in the serial analysis of patient data to evaluate 
evolutionary hypotheses for the cause/effect mechanisms underlying the observed 
trends. However, the findings from these preliminary patient data were lacking in clear 
trends in many critical areas that are needed to inform such modeling.  
There was a non-specific trend toward serially increasing TCPC-EDI that could form the 
basis for one analysis; however, Sundareswaran et al. have already shown the results 
from a parametric sweep of TCPC resistance in a lumped parameter model55. They 
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reported decreasing cardiac output and ventricular preload as well as increased central 
venous pressure; repeating such a study would not produce novel findings.  
Otherwise, cardiac index, systemic venous flow, and ventricular function results revealed 
varying responses. This finding should in some sense not be surprising given that 
patient outcomes have a wide range; however, this variety (coupled with the small 
patient sample available for analysis) effectively precludes the ability to conduct a 
meaningful, hypothesis-driven lumped parameter study. Rather than being able to 
identify a trend from patient data to inform the model (and cross-reference model results 
back to patient data to check its validity), the selected trends would be arbitrary and 
without the foundation in clinical experience needed to extrapolate the findings. As such, 
the lumped parameter modeling study has been excluded from the present analysis in 
the hope that, with the inclusion of more serial patient data through the ongoing 
longitudinal patient function/quality of life study, trends might emerge to facilitate a more 
focused and effective modeling study. 
 
9.6 Chapter Summary 
9.6.1 Major Findings 
 Changes in power loss were strongly related (r= -0.80) to average percentage 
changes in mean normalized PA diameter and, to a lesser extent (r= -0.57), 
mean normalized Fontan diameter percentage change. 
 Ventricular function was seen to both increase and decrease in different cases; 
percentage changes in EDV were strongly (positively) associated with 
percentage changes in StV, PFR, and CI. 
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A few studies have begun to longitudinally follow and hemodynamically evaluate Fontan 
patients178. Such investigations, while potentially complex in study design, will play a 
critical role in solving the broader questions of single ventricle physiology. This specific 
aim represents a preliminary serial analysis of 15 TCPC patients with three objectives: 1) 
characterize TCPC hemodynamic changes, 2) characterize VF changes, and 3) 
investigate how TCPC changes relate to VF changes. Importantly, this study represents 
the first attempt to investigate that third critical component. 
Power losses were seen to both increase and decrease on a patient-by-patient basis, 
with a non-significant trend towards serial increases. Through a detailed analysis of each 
case, the consistent trend that was found to determine whether power loss went up or 
down was the change in vessel sizes. This observation was confirmed by a strong 
correlation (r= -0.80) between changes in mean PA diameters and changes in TCPC-
EDI (Figure 9.47).  
Beyond simply helping to explain power loss changes, this trend also suggested that PA 
growth (even on a BSA normalized basis) may be a requirement to maintain consistent 
levels of indexed power loss. In other words, if the mean PA diameters increase at a rate 
equal to BSA0.5, TCPC-EDI is likely to increase. Instead, a statistically significant 
decrease in minimum LPA diameter was noted in this data set, with the other PA 
dimensions not demonstrating any significant change. Furthermore, past studies have 
shown a confounding influence of a large aortic arch on LPA size143. So while no 
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conclusive trend was observed in power loss in the present patient sample, much of the 
supporting data and trends (i.e., the mediating effects of PA growth) suggest that, on a 
general level, biases toward increasing power losses may exist. 
For ventricular function, a decrease in metrics such as cardiac index was expected given 
the gradual nature of Fontan failure; however, no such trend was observed in the 
present data. It is possible that there were changes in the underlying ventricular 
compliance based on the generally uniform increase or decrease in all metrics (i.e., 
EDV, CI, PFR, SV), but imaging methods for tissue characterization (e.g, late gadolinium 
enhancement or T1 mapping for myocardial fibrosis) would likely be needed to directly 
assess such questions.  
Finally, the comparison that was ultimately sought in this study is the relationship 
between serial changes in both the TCPC and the single ventricle, which would provide 
insight into how the TCPC is related to patient functional status over time. There was no 
evidence of this association from these data (Figure 9.55), but much more work is 
needed. Based on the correlations between power loss and ventricular function 
established in Chapter 6 with 40 patients, it is suggested that at least 25 additional 
patients be added to this study to provide a more detailed sample. 
In summary, this chapter detailed one of the first attempts to characterize longitudinal 
changes in TCPC hemodynamics and ventricular function late after the Fontan 
procedure. Continued efforts are needed in this regard to sufficiently power the analyses 
and overcome large patient-to-patient variabilities in the data, especially given the value 
of what these types of studies can tell us about Fontan failure. What is clear from this 
preliminary study is that the evolution of TCPC power loss is tightly coupled to growth of 
the pulmonary arteries. Given the potential role these losses may play in chronic 
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ventricular preload limitations, there is thus a need to monitor and ensure reasonable 




Chapter 10. Discussion 
The consistent theme of this thesis was the evaluation of TCPC hemodynamics: what 
are the ‘normal’ values and ranges (Chapter 5); what are the physiologic implications 
(Chapters 5 & 6) and serial adaptations (Chapter 9); what are potential engineering tools 
that can be translated into patient-level improvements (Chapters 7 & 8)? The two end 
points that were the primary foci of these questions were: 1) power loss and 2) HFD, and 
the individual chapters have detailed the major findings the respective studies have 
independently revealed for both end points. However, synthesizing some of these major 
findings from across study aims will provide additional insights, and a broader picture of 
the cumulative knowledge gained. 
 
10.1 TCPC Power loss and single ventricle physiology (SA1, 2; Chapters 5, 6) 
de Leval et al. first proposed the TCPC as the successor to the atriopulmonary 
connection to reduce energy losses in the vascular circuit for single ventricles17. Since 
that time, the TCPC has become the standard for single ventricle palliation, but our 
understanding of the significance of those energy losses has not advanced appreciably. 
Some have mistakenly assumed/concluded that energy losses with the TCPC are not a 
concern66, 95. The results presented in this thesis thus represent an important step 
forward for understanding the role of the TCPC in single ventricle physiology.  
The major physiologic findings are as follows: 
1. From the largest modeling study of patient-specific Fontan connections to date, 
we saw that indexed power loss (TCPC-EDI) varied by two orders of magnitude, 
demonstrating that TCPC hemodynamics are far from uniform.  
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2. The magnitude of (indexed) power loss (TCPC-EDI) was negatively associated 
with both the systemic venous flow rate and the cardiac index, such that higher 
losses corresponded to lower flow rates (Figure 10.1). These relationships were 
relatively weak, reflective of the large number of variables mediating the 
dynamics of this pathway; however, the data indicate that the TCPC is indeed 
one of those factors.  
3. There is a significant negative association between TCPC-EDI and ventricular 
function (particularly EDV), such that higher losses were related to smaller 




Figure 10.1 Recreation of Figure 5.14 showing negative relationship between TCPC-EDI 






Figure 10.2 Recreation of Figure 6.5 showing a significant correlation between power loss 
and end diastolic volume.  
 
 
Statistical correlation does not imply mechanistic cause and effect, so further work will 
be needed to determine the exact nature of these interactions; however, the 
hypothesized linkage based on our current understanding is as follows. The inherent 
challenge of Fontan physiology is that, in the absence of a sub-pulmonary pumping 
chamber, the central venous pressure must provide the driving head pressure for the 
pulmonary circuit (see Figure 10.3). As the resistance (serial sum of the TCPC and PVR) 
between this source and the downstream ventricle increases, either the vasculature 
must compensate by reducing compliance to further increase the driving pressure and 
maintain constant flow, or the hydrodynamic energy filling the ventricle is reduced42. 
Decreased venous capacitance has been reported in single ventricles43; the relationship 
between power loss and QS reported here is evidence of decreased flow. It is likely that 
both responses occur, perhaps with flow/energy decreasing once the body can no longer 
continue adapting venous tone to preserve vascular potential energy. These losses 
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translate to decreased ventricular filling and lower EDV. That is, increased TCPC power 
loss contributes to the limited ventricular preload and preload reserve that is a known 
complication of Fontan physiology39. Finally, the positive correlation between EDV and 
CI (in conjunction with the Frank-Starling laws) potentially explains the observed TCPC-
EDI/CI correlation as: high power loss contributing to decreased EDV, which in turn 
suppresses cardiac output. In other words, the negative TCPC-EDI/CI relationship is 




Figure 10.3 Schematic representation of Fontan physiology with respect to the relative 
driving pressure through the various cardiovascular compartments. (Adapted from 
66
) LA- 
left atrium; V- ventricle; S- systemic circulation; CVP- central venous pressure; P- 






10.2 Surgical Planning for HFD (SA1, 3; Chapters 5, 7) 
The patients modeled and treated in the surgical planning studies were all (with the 
exception of CHB_M1) referred on the basis of PAVM and so the primary need was for 
optimized flow distribution through the Fontan connection. While surgical planning 
provides a powerful platform for evaluating and treating these patients, it is important to 
recognize that the technology is not yet widely available outside of three select US 
centers. Thus, as advocated by de Zelicourt et al.105, the ability to leverage past 
experience to establish generalizable trends is an equally valuable exercise.  
From the cohort geometric analysis (§5.5.2), the primary importance of vessel angles in 
mediating flow distribution through the connection was noted (Figure 10.4). Such 
relationships were both expected and intuitively obvious. However, what was not 
expected was the fact that the SVC connection angles appeared to have a stronger 
association with the IVC flow distribution than the IVC connection angles did. This 
finding suggests that the design of the Glenn (or Kawashima) connection can be as 
important in determining the flow distribution characteristics of the connection as the 
Fontan. Figure 10.5 aptly demonstrates this point as a favorable (i.e., large) SVC-RPA 
angle directs all SVC flow to the RPA, thus leaving the IVC flow to make up the balance 






Figure 10.4 Recreation of Figure 5.33 showing the relationship between TCPC vessel 




Figure 10.5 Representative TCPC case showing the potential impact of SVC anastomosis 





The surgical planning cases presented in this thesis were generally more anatomically 
complex than the standard TCPC geometries seen in the cohort analysis. Often they 
presented 3 or more inlet vessels, which does complicate the application of these 
geometric relationships. Yet the lessons learned can still be applied: foresight at the time 
of the Glenn procedure can ultimately help achieve a balanced flow profile, particularly if 
the approach that will be used for the Fontan is already known. 
Using CHOP_M9 as an example (§7.4.3, Figure 10.6), it is seen that the SVC-PA 
connection for this patient was relatively perpendicular with respect to the PA axis such 
that there was not a significant bias to either PA as flow entered the connection and the 
Y-Graft branches were able to span the superior flows with relative ease. It is easy to 
appreciate that if SVC connection angle had instead been angled toward one side (as 
with Figure 10.5), the LPA for example, then the ability to direct hepatic flow to that same 
side may have been compromised. While the introduction of an SVC angle in this 
instance is viewed as a negative feature, it can alternatively be used as an advantage. In 
the case of bilateral SVCs, for example, if the right SVC is angled to the RPA (assuming 
a right-sided IVC), then once the Fontan is completed, the flow through the two SVCs 
will presumably be unilaterally directed to their respective PAs and the IVC flow will 
provide the balance to both sides. Focused design studies would likely uncover other 
such possibilities of leveraging vessel angle relationships, but these examples represent 
pertinent relationships observed through the present surgical planning/cohort study 







Figure 10.6 Velocity streamlines from surgical planning Y-Graft model for CHOP_M9. 
 
 
10.3 Surgical Planning and power loss (SA1, 3; Chapters 5, 7) 
The capability to pre-operatively model vessel flow distributions is a demonstrated 
strength for the surgical planning methodology; however, PAVM is an uncommon 
pathology for single ventricles, so maintaining a singular focus on that disease will 
severely limit the patients who stand to benefit from the technology. To ultimately reach 
a broader population, the ability to optimize other hemodynamic end points will be 
necessary. Given the potential physiologic significance of TCPC power loss for single 
ventricle patients, working toward a predictive framework for that metric serves as a 
logical and important next step. Achieving this goal requires two important questions be 
addressed: 1) How accurate are pre-operative power loss predictions; 2) How much 
does power loss vary as a function of surgical design? 
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The first of these points was addressed, at least in a preliminary fashion, through the 
analysis of post-operative hemodynamic data for patients who had previously undergone 
prospective surgical planning (§7.5). Comparing the connection resistances between the 
prospective pre-operative surgical model and the simulated hemodynamics from the 
acute post-operative CMR study, it was found that power loss predictions were, on 
average, within 20% of actual values. However, without the context of how big an 
improvement in power loss can be realized through surgical planning, the merits of this 
finding cannot be determined. 
While the majority of surgical planning cases were referred for flow distribution 
optimization, select cases can be used to provide insights into the potential effect and 
limitations of surgical planning for power loss. Cases with interrupted IVC are not good 
candidates for such an analysis because the Fontan baffle in those patients carries only 
low momentum hepatic flow and experience has consistently demonstrated low power 
loss variance among designed options in those cases105. Instead, the patients depicted 
in Figure 10.7 provide a better basis for comparison as they are generally less 
anatomically complex than the interrupted IVC cases and power loss as a function of 
Fontan connection design is expected to vary more. Hence, the surgical planning cases 
for each of these patients were reviewed to identify the range of power loss among the 
virtual options investigated. Table 10.1 reports the highest and lowest power loss results 
recorded for each of these patients at the in vivo measured PA splits. The percentage 





Figure 10.7 Representative TCPC models for the surgical planning patients retained to 









Table 10.1 Range of observed power losses [mW] among virtual models investigated for 
specified patients. The options that yielded the specified value is provided in each case for 
reference. 
 Lowest value Highest value % difference 
CHOP_M12 2.3 (EC) 2.5 (Y2) 9 
CHOP_M13 3.3 (option b) 9.1 (option f) 176 
CHOP_M16 0.9 (right EC) 1.5 (Y) 67 
CHOA_M5 1.7 (22-11Y) 
2.3 (20-10Y, left 
medial branch) 
35 
CHB_M1* 2.7 2.7 0 
*Only 2 options simulated 
 
 
These values represent the results produced by all of the reasonable surgical 
alternatives for a given case. However, it cannot be assumed that the surgeon would 
routinely select the option with the highest losses without surgical planning; thus, this 
range represents an upper bound (over-estimate) of the surgical planning ‘benefit’ for 
power loss. Taking instead a conservative approach to these data (and considering the 
similar finding from published data95), it is estimated that routine surgical planning of the 
Fontan procedure could help to reduce power loss by 20-30%, on average. 
Critically, the low end of this range intersects with the uncertainty in predictive accuracy 
for power loss, which indicates that the present surgical planning paradigm is not yet 
sufficient for accurately evaluating power loss. If a given option is predicted to have 20% 
lower power loss than another, but the implementation of either option may produce a 
result 20% different from the model predictions, then there may not actually be a 
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practical difference between the two options. These findings thus provide further 
motivation for the continued method developments needed to improve power loss 






Chapter 11. Limitations and Future Directions 
This thesis has extensively leveraged the strong foundation of engineering tools 
developed and validated by past members of the Cardiovascular Fluid Mechanics lab to 
study TCPC hemodynamics and single ventricle physiology on an unprecedented scale. 
These tools include medical image segmentation and patient-specific anatomic 
reconstruction, reconstruction and interpolation of 4D phase contrast CMR data, and 
computational fluid dynamics simulations. Each of these components has its own 
associated limitations, which have been discussed at length in their respective 
development-focused dissertations119, 124, 179. However, given the particular use of CFD in 
these studies, additional attention to that method is presently warranted. Also, as with all 
research, this thesis has generated as many new questions as answers; some of these 
potential new investigational avenues are also explored in the following sections. 
 
11.1 Reducing CFD assumptions 
The primary limitations of the CFD modeling in this thesis were the significant number of 
assumptions made in performing the simulations. Specifically, most analyses relied on 
time-averaged flow boundary conditions with flat inlet velocity profiles and (for all cases) 
rigid vessel walls. Favorable comparisons with 4D CMR (both qualitative and with 
respect to quantitative flow distribution quantification) demonstrated that these 
assumptions were generally tolerable. However, as we continue to advance our 
appreciation for and knowledge of the physiologically relevant magnitudes and 
thresholds of power loss, the need to refine these models and improve the finer 
accuracy details will become more important. Incorporating vessel elasticity (either via 
fluid-structure interaction modeling or imposed wall motion165), flow pulsatility, and 
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patient-specific velocity cross-sectional profiles at the inlets represent the most logical 
means of accomplishing this objective. Many of these tasks are already under 
development. 
 
11.2 Relating function to patient outcomes 
The primary endpoints used in evaluating power losses in this thesis were other 
functional metrics that could be derived from medical imaging (i.e., VF, CI, Qs). It is 
implicitly hypothesized that these measures are effective surrogates for patient 
functional health and long term outcomes; however, these relationships have not been 
conclusively demonstrated. Ongoing efforts through an NIH-funded R01 should help to 
explicitly make these connections through exploring correlations between measures 
such as power loss, ventricular function, and exercise capacity to patient outcome and 
quality of life. Ultimately, these connections/relationships are needed to begin to 
establish statistically-based thresholds and surrogates for function, which can be 
translated to improved guidelines for patient management. 
 
11.3 More robust approach to surgical planning boundary condition definition 
As discussed in §7.5.2, there is a clear need to refine the means by which boundary 
conditions are derived and prescribed for surgical planning simulations to improve the 
fidelity of predicted outcomes. Retention of pre-operative measurements is not a 
sufficient strategy as there are significant physiologic changes taking place as a result of 
the surgery, particularly for initial Fontan procedures, which can alter those flows. 
Reduction of cardiac preload and output, increased resistance downstream of the 
IVC/hepatic veins, and introduction of a Fontan fenestration are all significant 
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confounders to consider and address. Lumped parameter modeling provides an 
excellent first step in the right direction based on the ability to mathematically 
approximate the physiology response to changing conditions. 
Continued follow-up of these early surgical planning cases is also a necessity to 
determine how the hemodynamics conditions change with time and how those changes 
impact the desirability of the retained surgical option. To date, the patients have 
generally been evaluated only in the immediate or acute post-operative period and that 
has been the basis for assessing model fidelity and utility. In contrast, the surgical 
connection is intended to last a “lifetime” through dynamic and varying anatomic and 
physiologic conditions. Thus, the use of a lumped parameter model to predict a singular 
post-operative state is not advisable either, and more robust protocols may be needed.  
11.4 The future of the Y-Graft 
This thesis was part of a ground-breaking effort to translate the Optiflo concept106 into 
clinical practice through the Fontan Y-Graft. Here again, solely considering the acute 
post-operative period limits the ability to fully evaluate the experience with an 
appropriate baseline reference state, and so close continuing clinical follow-up of these 
patients will be crucial.  
The other critical question that must be addressed (as discussed in §8.4) is the question 
of graft sizing within realistic surgical constraints. It is clear that, on paper, a larger graft 
is better, but that may not translate into practice. A parametric study combining virtual 
surgery expertise and the patient experience to date can provide important insights in 
this regard: is it energetically preferable to use a smaller graft that can be ‘optimally’ 
oriented or a larger graft that may provide lateral separation from the SVC but may not 
readily allow for streamlined transition to PA flow. If the larger design is found to be 
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superior under such a scenario, then it will be worth pursuing corporate partnership in 
manufacturing such a graft.  
 
11.5 Mechanical support 
Although not directly addressed in this thesis, mechanical cavopulmonary support is 
becoming a relevant and important topic for single ventricle patients86, 97, 180 as clinicians 
and researchers search for answers to address the growing problem of Fontan failure. 
Ultimately, optimizing TCPC power loss may provide physiologic benefit (as the present 
work has demonstrated), yet it will not solve Fontan failure in all cases. Thus, continued 
innovation is needed to ultimately achieve a normal life expectancy for these patients. 
Novel devices provide an intuitive answer; however, the difficulty in achieving regulatory 
approval and commercially manufacturing even a general pediatric ventricular assist 
device (at present, the Berlin Heart is the only one) should give pause to the long-term 
viability of that approach. Instead, identifying strategies to make use of existing devices97 
may ultimately provide more practical benefit.  
 
11.6 New Approaches to Fontan palliation 
Regardless of the upper limit to TCPC efficiency, the systemic venous system and the 
GI tract in particular will still be subjected to abnormally elevated pressures. As a result, 
problems associated with liver cirrhosis and failure181 and portal venous hypertension182 
are becoming more prevalent and may be related to the time since Fontan completion. 
These issues are beginning to raise the question of whether the current timing of staged 
palliation is appropriate (i.e., Fontan completion at age 3-4) or if the time between 
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ventricular unloading (the Glenn procedure) and Fontan could be safely extended to 
preserve low hepatic pressures for as long as possible. Additionally, some have gone so 
far as to propose a modification to the Fontan procedure in which only the sub-
diaphragmatic IVC is routed to the PAs such that the hepatic veins remain connected to 
the atrium and GI pressures are kept low (credit: Brian Kogon, MD, Emory University 
Department of Surgery). Obviously, PAVM may become a problem for a subset of 
patients58 in such a scenario, but may be treatable through systemic-to-arterial shunts to 
route the necessary “hepatic factor” to the lungs. Again, such novel ideas and 





Chapter 12. Conclusions 
At the beginning of this research endeavor, it was hypothesized that high TCPC power 
losses restrict preload and ventricular function in SV patients, with both deteriorating with 
time, and thus surgical planning and novel surgical approaches may improve these 
hemodynamics. Towards these ends, there are several major findings and conclusions 
that can be drawn from the studies performed as part of this thesis. 
1. TCPC power loss varies widely among patients and is negatively associated with 
systemic venous flow rate, cardiac index, and end diastolic volume.  
 Relationship between TCPC and SV has not been previously reported 
and provides strong support for the study hypothesis.  
 Motivates continued research and investigation into means of 
systematically lowering power losses  
 Strengthens the over-arching hypothesis of ongoing Fontan studies that 
the TCPC impacts long-term functional health and quality of life. 
 
2. Virtual surgical planning for the Fontan procedure provides a novel platform to 
prospectively evaluate complex patient cases and potential therapeutic options. 
Preliminary post-operative verification studies demonstrate promising agreement 
between model predictions and post-operative hemodynamics.  
 The ability to evaluate and identify desirable hemodynamic characteristics 
from among the array of potential surgical options fills an otherwise unmet 
need and has demonstrated potential for therapeutic benefit 
 Continued technological advances in these techniques are needed to 
improved modeling accuracy 
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 Efforts should be made to extend this approach to a wider array of end 
points and procedures to maximize the utility of the paradigm. 
 
3. The Y-Graft Fontan connection is a novel and surgically feasible alternative to 
standard extracardiac or lateral tunnel TCPCs with the potential to improve 
connection efficiency.  
 Short-term experience with this approach has been promising with strong 
modeling evidence to suggest improved hemodynamics (with respect to 
either power loss or hepatic flow split) in at least four patients 
 More work is needed to pragmatically optimize the surgical 
implementation of the Y-Graft with respect to graft sizing, and perhaps 





A. Appendix A- CFD Cohort Data 
1. Demographic data for 100 patient cohort 
Table 12.1 contains basic demographic details for all 100 patients included in the CFD 
Cohort analysis. These data include: Fontan type (Intra-atrial (IA), Extracardiac (EC), or 
Atriopulmonary connection (APC)), whether or not the patient was diagnosed with 
hypoplastic left heart syndrome (HLHS), whether or not the patient has bilateral SVC 
connections, whether or not the patient has a reconstructed aorta, age, gender, and 
body surface area (BSA). 
 


















N) Age Gender 
BSA 
(m^2) 
CHOP_M10 EC N N L  N 3 F 0.61 
CHOP_M11 IA H N R Y 10 F 1.03 
CHOP_M12 EC N Y L N 2 M 0.46 
CHOP_M7 EC N Y L N 11 M 1.16 
CHOP_M8 EC N Y R Y 6 M 0.89 
CHOP001B IA H N R Y 16 F 1.23 
CHOP004B IA N N L N 17 F 1.49 
CHOP005B IA N N L N 19 F 1.51 
CHOP007B IA N Y L N 18 M 2.01 
CHOP008A IA H N R Y 15 M 1.94 
CHOP010A IA H N R Y 15 M 1.62 
CHOP013A EC N N R N 16 M 1.9 
CHOP014A EC N N L Y 9 M 1.04 
CHOP016A EC H N R Y 6 M 0.83 
CHOP017B EC N N L N 15 F 1.64 
CHOP018A IA N N R N 7 M 0.68 
CHOP019A IA H N R Y 14 M 1.68 
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CHOP021A IA H N R Y 11 F 1.23 
CHOP022A EC H Y R Y 7 M 0.91 
CHOP023A IA N N R N 12 M 1.22 
CHOP024A IA N N L Y 7 F 0.74 
CHOP025A EC N Y M N 9 F 1.01 
CHOP026A IA H N R Y 6 F 0.83 
CHOP028A IA H N R Y 18 M 1.92 
CHOP029A IA H N R Y 9 M 1.08 
CHOP030B IA H N R Y 21 F 1.39 
CHOP031A IA N N L N 7 M 0.89 
CHOP032A IA N N L N 18 F 1.64 
CHOP033A IA N N L N 10 M 1.32 
CHOP034A IA N N L N 14 M 1.89 
CHOP035A EC N N M Y 8 F 0.69 
CHOP036A IA N N L N 11 M 1.19 
CHOP037A IA H N R Y 10 M 1 
CHOP038A EC N N R N 18 M 1.63 
CHOP039A IA H N R Y 10 F 1.02 
CHOP040A IA N N R N 19 F 2.05 
CHOP041A IA H N R Y 14 F 1.51 
CHOP042B EC N Y M N 3 F 0.62 
CHOP044A APC N N L Y 24 M 1.9 
CHOP047A APC  N N L N 20 M 1.84 
CHOP049A IA N N R N 19 M 1.3 
CHOP051B EC N Y M N 4 M 0.63 
CHOP052B EC N N L N 10 M 1.06 
CHOP053B EC H N R Y 3 F 0.59 
CHOP054A IA H N R Y 4 F 0.46 
CHOP057A EC N N R N 21 F 1.6 
CHOP061A IA H N R Y 10 M 1.13 
CHOP062A IA N N L N 12 F 1.11 
CHOP063A EC N N L N 9 F 1.06 
CHOP064A IA H N R Y 6 F 0.94 
CHOP065A IA H N R Y 16 M 1.36 
CHOP066A IA H N R Y 14 F 1.28 
CHOP068B IA H N R Y 4 F 0.61 
CHOP069B IA H N R Y 11 M 1.11 
CHOP072A IA N N M N 14 M 1.65 
CHOP073A  IA N N M N 20 F 1.54 
CHOP074A IA H N R Y 12 M 1.24 
CHOP080A IA N Y R N 17 F 1.91 
CHOP081A EC N N L Y 3 F 0.54 
CHOP082A EC N N L N 7 M 0.87 
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CHOP083A EC N N L N 8 F 1.15 
CHOP084A EC N N M N 8 M 0.99 
CHOP085A IA H N R Y 2 M 0.5 
CHOP086A IA N Y L N 6 F 0.81 
CHOP087A IA N N R Y 5 M 0.81 
CHOP088A EC N N L N 8 F 1.25 
CHOP089A IA N N L N 10 M 0.93 
CHOP090A APC N N M N 27 M 2.02 
CHOP091A IA N Y L N 18 M 2.08 
CHOP094A IA N N L Y 13 M 1.2 
CHOP097A IA H N R Y 5 F 0.67 
CHOP100A IA N N L N 19 M 1.66 
CHOP102A IA N Y R N 25 F 1.6 
CHOP103A IA N N R N 22 M 1.86 
CHOP105A IA H N R Y 8 M 0.95 
CHOP108A IA H N R Y 8 M 0.93 
CHOP109B EC N N R N 4 F 0.65 
CHOP114A IA H N R Y 15 M 1.75 
CHOP118A EC N N M Y 5 M 0.77 
CHOP119A IA N N L N 4 F 0.76 
CHOP121A EC N N M Y 5 M 0.75 
CHOP122A IA H Y R Y 15 M 1.51 
CHOP128A IA N N M N 10 F 0.93 
CHOP134A EC N N L Y 4 F 0.63 
CHOP135A EC N Y L N 6 M 0.77 
CHOP139A IA N N L Y 9 M 1.18 
CHOP143A EC N N M N 4 F 0.61 
CHOP144C EC N Y M Y 4 F 0.75 
CHOP145A IA N N L N 19 F 1.51 
CHOP148A IA N N L N 4 M 0.73 
CHOP152A IA N N M N 17 M 1.89 
CHOP155A IA N N M N 16 M 1.83 
CHOP159A IA N N M N 24 F 1.9 
CHOP161A EC N N M N 14 F 1.65 
CHOP166A IA H N R Y 15 M 1.41 
CHOP187A IA N N L N 42 F 1.64 
CHOP188A IA N N L N 17 M 1.51 
CHOP191A EC N N L N 16 F 1.25 
CHOP203A IA N N R Y 16 M 1.93 





2. PC CMR-derived vessel flow rates for the 100 patient cohort 
Table 12.2 presents the flow data derived from PC CMR for all 100 patients. A dash (‘-‘) 
indicates that no data were acquired for that particular entry while ‘N/A’ (not applicable) 
is used when a vessel (LSVC or Az) is not present for a particular patient. 
The reported values for collateral flow (Ao-[IVC+SVC+LSVC+Az]) and fenestration flow 
([IVC+SVC+Az+LSVC]-[LPA+RPA]) were derived from these values. Thus, when one of 
these values was represented as a dash, the value could not be calculated for that 
particular patient. 
 
















CHOP_M10 3.75 0.45 2.05 2.71 0.5 N/A 0.35 
CHOP_M11 3.92 1.26 1.3 0.7 1.21 N/A N/A 
CHOP_M12 1.79 0.68 0.24 0.7 0.42 0.26 N/A 
CHOP_M7 4.29 0.41 1.57 2.3 1.23 0.77 1.2 
CHOP_M8 3.59 0.31 0.73 1.48 1.23 1.04 1.21 
CHOP001B 2 1.56 0.62 0.7 1.1 N/A N/A 
CHOP004B 5.63 3.06 1.04 2.13 1.65 N/A N/A 
CHOP005B 4.54 3.59 0.98 2.55 - N/A N/A 
CHOP007B 8.44 4.89 0.94 1.56 4.03 1.06 N/A 
CHOP008A - 2.06 1.13 1.69 1.65 N/A N/A 
CHOP010A - 3.79 1.26 4.19 3.09 1.32 N/A 
CHOP013A - 2.62 0.41 1.3 1.2 0.39 N/A 
CHOP014A - 1.35 0.87 1.28 1.23 N/A N/A 
CHOP016A - 1.85 1.42 0.83 - N/A N/A 
CHOP017B - 2.48 1.26 0.6 3.11 N/A N/A 
CHOP018A 3.05 1.38 1.25 0.93 1.27 N/A N/A 
CHOP019A 5.52 3.54 1.44 1.93 2.83 N/A N/A 
CHOP021A 3.73 2.17 0.93 1.18 - N/A N/A 
CHOP022A 3.41 1.3 0.81 1.06 0.84 0.49 N/A 
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CHOP023A 3.89 2.1 0.38 1.38 1.93 N/A 0.48 
CHOP024A 2.65 1.58 0.97 0.85 1.15 N/A N/A 
CHOP025A 3.23 1.75 0.58 1.46 1.07 0.62 N/A 
CHOP026A 3.06 1.03 1.05 0.98 1.5 N/A N/A 
CHOP028A 3.53 2.83 0.91 1.11 1.94 N/A N/A 
CHOP029A 3.95 2.08 1.47 0.78 1.51 N/A N/A 
CHOP030B 4.6 3.27 0.79 1.4 1.47 N/A N/A 
CHOP031A 3.25 1.43 1.3 1.04 1.55 N/A N/A 
CHOP032A 5.82 3.57 1.09 1.97 2.77 N/A N/A 
CHOP033A 3.42 2.28 1.52 1.71 1.4 N/A N/A 
CHOP034A 8.22 4.15 0.89 1.67 2.24 N/A N/A 
CHOP035A 5.08 2.29 1.23 2.26 1.37 N/A N/A 
CHOP036A - 3.31 1.93 2.27 1.85 N/A N/A 
CHOP037A 3.81 1.51 0.92 0.84 - N/A N/A 
CHOP038A - 2.52 1.1 1.37 2.06 0.53 N/A 
CHOP039A 3.94 2.7 1.75 1.02 1.1 N/A N/A 
CHOP040A 5.83 4.84 2.06 1.55 1.91 N/A N/A 
CHOP041A 4.04 1.81 0.99 0.84 1.4 N/A N/A 
CHOP042B 2.15 0.3 0.16 0.98 0.3 0.54 0.49 
CHOP044A 4.43 3.64 1.81 2.65 0.72 N/A N/A 
CHOP047A 3.88 2.57 1.03 1.73 2.03 N/A N/A 
CHOP049A 9.06 - 1.8 - 3.63 N/A N/A 
CHOP051B 1.9 0.9 0.18 1.03 0.28 0.39 N/A 
CHOP052B 5.8 2.07 1.19 1.42 1.15 N/A N/A 
CHOP053B - 1.05 0.79 0.86 0.73 N/A N/A 
CHOP054A 2.1 1.12 0.92 0.28 1.08 N/A N/A 
CHOP057A 4.25 2.8 0.89 1.8 2.69 N/A N/A 
CHOP061A 5.02 3.15 1.29 1.53 1.07 N/A N/A 
CHOP062A 2.58 1.36 0.93 0.82 1.87 N/A N/A 
CHOP063A 3.68 2.29 1.18 1.23 1.25 N/A N/A 
CHOP064A 1.6 0.78 0.48 0.61 0.51 N/A N/A 
CHOP065A 3.34 1.94 0.47 0.78 1.45 N/A N/A 
CHOP066A 4.42 2.27 1.23 1.44 2.33 N/A N/A 
CHOP068B 2.33 1.14 1 0.52 0.7 N/A N/A 
CHOP069B 3.21 1.93 1.13 1.43 1.7 N/A N/A 
CHOP072A 4.58 3.07 1.57 2.36 2.14 N/A N/A 
CHOP073A 3.88 2.49 1.06 1.73 2.03 N/A N/A 
CHOP074A - 1.91 0.3 0.48 0.84 N/A N/A 
CHOP080A 5.55 2.57 1.25 2.07 1.87 0.53 N/A 
CHOP081A 3.88 0.34 1.12 0.52 0.85 N/A N/A 
CHOP082A 2.68 1.6 0.96 0.8 1.18 N/A N/A 
CHOP083A 3.8 2.38 1.06 1.8 0.78 N/A N/A 
CHOP084A 2.98 2.1 1.23 1.39 1.3 N/A N/A 
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CHOP085A 1.6 0.65 0.56 0.42 - N/A N/A 
CHOP086A 2.94 2.27 0.24 1.34 - 1.2 N/A 
CHOP087A 2.69 1.22 0.71 0.68 1.24 N/A N/A 
CHOP088A 3.35 1.78 0.9 1.65 1.51 N/A N/A 
CHOP089A 2.9 2.13 1.08 1.48 1.72 N/A N/A 
CHOP090A - 3.12 1.3 2.27 2.75 N/A N/A 
CHOP091A 5.03 3.53 1.04 2.24 2.64 0.69 N/A 
CHOP094A 5.5 2.89 1.59 1.58 2.83 N/A N/A 
CHOP097A 2.29 1.52 0.77 0.5 1.79 N/A N/A 
CHOP100A 3.53 2.04 1.18 1.4 1.89 N/A N/A 
CHOP102A 4.67 3.46 0.55 2.12 2.99 0.59 N/A 
CHOP103A 4.93 3.12 1.45 2.78 2.57 N/A N/A 
CHOP105A 3.86 1.47 1.5 0.83 1.65 N/A N/A 
CHOP108A 2.93 1.63 0.88 0.68 1.05 N/A N/A 
CHOP109B 2.64 1.07 1.59 1.15 1.13 N/A N/A 
CHOP114A 5.54 3.87 1.69 2.47 1.88 N/A N/A 
CHOP118A 3.26 0.98 1.25 0.59 1.15 N/A N/A 
CHOP119A 1.44 1.45 1.35 1.02 1.78 N/A N/A 
CHOP121A 2.15 0.89 1.03 0.76 0.66 N/A N/A 
CHOP122A 4.96 1.89 0.9 1.04 1.56 0.44 N/A 
CHOP128A - 2.13 1.57 1.52 2.64 N/A N/A 
CHOP134A 2.34 1.09 1.01 0.61 0.99 N/A N/A 
CHOP135A 3.16 1.14 0.75 0.97 0.94 0.52 N/A 
CHOP139A 4.49 2.3 1.6 1.11 2.46 N/A N/A 
CHOP143A 4.69 0.72 1.14 2.52 1.09 0.75 0.82 
CHOP144C 1.78 0.2 0.49 0.79 0.54 0.39 0.71 
CHOP145A 3.72 2.13 0.99 1.52 2.27 N/A N/A 
CHOP148A 2.47 1.04 0.74 0.74 1.03 N/A N/A 
CHOP152A 7.69 4.61 1 1.21 3.77 N/A N/A 
CHOP155A 7.51 3.75* 2.59 3.44 2.9 N/A N/A 
CHOP159A 4.1 2.75 0.98 1.96 2.08 N/A N/A 
CHOP161A 7.62 3.85 1.58 3.1 2.61 N/A N/A 
CHOP166A 5.25 1.42* 2.43 1 2.85 N/A N/A 
CHOP187A 4.17 2.45 1.06 1.26 2.42 N/A N/A 
CHOP188A 5.27 2.24 1.09 1.87 1.38 N/A N/A 
CHOP191A 3.91 1.63 0.72 0.99 1.22 N/A N/A 
CHOP203A 6.65 3.75* 1.45 2.66 2.95 N/A N/A 
CHOP204A 5.47 3.08* 1.41 1.67 2.82 N/A N/A 






3. Time-averaged CFD Results for 100 patient cohort 
Table 12.3 provides the time-averaged CFD results from the 100 patient cohort. The 
cardiac index (CI), indexed systemic venous flow rate (Qs), and global pulmonary flow 
distribution (GFD) (which are all derived from flow measurements in Table 12.2) were 
also included since they were frequently used to compare against the CFD data. 
Simulation end points included hepatic flow distribution (HFD), maximum pressure drop 
(ΔPmax), power loss (PL), TCPC resistance (R), and the TCPC energy dissipation index 






















CHOP_M10 6.15 4.67 85 87 0.99 4.07 0.14 0.013 
CHOP_M11 3.81 2.49 27 26 3.01 5.9 0.42 0.076 
CHOP_M12 3.89 2.57 62 54 0.41 0.72 0.18 0.019 
CHOP_M7 3.70 3.41 65 100 0.67 5.59 0.19 0.025 
CHOP_M8 4.03 3.7 55 0 1.74 5.06 0.19 0.023 
CHOP001B 1.62 1.77 39 44 0.9 1.94 0.23 0.058 
CHOP004B 3.78 2.75 56 71 1.26 6.69 0.27 0.044 
CHOP005B 3.01 3.03 56 68 3.31 17.88 0.58 0.087 
CHOP007B 4.20 3.43 28 17 1.46 9.63 0.18 0.024 
CHOP008A - 1.64 46 53 0.69 1.33 0.11 0.031 
CHOP010A - 3.93 44 33 3.32 26.55 0.47 0.055 
CHOP013A - 1.8 52 52 0.93 3.36 0.25 0.062 
CHOP014A 3.64 2.13 59 33 0.38 0.77 0.07 0.016 
CHOP016A - 3.94 25 3 5.15 10.5 0.36 0.042 
CHOP017B 3.13 2.28 16 0 0.76 3.38 0.18 0.035 
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CHOP018A 4.49 3.87 42 67 0.38 1.41 0.06 0.007 
CHOP019A 3.29 2.96 41 52 1.75 7.43 0.23 0.035 
CHOP021A 3.03 2.52 41 49 2.28 7.34 0.42 0.076 
CHOP022A 3.75 2.86 49 33 0.81 1.7 0.1 0.016 
CHOP023A 3.19 2.43 42 53 2.28 10.4 0.66 0.122 
CHOP024A 3.58 3.45 43 58 2.02 3.06 0.16 0.021 
CHOP025A 3.20 2.92 58 50 1.95 5.78 0.31 0.047 
CHOP026A 3.69 2.51 40 79 2.69 4.66 0.4 0.073 
CHOP028A 1.84 1.95 36 40 1.3 3.62 0.23 0.052 
CHOP029A 3.66 3.29 22 40 0.93 3.17 0.12 0.017 
CHOP030B 3.31 2.92 35 41 3.68 11.68 0.43 0.069 
CHOP031A 3.65 3.07 40 78 0.55 1.58 0.09 0.013 
CHOP032A 3.55 2.84 42 43 2.96 22.2 0.76 0.12 
CHOP033A 2.59 2.88 52 63 0.51 2.47 0.1 0.016 
CHOP034A 4.35 2.67 43 41 2.72 18.15 0.61 0.103 
CHOP035A 7.36 5.1 62 21 1.37 5.08 0.13 0.011 
CHOP036A 3.53 4.4 55 71 1.22 7.57 0.15 0.015 
CHOP037A 3.81 2.43 35 46 4.32 4.04 0.31 0.057 
CHOP038A 2.41 2.55 40 22 1.46 6.57 0.27 0.05 
CHOP039A 3.86 4.36 48 52 3.11 7.75 0.23 0.019 
CHOP040A 2.84 3.37 37 50 1.9 15.3 0.41 0.04 
CHOP041A 2.68 1.85 37 21 0.34 1.17 0.1 0.025 
CHOP042B 3.47 2.4 77 43 2.26 1.78 0.23 0.042 
CHOP044A 2.87 2.87 49 43 2.9 17.13 0.5 0.078 
CHOP047A 2.11 1.96 46 45 0.49 1.77 0.11 0.026 
CHOP049A 6.97 6.97 60 77 4.09 40.39 0.28 0.019 
CHOP051B 3.02 2.33 78 58 0.99 2 0.26 0.051 
CHOP052B 5.47 3.08 44 21 0.94 3.35 0.16 0.022 
CHOP053B 4.01 3.12 54 38 0.97 1.33 0.09 0.015 
CHOP054A 4.48 4.43 21 17 0.28 0.66 0.04 0.003 
CHOP057A 2.66 2.31 40 48 0.71 3.21 0.17 0.033 
CHOP061A 4.45 3.93 59 52 1.84 9.56 0.24 0.028 
CHOP062A 2.57 2.06 30 43 0.33 0.85 0.08 0.018 
CHOP063A 3.47 3.27 50 71 1.39 5.76 0.23 0.032 
CHOP064A 1.70 1.34 55 82 0.28 0.37 0.1 0.033 
CHOP065A 2.46 1.77 35 39 0.13 0.47 0.05 0.013 
CHOP066A 3.45 2.73 38 17 0.76 2.53 0.16 0.02 
CHOP068B 3.82 3.51 43 41 1.96 4.57 0.28 0.035 
CHOP069B 2.90 2.76 46 65 1.23 2.24 0.12 0.02 
CHOP072A 2.78 2.81 52 44 3.06 18.06 0.63 0.1 
CHOP073A  2.52 2.31 46 60 0.27 1.39 0.08 0.015 
CHOP074A - 1.78 37 60 0.5 1.31 0.15 0.038 
CHOP080A 2.91 2.28 53 29 2.4 11.8 0.54 0.107 
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CHOP081A 7.18 2.7 38 3 0.22 0.58 0.06 0.011 
CHOP082A 3.08 2.94 40 57 0.4 1.38 0.08 0.013 
CHOP083A 3.30 2.99 70 48 1.58 5.7 0.25 0.038 
CHOP084A 3.01 3.36 52 72 0.63 1.41 0.06 0.008 
CHOP085A 3.20 2.42 49 35 1.79 1.66 0.26 0.048 
CHOP086A 3.63 4.58 36 4 1.89 7.63 0.2 0.02 
CHOP087A 3.30 2.38 35 39 0.86 2.19 0.22 0.041 
CHOP088A 2.68 2.14 52 27 1.15 4.2 0.33 0.069 
CHOP089A 3.12 3.45 46 61 0.49 1.94 0.08 0.01 
CHOP090A - 2.19 45 74 0.24 1.28 0.06 0.012 
CHOP091A 2.42 2.53 46 33 0.37 5.25 0.18 0.032 
CHOP094A 4.58 3.73 36 45 1.69 9.09 0.24 0.03 
CHOP097A 3.41 3.42 22 30 3.05 2.63 0.15 0.02 
CHOP100A 2.13 1.94 43 13 0.2 0.95 0.07 0.016 
CHOP102A 2.92 2.88 42 31 1.09 6.32 0.22 0.034 
CHOP103A 2.65 2.46 52 76 2.96 18.18 0.72 0.134 
CHOP105A 4.06 3.13 33 44 1.05 2.56 0.12 0.018 
CHOP108A 3.15 2.7 39 42 1.34 3.7 0.25 0.041 
CHOP109B 4.06 4.09 51 5 1.57 3.2 0.13 0.015 
CHOP114A 3.17 3.18 44 49 2.38 11.62 0.3 0.042 
CHOP118A 4.23 2.9 27 44 0.45 1.26 0.09 0.014 
CHOP119A 3.68 3.68 36 1 1.02 3.14 0.14 0.017 
CHOP121A 2.87 2.56 53 38 1.45 2.09 0.19 0.034 
CHOP122A 3.28 2.14 40 30 1.61 3.88 0.34 0.053 
CHOP128A - 3.98 37 60 0.47 1.44 0.05 0.005 
CHOP134A 3.72 3.33 38 28 1.03 1.84 0.12 0.016 
CHOP135A 4.10 3.13 39 30 1.79 4.32 0.26 0.037 
CHOP139A 3.81 3.31 29 49 0.74 3.06 0.09 0.015 
CHOP143A 7.68 5.62 70 12 8.6 30 0.71 0.056 
CHOP144C 2.37 2.39 59 0 1.07 1.88 0.2 0.038 
CHOP145A 2.46 2.07 40 61 0.76 3.37 0.24 0.052 
CHOP148A 3.39 2.44 42 39 0.83 1.25 0.13 0.024 
CHOP152A 4.07 2.97 24 36 1.23 8.82 0.25 0.036 
CHOP155A 3.85 3.85 54 56 0.92 30 0.55 0.059 
CHOP159A 2.16 1.96 48 57 1.12 5.17 0.32 0.073 
CHOP161A 4.62 3.29 54 66 1.5 11.28 0.28 0.039 
CHOP166A 3.72 3.36 26 13 2.45 6.12 0.17 0.023 
CHOP187A 2.54 2.14 34 41 0.47 1.55 0.09 0.02 
CHOP188A 3.49 2.21 58 50 0.44 0.82 0.05 0.01 
CHOP191A 3.13 1.88 45 65 0.2 0.45 0.05 0.011 
CHOP203A 3.45 2.69 47 46 0.28 1.91 0.06 0.01 





Table 12.4 Comparison for single vs. bilateral SVC patients (N=100) 
 
Bilateral 














CHOP_M10 N 85 87 0.99 4.07 0.14 0.013 
CHOP_M11 N 27 26 3.01 5.9 0.42 0.076 
CHOP001B N 39 48 0.4 0.35 0.04 0.01 
CHOP004B N 56 71 1.26 6.69 0.27 0.044 
CHOP005B N 56 68 3.31 17.88 0.58 0.087 
CHOP008A N 46 53 0.69 1.33 0.11 0.031 
CHOP010A N 44 33 3.32 26.55 0.47 0.055 
CHOP013A N 52 52 0.93 3.36 0.25 0.062 
CHOP014A N 59 33 0.38 0.77 0.07 0.016 
CHOP016A N 25 3 5.15 10.5 0.36 0.042 
CHOP017B N 16 0 0.76 3.38 0.18 0.035 
CHOP018A N 42 67 0.38 1.41 0.06 0.007 
CHOP019A N 41 52 1.75 7.43 0.23 0.035 
CHOP021A N 41 49 2.28 7.34 0.42 0.076 
CHOP023A N 42 53 2.28 10.4 0.66 0.122 
CHOP024A N 43 58 2.02 3.06 0.16 0.021 
CHOP026A N 40 79 2.69 4.66 0.4 0.073 
CHOP028A N 36 40 1.3 3.62 0.23 0.052 
CHOP029A N 22 40 0.93 3.17 0.12 0.017 
CHOP030B N 35 41 3.68 11.68 0.43 0.069 
CHOP031A N 40 78 0.55 1.58 0.09 0.013 
CHOP032A N 42 43 2.96 22.2 0.76 0.12 
CHOP033A N 52 63 0.51 2.47 0.1 0.016 
CHOP034A N 43 41 2.72 18.15 0.61 0.103 
CHOP035A N 62 21 1.37 5.08 0.13 0.011 
CHOP036A N 55 71 1.22 7.57 0.15 0.015 
CHOP037A N 35 46 4.32 4.04 0.31 0.057 
CHOP038A N 40 22 1.46 6.57 0.27 0.05 
CHOP039A N 48 52 3.11 7.75 0.23 0.019 
CHOP040A N 37 50 1.9 15.3 0.41 0.04 
CHOP041A N 37 21 0.34 1.17 0.1 0.025 
CHOP044A N 49 43 2.9 17.13 0.5 0.078 
CHOP047A N 46 45 0.49 1.77 0.11 0.026 
CHOP049A N 60 77 4.09 40.39 0.28 0.019 
CHOP052B N 44 21 0.94 3.49 0.16 0.023 
CHOP053B N 54 38 0.97 1.33 0.09 0.015 
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CHOP054A N 21 17 0.28 0.66 0.04 
3.00E-
03 
CHOP057A N 40 48 0.71 3.21 0.17 0.033 
CHOP061A N 59 52 1.84 9.56 0.24 0.028 
CHOP062A N 30 43 0.33 0.85 0.08 0.018 
CHOP063A N 50 71 1.39 5.76 0.23 0.032 
CHOP064A N 55 82 0.28 0.37 0.1 0.033 
CHOP065A N 35 39 0.13 0.47 0.05 0.013 
CHOP066A N 38 17 0.76 2.53 0.16 0.02 
CHOP068B N 43 41 1.96 4.57 0.28 0.035 
CHOP069B N 46 65 1.23 2.24 0.12 0.02 
CHOP072A N 52 44 3.06 18.06 0.63 0.1 
CHOP073A N 46 60 0.27 1.39 0.08 0.015 
CHOP074A N 37 60 0.5 1.31 0.15 0.038 
CHOP081A N 38 3 0.22 0.58 0.06 0.011 
CHOP082A N 40 57 0.4 1.38 0.08 0.013 
CHOP083A N 70 48 1.58 5.7 0.25 0.038 
CHOP084A N 52 72 0.63 1.41 0.06 0.008 
CHOP085A N 49 35 1.79 1.66 0.26 0.048 
CHOP087A N 35 39 0.86 2.19 0.22 0.041 
CHOP088A N 52 27 1.15 4.2 0.33 0.069 
CHOP089A N 46 61 0.49 1.94 0.08 0.01 
CHOP090A N 45 74 0.24 1.28 0.06 0.012 
CHOP094A N 36 45 1.69 9.09 0.24 0.03 
CHOP097A N 22 30 3.05 2.63 0.15 0.02 
CHOP100A N 43 13 0.2 0.95 0.07 0.016 
CHOP103A N 52 76 2.96 18.18 0.72 0.134 
CHOP105A N 33 44 1.05 2.56 0.12 0.018 
CHOP108A N 39 42 1.34 3.7 0.25 0.041 
CHOP109B N 51 5 1.57 3.2 0.13 0.015 
CHOP114A N 44 49 2.38 11.62 0.3 0.042 
CHOP118A N 27 44 0.45 1.26 0.09 0.014 
CHOP119A N 36 1 1.02 3.14 0.14 0.017 
CHOP121A N 53 38 1.45 2.09 0.19 0.034 
CHOP128A N 37 60 0.47 1.44 0.05 0.005 
CHOP134A N 38 28 1.03 1.84 0.12 0.016 
CHOP139A N 29 49 0.74 2.75 0.09 0.013 
CHOP143A N 70 12.25 8.6 30 0.71 0.056 
CHOP145A N 40 61 0.76 3.37 0.24 0.052 
CHOP148A N 42 39 0.83 1.25 0.13 0.024 
CHOP152A N 24 36 1.23 9.39 0.25 0.039 
CHOP155A N 54 56 0.92 30 0.65 0.067 
CHOP159A N 48 57 1.12 5.17 0.32 0.073 
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CHOP161A N 54 66 1.5 11.28 0.28 0.039 
CHOP166A N 26 13 2.45 6.12 0.17 0.023 
CHOP187A N 34 41 0.47 1.55 0.09 0.02 
CHOP188A N 58 50 0.44 0.82 0.05 0.01 
CHOP191A N 45 65 0.2 0.45 0.05 0.011 
CHOP203A N 47 46 0.28 1.91 0.06 0.01 
CHOP204A N 37 47 0.86 6.73 0.23 0.035 
CHOP_M12 Y 62 54 0.41 0.72 0.18 0.019 
CHOP_M7 Y 35 0 0.67 5.59 0.19 0.025 
CHOP_M8 Y 55 0 1.74 5.06 0.19 0.023 
CHOP007B Y 28 17 1.46 9.63 0.18 0.024 
CHOP022A Y 49 33 0.81 1.7 0.1 0.016 
CHOP025A Y 58 50 1.95 5.78 0.31 0.047 
CHOP042B Y 77 43 2.26 1.78 0.23 0.042 
CHOP051B Y 78 58 0.99 2 0.26 0.051 
CHOP080A Y 53 29 2.4 11.8 0.54 0.107 
CHOP086A Y 36 4 1.89 7.63 0.2 0.02 
CHOP091A Y 46 33 0.37 5.25 0.18 0.032 
CHOP102A Y 42 31 1.09 6.32 0.22 0.034 
CHOP122A Y 40 30 1.61 3.88 0.34 0.053 
CHOP135A Y 39 30 1.79 4.32 0.26 0.037 
CHOP144C Y 59 0 1.07 1.88 0.2 0.038 















Table 12.5 TCPC Hemodynamocs for extracardiac and intra-atrial patients (N=97) 
 




















CHOP_M12 EC 2 0.46 3.89 62 54 0.41 0.18 0.019 
CHOP_M7 EC 11 1.16 3.70 65 100 0.67 0.19 0.025 
CHOP_M8 EC 6 0.89 4.03 55 0 1.74 0.19 0.023 
CHOP051B EC 4 0.63 3.02 78 58 0.99 0.26 0.051 
CHOP053B EC 3 0.59 4.01 54 38 0.97 0.09 0.015 
CHOP118A EC 5 0.77 4.23 27 44 0.45 0.09 0.014 
CHOP143A EC 4 0.61 7.68 70 12 8.6 0.71 0.056 
CHOP144C EC 4 0.75 2.37 59 0 1.07 0.2 0.038 
CHOP161A EC 14 1.65 4.62 54 66 1.5 0.28 0.039 
CHOP191A EC 16 1.25 3.13 45 65 0.2 0.05 0.011 
CHOP013A EC 16 1.9 1.80 52 52 0.93 0.25 0.062 
CHOP014A EC 9 1.04 3.64 59 33 0.38 0.07 0.016 
CHOP016A EC 6 0.83 3.94 25 3 5.15 0.36 0.042 
CHOP017B EC 15 1.64 3.13 16 0 0.76 0.18 0.035 
CHOP022A EC 7 0.91 3.75 49 33 0.81 0.1 0.016 
CHOP025A EC 9 1.01 3.20 58 50 1.95 0.31 0.047 
CHOP035A EC 8 0.69 7.36 62 21 1.37 0.13 0.011 
CHOP038A EC 18 1.63 2.41 40 22 1.46 0.27 0.05 
CHOP042B EC 3 0.62 3.47 77 43 2.26 0.23 0.042 
CHOP057A EC 21 1.6 2.66 40 48 0.71 0.17 0.033 
CHOP063A EC 9 1.06 3.47 50 71 1.39 0.23 0.032 
CHOP109B EC 4 0.65 4.06 51 5 1.57 0.13 0.015 
CHOP121A EC 5 0.75 2.87 53 38 1.45 0.19 0.034 
CHOP134A EC 4 0.63 3.72 38 28 1.03 0.12 0.016 
CHOP135A EC 6 0.77 4.10 39 30 1.79 0.26 0.037 
CHOP052B EC 10 1.06 5.47 44 21 0.94 0.16 0.023 
CHOP081A EC 3 0.54 7.18 38 3 0.22 0.06 0.011 
CHOP082A EC 7 0.87 3.08 40 57 0.4 0.08 0.013 
CHOP083A EC 8 1.15 3.30 70 48 1.58 0.25 0.038 
CHOP084A EC 8 0.99 3.01 52 72 0.63 0.06 0.008 
CHOP086A EC 6 0.81 3.63 36 4 1.89 0.2 0.02 
CHOP088A EC 8 1.25 2.68 52 27 1.15 0.33 0.069 
CHOP_M10 EC 3 0.61 6.15 85 87 0.99 0.14 0.013 
CHOP_M11 IA 10 1.03 3.81 27 26 3.01 0.42 0.076 
CHOP001B IA 16 1.23 1.62 39 48 0.4 0.04 0.01 
CHOP004B IA 17 1.49 3.78 56 71 1.26 0.27 0.044 
CHOP005B IA 19 1.51 3.01 56 68 3.31 0.58 0.087 
CHOP007B IA 18 2.01 4.20 28 17 1.46 0.18 0.024 
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CHOP008A IA 15 1.94 1.64 46 53 0.69 0.11 0.031 
CHOP010A IA 15 1.62 3.93 44 33 3.32 0.47 0.055 
CHOP023A IA 12 1.22 3.19 42 53 2.28 0.66 0.122 
CHOP024A IA 7 0.74 3.58 43 58 2.02 0.16 0.021 
CHOP028A IA 18 1.92 1.84 36 40 1.3 0.23 0.052 
CHOP030B IA 21 1.39 3.31 35 41 3.68 0.43 0.069 
CHOP032A IA 18 1.64 3.55 42 43 2.96 0.76 0.12 
CHOP033A IA 10 1.32 2.59 52 63 0.51 0.1 0.016 
CHOP034A IA 14 1.89 4.35 43 41 2.72 0.61 0.103 
CHOP036A IA 11 1.19 3.53 55 71 1.22 0.15 0.015 
CHOP037A IA 10 1 3.81 35 46 4.32 0.31 0.057 
CHOP041A IA 14 1.51 2.68 37 21 0.34 0.1 0.025 
CHOP064A IA 6 0.94 1.70 55 82 0.28 0.1 0.033 
CHOP065A IA 16 1.36 2.46 35 39 0.13 0.05 0.013 
CHOP073A  IA 20 1.54 2.52 46 60 0.27 0.08 0.015 
CHOP091A IA 18 2.08 2.42 46 33 0.37 0.18 0.032 
CHOP100A IA 19 1.66 2.13 43 13 0.2 0.07 0.016 
CHOP102A IA 25 1.6 2.92 42 31 1.09 0.22 0.034 
CHOP103A IA 22 1.86 2.65 52 76 2.96 0.72 0.134 
CHOP128A IA 10 0.93 3.97 37 60 0.47 0.05 0.005 
CHOP145A IA 19 1.51 2.46 40 61 0.76 0.24 0.052 
CHOP148A IA 4 0.73 3.39 42 39 0.83 0.13 0.024 
CHOP152A IA 17 1.89 4.07 24 36 1.23 0.25 0.039 
CHOP155A IA 16 1.95 3.85 54 56 0.92 0.65 0.067 
CHOP159A IA 24 1.9 2.16 48 57 1.12 0.32 0.073 
CHOP166A IA 15 1.41 3.72 26 13 2.45 0.17 0.023 
CHOP187A IA 42 1.64 2.54 34 41 0.47 0.09 0.02 
CHOP188A IA 17 1.51 3.49 58 50 0.44 0.05 0.01 
CHOP203A IA 16 1.93 3.45 47 46 0.28 0.06 0.01 
CHOP204A IA 17 1.51 3.62 37 47 0.86 0.23 0.035 
CHOP019A IA 14 1.68 3.29 41 52 1.75 0.23 0.035 
CHOP021A IA 11 1.23 3.03 41 49 2.28 0.42 0.076 
CHOP018A IA 7 0.68 4.49 42 67 0.38 0.06 0.007 
CHOP026A IA 6 0.83 3.69 40 79 2.69 0.4 0.073 
CHOP029A IA 9 1.08 3.66 22 40 0.93 0.12 0.017 
CHOP031A IA 7 0.89 3.65 40 78 0.55 0.09 0.013 
CHOP039A IA 10 1.02 3.86 48 52 3.11 0.23 0.019 
CHOP040A IA 19 2.05 2.84 37 50 1.9 0.41 0.04 
CHOP049A IA 19 1.3 6.97 60 77 4.09 0.28 0.019 
CHOP054A IA 4 0.46 4.48 21 17 0.28 0.04 
3.00E-
03 
CHOP061A IA 10 1.13 4.45 59 52 1.84 0.24 0.028 
CHOP062A IA 12 1.11 2.57 30 43 0.33 0.08 0.018 
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CHOP066A IA 14 1.28 3.45 38 17 0.76 0.16 0.02 
CHOP068B IA 4 0.61 3.82 43 41 1.96 0.28 0.035 
CHOP069B IA 11 1.11 2.90 46 65 1.23 0.12 0.02 
CHOP072A IA 14 1.65 2.78 52 44 3.06 0.63 0.1 
CHOP074A IA 12 1.24 1.78 37 60 0.5 0.15 0.038 
CHOP080A IA 17 1.91 2.91 53 29 2.4 0.54 0.107 
CHOP085A IA 2 0.5 3.20 49 35 1.79 0.26 0.048 
CHOP087A IA 5 0.81 3.30 35 39 0.86 0.22 0.041 
CHOP089A IA 10 0.93 3.12 46 61 0.49 0.08 0.01 
CHOP094A IA 13 1.2 4.58 36 45 1.69 0.24 0.03 
CHOP097A IA 5 0.67 3.41 22 30 3.05 0.15 0.02 
CHOP105A IA 8 0.95 4.06 33 44 1.05 0.12 0.018 
CHOP108A IA 8 0.93 3.15 39 42 1.34 0.25 0.041 
CHOP114A IA 15 1.75 3.17 44 49 2.38 0.3 0.042 
CHOP119A IA 4 0.76 3.68 36 1 1.02 0.14 0.017 
CHOP122A IA 15 1.51 3.28 40 30 1.61 0.34 0.053 
CHOP139A IA 9 1.18 3.81 29 49 0.74 0.09 0.013 
 
 














(mmHg) R (WU) 
TCPC-
EDI 
CHOP_M12 L 3.89 62 54 0.41 0.18 0.019 
CHOP_M7 L 3.70 65 100 0.67 0.19 0.025 
CHOP004B L 3.78 56 71 1.26 0.27 0.044 
CHOP005B L 3.01 56 68 3.31 0.58 0.087 
CHOP007B L 4.20 28 17 1.46 0.18 0.024 
CHOP014A L 3.64 59 33 0.38 0.07 0.016 
CHOP017B L 3.13 16 0 0.76 0.18 0.035 
CHOP024A L 3.58 43 58 2.02 0.16 0.021 
CHOP031A L 3.65 40 78 0.55 0.09 0.013 
CHOP032A L 3.55 42 43 2.96 0.76 0.12 
CHOP033A L 2.59 52 63 0.51 0.1 0.016 
CHOP034A L 4.35 43 41 2.72 0.61 0.103 
CHOP036A L 3.53 55 71 1.22 0.15 0.015 
CHOP044A L 2.87 49 43 2.9 0.5 0.078 
CHOP047A L 2.11 46 45 0.49 0.11 0.026 
CHOP052B L 5.47 44 21 0.94 0.16 0.023 
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CHOP062A L 2.57 30 43 0.33 0.08 0.018 
CHOP063A L 3.47 50 71 1.39 0.23 0.032 
CHOP081A L 7.18 38 3 0.22 0.06 0.011 
CHOP082A L 3.08 40 57 0.4 0.08 0.013 
CHOP083A L 3.30 70 48 1.58 0.25 0.038 
CHOP086A L 3.63 36 4 1.89 0.2 0.02 
CHOP088A L 2.68 52 27 1.15 0.33 0.069 
CHOP089A L 3.12 46 61 0.49 0.08 0.01 
CHOP091A L 2.42 46 33 0.37 0.18 0.032 
CHOP094A L 4.58 36 45 1.69 0.24 0.03 
CHOP100A L 2.13 43 13 0.2 0.07 0.016 
CHOP119A L 3.68 36 1 1.02 0.14 0.017 
CHOP134A L 3.72 38 28 1.03 0.12 0.016 
CHOP135A L 4.10 39 30 1.79 0.26 0.037 
CHOP139A L 3.81 29 49 0.74 0.09 0.013 
CHOP145A L 2.46 40 61 0.76 0.24 0.052 
CHOP148A L 3.39 42 39 0.83 0.13 0.024 
CHOP187A L 2.54 34 41 0.47 0.09 0.02 
CHOP188A L 3.49 58 50 0.44 0.05 0.01 
CHOP191A L 3.13 45 65 0.2 0.05 0.011 
CHOP204A L 3.62 37 47 0.86 0.23 0.035 
CHOP_M10 L 6.15 85 87 0.99 0.14 0.013 
CHOP_M11 R 3.81 27 26 3.01 0.42 0.076 
CHOP_M8 R 4.03 55 0 1.74 0.19 0.023 
CHOP001B R 1.62 39 48 0.4 0.04 0.01 
CHOP008A R 1.64 46 53 0.69 0.11 0.031 
CHOP010A R 3.93 44 33 3.32 0.47 0.055 
CHOP013A R 1.80 52 52 0.93 0.25 0.062 
CHOP016A R 3.94 25 3 5.15 0.36 0.042 
CHOP018A R 4.49 42 67 0.38 0.06 0.007 
CHOP019A R 3.29 41 52 1.75 0.23 0.035 
CHOP021A R 3.03 41 49 2.28 0.42 0.076 
CHOP022A R 3.75 49 33 0.81 0.1 0.016 
CHOP023A R 3.19 42 53 2.28 0.66 0.122 
CHOP026A R 3.69 40 79 2.69 0.4 0.073 
CHOP028A R 1.84 36 40 1.3 0.23 0.052 
CHOP029A R 3.66 22 40 0.93 0.12 0.017 
CHOP030B R 3.31 35 41 3.68 0.43 0.069 
CHOP037A R 3.81 35 46 4.32 0.31 0.057 
CHOP038A R 2.41 40 22 1.46 0.27 0.05 
CHOP039A R 3.86 48 52 3.11 0.23 0.019 
CHOP040A R 2.84 37 50 1.9 0.41 0.04 
CHOP041A R 2.68 37 21 0.34 0.1 0.025 
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CHOP049A R 6.97 60 77 4.09 0.28 0.019 
CHOP053B R 4.01 54 38 0.97 0.09 0.015 
CHOP054A R 4.48 21 17 0.28 0.04 
3.00E-
03 
CHOP057A R 2.66 40 48 0.71 0.17 0.033 
CHOP061A R 4.45 59 52 1.84 0.24 0.028 
CHOP064A R 1.70 55 82 0.28 0.1 0.033 
CHOP065A R 2.46 35 39 0.13 0.05 0.013 
CHOP066A R 3.45 38 17 0.76 0.16 0.02 
CHOP068B R 3.82 43 41 1.96 0.28 0.035 
CHOP069B R 2.90 46 65 1.23 0.12 0.02 
CHOP074A R 1.78 37 60 0.5 0.15 0.038 
CHOP080A R 2.91 53 29 2.4 0.54 0.107 
CHOP085A R 3.20 49 35 1.79 0.26 0.048 
CHOP087A R 3.30 35 39 0.86 0.22 0.041 
CHOP097A R 3.41 22 30 3.05 0.15 0.02 
CHOP102A R 2.92 42 31 1.09 0.22 0.034 
CHOP103A R 2.65 52 76 2.96 0.72 0.134 
CHOP105A R 4.06 33 44 1.05 0.12 0.018 
CHOP108A R 3.15 39 42 1.34 0.25 0.041 
CHOP109B R 4.06 51 5 1.57 0.13 0.015 
CHOP114A R 3.17 44 49 2.38 0.3 0.042 
CHOP122A R 3.28 40 30 1.61 0.34 0.053 
CHOP166A R 3.72 26 13 2.45 0.17 0.023 















Table 12.7 TCPC Hemodynamics for single LV patients without aortic reconstruction and 

















(mmHg) R (WU) 
TCPC-
EDI 
CHOP_M12 L N 3.89 62 54 0.41 0.18 0.019 
CHOP_M7 L N 3.70 65 100 0.67 0.19 0.025 
CHOP004B L N 3.78 56 71 1.26 0.27 0.044 
CHOP005B L N 3.01 56 68 3.31 0.58 0.087 
CHOP007B L N 4.20 28 17 1.46 0.18 0.024 
CHOP017B L N 3.13 16 0 0.76 0.18 0.035 
CHOP031A L N 3.65 40 78 0.55 0.09 0.013 
CHOP032A L N 3.55 42 43 2.96 0.76 0.12 
CHOP033A L N 2.59 52 63 0.51 0.1 0.016 
CHOP034A L N 4.35 43 41 2.72 0.61 0.103 
CHOP036A L N 3.53 55 71 1.22 0.15 0.015 
CHOP047A L N 2.11 46 45 0.49 0.11 0.026 
CHOP052B L N 5.47 44 21 0.94 0.16 0.023 
CHOP062A L N 2.57 30 43 0.33 0.08 0.018 
CHOP063A L N 3.47 50 71 1.39 0.23 0.032 
CHOP082A L N 3.08 40 57 0.4 0.08 0.013 
CHOP083A L N 3.30 70 48 1.58 0.25 0.038 
CHOP086A L N 3.63 36 4 1.89 0.2 0.02 
CHOP088A L N 2.68 52 27 1.15 0.33 0.069 
CHOP089A L N 3.12 46 61 0.49 0.08 0.01 
CHOP091A L N 2.42 46 33 0.37 0.18 0.032 
CHOP100A L N 2.13 43 13 0.2 0.07 0.016 
CHOP119A L N 3.68 36 1 1.02 0.14 0.017 
CHOP135A L N 4.10 39 30 1.79 0.26 0.037 
CHOP145A L N 2.46 40 61 0.76 0.24 0.052 
CHOP148A L N 3.39 42 39 0.83 0.13 0.024 
CHOP187A L N 2.54 34 41 0.47 0.09 0.02 
CHOP188A L N 3.49 58 50 0.44 0.05 0.01 
CHOP191A L N 3.13 45 65 0.2 0.05 0.011 
CHOP204A L N 3.62 37 47 0.86 0.23 0.035 
CHOP_M10 L N 6.15 85 87 0.99 0.14 0.013 
CHOP_M11 R Y 3.81 27 26 3.01 0.42 0.076 
CHOP_M8 R Y 4.03 55 0 1.74 0.19 0.023 
CHOP001B R Y 1.62 39 48 0.4 0.04 0.01 
CHOP008A R Y 1.64 46 53 0.69 0.11 0.031 
CHOP010A R Y 3.93 44 33 3.32 0.47 0.055 
CHOP016A R Y 3.94 25 3 5.15 0.36 0.042 
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CHOP019A R Y 3.29 41 52 1.75 0.23 0.035 
CHOP021A R Y 3.03 41 49 2.28 0.42 0.076 
CHOP022A R Y 3.75 49 33 0.81 0.1 0.016 
CHOP026A R Y 3.69 40 79 2.69 0.4 0.073 
CHOP028A R Y 1.84 36 40 1.3 0.23 0.052 
CHOP029A R Y 3.66 22 40 0.93 0.12 0.017 
CHOP030B R Y 3.31 35 41 3.68 0.43 0.069 
CHOP037A R Y 3.81 35 46 4.32 0.31 0.057 
CHOP039A R Y 3.86 48 52 3.11 0.23 0.019 
CHOP041A R Y 2.68 37 21 0.34 0.1 0.025 
CHOP053B R Y 4.01 54 38 0.97 0.09 0.015 
CHOP054A R Y 4.48 21 17 0.28 0.04 
3.00E-
03 
CHOP061A R Y 4.45 59 52 1.84 0.24 0.028 
CHOP064A R Y 1.70 55 82 0.28 0.1 0.033 
CHOP065A R Y 2.46 35 39 0.13 0.05 0.013 
CHOP066A R Y 3.45 38 17 0.76 0.16 0.02 
CHOP068B R Y 3.82 43 41 1.96 0.28 0.035 
CHOP069B R Y 2.90 46 65 1.23 0.12 0.02 
CHOP074A R Y 1.78 37 60 0.5 0.15 0.038 
CHOP085A R Y 3.20 49 35 1.79 0.26 0.048 
CHOP087A R Y 3.30 35 39 0.86 0.22 0.041 
CHOP097A R Y 3.41 22 30 3.05 0.15 0.02 
CHOP105A R Y 4.06 33 44 1.05 0.12 0.018 
CHOP108A R Y 3.15 39 42 1.34 0.25 0.041 
CHOP114A R Y 3.17 44 49 2.38 0.3 0.042 
CHOP122A R Y 3.28 40 30 1.61 0.34 0.053 
CHOP166A R Y 3.72 26 13 2.45 0.17 0.023 




B. Appendix B- Comparison of Pulsatile and Time-
Averaged CFD simulations 
 
Table 12.8 Comparison of power loss derived from both time-averaged and pulsatile CFD 












CHOP005B 17.9 18.7 68 72 
CHOP008B 8.2 9.9 50 41 
CHOP016A 10.5 11.5 3 6 
CHOP017B 3.4 4 0 3 
CHOP018A 1.4 1.8 67 61 
CHOP019A 7.4 9.1 52 48 
CHOP021A 7.3 7.5 49 45 
CHOP022A 1.7 1.7 33 33 
CHOP024A 3.1 3.6 58 66 
CHOP026A 4.7 5 79 76 
CHOP028A 3.6 5.2 40 38 
CHOP029A 3.2 3.9 40 35 
CHOP034A 18.2 19.1 41 38 
CHOP036A 7.6 7.8 71 69 
CHOP037A 4 4.4 46 47 
CHOP041A 1.2 1.5 13 11 
CHOP042B 1.8 3 43 48 
CHOP052D 2.7 2.6 30 33 
CHOP065A 0.5 0.4 39 35 
CHOP066A 2.5 2.7 17 25 
CHOP080A 11.8 10.2 29 48 
CHOP082B 10.6 15.5 51 46 
CHOP083A 5.7 6.1 48 48 
CHOP085A 1.7 2.2 35 40 
CHOP088A 4.2 5.6 27 35 
CHOP089A 1.9 2.6 61 66 
CHOP091A 5.3 5.7 33 47 
CHOP094A 9.1 11.6 45 46 
CHOP108A 3.7 5.4 42 37 
CHOP114A 11.6 12.7 49 50 
CHOP118A 1.3 2 44 45 
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CHOP122A 3.9 5.9 30 31 
CHOP135A 5 6.8 36 43 
















C. Appendix C- TCPC geometric parameters from 
VMTK analysis 
 
This appendix presents the protocol for and data derived from the geometric analysis of 
the TCPC cohort using VMTK. Patients with an atriopulmonary connection (3) or a Y-
Graft (1) connection were excluded leaving N=96.  
 
4. VMTK Protocol (Credit: Elaine Tang) 
Outputs from code 
Each vessel 
 Vessel Diameter 
 Vessel Area 
 Shape factor 
 Bifurcation angle 
 Tortuosity 
 Vessel length extracted 
 
Across vessels (Single SVC) Across vessels (BilateralSVC) 
 IVC-SVC offsets (projected on 
AP, RL or PA axis) 
 VC-PA offset 
 IVC-SVC angle 
 LPA-RPA angle 
 Angle between adjacent vessels 
(each VC to each PA) 
 IVC-LSVC, IVC-SVC, LSVC-SVC 
offsets (projected on AP, RL or 
PA axis) 
 VC-PA offset 
 Angle between adjacent vessels 
(each VC to each PA) 





With Azygos Vein (AZY)? 
Individual vessel Across vessels 
 Vessel Diameter 
 Vessel Area 
 Shape factor 
 Bifurcation angle 
 Tortuosity 
 Vessel length extracted 
 IVC-AZY, AZY-SVC, AZY-LSVC 
offsets (projected on AP, RL or 
PA axis) 
 AZY- PA offset 
 Angle between AZY and other 
vessels 
 
With Right Upper-lobe Pulmonary Artery (RUPA)? 
Individual vessel 
 Vessel Diameter 
 Vessel Area 
 Shape factor 
 Bifurcation angle 
 Tortuosity 
 Vessel length extracted 
 
 
The parameters were computed in the following ways: 
 Vessel diameter = Maximum Inscribed Radius (r) X 2 
 Cross section area =     
 Shape factor = dmin/dmax 
 Bifurcation angle =       
    
        
 , where b2 and b3 are two vectors coming out 
from the main branch, and |b2|,|b3| are their respective magnitudes, and b2.b3 is 
the dot product of the two vectors 
 Angle across vessel = angle between specified vectors 
 Tortuosity (Curvature) = Length of vessel / (Shortest distance between starting 
point to ending point of the vessel) 
 IVC-SVC offset = distance between IVC and SVC vectors projected on the 
anterior-posterior (AP) / right-left (RL) / pulmonary artery (PA) axis 
502 
 
 VC-PA offset = closet distance between points on PA line and points on VC line 




1) Mesh preparation from GAMBIT 
2) VMTK code (Centerlines + VC line and PA line) 





1) Mesh Preparation with GAMBIT 
 
a. With the TCPC geometry prepared in GAMBIT (no flow extension yet), add the 
following flow extensions: 
- IVC: 10 
- SVC, LPA, RPA: 5 (If RPA is much bigger than LPA, use 8 for RPA) 
- (If present) LSVC, AZY, RUPA: 5 
(The flow extension is necessary as VMTK centerline starts at certain length (~ 
radius of that vessel) from the edge of the vessel. You can change the extension 
length if your centerline end-up sticks out too much from the original geometry or 
vice versa) 
b. Mesh the extended TCPC at the only the TCPC wall, the flow extensions but not 
the end caps, (Triangular mesh, “.FDNEUT” format), mesh size is same as how 
you prepare the mesh for IB code preprocessing. 
 
2) VMTK code 
 
a. Create a new folder for each patient case, copy the following textfiles: 
i. Single SVC: “1TCPC_resamp_geo_bv.txt” and “2VCPAline.txt” 
ii. Bilateral SVC: “1BLSVC_resamp_geo_bv.txt” and “2BLSVC_VCPAline.txt” 
And also the .FDNEUT mesh file inside the folder created 
b. Open the first text file (“1TCPC_resamp_geo_bv.txt” or 
“1BLSVC_resamp_geo_bv.txt”), rename the file in the first line. 
vmtkmeshtosurface -ifile MESHNAME.FDNEUT -ofile surface.stl \ 
And save the text file. 
c. Run the first part of code by typing “vmtk --file 1TCPC_resamp_geo_bv.txt” 





d. Plotting centerlines for IVC 
i. A window with the model will pop up, showing the translucent mesh with 
numbers denoted on the inlets/outlets. Rotate the model view using left mouse 
click, zoom in/out using right/middle mouse click, until you can see all vessels 
and numbers, then press “q” in the new window. 
ii. Go back to the command window, enter the vessel number for inlet (0 for IVC 
in this case) 
iii. Enter the vessel numbers for outlets (2 [space] 3 for LPA,RPA in this case, 
don’t put commas in between vessel number as the code does not like it) 
 
e. Repeat step d for other vessels according to this: 
 
 
Sequence of plotting points for the outlets does not matter, but the sequence of 
specifying the inlets does matter. The program first saves the IVC centerline first, 
then SVC, LPA and RPA. So it is important to follow that order to save the 
centerline with the right name. (You can change the sequence in the text file to 




Run the second part of code by typing “vmtk --file 2VCPAline.txt” (Single SVC) or 
“vmtk --file 2BLSVC_VCPAline” (Bilateral SVC) in the command line 
A window with the model will pop up, showing the translucent mesh with 
numbers denoted on the inlets/outlets. Rotate the model view using left mouse 
click, zoom in/out using right/middle mouse click, until you can see all vessels 
and numbers, then press “q” in the new window. 
Enter inlets and outlets according to the following: 
 
 
3) MATLAB code 
 
a. To run the MATLAB code for data processing, you will need the “XXXclgeo.vtk” 
and “XXXbv.vtk” for each vessel, and also the “IVC_SVCline.vtk” , 
“LPA_RPAline.vtk” (And “IVC_LSVCline.vtk” and/or “Azy_VCline.vtk”) to reference 
your offset to the LPA-RPA centerline. 
b. Copy the “TCPCgeo2.m”, “compute_vessel2.m”, “PAVC_offset.m”, 
“searchPApt.m” and “comAngle.m” MATLAB files to the folder one level above 
the folder you created. (If they are already there then you don’t need to) 
c. In matlab command, type “TCPCgeo2 ('foldername’,has LSVC?, has 
AZY?,has_RUPA? export txt? Export excel?) e.g. TCPCgeo2 
(‘CHOP051B’,1,0,0,1,1) “ 
i. Single SVC, no AZY, no RUPA: TCPCgeo2 (‘CHOP057A’,0,0,0,1,1) 
ii. BilateralSVC, no AZY, no RUPA: TCPCgeo2 (‘CHOP057A,1,0,0,1,1) 
iii. Single SVC, has AZY, no RUPA: TCPCgeo2 (‘CHOP057A,0,1,0,1,1) 
iv. BilateralSVC, has AZY, no RUPA: TCPCgeo2 (‘CHOP057A,1,1,0,1,1) 
 
d. As it finishes running, go into the folder, you will see text files with vessel name 
and the date and time which the file was created (e.g. “LPA_2011510_151625”). 





Another text file created “Offsets_2011427_175856” showing vessel offsets  
 






e. You can open the geometry and centerlines files in Paraview in case you have 
any doubts. 
 
















Min Mean Max 
IVC 15.85 18.40 19.70 0.80 1.03 
 
29.49 
SVC 16.55 17.41 19.31 0.86 1.03 38.89 
LPA 14.23 15.60 17.77 0.80 1.03 21.13 
RPA 9.67 11.06 12.70 0.76 1.02 17.31 
 
SVC-IVC offset projected on LPA-RPA axis (mm): 38.22 mm 
AP IVC_SVC offset (mm): 17.381200   (IVC anterior of SVC --> positive) 
RL IVC_SVC offset (mm): 33.65800    (IVC right of SVC --> positive)  
VC-PA offset (mm): 0.000000     (VC anterior of PA --> positive)  
 
IVC-SVC Angle (degree): 166.78 








IVC 93.76 76.36 





















Min Mean Max 
IVC 16.86  17.95  18.72  0.90  1.01  49.98  
LSVC 9.30  10.37  11.04  0.84  1.00  23.95  
SVC 8.31  8.94  11.39  0.73  1.01  31.98  
LPA 9.40  10.84  11.98  0.78  1.01  23.43  
RPA 10.44  11.05  11.95  0.87  1.03  9.83  
 
Offsets 
Offset (mm) IVC-LSVC IVC-SVC LSVC-SVC 
Projected on LPA/RPA axis 30.10 0.93 29.17 
Anterior-posterior (AP) -2.51 -0.133 2.38 
Right-left (RL) 29.37 0.90 28.48 
VC-PA offset (LSVC) (mm): 0.00 
VC-PA offset (SVC) (mm): 0.00 
 
Angles 






IVC 52.28 81.05 
LSVC 115.07  
SVC  88.16 
 
(Inlet VS inlet) 
LSVC/SVC Angle (degree): 25.13 
IVC/LSVC Angle (degree): 164.707018 
IVC/SVC Angle (degree): 169.016106 
(Outlet VS outlet) 
LPA/RPA Angle (degree): 90.694991 
 
 
5. Vessel Diameters 





Table 12.10 provides those data for the LPA and RPA. Since the azygos vein and LSVC 






















15.5 20.3 23.4 0.3 12.5 13.7 14.5 0.1 
CHOP_M12 
0.019 
23.0 25.2 26.8 0.1 10.4 11.3 14.0 0.3 
CHOP_M7 
0.025 
11.0 13.6 15.8 0.3 10.4 12.0 15.6 0.3 
CHOP_M8 
0.023 
13.2 14.0 16.1 0.2 8.4 8.9 9.2 0.1 
CHOP001B 
0.01 
15.6 19.8 22.4 0.3 10.2 13.3 18.0 0.4 
CHOP004B 
0.044 
12.2 15.9 20.1 0.4 9.4 11.0 13.9 0.3 
CHOP005B 
0.087 
15.2 21.1 26.4 0.4 8.1 10.1 11.7 0.3 
CHOP007B 
0.024 
13.3 16.1 18.9 0.3 7.1 9.1 13.9 0.5 
CHOP008A 
0.031 
14.7 17.9 23.3 0.4 11.5 14.2 19.2 0.4 
CHOP010A 
0.055 
15.7 19.2 20.4 0.2 7.8 8.4 12.0 0.4 
CHOP013A 
0.062 
10.1 17.5 25.0 0.6 6.5 8.0 15.3 0.6 
CHOP014A 
0.016 
16.1 18.6 22.0 0.3 12.9 14.5 20.5 0.4 
CHOP016A 
0.042 
14.1 17.3 20.7 0.3 14.8 15.5 16.1 0.1 
CHOP017B 
0.035 
11.5 13.9 19.1 0.4 11.2 12.2 12.9 0.1 
CHOP018A 
0.007 
20.3 21.5 23.2 0.1 14.1 14.9 16.6 0.2 
CHOP019A 
0.035 
12.2 16.0 19.1 0.4 9.0 11.8 16.2 0.4 
CHOP021A 
0.076 
12.4 15.1 18.2 0.3 9.4 10.3 12.3 0.2 
CHOP022A 
0.016 
15.1 16.0 17.4 0.1 11.2 13.3 17.7 0.4 
CHOP023A 
0.122 
7.1 11.8 20.9 0.7 12.4 14.7 17.8 0.3 
CHOP024A 
0.021 
17.4 19.6 23.4 0.3 15.2 17.4 19.2 0.2 
CHOP025A 
0.047 
9.4 10.7 13.3 0.3 7.8 8.6 10.4 0.3 
CHOP026A 
0.073 
20.6 21.9 23.4 0.1 12.9 15.1 15.7 0.2 
CHOP028A 
0.052 
11.6 14.6 18.3 0.4 9.7 11.1 14.2 0.3 
CHOP029A 
0.017 
15.6 19.8 23.2 0.3 14.3 15.8 17.7 0.2 
CHOP030B 
0.069 
15.4 18.8 21.9 0.3 7.6 8.4 10.0 0.2 
CHOP031A 
0.013 





8.3 11.4 19.2 0.6 10.8 12.4 15.4 0.3 
CHOP033A 
0.016 
14.1 15.2 18.1 0.2 10.4 12.7 16.7 0.4 
CHOP034A 
0.103 
10.1 13.8 17.0 0.4 12.0 13.9 16.7 0.3 
CHOP035A 
0.011 
14.0 17.8 23.0 0.4 14.6 15.5 17.0 0.1 
CHOP036A 
0.015 
14.0 18.0 23.6 0.4 11.4 12.7 15.4 0.3 
CHOP037A 
0.057 
11.8 15.1 21.4 0.4 11.6 13.6 17.8 0.3 
CHOP038A 
0.05 
15.7 17.6 19.9 0.2 6.7 11.0 17.7 0.6 
CHOP039A 
0.019 
17.1 20.1 22.2 0.2 14.2 16.4 19.3 0.3 
CHOP040A 
0.04 
11.5 15.0 20.1 0.4 11.1 11.9 15.1 0.3 
CHOP041A 
0.025 
14.6 17.1 21.6 0.3 10.1 11.0 11.7 0.1 
CHOP042B 
0.042 
14.0 14.5 15.8 0.1 7.4 7.8 8.0 0.1 
CHOP051B 
0.051 
19.5 21.4 22.7 0.1 9.3 10.4 14.3 0.3 
CHOP052B 
0.023 
13.6 14.7 16.0 0.2 13.4 13.5 13.7 0.0 
CHOP053B 
0.015 
17.8 20.0 21.2 0.2 10.5 12.0 16.1 0.3 
CHOP054A 
0.003 
27.6 31.2 34.0 0.2 19.9 23.5 26.2 0.2 
CHOP057A 
0.033 
9.8 13.1 15.4 0.4 12.4 13.1 13.6 0.1 
CHOP061A 
0.028 
20.6 23.8 26.1 0.2 14.6 16.7 21.5 0.3 
CHOP062A 
0.018 
13.7 15.7 18.3 0.2 12.2 13.4 15.5 0.2 
CHOP063A 
0.032 
12.0 13.6 18.9 0.4 12.8 15.4 17.5 0.3 
CHOP064A 
0.033 
15.7 18.1 20.3 0.2 11.5 13.6 15.8 0.3 
CHOP065A 
0.013 
14.8 18.1 24.2 0.4 13.8 15.7 19.9 0.3 
CHOP066A 
0.02 
12.5 15.1 19.2 0.3 11.0 13.5 19.2 0.4 
CHOP068B 
0.035 
20.2 23.2 27.0 0.3 16.8 20.2 24.6 0.3 
CHOP069B 
0.02 
18.4 22.7 27.3 0.3 11.6 16.4 22.8 0.5 
CHOP072A 
0.1 
8.9 12.9 19.2 0.5 10.0 12.9 15.3 0.3 
CHOP073A 
0.015 
13.2 17.2 22.7 0.4 13.7 14.8 15.3 0.1 
CHOP074A 
0.038 
11.7 15.0 19.4 0.4 9.4 12.5 16.1 0.4 
CHOP080A 
0.107 
7.5 12.0 18.2 0.6 12.7 16.3 19.5 0.3 
CHOP081A 
0.011 
24.5 27.3 28.7 0.1 19.1 20.5 22.2 0.1 
CHOP082A 
0.013 





16.0 16.3 17.4 0.1 15.0 15.3 15.8 0.1 
CHOP084A 
0.008 
15.7 19.1 22.5 0.3 15.6 15.7 15.8 0.0 
CHOP085A 
0.048 
19.7 23.5 25.8 0.2 16.6 18.3 21.1 0.2 
CHOP086A 
0.02 
17.0 18.7 20.8 0.2 7.9 9.6 13.3 0.4 
CHOP087A 
0.041 
22.7 24.7 26.2 0.1 20.4 21.9 23.2 0.1 
CHOP088A 
0.069 
13.8 15.4 16.9 0.2 11.8 12.7 13.8 0.1 
CHOP089A 
0.01 
16.1 18.3 20.4 0.2 13.0 15.1 18.1 0.3 
CHOP091A 
0.032 
12.0 14.4 16.7 0.3 6.5 8.5 11.6 0.4 
CHOP094A 
0.03 
13.7 15.6 18.7 0.3 13.5 14.1 14.7 0.1 
CHOP097A 
0.02 
21.0 22.7 24.6 0.1 16.6 18.1 19.6 0.2 
CHOP100A 
0.016 
14.1 18.0 22.6 0.4 16.4 17.7 18.7 0.1 
CHOP102A 
0.034 
12.0 13.9 19.6 0.4 8.8 11.2 18.4 0.5 
CHOP103A 
0.134 
7.8 12.2 18.4 0.6 9.9 12.1 16.3 0.4 
CHOP105A 
0.018 
18.1 19.6 21.7 0.2 13.0 15.8 20.2 0.4 
CHOP108A 
0.041 
18.0 19.4 21.7 0.2 13.5 15.3 16.9 0.2 
CHOP109B 
0.015 
17.4 21.4 23.5 0.3 14.3 14.7 15.4 0.1 
CHOP114A 
0.042 
10.0 13.3 18.8 0.5 9.6 12.1 16.7 0.4 
CHOP118A 
0.014 
17.1 18.4 20.7 0.2 12.4 13.4 15.4 0.2 
CHOP119A 
0.017 
14.1 20.1 22.6 0.4 13.9 14.2 14.5 0.0 
CHOP121A 
0.034 
14.1 16.2 17.8 0.2 13.9 14.2 15.1 0.1 
CHOP122A 
0.053 
14.7 16.8 18.3 0.2 11.6 13.3 15.9 0.3 
CHOP128A 
0.005 
18.1 19.6 21.4 0.2 13.7 14.9 17.6 0.2 
CHOP134A 
0.016 
16.9 20.2 22.2 0.2 11.9 13.5 15.9 0.3 
CHOP135A 
0.037 
17.3 18.9 19.4 0.1 11.3 12.2 14.9 0.2 
CHOP139A 
0.013 
16.8 19.6 23.5 0.3 12.4 13.9 17.3 0.3 
CHOP143A 
0.056 
14.9 16.4 17.7 0.2 12.1 15.7 24.7 0.5 
CHOP144C 
0.038 
10.8 14.2 16.5 0.3 9.7 11.1 12.4 0.2 
CHOP145A 
0.052 
12.1 15.7 22.0 0.4 13.7 14.8 15.5 0.1 
CHOP148A 
0.024 
16.9 20.5 23.1 0.3 14.9 15.5 15.8 0.1 
CHOP152A 
0.039 





11.4 14.0 17.1 0.3 13.3 14.1 15.7 0.2 
CHOP159A 
0.073 
12.9 18.9 28.1 0.5 10.7 13.5 18.9 0.4 
CHOP161A 
0.039 
10.2 11.3 16.4 0.4 13.8 14.3 14.6 0.1 
CHOP166A 
0.023 
16.6 19.5 22.4 0.3 9.6 12.6 18.9 0.5 
CHOP187A 
0.02 
23.2 28.5 33.6 0.3 13.2 15.2 17.6 0.3 
CHOP188A 
0.01 
17.9 20.7 25.1 0.3 12.2 13.5 16.1 0.2 
CHOP191A 
0.011 
16.3 17.1 18.5 0.1 10.0 11.2 13.5 0.3 
CHOP203A 
0.01 
15.5 17.3 21.7 0.3 12.5 14.3 15.5 0.2 
CHOP204A 
0.035 





































































































































































































































































































































































































































Table 12.11 presents the connection angles between indicated the vessels; Table 12.12 
shows the offset distances, normalized by IVC diameter. 
 
 


















121.5 92.9 96.1 105.7 140.1 82.1 
CHOP_M12 
54 
122.6 97.6 98.6 57.8 125.7 75.0 
CHOP_M7 
100 
90.1 112.4 111.3 118.5 118.3 100.7 
CHOP_M8 
0 
110.4 88.9 124.0 61.5 113.2 86.5 
CHOP001B 
48 
110.5 71.3 84.4 102.5 165.1 120.5 
CHOP004B 
71 
121.2 95.5 96.5 93.0 115.9 132.1 
CHOP005B 
68 
99.8 85.6 82.0 104.9 136.4 163.6 
CHOP007B 
17 
101.0 106.5 122.5 76.7 122.0 54.3 
CHOP008A 
53 
115.4 63.7 128.0 96.1 114.2 119.1 
CHOP010A 
33 
125.2 75.1 99.8 112.3 127.8 113.9 
CHOP013A 
52 
116.8 96.6 97.1 90.1 129.3 127.5 
CHOP014A 
33 
109.8 83.6 104.5 120.1 121.1 117.3 
CHOP016A 
3 
102.2 86.6 109.4 84.8 142.7 135.1 
CHOP017B 
0 
95.1 102.5 87.4 82.7 128.7 162.4 
CHOP018A 
67 
127.1 78.1 105.9 99.8 122.7 115.0 
CHOP019A 
52 
121.5 108.4 102.4 110.5 111.1 102.5 
CHOP021A 
49 
122.6 61.2 94.4 104.1 142.9 118.7 
CHOP022A 
33 
85.4 92.1 128.8 74.4 145.2 106.0 
CHOP023A 
53 
104.5 90.2 93.5 100.7 161.0 73.3 
CHOP024A 
58 
121.3 110.4 116.7 127.4 104.7 75.6 
CHOP025A 
50 
146.2 118.2 130.9 104.5 82.5 64.1 
CHOP026A 
79 
124.7 87.6 103.6 107.8 131.1 81.7 
CHOP028A 
40 





114.0 91.7 105.8 115.0 134.1 84.0 
CHOP030B 
41 
127.9 60.9 74.5 96.5 155.7 138.5 
CHOP031A 
78 
133.4 79.9 83.8 104.9 140.1 107.6 
CHOP032A 
43 
111.1 90.9 97.8 101.3 128.4 131.2 
CHOP033A 
63 
122.9 96.8 80.0 90.7 146.6 119.0 
CHOP034A 
41 
115.5 88.5 108.0 91.6 135.2 103.9 
CHOP035A 
21 
91.0 89.6 93.4 96.7 171.9 96.4 
CHOP036A 
71 
111.4 75.5 80.9 98.2 114.2 172.8 
CHOP037A 
46 
114.4 98.0 107.5 113.8 112.0 111.0 
CHOP038A 
22 
128.0 106.9 128.0 106.9 0.0 79.8 
CHOP039A 
52 
116.7 79.9 105.7 88.5 137.5 111.1 
CHOP040A 
50 
112.9 109.0 130.1 117.4 97.3 89.9 
CHOP041A 
21 
104.3 77.0 96.6 110.8 156.5 98.5 
CHOP042B 
43 
88.6 57.5 120.1 65.8 110.4 81.5 
CHOP051B 
58 
51.1 77.4 128.1 89.7 166.8 74.5 
CHOP052B 
21 
101.4 104.1 91.7 72.3 162.4 138.4 
CHOP053B 
38 
113.5 92.6 114.0 90.1 125.6 115.3 
CHOP054A 
17 
93.6 75.3 102.0 93.3 162.2 100.4 
CHOP057A 
48 
81.5 91.8 92.2 91.7 173.4 106.6 
CHOP061A 
52 
128.2 78.4 94.0 100.9 135.4 111.7 
CHOP062A 
43 
115.4 110.5 101.5 115.7 91.1 119.0 
CHOP063A 
71 
96.8 81.9 116.3 99.4 127.0 134.3 
CHOP064A 
82 
123.0 94.5 115.6 104.4 121.3 72.8 
CHOP065A 
39 
112.9 81.7 115.9 100.9 126.1 110.8 
CHOP066A 
17 
110.3 80.1 114.7 98.2 133.1 107.3 
CHOP068B 
41 
114.5 82.1 94.9 104.4 150.6 76.5 
CHOP069B 
65 
116.8 99.2 110.5 109.3 114.8 104.9 
CHOP072A 
44 
119.0 55.0 81.6 107.1 153.8 103.1 
CHOP073A 
60 
109.1 89.8 109.1 105.3 115.8 127.2 
CHOP074A 
60 





116.1 116.9 129.9 101.0 111.8 43.6 
CHOP081A 
3 
96.1 91.1 111.7 80.7 148.9 132.0 
CHOP082A 
57 
119.1 70.2 84.1 97.4 154.5 144.6 
CHOP083A 
48 
76.0 95.7 112.6 88.1 144.1 154.9 
CHOP084A 
72 
120.5 60.7 105.4 90.0 133.2 140.6 
CHOP085A 
35 
100.6 74.8 114.4 108.5 142.6 102.1 
CHOP086A 
4 
74.5 79.2 119.7 87.7 156.5 71.3 
CHOP087A 
39 
108.5 90.6 98.7 120.9 137.3 92.7 
CHOP088A 
27 
103.7 81.7 114.8 89.2 137.7 126.0 
CHOP089A 
61 
119.4 101.0 83.3 107.8 131.9 113.0 
CHOP091A 
33 
105.2 86.0 97.0 78.5 152.2 87.3 
CHOP094A 
45 
125.0 128.9 110.4 111.1 104.1 75.1 
CHOP097A 
30 
113.8 81.1 108.7 122.9 131.0 89.8 
CHOP100A 
13 
111.2 89.6 111.0 93.9 122.8 127.5 
CHOP102A 
31 
71.4 81.4 131.3 96.8 145.5 47.8 
CHOP103A 
76 
104.1 92.0 83.6 114.2 129.8 139.4 
CHOP105A 
44 
104.3 83.4 108.8 92.9 146.3 107.2 
CHOP108A 
42 
116.7 88.0 87.9 96.8 154.8 92.3 
CHOP109B 
5 
106.6 95.7 116.5 76.7 136.9 100.3 
CHOP114A 
49 
83.4 68.1 92.8 129.8 158.9 121.7 
CHOP118A 
44 
121.4 70.9 96.7 114.9 130.6 123.7 
CHOP119A 
1 
89.6 75.4 104.7 105.4 148.3 143.4 
CHOP121A 
38 
117.9 116.9 119.2 65.0 121.4 99.5 
CHOP122A 
30 
121.5 72.6 114.2 98.9 118.5 76.0 
CHOP128A 
60 
127.8 102.7 115.0 91.1 114.6 91.6 
CHOP134A 
28 
104.7 85.4 115.9 94.2 132.2 120.8 
CHOP135A 
30 
105.0 89.4 120.5 89.6 119.7 51.9 
CHOP139A 
49 
106.3 105.1 122.0 114.4 103.1 104.6 
CHOP143A 
12.25 
117.7 73.2 100.5 94.5 141.5 116.5 
CHOP144C 
0 





125.8 88.6 103.1 119.9 125.0 87.5 
CHOP148A 
39 
97.6 101.5 109.7 93.2 131.6 126.8 
CHOP152A 
36 
91.6 56.8 132.0 90.2 135.1 133.2 
CHOP155A 
56 
124.2 74.4 88.0 98.4 141.0 136.2 
CHOP159A 
57 
106.2 90.1 101.2 97.4 144.3 117.5 
CHOP161A 
66 
61.7 90.8 109.4 115.9 130.6 134.4 
CHOP166A 
13 
98.6 107.2 125.2 100.9 106.7 116.9 
CHOP187A 
41 
108.4 72.2 90.5 92.0 160.9 138.0 
CHOP188A 
50 
116.1 57.7 76.2 141.3 149.5 122.7 
CHOP191A 
65 
116.0 73.1 69.4 120.7 158.4 130.6 
CHOP203A 
46 
145.1 90.9 93.7 104.2 119.5 90.7 
CHOP204A 
47 
126.0 87.9 94.3 97.6 108.3 137.8 
 
 
Table 12.12 Cavopulmonary offset distances normalized by IVC diameter in the Antero-






AP RL VC abs(RL) 
CHOP_M11 
0.076 26 
0.04 0.08 0.37 0.08 
CHOP_M12 
0.019 54 
0.05 -0.36 0.01 0.36 
CHOP_M7 
0.025 100 
0.60 1.81 0.00 1.81 
CHOP_M8 
0.023 0 
0.04 0.14 0.14 0.14 
CHOP001B 
0.01 48 
0.03 0.24 -0.01 0.24 
CHOP004B 
0.044 71 
0.04 0.14 0.37 0.14 
CHOP005B 
0.087 68 
0.11 0.22 0.00 0.22 
CHOP007B 
0.024 17 
0.06 0.13 0.32 0.13 
CHOP008A 
0.031 53 
0.00 0.00 0.29 0.00 
CHOP010A 
0.055 33 
0.03 0.21 0.51 0.21 
CHOP013A 
0.062 52 
0.02 0.04 0.25 0.04 
CHOP014A 
0.016 33 





-0.04 -0.19 0.05 0.19 
CHOP017B 
0.035 0 
0.02 -0.33 0.01 0.33 
CHOP018A 
0.007 67 
0.13 0.24 0.21 0.24 
CHOP019A 
0.035 52 
0.00 0.09 0.43 0.09 
CHOP021A 
0.076 49 
0.06 0.26 0.57 0.26 
CHOP022A 
0.016 33 
-0.03 -0.16 0.08 0.16 
CHOP023A 
0.122 53 
0.00 0.00 0.56 0.00 
CHOP024A 
0.021 58 
0.18 0.29 0.60 0.29 
CHOP025A 
0.047 50 
0.35 1.52 0.00 1.52 
CHOP026A 
0.073 79 
0.19 0.23 0.35 0.23 
CHOP028A 
0.052 40 
0.01 0.12 0.58 0.12 
CHOP029A 
0.017 40 
0.07 0.12 0.29 0.12 
CHOP030B 
0.069 41 
0.41 0.38 0.01 0.38 
CHOP031A 
0.013 78 
0.23 0.33 0.42 0.33 
CHOP032A 
0.12 43 
0.03 0.05 0.68 0.05 
CHOP033A 
0.016 63 
0.04 0.18 0.34 0.18 
CHOP034A 
0.103 41 
0.01 0.02 0.16 0.02 
CHOP035A 
0.011 21 
-0.10 -2.15 0.00 2.15 
CHOP036A 
0.015 71 
0.01 0.22 0.17 0.22 
CHOP037A 
0.057 46 
0.00 0.00 0.59 0.00 
CHOP038A 
0.05 22 
0.00 0.00 0.56 0.00 
CHOP039A 
0.019 52 
0.00 0.00 0.24 0.00 
CHOP040A 
0.04 50 
-0.02 -0.01 0.80 0.01 
CHOP041A 
0.025 21 
0.11 0.16 0.10 0.16 
CHOP042B 
0.042 43 
0.35 0.67 0.00 0.67 
CHOP051B 
0.051 58 
-0.02 -0.12 0.01 0.12 
CHOP052B 
0.023 21 
-0.17 -0.45 0.00 0.45 
CHOP053B 
0.015 38 
0.01 0.03 0.21 0.03 
CHOP054A 
0.003 17 
-0.01 -0.03 0.33 0.03 
CHOP057A 
0.033 48 





0.03 0.06 0.21 0.06 
CHOP062A 
0.018 43 
0.04 0.03 0.57 0.03 
CHOP063A 
0.032 71 
-0.03 -0.08 0.17 0.08 
CHOP064A 
0.033 82 
0.04 0.09 0.49 0.09 
CHOP065A 
0.013 39 
-0.02 -0.09 0.49 0.09 
CHOP066A 
0.02 17 
0.05 0.06 0.08 0.06 
CHOP068B 
0.035 41 
0.03 0.05 0.42 0.05 
CHOP069B 
0.02 65 
0.05 0.07 0.17 0.07 
CHOP072A 
0.1 44 
0.27 0.33 0.85 0.33 
CHOP073A 
0.015 60 
0.15 0.26 0.30 0.26 
CHOP074A 
0.038 60 
0.08 0.12 0.27 0.12 
CHOP080A 
0.107 29 
0.11 0.30 0.81 0.30 
CHOP081A 
0.011 3 
-0.05 -0.28 0.00 0.28 
CHOP082A 
0.013 57 
0.12 0.17 0.29 0.17 
CHOP083A 
0.038 48 
-0.19 -0.42 0.00 0.42 
CHOP084A 
0.008 72 
0.03 0.16 0.00 0.16 
CHOP085A 
0.048 35 
0.00 0.00 0.33 0.00 
CHOP086A 
0.02 4 
0.08 0.20 0.00 0.20 
CHOP087A 
0.041 39 
0.03 0.10 0.31 0.10 
CHOP088A 
0.069 27 
-0.12 -0.37 0.00 0.37 
CHOP089A 
0.01 61 
0.11 0.20 0.57 0.20 
CHOP091A 
0.032 33 
0.00 0.00 0.00 0.00 
CHOP094A 
0.03 45 
-0.02 -0.03 0.61 0.03 
CHOP097A 
0.02 30 
0.03 0.20 0.32 0.20 
CHOP100A 
0.016 13 
-0.10 -0.17 0.57 0.17 
CHOP102A 
0.034 31 
0.07 0.25 0.43 0.25 
CHOP103A 
0.134 76 
0.01 0.02 0.09 0.02 
CHOP105A 
0.018 44 
0.03 0.10 0.35 0.10 
CHOP108A 
0.041 42 
0.15 0.14 0.28 0.14 
CHOP109B 
0.015 5 





0.13 0.18 0.36 0.18 
CHOP118A 
0.014 44 
0.10 0.22 0.10 0.22 
CHOP119A 
0.017 1 
-0.16 -0.23 0.00 0.23 
CHOP121A 
0.034 38 
-0.13 -0.20 0.19 0.20 
CHOP122A 
0.053 30 
0.06 0.07 0.49 0.07 
CHOP128A 
0.005 60 
0.04 0.05 0.38 0.05 
CHOP134A 
0.016 28 
0.02 -0.12 0.07 0.12 
CHOP135A 
0.037 30 
0.00 0.00 0.28 0.00 
CHOP139A 
0.013 49 
0.03 0.10 0.51 0.10 
CHOP143A 
0.056 12.25 
0.02 0.04 0.00 0.04 
CHOP144C 
0.038 0 
-0.02 -0.06 0.42 0.06 
CHOP145A 
0.052 61 
0.20 0.30 0.49 0.30 
CHOP148A 
0.024 39 
-0.04 -0.26 0.00 0.26 
CHOP152A 
0.039 36 
0.13 0.32 0.00 0.32 
CHOP155A 
0.059 56 
0.12 0.21 0.39 0.21 
CHOP159A 
0.073 57 
-0.01 -0.02 0.26 0.02 
CHOP161A 
0.039 66 
-0.14 0.36 0.27 0.36 
CHOP166A 
0.023 13 
0.01 0.02 0.50 0.02 
CHOP187A 
0.02 41 
0.10 0.10 0.00 0.10 
CHOP188A 
0.01 50 
0.00 -0.03 0.03 0.03 
CHOP191A 
0.011 65 
0.11 0.50 0.00 0.50 
CHOP203A 
0.01 46 
0.11 0.17 0.54 0.17 
CHOP204A 
0.035 47 





D. Appendix D- Ventricular Function Patients 
7. Demographic details 
Table 12.13 Demographic details for patients included in ventricular function analysis 
 
Age Gender BSA 
Ventricle 
Morphology 
CHOP004D 22 M 1.58 L 
CHOP005B 19 F 1.51 L 
CHOP024A 7 F 0.74 L 
CHOP033A 10 M 1.32 L 
CHOP034A 14 M 1.89 L 
CHOP036A 11 M 1.19 L 
CHOP052B 10 M 1.06 L 
CHOP082B 22 F 1.32 L 
CHOP088B 13 F 1.72 L 
CHOP089A 10 M 0.93 L 
CHOP091A 18 M 2.08 L 
CHOP094A 13 M 1.2 L 
CHOP135A 6 M 0.77 L 
CHOP145A 19 F 1.51 L 
CHOP188A 17 M 1.51 L 
CHOP204A 17 F 1.51 L 
CHOP008B 16 M 1.94 R 
CHOP016A 6 M 0.83 R 
CHOP019A 14 M 1.68 R 
CHOP021A 11 F 1.23 R 
CHOP022A 7 M 0.91 R 
CHOP023A 12 M 1.22 R 
CHOP028A 18 M 1.92 R 
CHOP029A 9 M 1.08 R 
CHOP037A 10 M 1 R 
CHOP041A 14 F 1.51 R 
CHOP065A 16 M 1.36 R 
CHOP066A 14 F 1.28 R 
CHOP080A 17 F 1.91 R 
CHOP085A 2 M 0.5 R 
CHOP108A 8 M 0.93 R 
CHOP114A 15 M 1.75 R 
CHOP166A 15 M 1.41 R 
CHOP203A 16 M 1.93 R 
527 
 
CHOP018C 14 M 1.24 B 
CHOP040A 19 F 2.05 B 
CHOP042B 3 F 0.62 B 
CHOP118A 5 M 0.77 B 
CHOP155A 16 M 1.83 B 
CHOP161A 14 F 1.65 B 
 
8. Imaging details 









CHOP004D 30 8 0.032 8 1.56 
CHOP005B 23 12 0.041 10 1.46 
CHOP024A 33 10 0.027 5 1.88 
CHOP033A 30 8 0.035 9 1.46 
CHOP034A 23 8 0.026 10 1.67 
CHOP036A 20 6 0.035 8 1.95 
CHOP052B 20 7 0.028 10 0.57 
CHOP082B 30 7 0.041 10 1.17 
CHOP088B 24 8 0.028 10 1.77 
CHOP089A 25 8 0.044 9 1.04 
CHOP091A 25 7 0.029 10 1.82 
CHOP094A 25 8 0.023 8 1.35 
CHOP135A 26 8 0.03 8 0.6 
CHOP145A 28 9 0.038 8 1.77 
CHOP188A 30 7 0.038 10 1.37 
CHOP204A 30 10 0.035 8 1.25 
CHOP008B 18 9 0.037 9 1.56 
CHOP016A 22 7 0.029 6 1.41 
CHOP019A 22 7 0.034 8 1.46 
CHOP021A 21 7 0.042 7 1.46 
CHOP022A 22 9 0.032 7 1.56 
CHOP023A 31 8 0.029 7 1.72 
CHOP028A 25 6 0.035 10 1.67 
CHOP029A 25 8 0.037 7 1.36 
CHOP037A 16 6 0.041 8 1.15 
CHOP041A 20 8 0.039 8 1.3 
CHOP065A 30 8 0.034 10 1.56 
CHOP066A 30 7 0.036 8 1.46 
CHOP080A 27 6 0.033 10 1.77 
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CHOP085A 25 9 0.024 7 0.94 
CHOP108A 25 8 0.032 8 0.5 
CHOP114A 29 8 0.034 10 0.83 
CHOP166A 25 9 0.03 7 1.35 
CHOP203A 30 8 0.032 10 1.41 
CHOP018C 27 7 0.028 10 1.35 
CHOP040A 30 8 0.033 9 1.77 
CHOP042B 26 8 0.023 5 1.41 
CHOP118A 22 7 0.03 7 0.82 
CHOP155A 25 8 0.026 10 1.25 
CHOP161A 25 8 0.029 8 1.25 
 
 
9. Functional analysis 












CHOP004D 0.034 59.49 24.68 34.81 58 2.16 
CHOP005B 0.087 92.72 46.36 45.7 50 2.92 
CHOP024A 0.021 82.43 36.49 45.95 55 3.08 
CHOP033A 0.016 75 39.39 35.61 47 2.03 
CHOP034A 0.103 70.9 29.63 41.27 58 4.17 
CHOP036A 0.015 62.18 23.53 39.5 63 3.4 
CHOP052B 0.023 87.74 37.74 50 57 5.45 
CHOP082B 0.033 92.42 43.94 48.48 52 2.38 
CHOP088B 0.029 84.88 40.7 43.6 52 3.84 
CHOP089A 0.01 96.77 48.39 48.39 50 2.66 
CHOP091A 0.032 41.83 19.71 21.63 52 1.82 
CHOP094A 0.03 89.17 36.67 52.5 59 5.41 
CHOP135A 0.037 88.31 22.08 66.23 75 5.1 
CHOP145A 0.052 66.23 20.53 45.7 69 2.56 
CHOP188A 0.01 88.08 26.49 61.59 70 3.2 
CHOP204A 0.035 88.74 42.38 46.36 48 2.64 
CHOP008B 0.065 75.26 41.75 33.51 45 2.98 
CHOP016A 0.042 57.83 25.3 32.53 57 3.09 
CHOP019A 0.035 45.83 17.86 27.98 61 2.27 
CHOP021A 0.076 77.24 34.15 43.09 55 2.93 
CHOP022A 0.016 97.8 67.03 31.87 32 2.74 
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CHOP023A 0.122 76.23 27.87 48.36 64 3.19 
CHOP028A 0.052 54.17 21.35 32.29 60 2.23 
CHOP029A 0.017 86.11 32.41 53.7 62 3.49 
CHOP037A 0.057 55 30 25 46 2.28 
CHOP041A 0.025 62.25 19.21 42.38 69 3.26 
CHOP065A 0.013 109.56 55.88 52.94 49 3.12 
CHOP066A 0.02 93.75 38.28 55.47 59 3.05 
CHOP080A 0.107 58.64 22.51 36.13 61 2.46 
CHOP085A 0.048 58 24 34 59 3.33 
CHOP108A 0.041 96.77 47.31 48.39 51 3.63 
CHOP114A 0.042 91.43 49.14 42.29 46 2.58 
CHOP166A 0.023 82.27 33.33 48.94 59 3.87 
CHOP203A 0.01 95.85 42.49 53.37 55 3.36 
CHOP018C 0.011 91.13 47.58 43.55 48 3.4 
CHOP040A 0.04 70.24 34.63 35.61 50 2.17 
CHOP042B 0.042 53.23 32.26 20.97 40 2.12 
CHOP118A 0.014 84.42 50.65 33.77 40 3.07 
CHOP155A 0.059 74.36 38.97 35.9 48 3.27 
CHOP161A 0.039 76.97 35.76 40.61 53 3.41 
 















CHOP004D -189.87 -3.19 146.84 2.47 0.17 62 
CHOP005B -194.04 -2.09 190.73 2.06 0.15 64 
CHOP024A -227.03 -2.75 310.81 3.77 0.19 67 
CHOP033A -162.12 -2.16 185.61 2.47 0.14 57 
CHOP034A -288.36 -4.07 197.35 2.78 0.29 101 
CHOP036A -208.4 -3.35 241.18 3.88 0.19 86 
CHOP052B -342.45 -3.9 267.92 3.05 0.2 109 
CHOP082B -228.03 -2.47 229.55 2.48 0.13 49 
CHOP088B -233.14 -2.75 220.93 2.6 0.17 88 
CHOP089A -229.03 -2.37 208.6 2.16 0.12 55 
CHOP091A -110.58 -2.64 102.4 2.45 0.24 84 
CHOP094A -289.17 -3.24 408.33 4.58 0.24 103 
CHOP135A -402.6 -4.56 331.17 3.75 0.22 77 
CHOP145A -235.76 -3.56 217.88 3.29 0.27 56 
CHOP188A -284.11 -3.23 288.08 3.27 0.16 52 
CHOP204A -218.54 -2.46 139.74 1.57 0.09 57 
CHOP008B -177.32 -2.36 148.45 1.97 0.24 89 
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CHOP016A -191.57 -3.31 212.05 3.67 0.25 95 
CHOP019A -148.21 -3.23 132.14 2.88 0.16 81 
CHOP021A -168.29 -2.18 144.72 1.87 0.19 68 
CHOP022A -141.76 -1.45 253.85 2.6 0.2 86 
CHOP023A -266.39 -3.49 263.11 3.45 0.18 66 
CHOP028A -170.83 -3.15 163.02 3.01 0.23 69 
CHOP029A -254.63 -2.96 271.3 3.15 0.2 65 
CHOP037A -119 -2.16 118 2.15 0.32 91 
CHOP041A -203.31 -3.27 191.39 3.07 0.26 77 
CHOP065A -243.38 -2.22 172.79 1.58 0.24 59 
CHOP066A -227.34 -2.43 175 1.87 0.14 55 
CHOP080A -184.29 -3.14 112.57 1.92 0.31 68 
CHOP085A -230 -3.97 206 3.55 0.25 98 
CHOP108A -252.69 -2.61 210.75 2.18 0.16 75 
CHOP114A -229.14 -2.51 176 1.93 0.07 61 
CHOP166A -214.89 -2.61 261.7 3.18 0.2 79 
CHOP203A -308.81 -3.22 267.88 2.79 0.17 63 
CHOP018C -257.26 -2.82 272.58 2.99 0.26 78 
CHOP040A -140 -1.99 119.51 1.7 0.23 61 
CHOP042B -154.84 -2.91 170.97 3.21 0.2 101 
CHOP118A -179.22 -2.12 187.01 2.22 0.18 91 
CHOP155A -245.9 -3.1 271.04 3.42 0.24 91 
CHOP161A -228.48 -2.97 165.45 2.15 0.15 84 
 
 
10. Comparison of Single LV and Single RV Volumes 









(mL/BSA) EF (%) 
CHOP004D L 59.49 24.68 34.81 58 
CHOP005B L 92.72 46.36 45.7 50 
CHOP024A L 82.43 36.49 45.95 55 
CHOP033A L 75 39.39 35.61 47 
CHOP034A L 70.9 29.63 41.27 58 
CHOP036A L 62.18 23.53 39.5 63 
CHOP052B L 87.74 37.74 50 57 
CHOP082B L 92.42 43.94 48.48 52 
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CHOP088B L 84.88 40.7 43.6 52 
CHOP089A L 96.77 48.39 48.39 50 
CHOP091A L 41.83 19.71 21.63 52 
CHOP094A L 89.17 36.67 52.5 59 
CHOP135A L 88.31 22.08 66.23 75 
CHOP145A L 66.23 20.53 45.7 69 
CHOP188A L 88.08 26.49 61.59 70 
CHOP204A L 88.74 42.38 46.36 48 
CHOP008B R 75.26 41.75 33.51 45 
CHOP016A R 57.83 25.3 32.53 57 
CHOP019A R 45.83 17.86 27.98 61 
CHOP021A R 77.24 34.15 43.09 55 
CHOP022A R 97.8 67.03 31.87 32 
CHOP023A R 76.23 27.87 48.36 64 
CHOP028A R 54.17 21.35 32.29 60 
CHOP029A R 86.11 32.41 53.7 62 
CHOP037A R 55 30 25 46 
CHOP041A R 62.25 19.21 42.38 69 
CHOP065A R 109.56 55.88 52.94 49 
CHOP066A R 93.75 38.28 55.47 59 
CHOP080A R 58.64 22.51 36.13 61 
CHOP085A R 58 24 34 59 
CHOP108A R 96.77 47.31 48.39 51 
CHOP114A R 91.43 49.14 42.29 46 
CHOP166A R 82.27 33.33 48.94 59 
CHOP203A R 95.85 42.49 53.37 55 
 
11. Inter-user variability 
To evaluate user-dependence on the derived values, results were compared between 
my segmentations and those of Kartik Sundareswaran with the volume data presented in 
Table 12.18. 
Table 12.18 Comparison of derived volumes for 8 patients from separate segmentations of 





(mL) SV (mL) 
CHOP108A 
CH 100.4 49.1 50.2 




CH 69.1 37.2 32.0 
KS 70.4 30.7 39.7 
CHOP033A 
CH 65.3 34.3 31.0 
KS 52.3 25.8 26.4 
CHOP036A 
CH 57.0 21.6 36.2 
KS 50.2 21.2 29.0 
CHOP052B 
CH 85.2 36.7 48.6 
KS 64.9 30.7 34.1 
CHOP065A 
CH 94.0 47.9 45.4 
KS 99.6 59.9 39.7 
CHOP066A 
CH 82.9 33.8 49.0 
KS 96.0 38.7 58.0 
CHOP085A 
CH 82.0 33.9 48.1 
KS 80.9 34.8 46.1 
 
12. Intra-User variability 
To evaluate the repeatability of the analysis, 5 cases were selected at random for repeat 
segmentations 7-8 months removed from the original analysis with the volume results 
provided in Table 12.19. 
Table 12.19 Volume results from repeat segmentations of 5 patients by the same user 
(CH). The second evaluation is denoted by ‘-2’ 
 
EDV (mL) ESV (mL) SV (mL) 
CHOP036A 74 28 47 
CHOP036A-2 67 31 35 
CHOP089A 90 45 45 
CHOP089A-2 87 45 42 
CHOP008B 146 81 65 
CHOP008B-2 151 81 70 
CHOP021A 95 42 53 
CHOP021A-2 98 47 51 
CHOP028A 104 41 62 





E. Appendix E- Serial Patient Studies 
13. Evaluating BSA normalization scheme 









CHOP019A 31 1.68 1.30 
CHOP019B 37.1 1.84 1.36 
CHOP005B 37.4 1.51 1.23 
CHOP005C 44.6 1.5 1.22 
CHOP018A 20.3 0.68 0.82 
CHOP018B 26.9 0.93 0.96 
CHOP018C 36.3 1.24 1.11 
CHOP021A 31.3 1.23 1.11 
CHOP021B 33.5 1.63 1.28 
CHOP022A 32.3 0.91 0.95 
CHOP022B 32.4 1.19 1.09 
CHOP033A 23 1.32 1.15 
CHOP033B 33.2 1.78 1.33 
CHOP036A 29.9 1.19 1.09 
CHOP036B 27.5 1.46 1.21 
CHOP065A 35.5 1.36 1.17 
CHOP065B 43.7 1.83 1.35 
CHOP080A 40.5 1.91 1.38 
CHOP080B 38.4 2.27 1.51 
CHOP082A 29.3 0.87 0.93 
CHOP082B 32.4 1.32 1.15 
CHOP088A 32 1.25 1.12 
CHOP088B 36.6 1.74 1.32 
CHOP091A 41.6 2.08 1.44 
CHOP091B 37.3 2.21 1.49 
 





















Scan 2 3.6 1 2.4 0.7 3.1 
Scan 3 1.2 1.1 0.8 0.7 1.5 
CHOP008 
Scan 2 3.8 0.8 2 0.4 2.4 
Scan 3 3.5 1.1 1.8 0.6 2.4 
CHOP017 
Scan 2 2.5 1.3 1.5 0.8 2.3 
Scan 3 3 1 1.6 0.5 2.1 
CHOP018 
Scan 1 1.4 1.3 2.1 1.9 4 
Scan 3 2.3 1 1.9 0.8 2.7 
CHOP019 
Scan 1 3.5 1.4 2.1 0.8 2.9 
Scan 2 3.8 1.8 2.1 1 3.1 
CHOP021 
Scan 1 2.2 0.9 1.8 0.7 2.5 
Scan 2 3.2 1.3 2 0.8 2.8 
CHOP022 
Scan 1 1.3 1.3 1.4 1.4 2.8 
Scan 2 2.7 1.9 2.3 1.6 3.9 
CHOP033 
Scan 1 2.3 1.5 1.7 1.1 2.8 
Scan 2 2.9 1.2 1.6 0.7 2.3 
CHOP036 
Scan 1 3.3 1.9 2.8 1.6 4.4 
Scan 2 2.4 2 1.6 1.4 3 
CHOP052 
Scan 2 2.1 1.2 2 1.1 3.1 
Scan 5 2.4 1.6 1.5 1 2.5 
CHOP065 
Scan 1 1.9 0.5 1.4 0.4 1.8 
Scan 2 2.2 1.1 1.2 0.6 1.8 
CHOP080 
Scan 1 2.6 1.8 1.4 0.9 2.3 
Scan 2 4.2 1.9 1.9 0.8 2.7 
CHOP082 
Scan 1 1.6 1 1.8 1.1 2.9 
Scan 2 3.2 1.6 2.4 1.2 3.6 
CHOP088 
Scan 1 1.8 0.9 1.4 0.7 2.1 
Scan 2 3.6 1.3 2.1 0.7 2.8 
CHOP091 
Scan 1 3.5 1.7 1.7 0.8 2.5 







Table 12.22 Respective differences in global pulmonary flow distribution (GFD) and HFD 






CHOP005 2 25 
CHOP008 -9 -8 
CHOP017 -1 2 
CHOP018* -2 -8 
CHOP019 1 8 
CHOP021 -8 -11 
CHOP022 -11 -2 
CHOP033 0 2 
CHOP036 7 19 
CHOP052* 8 11 
CHOP065 20 19 
CHOP080 -4 0 
CHOP082 -7 -6 
CHOP088 -9 23 
CHOP091 9 3 
*Difference taken between earliest and latest time points 
15. Relating change in vessel size to change in power loss 
























CHOP005 -8.55 9.1 0.25 3.40 33 
CHOP008 -12.5 -10.5 -12.00 -7.50 249 
CHOP017 -11.7 11.7 0.10 -13.40 71.8 
CHOP018* -11.20 0.50 -5.00 8.00 29.2 
CHOP019 13.80 -11.70 1.00 7.20 -13.5 
CHOP021 23.90 15.30 20.00 -1.00 -24.3 
CHOP022 5.00 -12.50 -4.00 -10.80 92.5 
CHOP033 -9.90 -26.10 -18.00 1.50 138.4 
CHOP036 2.10 1.90 2.00 -10.60 46.7 
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CHOP052* -14.00 6.00 -4.00 -17.80 104.4 
CHOP065 -23.80 -3.30 -14.00 -16.60 172.7 
CHOP080 46.00 8.60 27.00 -5.80 -4 
CHOP082 -15.50 -28.10 -22.00 -29.90 175.8 
CHOP088 -2.60 20.50 9.00 -11.70 -57.1 
CHOP091 5.70 13.90 10.00 14.30 -27.1 
*Difference taken between earliest and latest time points 
 
16. Flow rate and pulsatility related to PA sizes 
Table 12.24 and Table 12.25 provide serially averaged (i.e., [value @ time 1+value @ 
time 2]/2) flow, diameter, and pulsatility data for the LPA and RPA, respectively. 
Additionally, the entry labeled ‘ΔDmean’ provides the percentage difference between the 
serial values. 





















CHOP005 9.3 -8.6 11.5 -9.2 2.2 1.46 0.56 
CHOP008 8.9 -12.5 12.5 -11.4 1.7 0.86 0.965 
CHOP017 7.0 -11.7 9.4 -5.2 0.6 0.33 0.665 
CHOP018* 13.3 -11.2 12.8 19.8 1.1 1.14 1.05 
CHOP019 9.4 13.8 12.5 19.5 2.2 1.22 0.71 
CHOP021 10.4 23.9 12.5 42.7 1.3 0.94 0.435 
CHOP022 8.6 5 8.8 20.0 1.4 1.30 0.535 
CHOP033 11.9 -9.9 10.1 4.9 1.9 1.25 0.885 
CHOP036 12.8 2.1 14.7 13.0 2.2 1.67 0.785 
CHOP052* 10.9 -14 12.5 5.8 1.6 1.25 0.73 
CHOP065 13.9 -23.8 17.4 -11.4 1.3 0.77 1.075 
CHOP080 9.1 46 13.2 58.8 3.1 1.45 0.37 
CHOP082 12.4 -15.5 12.9 4.0 1.2 1.05 1.395 
CHOP088 10.2 -2.6 12.5 14.7 2.3 1.52 0.57 
CHOP091 9.6 5.7 14.1 8.9 2.6 1.22 0.735 















CHOP005 11.90 9.10 N/A N/A 1.09 
CHOP008 13.06 -10.50 2.4 1.23 0.93 
CHOP017 13.14 11.70 3.1 1.77 1.24 
CHOP018* 13.30 0.50 1.4 1.47 1.04 
CHOP019 12.66 -11.70 3.1 1.74 0.82 
CHOP021 10.02 15.30 3.5 2.15 0.46 
CHOP022 10.80 -12.50 1.3 1.18 0.46 
CHOP033 11.29 -26.10 1.7 1.09 1.48 
CHOP036 12.14 1.90 1.6 1.22 0.83 
CHOP052* 7.10 6.00 1.6 1.23 1.15 
CHOP065 11.20 -3.30 1.5 0.93 0.94 
CHOP080 13.26 8.60 3.1 1.43 0.60 
CHOP082 10.82 -28.10 1.7 1.54 1.48 
CHOP088 8.39 20.50 1.7 1.14 1.22 
CHOP091 10.49 13.90 2.6 1.20 0.78 
*Difference taken between earliest and latest time points 
 
17. Change in Cardiac Index with Age 
 






CI scan 1 
(L/min/m2) 
CI scan 2 
(L/min/m2) %CI 
CHOP005 19 3 2.4 -20% 
CHOP008 16 3 3.1 3% 
CHOP017 15 3.1 2.4 -23% 
CHOP018* 7 4.5 3.1 -31% 
CHOP019 14 3.3 2.8 -15% 
CHOP021 11 3 2.7 -10% 
CHOP022 7 3.7 4.1 11% 
538 
 
CHOP033 10 2.6 3.1 19% 
CHOP036 11 4.7 2.7 -43% 
CHOP052* 10 5.5 4.2 -24% 
CHOP065 16 2.5 2.2 -12% 
CHOP080 17 2.9 3.5 21% 
CHOP082 7 3.1 3.8 23% 
CHOP088 8 2.7 3.5 30% 
CHOP091 18 2.4 2.7 13% 
*Difference taken between earliest and latest time points 
 
18. Serial Ventricular Function Changes 
 
Table 12.27 Percentage changes in serial ventricular function measures 
 
EDV% SV% ESV% PER% PFR% CI% 
TCPC-
EDI% 
CHOP005 -9% -8 -11% 37 -15 -18 33% 
CHOP008 31% 35 29% 3 20 14 251% 
CHOP019 33% 46 9% 31 15 51 -12% 
CHOP033 10% -10 28% -19 -13 -29 138% 
CHOP052 3% -23 38% -23 9 -27 105% 
CHOP080 -13% -16 -8% -27 -21 -39 -4% 








Table 12.28 Serial measures of Qs, cardiac index, and TCPC-EDI 
 
Qs scan 1 
(L/min/m2) 
Qs scan 2 
(L/min/m2) 
CI scan 1 
(L/min/m2) 






CHOP005 3.0 2.1 3.0 2.4 0.087 0.116 
CHOP008 2.4 2.3 3.0 3.1 0.065 0.228 
CHOP017 2.3 2.1 3.1 2.4 0.035 0.061 
CHOP018* 3.8 2.7 4.5 3.1 0.008 0.01 
CHOP019 3.0 3.0 3.3 2.8 0.034 0.03 
CHOP021 2.5 2.8 3.0 2.7 0.076 0.057 
CHOP022 2.9 3.9 3.7 4.1 0.016 0.031 
CHOP033 2.9 2.3 2.6 3.1 0.016 0.038 
CHOP036 4.4 3.0 3.4 2.7 0.016 0.023 
CHOP052* 3.1 2.5 5.5 4.2 0.022 0.027 
CHOP065 1.8 1.8 2.5 2.2 0.013 0.035 
CHOP080 2.3 2.7 2.9 3.5 0.11 0.106 
CHOP082 3.0 3.7 3.1 3.8 0.012 0.033 
CHOP088 2.2 2.8 2.7 3.5 0.068 0.029 
CHOP091 2.5 2.4 2.4 2.7 0.031 0.023 
*Difference taken between earliest and latest time points 
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F. Appendix F- List of Codes and Programs Used 
19. MRI Data Sorting 
 “DICOM-sort.py” (Credit: Jonathan Suever)- Reads in the raw dicom files for 
a patient scan (which usually have arbitrary numbers as file names) and can 
sort and organize by information provided in the dicom headers (“Series 
Description” for example). 
20. Axial Interpolation 
 Adaptive Control Grid Interpolation (ACGI) (Credit: David Frakes)- all sub-
routines entirely contained within the ‘ACGI’ directory and driven by 
“acgi_driver.m” 
21. TCPC Segmentation 
 “Bouncing Ball” Algorithm (Credit: David Frakes)- all sub-routines entirely 
contained within the “Segmentation Code” directory and driven by “runit.m” 
 3D Level Set (Credit Kartik Sundareswaran)- creates 3D point cloud by 
reading in segmentation masks from bouncing ball. Consists of 4 files: 
“LevelSetSegmentation_3D_Phasic_v3.m” (driver file); 
“levelsetEvolution_3D.m”; “MRI_Coord_Transform_3D_axial.m”; and 
“Image_To_MRI_Coord_Transform.m” 
22. Phase contrast velocity segmentation 
 “flow_chop.m”- read in, segment, and export velocity and flow data for 
through plane PC data 
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 “auto_noise_fuzzy_resegm_specific_dataset.m” –(credit Kartik 
Sundareswaran) post-processing step for velocity data that filters results with 
fuzzy rules 
23. Divergence Free Interpolation (credit: Kartik Sundareswaran) 
 “SegmentationCoronal.m”- registers coronal velocity data to axial anatomic 
data 
 “Interpolation_Driver_Pulsatile.m” – interpolation driver file 
 “ErrorAnalysis.m” – optional step to compare interpolated results for a 
given slice to the measured velocity on that slice 
24. CFD Solver (credit: Diane de Zélicourt) 
 PreProcessor (IBUns_Li_MPI_PreProcess) 
 Solver (FS_MPI_Solver) 
 PostProcessor (GetFlowField) (note- I added a second version of the post-
processor “GetFlowField-s” that does not write the tecplot flow fields, which 
helps to speed up post-processing for pulsatile runs) 
 Auxillary- input_MPI.txt; control.txt; GetFlowField_input.txt; 
pulseBC_forCode.f90 (reads in BC_input.txt and creates BC.txt input for 
pulse simulations); makeBC_input_forCFD.m (reads in output from velocity 




25. CFD Data Analysis 
 Steady power loss calculation- done using spreadsheets (see 
“Template.xls” in CFD code backup 
 Pulsatile power loss calculation- “CFDpulsatile_powerloss_compute.m” 
(reads in “GetDvol.m”) 
26. HFD Quantification 
 Steady streamtraces- (credit: Diane de Zélicourt) “compute_IVC_split.f90” 
and “exact_streamtraces.f90” (require tecplot) 
 Pulsatile particle tracking- (credit: Diane de Zélicourt) “all_data.f”, “main.f”, 
Makefile  
 From DFI data- (credit: Lucia Mirabella)- “HFDfromParticles.m”, 
“pointIsInBox.m” (require Paraview, see protocol in methods chapter)  
27. VF Analysis 
 “SV_Segment.m”- driver file for semi-automatic ventricular short axis 
segmentation 
 “VF_analysis.m” – reads in results of segmentation and outputs results 
28. Miscellaneous Tecplot Macros 
 “PlotQ.mcr” (credit- Min Yun)- calculates Q-criterion 
 “anatomy_rotate.mcr”- creates a movie of a rotating body 
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 “image_setup.mcr” – expedites figure creation from steady CFD results 
after loading flow field and body file into tecplot 
 “make_streamtraces.f90” – derived from “extract_streamtraces.f90” but 
creates volume ribbons and does not create individual zones 
 “StreamtraceMovieMaker.mcr” – writes an avi by consecutively cycling 
through zones of a pulsatile data series with streamtraces already drawn in. 
 “PT_presentation.mcr”- like the streamtrace file, but designed for particle 
tracking data sets 
 “Jpg-movie.mcr” – tecplot writes avi files using a broken windows codec 
making it non-compatible with linux or adobe players, my work-around for this 
(to insert movies into the thesis pdf, for example) was to export individual 
frames as jpg files (with this macro) and stitch them together with ffmpeg into 
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